#METABOLOMICS WORKBENCH estancliffe_20210129_082646 DATATRACK_ID:2434 STUDY_ID:ST001849 ANALYSIS_ID:AN002993 VERSION 1 CREATED_ON 02-08-2024 #PROJECT PR:PROJECT_TITLE Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of PR:PROJECT_TITLE COVID-19 Disease Severity PR:PROJECT_SUMMARY There is an urgent need to identify which COVID-19 patients will develop PR:PROJECT_SUMMARY life-threatening illness so that medical resources can be optimally allocated PR:PROJECT_SUMMARY and rapid treatment can be administered early in the disease course, when PR:PROJECT_SUMMARY clinical management is most effective. To aid in the prognostic classification PR:PROJECT_SUMMARY of disease severity, we perform untargeted metabolomics on plasma from 339 PR:PROJECT_SUMMARY patients, with samples collected at six longitudinal time points. Using the PR:PROJECT_SUMMARY temporal metabolic profiles and machine learning, we build a predictive model of PR:PROJECT_SUMMARY disease severity. We discover that a panel of metabolites measured at the time PR:PROJECT_SUMMARY of study entry successfully determine disease severity. Through analysis of PR:PROJECT_SUMMARY longitudinal samples, we confirm that the majority of these markers are directly PR:PROJECT_SUMMARY related to disease progression and that their levels are restored to baseline PR:PROJECT_SUMMARY upon disease recovery. Finally, we validate that these metabolites are also PR:PROJECT_SUMMARY altered in a hamster model of COVID-19. Our results indicate that metabolic PR:PROJECT_SUMMARY changes associated with COVID-19 severity can be effectively used to stratify PR:PROJECT_SUMMARY patients and inform resource allocation during the pandemic. PR:INSTITUTE Washington University in St. Louis PR:DEPARTMENT Chemistry PR:LABORATORY Patti PR:LAST_NAME Patti PR:FIRST_NAME Gary PR:ADDRESS McMillen Chemistry Laboratory, Washington University, 1 Brookings Dr @ Throop PR:ADDRESS Drive, Rm 102, St. Louis, MO 63130-4899 PR:EMAIL gjpattij@wustl.edu PR:PHONE 314-935-3512 PR:DOI http://dx.doi.org/10.21228/M80981 #STUDY ST:STUDY_TITLE Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of ST:STUDY_TITLE COVID-19 Disease Severity (part I) ST:STUDY_SUMMARY There is an urgent need to identify which COVID-19 patients will develop ST:STUDY_SUMMARY life-threatening illness so that medical resources can be optimally allocated ST:STUDY_SUMMARY and rapid treatment can be administered early in the disease course, when ST:STUDY_SUMMARY clinical management is most effective. To aid in the prognostic classification ST:STUDY_SUMMARY of disease severity, we perform untargeted metabolomics on plasma from 339 ST:STUDY_SUMMARY patients, with samples collected at six longitudinal time points. Using the ST:STUDY_SUMMARY temporal metabolic profiles and machine learning, we build a predictive model of ST:STUDY_SUMMARY disease severity. We discover that a panel of metabolites measured at the time ST:STUDY_SUMMARY of study entry successfully determine disease severity. Through analysis of ST:STUDY_SUMMARY longitudinal samples, we confirm that the majority of these markers are directly ST:STUDY_SUMMARY related to disease progression and that their levels are restored to baseline ST:STUDY_SUMMARY upon disease recovery. Finally, we validate that these metabolites are also ST:STUDY_SUMMARY altered in a hamster model of COVID-19. Our results indicate that metabolic ST:STUDY_SUMMARY changes associated with COVID-19 severity can be effectively used to stratify ST:STUDY_SUMMARY patients and inform resource allocation during the pandemic. ST:INSTITUTE Washington University in St. Louis ST:DEPARTMENT Chemistry ST:LABORATORY Patti ST:LAST_NAME Patti ST:FIRST_NAME Gary ST:ADDRESS McMillen Chemistry Laboratory Washington University 1 Brookings Dr @ Throop ST:ADDRESS Drive Rm 102 St. Louis, MO 63130-4899 ST:EMAIL gjpattij@wustl.edu ST:PHONE 314-935-3512 ST:SUBMIT_DATE 2021-01-29 #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS WU350-013 B1_WU350-013_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-013_d0_polar_pos.mzML B1_WU350-013_d0_polar_neg.mzML B1_WU350-013_d0_lipid_pos.mzML B1_WU350-013_d0_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-014 B1_WU350-014_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-014_d0_polar_pos.mzML B1_WU350-014_d0_polar_neg.mzML B1_WU350-014_d0_lipid_pos.mzML B1_WU350-014_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=25.5; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=41.5; D-dimer=1530; Neutrophil %=52.2; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=0.9; Lymphocyte absolute=0.7; Lymphocyte %=37.4; IL1b=0.811503836; IL10=23.88846397; IL6=25.96411109; RANTES=693.3801726; MIP1a=27.25334281; GMCSF=1.497099241; MCP1=505.525744; IL15=61.77101181; HGF=66.59597601; VEGF=0.975492592; IL1Ra=54.78235533; IL2R=35.01993895; MIG=43.56103392; IL8=26.27460047 SUBJECT_SAMPLE_FACTORS WU350-021 B1_WU350-021_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-021_d0_polar_pos.mzML B1_WU350-021_d0_polar_neg.mzML B1_WU350-021_d0_lipid_pos.mzML B1_WU350-021_d0_lipid_neg.mzML; Days post symptom onset=15; Sex=Female; BMI=30.1; Age at Symptom onset (years)=68; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=334.2; D-dimer=3853; Neutrophil %=72.1; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.8; Lymphocyte absolute=2; Lymphocyte %=18.6; IL1b=2.564215126; IL10=15.46525346; IL6=166.7735688; RANTES=443.394363; MIP1a=17.92951592; GMCSF=1.306346239; MCP1=318.8497179; IL15=82.76911121; HGF=1851.039214; VEGF=5.260831608; IL1Ra=1464.274665; IL2R=71.55218583; MIG=147.4940306; IL8=20.04562796 SUBJECT_SAMPLE_FACTORS WU350-029 B1_WU350-029_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-029_d0_polar_pos.mzML B1_WU350-029_d0_polar_neg.mzML B1_WU350-029_d0_lipid_pos.mzML B1_WU350-029_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=32.8; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=150.3; D-dimer=5977; Neutrophil %=82.1; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.5; Lymphocyte %=7.4; IL1b=0.715624543; IL10=62.18637883; IL6=14.17662594; RANTES=649.5255178; MIP1a=12.36174818; GMCSF=18.83099743; MCP1=570.1185771; IL15=52.50121538; HGF=119.1798849; VEGF=1.87128378; IL1Ra=62.29341051; IL2R=93.5288825; MIG=37.41580246; IL8=17.5441893 SUBJECT_SAMPLE_FACTORS WU350-031 B1_WU350-031_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-031_d0_polar_pos.mzML B1_WU350-031_d0_polar_neg.mzML B1_WU350-031_d0_lipid_pos.mzML B1_WU350-031_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=35.5; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=25.8; D-dimer=2502; Neutrophil %=81.7; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.5; Lymphocyte %=11.3; IL1b=1.609776208; IL10=22.18959729; IL6=23.33610543; RANTES=959.3439838; MIP1a=1.00684193; GMCSF=0.950151926; MCP1=803.1537554; IL15=<8.3; HGF=218.3478923; VEGF=0.466090286; IL1Ra=68.23701628; IL2R=107.2469566; MIG=45.53312978; IL8=47.66419023 SUBJECT_SAMPLE_FACTORS WU350-041 B1_WU350-041_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-041_d0_polar_pos.mzML B1_WU350-041_d0_polar_neg.mzML B1_WU350-041_d0_lipid_pos.mzML B1_WU350-041_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=30.3; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=82.7; D-dimer=4752; Neutrophil %=74.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=0.760294705; IL10=2.196532189; IL6=12.54552719; RANTES=659.9494775; MIP1a=<1; GMCSF=0.888897678; MCP1=546.0734817; IL15=30.01173681; HGF=685.9359253; VEGF=1.682410164; IL1Ra=53.83351701; IL2R=12.36250909; MIG=60.64036826; IL8=30.84288681 SUBJECT_SAMPLE_FACTORS WU350-047 B1_WU350-047_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-047_d0_polar_pos.mzML B1_WU350-047_d0_polar_neg.mzML B1_WU350-047_d0_lipid_pos.mzML B1_WU350-047_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.7; Age at Symptom onset (years)=70.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=208.4; D-dimer=-1; Neutrophil %=66.4; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=70.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.5; Lymphocyte absolute=3; Lymphocyte %=26.7; IL1b=0.721716561; IL10=22.89902819; IL6=115.1881994; RANTES=84875.79133; MIP1a=12.39289672; GMCSF=0.201467305; MCP1=593.9049268; IL15=36.39733624; HGF=749.9059098; VEGF=2.863405239; IL1Ra=59.35965373; IL2R=388.3641296; MIG=163.7772012; IL8=17.28513739 SUBJECT_SAMPLE_FACTORS WU350-050 B1_WU350-050_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-050_d0_polar_pos.mzML B1_WU350-050_d0_polar_neg.mzML B1_WU350-050_d0_lipid_pos.mzML B1_WU350-050_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=24.4; Age at Symptom onset (years)=61.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=379; D-dimer=2352; Neutrophil %=87; CO2=44; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.6; Lymphocyte absolute=0.7; Lymphocyte %=4.6; IL1b=2.848917758; IL10=153.5725103; IL6=267.1820298; RANTES=959.9618241; MIP1a=27.91900928; GMCSF=2.449666442; MCP1=1898.04711; IL15=135.3076684; HGF=11714.84867; VEGF=1.285622707; IL1Ra=199.1739012; IL2R=60.11581187; MIG=224.7485143; IL8=43.13522009 SUBJECT_SAMPLE_FACTORS WU350-055 B1_WU350-055_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-055_d0_polar_pos.mzML B1_WU350-055_d0_polar_neg.mzML B1_WU350-055_d0_lipid_pos.mzML B1_WU350-055_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=24.3; Age at Symptom onset (years)=79.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.4; D-dimer=936; Neutrophil %=37.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=79.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=0.7; Lymphocyte absolute=0.7; Lymphocyte %=39.5; IL1b=2.330575872; IL10=13.87728587; IL6=31.41294916; RANTES=1243.058906; MIP1a=1.630441719; GMCSF=0.996461633; MCP1=439.4720124; IL15=27.46931093; HGF=233.537326; VEGF=0.76763317; IL1Ra=214.0162865; IL2R=145.7396059; MIG=44.60888737; IL8=180.7444869 SUBJECT_SAMPLE_FACTORS WU350-065 B1_WU350-065_d0 batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-065_d0_polar_pos.mzML B1_WU350-065_d0_polar_neg.mzML B1_WU350-065_d0_lipid_pos.mzML B1_WU350-065_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=32.4; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.1; D-dimer=372; Neutrophil %=88.9; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=73.7; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.3; Lymphocyte %=5.2; IL1b=1.933800515; IL10=1454.559414; IL6=379.5929623; RANTES=652.2572197; MIP1a=2.953122527; GMCSF=575.3349883; MCP1=627.1981562; IL15=51.69292859; HGF=2306.20299; VEGF=2.947989887; IL1Ra=121.6108625; IL2R=55.01694945; MIG=66.37774287; IL8=25.34769801 SUBJECT_SAMPLE_FACTORS WU350-008 B1_WU350-008_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-008_d14_polar_pos.mzML B1_WU350-008_d14_polar_neg.mzML B1_WU350-008_d14_lipid_pos.mzML B1_WU350-008_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=46.5; Age at Symptom onset (years)=38; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=56.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=38; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=2.2; Lymphocyte %=31.1; IL1b=6.678897664; IL10=99.27222914; IL6=21.22032598; RANTES=25290.90851; MIP1a=24.04914813; GMCSF=78.84825845; MCP1=166.3584418; IL15=29.87621463; HGF=502.3617433; VEGF=0.543486802; IL1Ra=43.85434445; IL2R=68.50265684; MIG=26.67285055; IL8=3.812571673 SUBJECT_SAMPLE_FACTORS WU350-005 B1_WU350-005_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-005_d14_polar_pos.mzML B1_WU350-005_d14_polar_neg.mzML B1_WU350-005_d14_lipid_pos.mzML B1_WU350-005_d14_lipid_neg.mzML; Days post symptom onset=26; Sex=Male; BMI=19.6; Age at Symptom onset (years)=65.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=265.6; D-dimer=-1; Neutrophil %=83.5; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=65.3; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=8; Lymphocyte absolute=1.1; Lymphocyte %=11.2; IL1b=18.94722051; IL10=49.90879243; IL6=24632.67612; RANTES=1108.260683; MIP1a=47.5789234; GMCSF=1.668886906; MCP1=6914.503222; IL15=33.73919216; HGF=1021.053041; VEGF=2.323624784; IL1Ra=1817.950998; IL2R=100.6286357; MIG=42.83740456; IL8=796.0317975 SUBJECT_SAMPLE_FACTORS WU350-006 B1_WU350-006_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-006_d14_polar_pos.mzML B1_WU350-006_d14_polar_neg.mzML B1_WU350-006_d14_lipid_pos.mzML B1_WU350-006_d14_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=29.1; Age at Symptom onset (years)=74.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=273.3; D-dimer=7279; Neutrophil %=64.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=1; Age=74.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2; Lymphocyte absolute=1; Lymphocyte %=30.7; IL1b=6.407101377; IL10=630.2442659; IL6=512.5536265; RANTES=939.3844282; MIP1a=14.33099844; GMCSF=446.8787402; MCP1=877.7866027; IL15=10.66807132; HGF=329.1129911; VEGF=0.673823306; IL1Ra=126.097449; IL2R=60.07848135; MIG=22.21072098; IL8=38.48142042 SUBJECT_SAMPLE_FACTORS WU350-007 B1_WU350-007_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-007_d14_polar_pos.mzML B1_WU350-007_d14_polar_neg.mzML B1_WU350-007_d14_lipid_pos.mzML B1_WU350-007_d14_lipid_neg.mzML; Days post symptom onset=22; Sex=Male; BMI=24.7; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=292.4; D-dimer=727; Neutrophil %=84.2; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=10.4; Lymphocyte absolute=0.9; Lymphocyte %=7; IL1b=6.534484849; IL10=19.10967038; IL6=486.5806279; RANTES=1018.907336; MIP1a=34.58397542; GMCSF=11.03248171; MCP1=1332.399745; IL15=44.61366715; HGF=1582.715841; VEGF=1.860819849; IL1Ra=261.0672563; IL2R=102.2135046; MIG=66.78111724; IL8=28.80814927 SUBJECT_SAMPLE_FACTORS WU350-009 B1_WU350-009_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-009_d14_polar_pos.mzML B1_WU350-009_d14_polar_neg.mzML B1_WU350-009_d14_lipid_pos.mzML B1_WU350-009_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=44.6; Age at Symptom onset (years)=73.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=168.7; D-dimer=434; Neutrophil %=83.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=73.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=1.1; Lymphocyte %=10.4; IL1b=6.26310798; IL10=112.6281277; IL6=55.01191889; RANTES=901.0125835; MIP1a=27.07137833; GMCSF=75.60611339; MCP1=562.6808179; IL15=37.24941275; HGF=365.1148422; VEGF=1.223645414; IL1Ra=286.9898922; IL2R=41.76024086; MIG=28.71250377; IL8=11.31146216 SUBJECT_SAMPLE_FACTORS WU350-011 B1_WU350-011_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-011_d14_polar_pos.mzML B1_WU350-011_d14_polar_neg.mzML B1_WU350-011_d14_lipid_pos.mzML B1_WU350-011_d14_lipid_neg.mzML; Days post symptom onset=23; Sex=Male; BMI=24.7; Age at Symptom onset (years)=66.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=257.7; D-dimer=21298; Neutrophil %=82.4; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=7.7; Lymphocyte absolute=0.5; Lymphocyte %=5.2; IL1b=8.317220633; IL10=21.03958571; IL6=739.6926742; RANTES=1037.073544; MIP1a=35.49929368; GMCSF=7.503709431; MCP1=1112.458826; IL15=55.55697445; HGF=8078.966627; VEGF=1.183174379; IL1Ra=105.7668468; IL2R=101.37641; MIG=106.7553973; IL8=29.56222067 SUBJECT_SAMPLE_FACTORS WU350-013 B1_WU350-013_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-013_d14_polar_pos.mzML B1_WU350-013_d14_polar_neg.mzML B1_WU350-013_d14_lipid_pos.mzML B1_WU350-013_d14_lipid_neg.mzML; Days post symptom onset=25; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-014 B1_WU350-014_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-014_d14_polar_pos.mzML B1_WU350-014_d14_polar_neg.mzML B1_WU350-014_d14_lipid_pos.mzML B1_WU350-014_d14_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=25.5; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=41.5; D-dimer=1530; Neutrophil %=52.2; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=0.9; Lymphocyte absolute=0.7; Lymphocyte %=37.4; IL1b=0.811503836; IL10=23.88846397; IL6=25.96411109; RANTES=693.3801726; MIP1a=27.25334281; GMCSF=1.497099241; MCP1=505.525744; IL15=61.77101181; HGF=66.59597601; VEGF=0.975492592; IL1Ra=54.78235533; IL2R=35.01993895; MIG=43.56103392; IL8=26.27460047 SUBJECT_SAMPLE_FACTORS WU350-021 B1_WU350-021_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-021_d14_polar_pos.mzML B1_WU350-021_d14_polar_neg.mzML B1_WU350-021_d14_lipid_pos.mzML B1_WU350-021_d14_lipid_neg.mzML; Days post symptom onset=29; Sex=Female; BMI=30.1; Age at Symptom onset (years)=68; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=334.2; D-dimer=3853; Neutrophil %=72.1; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.8; Lymphocyte absolute=2; Lymphocyte %=18.6; IL1b=2.564215126; IL10=15.46525346; IL6=166.7735688; RANTES=443.394363; MIP1a=17.92951592; GMCSF=1.306346239; MCP1=318.8497179; IL15=82.76911121; HGF=1851.039214; VEGF=5.260831608; IL1Ra=1464.274665; IL2R=71.55218583; MIG=147.4940306; IL8=20.04562796 SUBJECT_SAMPLE_FACTORS WU350-029 B1_WU350-029_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-029_d14_polar_pos.mzML B1_WU350-029_d14_polar_neg.mzML B1_WU350-029_d14_lipid_pos.mzML B1_WU350-029_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=32.8; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=150.3; D-dimer=5977; Neutrophil %=82.1; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.5; Lymphocyte %=7.4; IL1b=0.715624543; IL10=62.18637883; IL6=14.17662594; RANTES=649.5255178; MIP1a=12.36174818; GMCSF=18.83099743; MCP1=570.1185771; IL15=52.50121538; HGF=119.1798849; VEGF=1.87128378; IL1Ra=62.29341051; IL2R=93.5288825; MIG=37.41580246; IL8=17.5441893 SUBJECT_SAMPLE_FACTORS WU350-031 B1_WU350-031_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-031_d14_polar_pos.mzML B1_WU350-031_d14_polar_neg.mzML B1_WU350-031_d14_lipid_pos.mzML B1_WU350-031_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=35.5; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=25.8; D-dimer=2502; Neutrophil %=81.7; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.5; Lymphocyte %=11.3; IL1b=1.609776208; IL10=22.18959729; IL6=23.33610543; RANTES=959.3439838; MIP1a=1.00684193; GMCSF=0.950151926; MCP1=803.1537554; IL15=<8.3; HGF=218.3478923; VEGF=0.466090286; IL1Ra=68.23701628; IL2R=107.2469566; MIG=45.53312978; IL8=47.66419023 SUBJECT_SAMPLE_FACTORS WU350-041 B1_WU350-041_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-041_d14_polar_pos.mzML B1_WU350-041_d14_polar_neg.mzML B1_WU350-041_d14_lipid_pos.mzML B1_WU350-041_d14_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=30.3; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=82.7; D-dimer=4752; Neutrophil %=74.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=0.760294705; IL10=2.196532189; IL6=12.54552719; RANTES=659.9494775; MIP1a=<1; GMCSF=0.888897678; MCP1=546.0734817; IL15=30.01173681; HGF=685.9359253; VEGF=1.682410164; IL1Ra=53.83351701; IL2R=12.36250909; MIG=60.64036826; IL8=30.84288681 SUBJECT_SAMPLE_FACTORS WU350-047 B1_WU350-047_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-047_d14_polar_pos.mzML B1_WU350-047_d14_polar_neg.mzML B1_WU350-047_d14_lipid_pos.mzML B1_WU350-047_d14_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=27.7; Age at Symptom onset (years)=70.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=208.4; D-dimer=-1; Neutrophil %=66.4; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=70.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.5; Lymphocyte absolute=3; Lymphocyte %=26.7; IL1b=0.721716561; IL10=22.89902819; IL6=115.1881994; RANTES=84875.79133; MIP1a=12.39289672; GMCSF=0.201467305; MCP1=593.9049268; IL15=36.39733624; HGF=749.9059098; VEGF=2.863405239; IL1Ra=59.35965373; IL2R=388.3641296; MIG=163.7772012; IL8=17.28513739 SUBJECT_SAMPLE_FACTORS WU350-050 B1_WU350-050_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-050_d14_polar_pos.mzML B1_WU350-050_d14_polar_neg.mzML B1_WU350-050_d14_lipid_pos.mzML B1_WU350-050_d14_lipid_neg.mzML; Days post symptom onset=24; Sex=Male; BMI=24.4; Age at Symptom onset (years)=61.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=379; D-dimer=2352; Neutrophil %=87; CO2=44; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.6; Lymphocyte absolute=0.7; Lymphocyte %=4.6; IL1b=2.848917758; IL10=153.5725103; IL6=267.1820298; RANTES=959.9618241; MIP1a=27.91900928; GMCSF=2.449666442; MCP1=1898.04711; IL15=135.3076684; HGF=11714.84867; VEGF=1.285622707; IL1Ra=199.1739012; IL2R=60.11581187; MIG=224.7485143; IL8=43.13522009 SUBJECT_SAMPLE_FACTORS WU350-055 B1_WU350-055_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-055_d14_polar_pos.mzML B1_WU350-055_d14_polar_neg.mzML B1_WU350-055_d14_lipid_pos.mzML B1_WU350-055_d14_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=24.3; Age at Symptom onset (years)=79.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.4; D-dimer=936; Neutrophil %=37.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=79.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=0.7; Lymphocyte absolute=0.7; Lymphocyte %=39.5; IL1b=2.330575872; IL10=13.87728587; IL6=31.41294916; RANTES=1243.058906; MIP1a=1.630441719; GMCSF=0.996461633; MCP1=439.4720124; IL15=27.46931093; HGF=233.537326; VEGF=0.76763317; IL1Ra=214.0162865; IL2R=145.7396059; MIG=44.60888737; IL8=180.7444869 SUBJECT_SAMPLE_FACTORS WU350-065 B1_WU350-065_d14 batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-065_d14_polar_pos.mzML B1_WU350-065_d14_polar_neg.mzML B1_WU350-065_d14_lipid_pos.mzML B1_WU350-065_d14_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=32.4; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.1; D-dimer=372; Neutrophil %=88.9; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=73.7; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.3; Lymphocyte %=5.2; IL1b=1.933800515; IL10=1454.559414; IL6=379.5929623; RANTES=652.2572197; MIP1a=2.953122527; GMCSF=575.3349883; MCP1=627.1981562; IL15=51.69292859; HGF=2306.20299; VEGF=2.947989887; IL1Ra=121.6108625; IL2R=55.01694945; MIG=66.37774287; IL8=25.34769801 SUBJECT_SAMPLE_FACTORS WU350-006 B1_WU350-006_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-006_d3_polar_pos.mzML B1_WU350-006_d3_polar_neg.mzML B1_WU350-006_d3_lipid_pos.mzML B1_WU350-006_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=29.1; Age at Symptom onset (years)=74.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=273.3; D-dimer=7279; Neutrophil %=64.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=1; Age=74.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2; Lymphocyte absolute=1; Lymphocyte %=30.7; IL1b=6.407101377; IL10=630.2442659; IL6=512.5536265; RANTES=939.3844282; MIP1a=14.33099844; GMCSF=446.8787402; MCP1=877.7866027; IL15=10.66807132; HGF=329.1129911; VEGF=0.673823306; IL1Ra=126.097449; IL2R=60.07848135; MIG=22.21072098; IL8=38.48142042 SUBJECT_SAMPLE_FACTORS WU350-007 B1_WU350-007_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-007_d3_polar_pos.mzML B1_WU350-007_d3_polar_neg.mzML B1_WU350-007_d3_lipid_pos.mzML B1_WU350-007_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=24.7; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=292.4; D-dimer=727; Neutrophil %=84.2; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=10.4; Lymphocyte absolute=0.9; Lymphocyte %=7; IL1b=6.534484849; IL10=19.10967038; IL6=486.5806279; RANTES=1018.907336; MIP1a=34.58397542; GMCSF=11.03248171; MCP1=1332.399745; IL15=44.61366715; HGF=1582.715841; VEGF=1.860819849; IL1Ra=261.0672563; IL2R=102.2135046; MIG=66.78111724; IL8=28.80814927 SUBJECT_SAMPLE_FACTORS WU350-009 B1_WU350-009_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-009_d3_polar_pos.mzML B1_WU350-009_d3_polar_neg.mzML B1_WU350-009_d3_lipid_pos.mzML B1_WU350-009_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=44.6; Age at Symptom onset (years)=73.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=168.7; D-dimer=434; Neutrophil %=83.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=73.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=1.1; Lymphocyte %=10.4; IL1b=6.26310798; IL10=112.6281277; IL6=55.01191889; RANTES=901.0125835; MIP1a=27.07137833; GMCSF=75.60611339; MCP1=562.6808179; IL15=37.24941275; HGF=365.1148422; VEGF=1.223645414; IL1Ra=286.9898922; IL2R=41.76024086; MIG=28.71250377; IL8=11.31146216 SUBJECT_SAMPLE_FACTORS WU350-011 B1_WU350-011_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-011_d3_polar_pos.mzML B1_WU350-011_d3_polar_neg.mzML B1_WU350-011_d3_lipid_pos.mzML B1_WU350-011_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=24.7; Age at Symptom onset (years)=66.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=257.7; D-dimer=21298; Neutrophil %=82.4; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=7.7; Lymphocyte absolute=0.5; Lymphocyte %=5.2; IL1b=8.317220633; IL10=21.03958571; IL6=739.6926742; RANTES=1037.073544; MIP1a=35.49929368; GMCSF=7.503709431; MCP1=1112.458826; IL15=55.55697445; HGF=8078.966627; VEGF=1.183174379; IL1Ra=105.7668468; IL2R=101.37641; MIG=106.7553973; IL8=29.56222067 SUBJECT_SAMPLE_FACTORS WU350-013 B1_WU350-013_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-013_d3_polar_pos.mzML B1_WU350-013_d3_polar_neg.mzML B1_WU350-013_d3_lipid_pos.mzML B1_WU350-013_d3_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-014 B1_WU350-014_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-014_d3_polar_pos.mzML B1_WU350-014_d3_polar_neg.mzML B1_WU350-014_d3_lipid_pos.mzML B1_WU350-014_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=25.5; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=41.5; D-dimer=1530; Neutrophil %=52.2; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=0.9; Lymphocyte absolute=0.7; Lymphocyte %=37.4; IL1b=0.811503836; IL10=23.88846397; IL6=25.96411109; RANTES=693.3801726; MIP1a=27.25334281; GMCSF=1.497099241; MCP1=505.525744; IL15=61.77101181; HGF=66.59597601; VEGF=0.975492592; IL1Ra=54.78235533; IL2R=35.01993895; MIG=43.56103392; IL8=26.27460047 SUBJECT_SAMPLE_FACTORS WU350-021 B1_WU350-021_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-021_d3_polar_pos.mzML B1_WU350-021_d3_polar_neg.mzML B1_WU350-021_d3_lipid_pos.mzML B1_WU350-021_d3_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=30.1; Age at Symptom onset (years)=68; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=334.2; D-dimer=3853; Neutrophil %=72.1; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.8; Lymphocyte absolute=2; Lymphocyte %=18.6; IL1b=2.564215126; IL10=15.46525346; IL6=166.7735688; RANTES=443.394363; MIP1a=17.92951592; GMCSF=1.306346239; MCP1=318.8497179; IL15=82.76911121; HGF=1851.039214; VEGF=5.260831608; IL1Ra=1464.274665; IL2R=71.55218583; MIG=147.4940306; IL8=20.04562796 SUBJECT_SAMPLE_FACTORS WU350-029 B1_WU350-029_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-029_d3_polar_pos.mzML B1_WU350-029_d3_polar_neg.mzML B1_WU350-029_d3_lipid_pos.mzML B1_WU350-029_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=32.8; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=150.3; D-dimer=5977; Neutrophil %=82.1; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.5; Lymphocyte %=7.4; IL1b=0.715624543; IL10=62.18637883; IL6=14.17662594; RANTES=649.5255178; MIP1a=12.36174818; GMCSF=18.83099743; MCP1=570.1185771; IL15=52.50121538; HGF=119.1798849; VEGF=1.87128378; IL1Ra=62.29341051; IL2R=93.5288825; MIG=37.41580246; IL8=17.5441893 SUBJECT_SAMPLE_FACTORS WU350-031 B1_WU350-031_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-031_d3_polar_pos.mzML B1_WU350-031_d3_polar_neg.mzML B1_WU350-031_d3_lipid_pos.mzML B1_WU350-031_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=35.5; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=25.8; D-dimer=2502; Neutrophil %=81.7; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.5; Lymphocyte %=11.3; IL1b=1.609776208; IL10=22.18959729; IL6=23.33610543; RANTES=959.3439838; MIP1a=1.00684193; GMCSF=0.950151926; MCP1=803.1537554; IL15=<8.3; HGF=218.3478923; VEGF=0.466090286; IL1Ra=68.23701628; IL2R=107.2469566; MIG=45.53312978; IL8=47.66419023 SUBJECT_SAMPLE_FACTORS WU350-041 B1_WU350-041_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-041_d3_polar_pos.mzML B1_WU350-041_d3_polar_neg.mzML B1_WU350-041_d3_lipid_pos.mzML B1_WU350-041_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=30.3; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=82.7; D-dimer=4752; Neutrophil %=74.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=0.760294705; IL10=2.196532189; IL6=12.54552719; RANTES=659.9494775; MIP1a=<1; GMCSF=0.888897678; MCP1=546.0734817; IL15=30.01173681; HGF=685.9359253; VEGF=1.682410164; IL1Ra=53.83351701; IL2R=12.36250909; MIG=60.64036826; IL8=30.84288681 SUBJECT_SAMPLE_FACTORS WU350-047 B1_WU350-047_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-047_d3_polar_pos.mzML B1_WU350-047_d3_polar_neg.mzML B1_WU350-047_d3_lipid_pos.mzML B1_WU350-047_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=27.7; Age at Symptom onset (years)=70.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=208.4; D-dimer=-1; Neutrophil %=66.4; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=70.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.5; Lymphocyte absolute=3; Lymphocyte %=26.7; IL1b=0.721716561; IL10=22.89902819; IL6=115.1881994; RANTES=84875.79133; MIP1a=12.39289672; GMCSF=0.201467305; MCP1=593.9049268; IL15=36.39733624; HGF=749.9059098; VEGF=2.863405239; IL1Ra=59.35965373; IL2R=388.3641296; MIG=163.7772012; IL8=17.28513739 SUBJECT_SAMPLE_FACTORS WU350-050 B1_WU350-050_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-050_d3_polar_pos.mzML B1_WU350-050_d3_polar_neg.mzML B1_WU350-050_d3_lipid_pos.mzML B1_WU350-050_d3_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=24.4; Age at Symptom onset (years)=61.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=379; D-dimer=2352; Neutrophil %=87; CO2=44; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.6; Lymphocyte absolute=0.7; Lymphocyte %=4.6; IL1b=2.848917758; IL10=153.5725103; IL6=267.1820298; RANTES=959.9618241; MIP1a=27.91900928; GMCSF=2.449666442; MCP1=1898.04711; IL15=135.3076684; HGF=11714.84867; VEGF=1.285622707; IL1Ra=199.1739012; IL2R=60.11581187; MIG=224.7485143; IL8=43.13522009 SUBJECT_SAMPLE_FACTORS WU350-055 B1_WU350-055_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-055_d3_polar_pos.mzML B1_WU350-055_d3_polar_neg.mzML B1_WU350-055_d3_lipid_pos.mzML B1_WU350-055_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=24.3; Age at Symptom onset (years)=79.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.4; D-dimer=936; Neutrophil %=37.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=79.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=0.7; Lymphocyte absolute=0.7; Lymphocyte %=39.5; IL1b=2.330575872; IL10=13.87728587; IL6=31.41294916; RANTES=1243.058906; MIP1a=1.630441719; GMCSF=0.996461633; MCP1=439.4720124; IL15=27.46931093; HGF=233.537326; VEGF=0.76763317; IL1Ra=214.0162865; IL2R=145.7396059; MIG=44.60888737; IL8=180.7444869 SUBJECT_SAMPLE_FACTORS WU350-065 B1_WU350-065_d3 batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-065_d3_polar_pos.mzML B1_WU350-065_d3_polar_neg.mzML B1_WU350-065_d3_lipid_pos.mzML B1_WU350-065_d3_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=32.4; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.1; D-dimer=372; Neutrophil %=88.9; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=73.7; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.3; Lymphocyte %=5.2; IL1b=1.933800515; IL10=1454.559414; IL6=379.5929623; RANTES=652.2572197; MIP1a=2.953122527; GMCSF=575.3349883; MCP1=627.1981562; IL15=51.69292859; HGF=2306.20299; VEGF=2.947989887; IL1Ra=121.6108625; IL2R=55.01694945; MIG=66.37774287; IL8=25.34769801 SUBJECT_SAMPLE_FACTORS WU350-004 B1_WU350-004_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-004_d7_polar_pos.mzML B1_WU350-004_d7_polar_neg.mzML B1_WU350-004_d7_lipid_pos.mzML B1_WU350-004_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=49; Age at Symptom onset (years)=62.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=80.6; D-dimer=-1; Neutrophil %=73.8; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=62.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.8; Lymphocyte %=17.2; IL1b=88077.65011; IL10=247300.163; IL6=101578.4032; RANTES=>15330; MIP1a=32438.4314; GMCSF=44772.44767; MCP1=63593.05399; IL15=577703.7309; HGF=1513925.994; VEGF=8.321801322; IL1Ra=5069.217043; IL2R=16182.30063; MIG=468.9662606; IL8=41.10503544 SUBJECT_SAMPLE_FACTORS WU350-005 B1_WU350-005_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-005_d7_polar_pos.mzML B1_WU350-005_d7_polar_neg.mzML B1_WU350-005_d7_lipid_pos.mzML B1_WU350-005_d7_lipid_neg.mzML; Days post symptom onset=19; Sex=Male; BMI=19.6; Age at Symptom onset (years)=65.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=265.6; D-dimer=-1; Neutrophil %=83.5; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=65.3; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=8; Lymphocyte absolute=1.1; Lymphocyte %=11.2; IL1b=18.94722051; IL10=49.90879243; IL6=24632.67612; RANTES=1108.260683; MIP1a=47.5789234; GMCSF=1.668886906; MCP1=6914.503222; IL15=33.73919216; HGF=1021.053041; VEGF=2.323624784; IL1Ra=1817.950998; IL2R=100.6286357; MIG=42.83740456; IL8=796.0317975 SUBJECT_SAMPLE_FACTORS WU350-006 B1_WU350-006_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-006_d7_polar_pos.mzML B1_WU350-006_d7_polar_neg.mzML B1_WU350-006_d7_lipid_pos.mzML B1_WU350-006_d7_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=29.1; Age at Symptom onset (years)=74.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=273.3; D-dimer=7279; Neutrophil %=64.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=1; Age=74.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2; Lymphocyte absolute=1; Lymphocyte %=30.7; IL1b=6.407101377; IL10=630.2442659; IL6=512.5536265; RANTES=939.3844282; MIP1a=14.33099844; GMCSF=446.8787402; MCP1=877.7866027; IL15=10.66807132; HGF=329.1129911; VEGF=0.673823306; IL1Ra=126.097449; IL2R=60.07848135; MIG=22.21072098; IL8=38.48142042 SUBJECT_SAMPLE_FACTORS WU350-007 B1_WU350-007_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-007_d7_polar_pos.mzML B1_WU350-007_d7_polar_neg.mzML B1_WU350-007_d7_lipid_pos.mzML B1_WU350-007_d7_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=24.7; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=292.4; D-dimer=727; Neutrophil %=84.2; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=10.4; Lymphocyte absolute=0.9; Lymphocyte %=7; IL1b=6.534484849; IL10=19.10967038; IL6=486.5806279; RANTES=1018.907336; MIP1a=34.58397542; GMCSF=11.03248171; MCP1=1332.399745; IL15=44.61366715; HGF=1582.715841; VEGF=1.860819849; IL1Ra=261.0672563; IL2R=102.2135046; MIG=66.78111724; IL8=28.80814927 SUBJECT_SAMPLE_FACTORS WU350-009 B1_WU350-009_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-009_d7_polar_pos.mzML B1_WU350-009_d7_polar_neg.mzML B1_WU350-009_d7_lipid_pos.mzML B1_WU350-009_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=44.6; Age at Symptom onset (years)=73.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=168.7; D-dimer=434; Neutrophil %=83.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=73.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=1.1; Lymphocyte %=10.4; IL1b=6.26310798; IL10=112.6281277; IL6=55.01191889; RANTES=901.0125835; MIP1a=27.07137833; GMCSF=75.60611339; MCP1=562.6808179; IL15=37.24941275; HGF=365.1148422; VEGF=1.223645414; IL1Ra=286.9898922; IL2R=41.76024086; MIG=28.71250377; IL8=11.31146216 SUBJECT_SAMPLE_FACTORS WU350-011 B1_WU350-011_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-011_d7_polar_pos.mzML B1_WU350-011_d7_polar_neg.mzML B1_WU350-011_d7_lipid_pos.mzML B1_WU350-011_d7_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=24.7; Age at Symptom onset (years)=66.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=257.7; D-dimer=21298; Neutrophil %=82.4; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=7.7; Lymphocyte absolute=0.5; Lymphocyte %=5.2; IL1b=8.317220633; IL10=21.03958571; IL6=739.6926742; RANTES=1037.073544; MIP1a=35.49929368; GMCSF=7.503709431; MCP1=1112.458826; IL15=55.55697445; HGF=8078.966627; VEGF=1.183174379; IL1Ra=105.7668468; IL2R=101.37641; MIG=106.7553973; IL8=29.56222067 SUBJECT_SAMPLE_FACTORS WU350-013 B1_WU350-013_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-013_d7_polar_pos.mzML B1_WU350-013_d7_polar_neg.mzML B1_WU350-013_d7_lipid_pos.mzML B1_WU350-013_d7_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-014 B1_WU350-014_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-014_d7_polar_pos.mzML B1_WU350-014_d7_polar_neg.mzML B1_WU350-014_d7_lipid_pos.mzML B1_WU350-014_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=25.5; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=41.5; D-dimer=1530; Neutrophil %=52.2; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=0.9; Lymphocyte absolute=0.7; Lymphocyte %=37.4; IL1b=0.811503836; IL10=23.88846397; IL6=25.96411109; RANTES=693.3801726; MIP1a=27.25334281; GMCSF=1.497099241; MCP1=505.525744; IL15=61.77101181; HGF=66.59597601; VEGF=0.975492592; IL1Ra=54.78235533; IL2R=35.01993895; MIG=43.56103392; IL8=26.27460047 SUBJECT_SAMPLE_FACTORS WU350-021 B1_WU350-021_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-021_d7_polar_pos.mzML B1_WU350-021_d7_polar_neg.mzML B1_WU350-021_d7_lipid_pos.mzML B1_WU350-021_d7_lipid_neg.mzML; Days post symptom onset=22; Sex=Female; BMI=30.1; Age at Symptom onset (years)=68; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=334.2; D-dimer=3853; Neutrophil %=72.1; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.8; Lymphocyte absolute=2; Lymphocyte %=18.6; IL1b=2.564215126; IL10=15.46525346; IL6=166.7735688; RANTES=443.394363; MIP1a=17.92951592; GMCSF=1.306346239; MCP1=318.8497179; IL15=82.76911121; HGF=1851.039214; VEGF=5.260831608; IL1Ra=1464.274665; IL2R=71.55218583; MIG=147.4940306; IL8=20.04562796 SUBJECT_SAMPLE_FACTORS WU350-029 B1_WU350-029_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-029_d7_polar_pos.mzML B1_WU350-029_d7_polar_neg.mzML B1_WU350-029_d7_lipid_pos.mzML B1_WU350-029_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=32.8; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=150.3; D-dimer=5977; Neutrophil %=82.1; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.5; Lymphocyte %=7.4; IL1b=0.715624543; IL10=62.18637883; IL6=14.17662594; RANTES=649.5255178; MIP1a=12.36174818; GMCSF=18.83099743; MCP1=570.1185771; IL15=52.50121538; HGF=119.1798849; VEGF=1.87128378; IL1Ra=62.29341051; IL2R=93.5288825; MIG=37.41580246; IL8=17.5441893 SUBJECT_SAMPLE_FACTORS WU350-031 B1_WU350-031_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-031_d7_polar_pos.mzML B1_WU350-031_d7_polar_neg.mzML B1_WU350-031_d7_lipid_pos.mzML B1_WU350-031_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=35.5; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=25.8; D-dimer=2502; Neutrophil %=81.7; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.5; Lymphocyte %=11.3; IL1b=1.609776208; IL10=22.18959729; IL6=23.33610543; RANTES=959.3439838; MIP1a=1.00684193; GMCSF=0.950151926; MCP1=803.1537554; IL15=<8.3; HGF=218.3478923; VEGF=0.466090286; IL1Ra=68.23701628; IL2R=107.2469566; MIG=45.53312978; IL8=47.66419023 SUBJECT_SAMPLE_FACTORS WU350-041 B1_WU350-041_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-041_d7_polar_pos.mzML B1_WU350-041_d7_polar_neg.mzML B1_WU350-041_d7_lipid_pos.mzML B1_WU350-041_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=30.3; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=82.7; D-dimer=4752; Neutrophil %=74.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=0.760294705; IL10=2.196532189; IL6=12.54552719; RANTES=659.9494775; MIP1a=<1; GMCSF=0.888897678; MCP1=546.0734817; IL15=30.01173681; HGF=685.9359253; VEGF=1.682410164; IL1Ra=53.83351701; IL2R=12.36250909; MIG=60.64036826; IL8=30.84288681 SUBJECT_SAMPLE_FACTORS WU350-047 B1_WU350-047_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-047_d7_polar_pos.mzML B1_WU350-047_d7_polar_neg.mzML B1_WU350-047_d7_lipid_pos.mzML B1_WU350-047_d7_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=27.7; Age at Symptom onset (years)=70.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=208.4; D-dimer=-1; Neutrophil %=66.4; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=70.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.5; Lymphocyte absolute=3; Lymphocyte %=26.7; IL1b=0.721716561; IL10=22.89902819; IL6=115.1881994; RANTES=84875.79133; MIP1a=12.39289672; GMCSF=0.201467305; MCP1=593.9049268; IL15=36.39733624; HGF=749.9059098; VEGF=2.863405239; IL1Ra=59.35965373; IL2R=388.3641296; MIG=163.7772012; IL8=17.28513739 SUBJECT_SAMPLE_FACTORS WU350-050 B1_WU350-050_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-050_d7_polar_pos.mzML B1_WU350-050_d7_polar_neg.mzML B1_WU350-050_d7_lipid_pos.mzML B1_WU350-050_d7_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=24.4; Age at Symptom onset (years)=61.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=379; D-dimer=2352; Neutrophil %=87; CO2=44; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.6; Lymphocyte absolute=0.7; Lymphocyte %=4.6; IL1b=2.848917758; IL10=153.5725103; IL6=267.1820298; RANTES=959.9618241; MIP1a=27.91900928; GMCSF=2.449666442; MCP1=1898.04711; IL15=135.3076684; HGF=11714.84867; VEGF=1.285622707; IL1Ra=199.1739012; IL2R=60.11581187; MIG=224.7485143; IL8=43.13522009 SUBJECT_SAMPLE_FACTORS WU350-055 B1_WU350-055_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-055_d7_polar_pos.mzML B1_WU350-055_d7_polar_neg.mzML B1_WU350-055_d7_lipid_pos.mzML B1_WU350-055_d7_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=24.3; Age at Symptom onset (years)=79.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.4; D-dimer=936; Neutrophil %=37.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=79.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=0.7; Lymphocyte absolute=0.7; Lymphocyte %=39.5; IL1b=2.330575872; IL10=13.87728587; IL6=31.41294916; RANTES=1243.058906; MIP1a=1.630441719; GMCSF=0.996461633; MCP1=439.4720124; IL15=27.46931093; HGF=233.537326; VEGF=0.76763317; IL1Ra=214.0162865; IL2R=145.7396059; MIG=44.60888737; IL8=180.7444869 SUBJECT_SAMPLE_FACTORS WU350-065 B1_WU350-065_d7 batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B1_WU350-065_d7_polar_pos.mzML B1_WU350-065_d7_polar_neg.mzML B1_WU350-065_d7_lipid_pos.mzML B1_WU350-065_d7_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=32.4; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.1; D-dimer=372; Neutrophil %=88.9; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=73.7; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.3; Lymphocyte %=5.2; IL1b=1.933800515; IL10=1454.559414; IL6=379.5929623; RANTES=652.2572197; MIP1a=2.953122527; GMCSF=575.3349883; MCP1=627.1981562; IL15=51.69292859; HGF=2306.20299; VEGF=2.947989887; IL1Ra=121.6108625; IL2R=55.01694945; MIG=66.37774287; IL8=25.34769801 SUBJECT_SAMPLE_FACTORS WU350-024 B2_WU350-024_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-024_d0_polar_pos.mzML B2_WU350-024_d0_polar_neg.mzML B2_WU350-024_d0_lipid_pos.mzML B2_WU350-024_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=17.4; Age at Symptom onset (years)=81.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=70.6; CO2=29; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=81.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.5; Lymphocyte %=9.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-026 B2_WU350-026_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-026_d0_polar_pos.mzML B2_WU350-026_d0_polar_neg.mzML B2_WU350-026_d0_lipid_pos.mzML B2_WU350-026_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=23.9; Age at Symptom onset (years)=41.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=45.4; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=41.8; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=2.4; Lymphocyte %=42.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-058 B2_WU350-058_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-058_d0_polar_pos.mzML B2_WU350-058_d0_polar_neg.mzML B2_WU350-058_d0_lipid_pos.mzML B2_WU350-058_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=29.6; Age at Symptom onset (years)=53.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=55.5; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=3.6; Lymphocyte %=36.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-017 B2_WU350-017_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-017_d0_polar_pos.mzML B2_WU350-017_d0_polar_neg.mzML B2_WU350-017_d0_lipid_pos.mzML B2_WU350-017_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=20.3; Age at Symptom onset (years)=36.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=116.8; D-dimer=-1; Neutrophil %=61; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.4; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.7; Lymphocyte absolute=1.7; Lymphocyte %=18.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-044 B2_WU350-044_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-044_d0_polar_pos.mzML B2_WU350-044_d0_polar_neg.mzML B2_WU350-044_d0_lipid_pos.mzML B2_WU350-044_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=39.5; Age at Symptom onset (years)=62; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=57.2; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=62; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.7; Lymphocyte absolute=0.9; Lymphocyte %=28.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-045 B2_WU350-045_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-045_d0_polar_pos.mzML B2_WU350-045_d0_polar_neg.mzML B2_WU350-045_d0_lipid_pos.mzML B2_WU350-045_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=30.9; Age at Symptom onset (years)=30.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=76.7; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=30.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=8.1; Lymphocyte absolute=0.9; Lymphocyte %=8.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-019 B2_WU350-019_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-019_d0_polar_pos.mzML B2_WU350-019_d0_polar_neg.mzML B2_WU350-019_d0_lipid_pos.mzML B2_WU350-019_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=29.9; Age at Symptom onset (years)=77.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=231.1; D-dimer=1472; Neutrophil %=81.3; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=77.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.4; Lymphocyte absolute=0.6; Lymphocyte %=14.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-020 B2_WU350-020_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-020_d0_polar_pos.mzML B2_WU350-020_d0_polar_neg.mzML B2_WU350-020_d0_lipid_pos.mzML B2_WU350-020_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=50.2; Age at Symptom onset (years)=65.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=79.7; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=65.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=8.6; Lymphocyte absolute=1.1; Lymphocyte %=10.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-022 B2_WU350-022_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-022_d0_polar_pos.mzML B2_WU350-022_d0_polar_neg.mzML B2_WU350-022_d0_lipid_pos.mzML B2_WU350-022_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=30.5; Age at Symptom onset (years)=56; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=89.2; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=56; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=3; Lymphocyte absolute=0.2; Lymphocyte %=6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-040 B2_WU350-040_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-040_d0_polar_pos.mzML B2_WU350-040_d0_polar_neg.mzML B2_WU350-040_d0_lipid_pos.mzML B2_WU350-040_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=33.5; Age at Symptom onset (years)=38.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=73.7; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=38.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=8.6; Lymphocyte absolute=1.4; Lymphocyte %=15.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-016 B2_WU350-016_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-016_d0_polar_pos.mzML B2_WU350-016_d0_polar_neg.mzML B2_WU350-016_d0_lipid_pos.mzML B2_WU350-016_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=30.4; Age at Symptom onset (years)=35.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=35.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=1.603261997; IL10=85.17555857; IL6=11.20921833; RANTES=603.4876672; MIP1a=35.16758823; GMCSF=7.389167264; MCP1=222.0230269; IL15=124.5022292; HGF=96.71514931; VEGF=0.079139168; IL1Ra=184.9510521; IL2R=47.93393325; MIG=17.53553492; IL8=10.03266973 SUBJECT_SAMPLE_FACTORS WU350-035 B2_WU350-035_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-035_d0_polar_pos.mzML B2_WU350-035_d0_polar_neg.mzML B2_WU350-035_d0_lipid_pos.mzML B2_WU350-035_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=34.4; Age at Symptom onset (years)=59.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=62.4; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.8; Lymphocyte absolute=1.5; Lymphocyte %=19.7; IL1b=3.348309549; IL10=5.217648498; IL6=8.153595209; RANTES=464.0740805; MIP1a=22.98767507; GMCSF=2.613468044; MCP1=284.6618269; IL15=68.51183657; HGF=484.189929; VEGF=23.19574627; IL1Ra=99.27163704; IL2R=223.2755953; MIG=30.24644831; IL8=20.04013164 SUBJECT_SAMPLE_FACTORS WU350-036 B2_WU350-036_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-036_d0_polar_pos.mzML B2_WU350-036_d0_polar_neg.mzML B2_WU350-036_d0_lipid_pos.mzML B2_WU350-036_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=27.4; Age at Symptom onset (years)=57; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=59.6; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=1.5; Lymphocyte %=25.5; IL1b=1.904871819; IL10=20.07281883; IL6=9.862471501; RANTES=831.1385769; MIP1a=48.67981464; GMCSF=3.657895366; MCP1=127.5863085; IL15=17.38181502; HGF=153.8297321; VEGF=1.07192045; IL1Ra=38.62578352; IL2R=128.6952612; MIG=35.00076713; IL8=9.529992975 SUBJECT_SAMPLE_FACTORS WU350-063 B2_WU350-063_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-063_d0_polar_pos.mzML B2_WU350-063_d0_polar_neg.mzML B2_WU350-063_d0_lipid_pos.mzML B2_WU350-063_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=31; Age at Symptom onset (years)=31.1; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.3; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=31.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=2.8; Lymphocyte %=37.9; IL1b=1.072354139; IL10=561.0510489; IL6=2.176575364; RANTES=656.6606761; MIP1a=3.01268046; GMCSF=36.14170852; MCP1=227.8561927; IL15=145.4003459; HGF=139.9785848; VEGF=0.285078161; IL1Ra=32.76876093; IL2R=78.09235326; MIG=7.883441071; IL8=8.241359582 SUBJECT_SAMPLE_FACTORS WU350-025 B2_WU350-025_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-025_d0_polar_pos.mzML B2_WU350-025_d0_polar_neg.mzML B2_WU350-025_d0_lipid_pos.mzML B2_WU350-025_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=24.8; Age at Symptom onset (years)=64.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=77; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=0.5; Lymphocyte %=15.3; IL1b=0.334111293; IL10=12.28156552; IL6=26.47902453; RANTES=774.9869506; MIP1a=<1; GMCSF=0.694132102; MCP1=212.7214972; IL15=<8.3; HGF=104.1175127; VEGF=5.027117086; IL1Ra=37.97530185; IL2R=40.96344227; MIG=48.78528622; IL8=12.16369395 SUBJECT_SAMPLE_FACTORS WU350-030 B2_WU350-030_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-030_d0_polar_pos.mzML B2_WU350-030_d0_polar_neg.mzML B2_WU350-030_d0_lipid_pos.mzML B2_WU350-030_d0_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=27.1; Age at Symptom onset (years)=58.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.7; D-dimer=-1; Neutrophil %=71; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=0.8; Lymphocyte %=23; IL1b=1.931278119; IL10=27.209789; IL6=329.7547491; RANTES=750.494667; MIP1a=<1; GMCSF=4.079093694; MCP1=1768.784287; IL15=32.11804101; HGF=1718.682457; VEGF=2.618810753; IL1Ra=534.3667659; IL2R=6.641942065; MIG=99.00493405; IL8=76.02472765 SUBJECT_SAMPLE_FACTORS WU350-032 B2_WU350-032_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-032_d0_polar_pos.mzML B2_WU350-032_d0_polar_neg.mzML B2_WU350-032_d0_lipid_pos.mzML B2_WU350-032_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=20.7; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=304.2; D-dimer=1615; Neutrophil %=83.4; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=11.4; Lymphocyte absolute=1.3; Lymphocyte %=9.3; IL1b=1.655641489; IL10=146.1786802; IL6=166.7825454; RANTES=922.8728524; MIP1a=8.804541132; GMCSF=4.768413144; MCP1=838.467323; IL15=100.5174096; HGF=2857.71957; VEGF=1.417726608; IL1Ra=249.5319953; IL2R=72.74637466; MIG=183.693946; IL8=32.00626232 SUBJECT_SAMPLE_FACTORS WU350-038 B2_WU350-038_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-038_d0_polar_pos.mzML B2_WU350-038_d0_polar_neg.mzML B2_WU350-038_d0_lipid_pos.mzML B2_WU350-038_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=38; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=68.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=0.9; Lymphocyte %=24.5; IL1b=0.734645585; IL10=4.44111592; IL6=73.85550557; RANTES=979.9897503; MIP1a=2.01818982; GMCSF=0.694254691; MCP1=389.9006905; IL15=25.01292551; HGF=737.4789363; VEGF=6.082811304; IL1Ra=84.57424659; IL2R=51.79443676; MIG=68.18524254; IL8=54.04201195 SUBJECT_SAMPLE_FACTORS WU350-039 B2_WU350-039_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-039_d0_polar_pos.mzML B2_WU350-039_d0_polar_neg.mzML B2_WU350-039_d0_lipid_pos.mzML B2_WU350-039_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=35.6; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=95.5; D-dimer=1484; Neutrophil %=-1; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=1.5; Lymphocyte %=24.4; IL1b=1.231687066; IL10=9.080496826; IL6=34.03480648; RANTES=622.9021385; MIP1a=<1; GMCSF=0.949913574; MCP1=152.7891152; IL15=14.33839627; HGF=10541.1589; VEGF=0.920228118; IL1Ra=31.0884806; IL2R=17.55972379; MIG=142.7915906; IL8=174.5714619 SUBJECT_SAMPLE_FACTORS WU350-042 B2_WU350-042_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-042_d0_polar_pos.mzML B2_WU350-042_d0_polar_neg.mzML B2_WU350-042_d0_lipid_pos.mzML B2_WU350-042_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=25.4; Age at Symptom onset (years)=65.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.8; D-dimer=5282; Neutrophil %=63.8; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=65.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.2; Lymphocyte %=32; IL1b=1.166853978; IL10=20.04985841; IL6=58.52394579; RANTES=542.7830772; MIP1a=39.53202251; GMCSF=0.934492307; MCP1=751.059898; IL15=23.17516064; HGF=460.657324; VEGF=1.978168405; IL1Ra=50.2788368; IL2R=91.92804148; MIG=32.99294913; IL8=43.18738845 SUBJECT_SAMPLE_FACTORS WU350-043 B2_WU350-043_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-043_d0_polar_pos.mzML B2_WU350-043_d0_polar_neg.mzML B2_WU350-043_d0_lipid_pos.mzML B2_WU350-043_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=35.1; Age at Symptom onset (years)=43.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.3; D-dimer=1667; Neutrophil %=52.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.9; Lymphocyte absolute=3.9; Lymphocyte %=36.5; IL1b=0.657650517; IL10=8.677513933; IL6=1.345809483; RANTES=626.8693946; MIP1a=<1; GMCSF=2.039050513; MCP1=229.6081853; IL15=<8.3; HGF=193.0350464; VEGF=10.68401031; IL1Ra=23.24319934; IL2R=25.71624547; MIG=5.260771463; IL8=10.44799631 SUBJECT_SAMPLE_FACTORS WU350-051 B2_WU350-051_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-051_d0_polar_pos.mzML B2_WU350-051_d0_polar_neg.mzML B2_WU350-051_d0_lipid_pos.mzML B2_WU350-051_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=30.2; Age at Symptom onset (years)=68.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=65.5; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.6; Lymphocyte absolute=1.8; Lymphocyte %=25.5; IL1b=1.41783737; IL10=5.98951388; IL6=14.2007141; RANTES=717.3094448; MIP1a=2.995046654; GMCSF=5.670788166; MCP1=356.8801785; IL15=15.19474613; HGF=133.7866103; VEGF=1.153940571; IL1Ra=77.68225686; IL2R=33.34883429; MIG=16.93683761; IL8=9.159109812 SUBJECT_SAMPLE_FACTORS WU350-052 B2_WU350-052_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-052_d0_polar_pos.mzML B2_WU350-052_d0_polar_neg.mzML B2_WU350-052_d0_lipid_pos.mzML B2_WU350-052_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=47.5; Age at Symptom onset (years)=52.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6.5; D-dimer=460; Neutrophil %=72.9; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=52.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=0.7; Lymphocyte %=14.1; IL1b=1.544737358; IL10=4.346484663; IL6=134.537376; RANTES=473.6486053; MIP1a=0.22; GMCSF=1.392675982; MCP1=188.6799111; IL15=84.14672432; HGF=471.607392; VEGF=6.16503875; IL1Ra=56.90173608; IL2R=65.26266863; MIG=85.03094063; IL8=12.30347764 SUBJECT_SAMPLE_FACTORS WU350-054 B2_WU350-054_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-054_d0_polar_pos.mzML B2_WU350-054_d0_polar_neg.mzML B2_WU350-054_d0_lipid_pos.mzML B2_WU350-054_d0_lipid_neg.mzML; Days post symptom onset=31; Sex=Female; BMI=38.4; Age at Symptom onset (years)=30.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.5; D-dimer=541; Neutrophil %=69.1; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=30.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3; Lymphocyte absolute=0.7; Lymphocyte %=17.2; IL1b=0.403391033; IL10=33.04308019; IL6=6.444603464; RANTES=785.2125337; MIP1a=7.718949281; GMCSF=2.522292368; MCP1=187.0811042; IL15=24.22235056; HGF=65.96553883; VEGF=0.196193332; IL1Ra=33.96158651; IL2R=11.46580811; MIG=21.12768238; IL8=23.53087766 SUBJECT_SAMPLE_FACTORS WU350-057 B2_WU350-057_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-057_d0_polar_pos.mzML B2_WU350-057_d0_polar_neg.mzML B2_WU350-057_d0_lipid_pos.mzML B2_WU350-057_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=22.6; Age at Symptom onset (years)=48.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=60.2; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=48.3; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=1.2; Lymphocyte %=27.7; IL1b=3.515914645; IL10=12.90023214; IL6=10.10592724; RANTES=1202.119736; MIP1a=<0.22; GMCSF=0.577150164; MCP1=194.2144955; IL15=11.33619851; HGF=588.9006276; VEGF=<0.09; IL1Ra=41.47552143; IL2R=80.98174261; MIG=30.05478481; IL8=56.5210818 SUBJECT_SAMPLE_FACTORS WU350-059 B2_WU350-059_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-059_d0_polar_pos.mzML B2_WU350-059_d0_polar_neg.mzML B2_WU350-059_d0_lipid_pos.mzML B2_WU350-059_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=27.1; Age at Symptom onset (years)=51.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.1; D-dimer=443; Neutrophil %=64.6; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=0.9; Lymphocyte %=21.7; IL1b=0.973059682; IL10=5.819472912; IL6=21.01243452; RANTES=1035.565165; MIP1a=0.946296474; GMCSF=1.167691272; MCP1=366.5020672; IL15=<2.77; HGF=74.08510034; VEGF=0.795015097; IL1Ra=68.43571516; IL2R=60.66993446; MIG=21.28021373; IL8=12.44605834 SUBJECT_SAMPLE_FACTORS WU350-060 B2_WU350-060_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-060_d0_polar_pos.mzML B2_WU350-060_d0_polar_neg.mzML B2_WU350-060_d0_lipid_pos.mzML B2_WU350-060_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=49.6; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=88.6; D-dimer=338; Neutrophil %=74; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=1.1; Lymphocyte %=14.4; IL1b=1.491018816; IL10=5.916621034; IL6=32.14271914; RANTES=702.5496346; MIP1a=10.43483518; GMCSF=1.116517573; MCP1=646.2167168; IL15=4.664520778; HGF=395.6656012; VEGF=3.773860379; IL1Ra=124.9161659; IL2R=92.05778706; MIG=29.48413612; IL8=17.8657169 SUBJECT_SAMPLE_FACTORS WU350-061 B2_WU350-061_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-061_d0_polar_pos.mzML B2_WU350-061_d0_polar_neg.mzML B2_WU350-061_d0_lipid_pos.mzML B2_WU350-061_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=29.7; Age at Symptom onset (years)=58.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1.6; D-dimer=-1; Neutrophil %=37.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=58.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=2.7; Lymphocyte %=37.3; IL1b=1.00554835; IL10=8.50915596; IL6=8.403371434; RANTES=636.2673643; MIP1a=2.08653855; GMCSF=1.973464559; MCP1=94.2616763; IL15=6.284255107; HGF=416.7980553; VEGF=2.113257355; IL1Ra=149.3964585; IL2R=42.38048399; MIG=10.00805729; IL8=21.99414628 SUBJECT_SAMPLE_FACTORS WU350-015 B2_WU350-015_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-015_d0_polar_pos.mzML B2_WU350-015_d0_polar_neg.mzML B2_WU350-015_d0_lipid_pos.mzML B2_WU350-015_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=30.9; Age at Symptom onset (years)=78.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=91.9; D-dimer=1415; Neutrophil %=86.4; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=0.4; Lymphocyte %=5.1; IL1b=2.049405275; IL10=29.62516059; IL6=31.70475443; RANTES=815.7686719; MIP1a=16.13191175; GMCSF=0.724976214; MCP1=258.7628528; IL15=42.46729653; HGF=6689.816838; VEGF=0.509678834; IL1Ra=134.5444749; IL2R=311.157981; MIG=72.43498384; IL8=35.93983954 SUBJECT_SAMPLE_FACTORS WU350-018 B2_WU350-018_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-018_d0_polar_pos.mzML B2_WU350-018_d0_polar_neg.mzML B2_WU350-018_d0_lipid_pos.mzML B2_WU350-018_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=28.4; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=138.4; D-dimer=2335; Neutrophil %=73; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3; Lymphocyte absolute=0.7; Lymphocyte %=18; IL1b=0.740881274; IL10=42.832432; IL6=114.0999344; RANTES=476.8715456; MIP1a=<1; GMCSF=3.183217312; MCP1=362.1027994; IL15=43.32913459; HGF=636.1774051; VEGF=2.280215214; IL1Ra=27.62588078; IL2R=172.2248677; MIG=53.63465501; IL8=21.73479617 SUBJECT_SAMPLE_FACTORS WU350-023 B2_WU350-023_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-023_d0_polar_pos.mzML B2_WU350-023_d0_polar_neg.mzML B2_WU350-023_d0_lipid_pos.mzML B2_WU350-023_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=26.6; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=17; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=75.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=0.9; Lymphocyte %=16.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-027 B2_WU350-027_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-027_d0_polar_pos.mzML B2_WU350-027_d0_polar_neg.mzML B2_WU350-027_d0_lipid_pos.mzML B2_WU350-027_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=37; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=73.3; D-dimer=1775; Neutrophil %=56.2; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2.7; Lymphocyte absolute=1.6; Lymphocyte %=32.4; IL1b=1.780432549; IL10=6.094018059; IL6=23.0224779; RANTES=593.2905112; MIP1a=1.849631839; GMCSF=1.229295159; MCP1=339.5093568; IL15=9.236250486; HGF=763.6222791; VEGF=2.872277523; IL1Ra=202.1802469; IL2R=184.2435011; MIG=34.83502321; IL8=66.08164032 SUBJECT_SAMPLE_FACTORS WU350-028 B2_WU350-028_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-028_d0_polar_pos.mzML B2_WU350-028_d0_polar_neg.mzML B2_WU350-028_d0_lipid_pos.mzML B2_WU350-028_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=28.5; Age at Symptom onset (years)=89.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=338; D-dimer=>80000; Neutrophil %=89.5; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=89.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=22.2; Lymphocyte absolute=1; Lymphocyte %=4.2; IL1b=451631.1441; IL10=564234.8809; IL6=153690.3085; RANTES=>3912; MIP1a=225249.2794; GMCSF=93448.5033; MCP1=422487.883; IL15=1311386.215; HGF=246161.1975; VEGF=801.4295179; IL1Ra=63039.71312; IL2R=475386.8143; MIG=2610.122653; IL8=256.3721982 SUBJECT_SAMPLE_FACTORS WU350-037 B2_WU350-037_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-037_d0_polar_pos.mzML B2_WU350-037_d0_polar_neg.mzML B2_WU350-037_d0_lipid_pos.mzML B2_WU350-037_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=14.2; Age at Symptom onset (years)=85.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=62; D-dimer=1091; Neutrophil %=81.8; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=85.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=9.5; Lymphocyte absolute=0.9; Lymphocyte %=7.9; IL1b=1.891992104; IL10=377.0732903; IL6=50.67863898; RANTES=492.4934532; MIP1a=2.901111316; GMCSF=3.450348998; MCP1=190.4124211; IL15=54.94738633; HGF=9529.890785; VEGF=3.18171445; IL1Ra=424.0215236; IL2R=607.5129045; MIG=99.36513199; IL8=50.20100665 SUBJECT_SAMPLE_FACTORS WU350-048 B2_WU350-048_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-048_d0_polar_pos.mzML B2_WU350-048_d0_polar_neg.mzML B2_WU350-048_d0_lipid_pos.mzML B2_WU350-048_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=16.6; Age at Symptom onset (years)=66.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=53.3; D-dimer=1797; Neutrophil %=74.9; CO2=18; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=66.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=1.4; Lymphocyte absolute=0.2; Lymphocyte %=13.4; IL1b=1.905171192; IL10=100.4603276; IL6=34.29433942; RANTES=1199.246276; MIP1a=24.20755175; GMCSF=2.910650369; MCP1=1002.638697; IL15=278.3540798; HGF=178.1937822; VEGF=2.301587238; IL1Ra=38.25548334; IL2R=108.5490488; MIG=141.5603014; IL8=500.0592793 SUBJECT_SAMPLE_FACTORS WU350-053 B2_WU350-053_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-053_d0_polar_pos.mzML B2_WU350-053_d0_polar_neg.mzML B2_WU350-053_d0_lipid_pos.mzML B2_WU350-053_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=19.4; Age at Symptom onset (years)=80.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=74.4; D-dimer=1819; Neutrophil %=73.4; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=80.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=0.9; Lymphocyte %=16; IL1b=1.692597815; IL10=36.69633374; IL6=32.02879541; RANTES=1001.294945; MIP1a=9.7963954; GMCSF=1.185069782; MCP1=261.3512624; IL15=9.78120338; HGF=1853.046766; VEGF=1.162350902; IL1Ra=181.0705694; IL2R=137.0597938; MIG=148.7795994; IL8=22.53116111 SUBJECT_SAMPLE_FACTORS WU350-062 B2_WU350-062_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-062_d0_polar_pos.mzML B2_WU350-062_d0_polar_neg.mzML B2_WU350-062_d0_lipid_pos.mzML B2_WU350-062_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=34.4; Age at Symptom onset (years)=62; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=213.7; D-dimer=793; Neutrophil %=94; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=62; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.3; Lymphocyte absolute=0.1; Lymphocyte %=1.2; IL1b=2.614118562; IL10=10.6839287; IL6=661.9173467; RANTES=1262.081076; MIP1a=19.28731485; GMCSF=1.673090394; MCP1=1532.292663; IL15=24.96558976; HGF=769.2021487; VEGF=2.233367234; IL1Ra=1492.16428; IL2R=174.7212879; MIG=33.45670222; IL8=8.776936134 SUBJECT_SAMPLE_FACTORS WU350-079 B2_WU350-079_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-079_d0_polar_pos.mzML B2_WU350-079_d0_polar_neg.mzML B2_WU350-079_d0_lipid_pos.mzML B2_WU350-079_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=45.1; Age at Symptom onset (years)=68.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.3; D-dimer=2229; Neutrophil %=79.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.8; Lymphocyte absolute=1.2; Lymphocyte %=12.4; IL1b=2.164688413; IL10=17.90368863; IL6=63.04259341; RANTES=494.6370146; MIP1a=7.667219129; GMCSF=4.324616579; MCP1=822.9573518; IL15=9.189439848; HGF=676.7304519; VEGF=0.661612925; IL1Ra=178.9436532; IL2R=52.40497342; MIG=92.04905808; IL8=21.88090924 SUBJECT_SAMPLE_FACTORS WU350-080 B2_WU350-080_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-080_d0_polar_pos.mzML B2_WU350-080_d0_polar_neg.mzML B2_WU350-080_d0_lipid_pos.mzML B2_WU350-080_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=19.6; Age at Symptom onset (years)=87.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=16790; Neutrophil %=73.3; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=87.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.2; Lymphocyte absolute=1.7; Lymphocyte %=17; IL1b=0.922582019; IL10=6.403032128; IL6=15.66307323; RANTES=840.0323603; MIP1a=3.791859394; GMCSF=1.612737717; MCP1=94.84414466; IL15=5.042690989; HGF=108.5231566; VEGF=0.201045355; IL1Ra=155.6968477; IL2R=36.57564637; MIG=55.5807632; IL8=5.979249658 SUBJECT_SAMPLE_FACTORS WU350-084 B2_WU350-084_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-084_d0_polar_pos.mzML B2_WU350-084_d0_polar_neg.mzML B2_WU350-084_d0_lipid_pos.mzML B2_WU350-084_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=27.1; Age at Symptom onset (years)=67.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=219.7; D-dimer=2033; Neutrophil %=76.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.8; Lymphocyte %=13.1; IL1b=238.2129151; IL10=2201.236727; IL6=276.3383023; RANTES=720.2523791; MIP1a=646.1002223; GMCSF=1559.239466; MCP1=3629.373646; IL15=2351.382129; HGF=5483.775688; VEGF=5.87145547; IL1Ra=697.6247535; IL2R=10069.44052; MIG=474.8651929; IL8=27.55799909 SUBJECT_SAMPLE_FACTORS WU350-097 B2_WU350-097_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-097_d0_polar_pos.mzML B2_WU350-097_d0_polar_neg.mzML B2_WU350-097_d0_lipid_pos.mzML B2_WU350-097_d0_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=30.1; Age at Symptom onset (years)=72.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=254.2; D-dimer=28184; Neutrophil %=88.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=72.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=0.9; Lymphocyte %=7.1; IL1b=0.87; IL10=32.23; IL6=48; RANTES=829.58; MIP1a=14.5; GMCSF=9.73; MCP1=647.14; IL15=8.12; HGF=604.95; VEGF=1.9; IL1Ra=99.79; IL2R=148.09; MIG=70.77; IL8=17.54 SUBJECT_SAMPLE_FACTORS WU350-098 B2_WU350-098_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-098_d0_polar_pos.mzML B2_WU350-098_d0_polar_neg.mzML B2_WU350-098_d0_lipid_pos.mzML B2_WU350-098_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=39.8; Age at Symptom onset (years)=74; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=74.4; D-dimer=1474; Neutrophil %=84.5; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=74; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.4; Lymphocyte %=8.6; IL1b=1.43; IL10=28.65; IL6=47.09; RANTES=1165.14; MIP1a=60.19; GMCSF=0.82; MCP1=1866.18; IL15=589.07; HGF=541.55; VEGF=1.87; IL1Ra=196.55; IL2R=62.03; MIG=53.08; IL8=56.92 SUBJECT_SAMPLE_FACTORS WU350-099 B2_WU350-099_d0 batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-099_d0_polar_pos.mzML B2_WU350-099_d0_polar_neg.mzML B2_WU350-099_d0_lipid_pos.mzML B2_WU350-099_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=27.5; Age at Symptom onset (years)=90.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=83.4; D-dimer=524; Neutrophil %=68.7; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=90.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.8; Lymphocyte absolute=1.6; Lymphocyte %=19.6; IL1b=1.32; IL10=20.9; IL6=102.06; RANTES=755.92; MIP1a=14.5; GMCSF=1.85; MCP1=543.03; IL15=33.56; HGF=160.46; VEGF=1.55; IL1Ra=88.95; IL2R=131.15; MIG=76.38; IL8=22.62 SUBJECT_SAMPLE_FACTORS WU350-079 B2_WU350-079_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-079_d14_polar_pos.mzML B2_WU350-079_d14_polar_neg.mzML B2_WU350-079_d14_lipid_pos.mzML B2_WU350-079_d14_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=45.1; Age at Symptom onset (years)=68.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.3; D-dimer=2229; Neutrophil %=79.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.8; Lymphocyte absolute=1.2; Lymphocyte %=12.4; IL1b=2.164688413; IL10=17.90368863; IL6=63.04259341; RANTES=494.6370146; MIP1a=7.667219129; GMCSF=4.324616579; MCP1=822.9573518; IL15=9.189439848; HGF=676.7304519; VEGF=0.661612925; IL1Ra=178.9436532; IL2R=52.40497342; MIG=92.04905808; IL8=21.88090924 SUBJECT_SAMPLE_FACTORS WU350-080 B2_WU350-080_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-080_d14_polar_pos.mzML B2_WU350-080_d14_polar_neg.mzML B2_WU350-080_d14_lipid_pos.mzML B2_WU350-080_d14_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=19.6; Age at Symptom onset (years)=87.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=16790; Neutrophil %=73.3; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=87.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.2; Lymphocyte absolute=1.7; Lymphocyte %=17; IL1b=0.922582019; IL10=6.403032128; IL6=15.66307323; RANTES=840.0323603; MIP1a=3.791859394; GMCSF=1.612737717; MCP1=94.84414466; IL15=5.042690989; HGF=108.5231566; VEGF=0.201045355; IL1Ra=155.6968477; IL2R=36.57564637; MIG=55.5807632; IL8=5.979249658 SUBJECT_SAMPLE_FACTORS WU350-084 B2_WU350-084_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-084_d14_polar_pos.mzML B2_WU350-084_d14_polar_neg.mzML B2_WU350-084_d14_lipid_pos.mzML B2_WU350-084_d14_lipid_neg.mzML; Days post symptom onset=19; Sex=Male; BMI=27.1; Age at Symptom onset (years)=67.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=219.7; D-dimer=2033; Neutrophil %=76.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.8; Lymphocyte %=13.1; IL1b=238.2129151; IL10=2201.236727; IL6=276.3383023; RANTES=720.2523791; MIP1a=646.1002223; GMCSF=1559.239466; MCP1=3629.373646; IL15=2351.382129; HGF=5483.775688; VEGF=5.87145547; IL1Ra=697.6247535; IL2R=10069.44052; MIG=474.8651929; IL8=27.55799909 SUBJECT_SAMPLE_FACTORS WU350-097 B2_WU350-097_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-097_d14_polar_pos.mzML B2_WU350-097_d14_polar_neg.mzML B2_WU350-097_d14_lipid_pos.mzML B2_WU350-097_d14_lipid_neg.mzML; Days post symptom onset=30; Sex=Female; BMI=30.1; Age at Symptom onset (years)=72.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=254.2; D-dimer=28184; Neutrophil %=88.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=72.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=0.9; Lymphocyte %=7.1; IL1b=0.87; IL10=32.23; IL6=48; RANTES=829.58; MIP1a=14.5; GMCSF=9.73; MCP1=647.14; IL15=8.12; HGF=604.95; VEGF=1.9; IL1Ra=99.79; IL2R=148.09; MIG=70.77; IL8=17.54 SUBJECT_SAMPLE_FACTORS WU350-098 B2_WU350-098_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-098_d14_polar_pos.mzML B2_WU350-098_d14_polar_neg.mzML B2_WU350-098_d14_lipid_pos.mzML B2_WU350-098_d14_lipid_neg.mzML; Days post symptom onset=17; Sex=Female; BMI=39.8; Age at Symptom onset (years)=74; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=74.4; D-dimer=1474; Neutrophil %=84.5; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=74; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.4; Lymphocyte %=8.6; IL1b=1.43; IL10=28.65; IL6=47.09; RANTES=1165.14; MIP1a=60.19; GMCSF=0.82; MCP1=1866.18; IL15=589.07; HGF=541.55; VEGF=1.87; IL1Ra=196.55; IL2R=62.03; MIG=53.08; IL8=56.92 SUBJECT_SAMPLE_FACTORS WU350-099 B2_WU350-099_d14 batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-099_d14_polar_pos.mzML B2_WU350-099_d14_polar_neg.mzML B2_WU350-099_d14_lipid_pos.mzML B2_WU350-099_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=27.5; Age at Symptom onset (years)=90.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=83.4; D-dimer=524; Neutrophil %=68.7; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=90.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.8; Lymphocyte absolute=1.6; Lymphocyte %=19.6; IL1b=1.32; IL10=20.9; IL6=102.06; RANTES=755.92; MIP1a=14.5; GMCSF=1.85; MCP1=543.03; IL15=33.56; HGF=160.46; VEGF=1.55; IL1Ra=88.95; IL2R=131.15; MIG=76.38; IL8=22.62 SUBJECT_SAMPLE_FACTORS WU350-012 B2_WU350-012_d28 batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-012_d28_polar_pos.mzML B2_WU350-012_d28_polar_neg.mzML B2_WU350-012_d28_lipid_pos.mzML B2_WU350-012_d28_lipid_neg.mzML; Days post symptom onset=32; Sex=Male; BMI=44.1; Age at Symptom onset (years)=62.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=105.9; D-dimer=991; Neutrophil %=89.3; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=62.8; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=0.2; Lymphocyte %=2.7; IL1b=7.474523333; IL10=11.55916841; IL6=110.2863586; RANTES=1322.830764; MIP1a=36.73113405; GMCSF=11.59301025; MCP1=388.8769742; IL15=28.29446947; HGF=485.4034952; VEGF=1.300736432; IL1Ra=94.47152335; IL2R=126.9379408; MIG=58.85782435; IL8=19.52026042 SUBJECT_SAMPLE_FACTORS WU350-013 B2_WU350-013_d28 batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-013_d28_polar_pos.mzML B2_WU350-013_d28_polar_neg.mzML B2_WU350-013_d28_lipid_pos.mzML B2_WU350-013_d28_lipid_neg.mzML; Days post symptom onset=39; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-029 B2_WU350-029_d28 batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-029_d28_polar_pos.mzML B2_WU350-029_d28_polar_neg.mzML B2_WU350-029_d28_lipid_pos.mzML B2_WU350-029_d28_lipid_neg.mzML; Days post symptom onset=29; Sex=Female; BMI=32.8; Age at Symptom onset (years)=88.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=150.3; D-dimer=5977; Neutrophil %=82.1; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=88.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.5; Lymphocyte %=7.4; IL1b=0.715624543; IL10=62.18637883; IL6=14.17662594; RANTES=649.5255178; MIP1a=12.36174818; GMCSF=18.83099743; MCP1=570.1185771; IL15=52.50121538; HGF=119.1798849; VEGF=1.87128378; IL1Ra=62.29341051; IL2R=93.5288825; MIG=37.41580246; IL8=17.5441893 SUBJECT_SAMPLE_FACTORS WU350-030 B2_WU350-030_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-030_d3_polar_pos.mzML B2_WU350-030_d3_polar_neg.mzML B2_WU350-030_d3_lipid_pos.mzML B2_WU350-030_d3_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=27.1; Age at Symptom onset (years)=58.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.7; D-dimer=-1; Neutrophil %=71; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=0.8; Lymphocyte %=23; IL1b=1.931278119; IL10=27.209789; IL6=329.7547491; RANTES=750.494667; MIP1a=<1; GMCSF=4.079093694; MCP1=1768.784287; IL15=32.11804101; HGF=1718.682457; VEGF=2.618810753; IL1Ra=534.3667659; IL2R=6.641942065; MIG=99.00493405; IL8=76.02472765 SUBJECT_SAMPLE_FACTORS WU350-032 B2_WU350-032_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-032_d3_polar_pos.mzML B2_WU350-032_d3_polar_neg.mzML B2_WU350-032_d3_lipid_pos.mzML B2_WU350-032_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=20.7; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=304.2; D-dimer=1615; Neutrophil %=83.4; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=11.4; Lymphocyte absolute=1.3; Lymphocyte %=9.3; IL1b=1.655641489; IL10=146.1786802; IL6=166.7825454; RANTES=922.8728524; MIP1a=8.804541132; GMCSF=4.768413144; MCP1=838.467323; IL15=100.5174096; HGF=2857.71957; VEGF=1.417726608; IL1Ra=249.5319953; IL2R=72.74637466; MIG=183.693946; IL8=32.00626232 SUBJECT_SAMPLE_FACTORS WU350-038 B2_WU350-038_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-038_d3_polar_pos.mzML B2_WU350-038_d3_polar_neg.mzML B2_WU350-038_d3_lipid_pos.mzML B2_WU350-038_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=38; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=68.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=0.9; Lymphocyte %=24.5; IL1b=0.734645585; IL10=4.44111592; IL6=73.85550557; RANTES=979.9897503; MIP1a=2.01818982; GMCSF=0.694254691; MCP1=389.9006905; IL15=25.01292551; HGF=737.4789363; VEGF=6.082811304; IL1Ra=84.57424659; IL2R=51.79443676; MIG=68.18524254; IL8=54.04201195 SUBJECT_SAMPLE_FACTORS WU350-039 B2_WU350-039_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-039_d3_polar_pos.mzML B2_WU350-039_d3_polar_neg.mzML B2_WU350-039_d3_lipid_pos.mzML B2_WU350-039_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=35.6; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=95.5; D-dimer=1484; Neutrophil %=-1; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=1.5; Lymphocyte %=24.4; IL1b=1.231687066; IL10=9.080496826; IL6=34.03480648; RANTES=622.9021385; MIP1a=<1; GMCSF=0.949913574; MCP1=152.7891152; IL15=14.33839627; HGF=10541.1589; VEGF=0.920228118; IL1Ra=31.0884806; IL2R=17.55972379; MIG=142.7915906; IL8=174.5714619 SUBJECT_SAMPLE_FACTORS WU350-042 B2_WU350-042_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-042_d3_polar_pos.mzML B2_WU350-042_d3_polar_neg.mzML B2_WU350-042_d3_lipid_pos.mzML B2_WU350-042_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=25.4; Age at Symptom onset (years)=65.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.8; D-dimer=5282; Neutrophil %=63.8; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=65.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.2; Lymphocyte %=32; IL1b=1.166853978; IL10=20.04985841; IL6=58.52394579; RANTES=542.7830772; MIP1a=39.53202251; GMCSF=0.934492307; MCP1=751.059898; IL15=23.17516064; HGF=460.657324; VEGF=1.978168405; IL1Ra=50.2788368; IL2R=91.92804148; MIG=32.99294913; IL8=43.18738845 SUBJECT_SAMPLE_FACTORS WU350-043 B2_WU350-043_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-043_d3_polar_pos.mzML B2_WU350-043_d3_polar_neg.mzML B2_WU350-043_d3_lipid_pos.mzML B2_WU350-043_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=35.1; Age at Symptom onset (years)=43.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.3; D-dimer=1667; Neutrophil %=52.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.9; Lymphocyte absolute=3.9; Lymphocyte %=36.5; IL1b=0.657650517; IL10=8.677513933; IL6=1.345809483; RANTES=626.8693946; MIP1a=<1; GMCSF=2.039050513; MCP1=229.6081853; IL15=<8.3; HGF=193.0350464; VEGF=10.68401031; IL1Ra=23.24319934; IL2R=25.71624547; MIG=5.260771463; IL8=10.44799631 SUBJECT_SAMPLE_FACTORS WU350-060 B2_WU350-060_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-060_d3_polar_pos.mzML B2_WU350-060_d3_polar_neg.mzML B2_WU350-060_d3_lipid_pos.mzML B2_WU350-060_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=49.6; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=88.6; D-dimer=338; Neutrophil %=74; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=1.1; Lymphocyte %=14.4; IL1b=1.491018816; IL10=5.916621034; IL6=32.14271914; RANTES=702.5496346; MIP1a=10.43483518; GMCSF=1.116517573; MCP1=646.2167168; IL15=4.664520778; HGF=395.6656012; VEGF=3.773860379; IL1Ra=124.9161659; IL2R=92.05778706; MIG=29.48413612; IL8=17.8657169 SUBJECT_SAMPLE_FACTORS WU350-061 B2_WU350-061_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-061_d3_polar_pos.mzML B2_WU350-061_d3_polar_neg.mzML B2_WU350-061_d3_lipid_pos.mzML B2_WU350-061_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=29.7; Age at Symptom onset (years)=58.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1.6; D-dimer=-1; Neutrophil %=37.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=58.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=2.7; Lymphocyte %=37.3; IL1b=1.00554835; IL10=8.50915596; IL6=8.403371434; RANTES=636.2673643; MIP1a=2.08653855; GMCSF=1.973464559; MCP1=94.2616763; IL15=6.284255107; HGF=416.7980553; VEGF=2.113257355; IL1Ra=149.3964585; IL2R=42.38048399; MIG=10.00805729; IL8=21.99414628 SUBJECT_SAMPLE_FACTORS WU350-015 B2_WU350-015_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-015_d3_polar_pos.mzML B2_WU350-015_d3_polar_neg.mzML B2_WU350-015_d3_lipid_pos.mzML B2_WU350-015_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=30.9; Age at Symptom onset (years)=78.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=91.9; D-dimer=1415; Neutrophil %=86.4; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=0.4; Lymphocyte %=5.1; IL1b=2.049405275; IL10=29.62516059; IL6=31.70475443; RANTES=815.7686719; MIP1a=16.13191175; GMCSF=0.724976214; MCP1=258.7628528; IL15=42.46729653; HGF=6689.816838; VEGF=0.509678834; IL1Ra=134.5444749; IL2R=311.157981; MIG=72.43498384; IL8=35.93983954 SUBJECT_SAMPLE_FACTORS WU350-027 B2_WU350-027_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-027_d3_polar_pos.mzML B2_WU350-027_d3_polar_neg.mzML B2_WU350-027_d3_lipid_pos.mzML B2_WU350-027_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=37; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=73.3; D-dimer=1775; Neutrophil %=56.2; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2.7; Lymphocyte absolute=1.6; Lymphocyte %=32.4; IL1b=1.780432549; IL10=6.094018059; IL6=23.0224779; RANTES=593.2905112; MIP1a=1.849631839; GMCSF=1.229295159; MCP1=339.5093568; IL15=9.236250486; HGF=763.6222791; VEGF=2.872277523; IL1Ra=202.1802469; IL2R=184.2435011; MIG=34.83502321; IL8=66.08164032 SUBJECT_SAMPLE_FACTORS WU350-037 B2_WU350-037_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-037_d3_polar_pos.mzML B2_WU350-037_d3_polar_neg.mzML B2_WU350-037_d3_lipid_pos.mzML B2_WU350-037_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=14.2; Age at Symptom onset (years)=85.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=62; D-dimer=1091; Neutrophil %=81.8; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=85.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=9.5; Lymphocyte absolute=0.9; Lymphocyte %=7.9; IL1b=1.891992104; IL10=377.0732903; IL6=50.67863898; RANTES=492.4934532; MIP1a=2.901111316; GMCSF=3.450348998; MCP1=190.4124211; IL15=54.94738633; HGF=9529.890785; VEGF=3.18171445; IL1Ra=424.0215236; IL2R=607.5129045; MIG=99.36513199; IL8=50.20100665 SUBJECT_SAMPLE_FACTORS WU350-062 B2_WU350-062_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-062_d3_polar_pos.mzML B2_WU350-062_d3_polar_neg.mzML B2_WU350-062_d3_lipid_pos.mzML B2_WU350-062_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=34.4; Age at Symptom onset (years)=62; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=213.7; D-dimer=793; Neutrophil %=94; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=62; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.3; Lymphocyte absolute=0.1; Lymphocyte %=1.2; IL1b=2.614118562; IL10=10.6839287; IL6=661.9173467; RANTES=1262.081076; MIP1a=19.28731485; GMCSF=1.673090394; MCP1=1532.292663; IL15=24.96558976; HGF=769.2021487; VEGF=2.233367234; IL1Ra=1492.16428; IL2R=174.7212879; MIG=33.45670222; IL8=8.776936134 SUBJECT_SAMPLE_FACTORS WU350-079 B2_WU350-079_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-079_d3_polar_pos.mzML B2_WU350-079_d3_polar_neg.mzML B2_WU350-079_d3_lipid_pos.mzML B2_WU350-079_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=45.1; Age at Symptom onset (years)=68.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.3; D-dimer=2229; Neutrophil %=79.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.8; Lymphocyte absolute=1.2; Lymphocyte %=12.4; IL1b=2.164688413; IL10=17.90368863; IL6=63.04259341; RANTES=494.6370146; MIP1a=7.667219129; GMCSF=4.324616579; MCP1=822.9573518; IL15=9.189439848; HGF=676.7304519; VEGF=0.661612925; IL1Ra=178.9436532; IL2R=52.40497342; MIG=92.04905808; IL8=21.88090924 SUBJECT_SAMPLE_FACTORS WU350-080 B2_WU350-080_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-080_d3_polar_pos.mzML B2_WU350-080_d3_polar_neg.mzML B2_WU350-080_d3_lipid_pos.mzML B2_WU350-080_d3_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=19.6; Age at Symptom onset (years)=87.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=16790; Neutrophil %=73.3; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=87.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.2; Lymphocyte absolute=1.7; Lymphocyte %=17; IL1b=0.922582019; IL10=6.403032128; IL6=15.66307323; RANTES=840.0323603; MIP1a=3.791859394; GMCSF=1.612737717; MCP1=94.84414466; IL15=5.042690989; HGF=108.5231566; VEGF=0.201045355; IL1Ra=155.6968477; IL2R=36.57564637; MIG=55.5807632; IL8=5.979249658 SUBJECT_SAMPLE_FACTORS WU350-084 B2_WU350-084_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-084_d3_polar_pos.mzML B2_WU350-084_d3_polar_neg.mzML B2_WU350-084_d3_lipid_pos.mzML B2_WU350-084_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=27.1; Age at Symptom onset (years)=67.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=219.7; D-dimer=2033; Neutrophil %=76.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.8; Lymphocyte %=13.1; IL1b=238.2129151; IL10=2201.236727; IL6=276.3383023; RANTES=720.2523791; MIP1a=646.1002223; GMCSF=1559.239466; MCP1=3629.373646; IL15=2351.382129; HGF=5483.775688; VEGF=5.87145547; IL1Ra=697.6247535; IL2R=10069.44052; MIG=474.8651929; IL8=27.55799909 SUBJECT_SAMPLE_FACTORS WU350-097 B2_WU350-097_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-097_d3_polar_pos.mzML B2_WU350-097_d3_polar_neg.mzML B2_WU350-097_d3_lipid_pos.mzML B2_WU350-097_d3_lipid_neg.mzML; Days post symptom onset=19; Sex=Female; BMI=30.1; Age at Symptom onset (years)=72.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=254.2; D-dimer=28184; Neutrophil %=88.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=72.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=0.9; Lymphocyte %=7.1; IL1b=0.87; IL10=32.23; IL6=48; RANTES=829.58; MIP1a=14.5; GMCSF=9.73; MCP1=647.14; IL15=8.12; HGF=604.95; VEGF=1.9; IL1Ra=99.79; IL2R=148.09; MIG=70.77; IL8=17.54 SUBJECT_SAMPLE_FACTORS WU350-098 B2_WU350-098_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-098_d3_polar_pos.mzML B2_WU350-098_d3_polar_neg.mzML B2_WU350-098_d3_lipid_pos.mzML B2_WU350-098_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=39.8; Age at Symptom onset (years)=74; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=74.4; D-dimer=1474; Neutrophil %=84.5; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=74; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.4; Lymphocyte %=8.6; IL1b=1.43; IL10=28.65; IL6=47.09; RANTES=1165.14; MIP1a=60.19; GMCSF=0.82; MCP1=1866.18; IL15=589.07; HGF=541.55; VEGF=1.87; IL1Ra=196.55; IL2R=62.03; MIG=53.08; IL8=56.92 SUBJECT_SAMPLE_FACTORS WU350-099 B2_WU350-099_d3 batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-099_d3_polar_pos.mzML B2_WU350-099_d3_polar_neg.mzML B2_WU350-099_d3_lipid_pos.mzML B2_WU350-099_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=27.5; Age at Symptom onset (years)=90.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=83.4; D-dimer=524; Neutrophil %=68.7; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=90.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.8; Lymphocyte absolute=1.6; Lymphocyte %=19.6; IL1b=1.32; IL10=20.9; IL6=102.06; RANTES=755.92; MIP1a=14.5; GMCSF=1.85; MCP1=543.03; IL15=33.56; HGF=160.46; VEGF=1.55; IL1Ra=88.95; IL2R=131.15; MIG=76.38; IL8=22.62 SUBJECT_SAMPLE_FACTORS WU350-032 B2_WU350-032_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-032_d7_polar_pos.mzML B2_WU350-032_d7_polar_neg.mzML B2_WU350-032_d7_lipid_pos.mzML B2_WU350-032_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=20.7; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=304.2; D-dimer=1615; Neutrophil %=83.4; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=11.4; Lymphocyte absolute=1.3; Lymphocyte %=9.3; IL1b=1.655641489; IL10=146.1786802; IL6=166.7825454; RANTES=922.8728524; MIP1a=8.804541132; GMCSF=4.768413144; MCP1=838.467323; IL15=100.5174096; HGF=2857.71957; VEGF=1.417726608; IL1Ra=249.5319953; IL2R=72.74637466; MIG=183.693946; IL8=32.00626232 SUBJECT_SAMPLE_FACTORS WU350-039 B2_WU350-039_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-039_d7_polar_pos.mzML B2_WU350-039_d7_polar_neg.mzML B2_WU350-039_d7_lipid_pos.mzML B2_WU350-039_d7_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=35.6; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=95.5; D-dimer=1484; Neutrophil %=-1; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=1.5; Lymphocyte %=24.4; IL1b=1.231687066; IL10=9.080496826; IL6=34.03480648; RANTES=622.9021385; MIP1a=<1; GMCSF=0.949913574; MCP1=152.7891152; IL15=14.33839627; HGF=10541.1589; VEGF=0.920228118; IL1Ra=31.0884806; IL2R=17.55972379; MIG=142.7915906; IL8=174.5714619 SUBJECT_SAMPLE_FACTORS WU350-042 B2_WU350-042_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-042_d7_polar_pos.mzML B2_WU350-042_d7_polar_neg.mzML B2_WU350-042_d7_lipid_pos.mzML B2_WU350-042_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=25.4; Age at Symptom onset (years)=65.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.8; D-dimer=5282; Neutrophil %=63.8; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=65.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.2; Lymphocyte %=32; IL1b=1.166853978; IL10=20.04985841; IL6=58.52394579; RANTES=542.7830772; MIP1a=39.53202251; GMCSF=0.934492307; MCP1=751.059898; IL15=23.17516064; HGF=460.657324; VEGF=1.978168405; IL1Ra=50.2788368; IL2R=91.92804148; MIG=32.99294913; IL8=43.18738845 SUBJECT_SAMPLE_FACTORS WU350-015 B2_WU350-015_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-015_d7_polar_pos.mzML B2_WU350-015_d7_polar_neg.mzML B2_WU350-015_d7_lipid_pos.mzML B2_WU350-015_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=30.9; Age at Symptom onset (years)=78.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=91.9; D-dimer=1415; Neutrophil %=86.4; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=0.4; Lymphocyte %=5.1; IL1b=2.049405275; IL10=29.62516059; IL6=31.70475443; RANTES=815.7686719; MIP1a=16.13191175; GMCSF=0.724976214; MCP1=258.7628528; IL15=42.46729653; HGF=6689.816838; VEGF=0.509678834; IL1Ra=134.5444749; IL2R=311.157981; MIG=72.43498384; IL8=35.93983954 SUBJECT_SAMPLE_FACTORS WU350-053 B2_WU350-053_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-053_d7_polar_pos.mzML B2_WU350-053_d7_polar_neg.mzML B2_WU350-053_d7_lipid_pos.mzML B2_WU350-053_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=19.4; Age at Symptom onset (years)=80.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=74.4; D-dimer=1819; Neutrophil %=73.4; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=80.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=0.9; Lymphocyte %=16; IL1b=1.692597815; IL10=36.69633374; IL6=32.02879541; RANTES=1001.294945; MIP1a=9.7963954; GMCSF=1.185069782; MCP1=261.3512624; IL15=9.78120338; HGF=1853.046766; VEGF=1.162350902; IL1Ra=181.0705694; IL2R=137.0597938; MIG=148.7795994; IL8=22.53116111 SUBJECT_SAMPLE_FACTORS WU350-062 B2_WU350-062_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-062_d7_polar_pos.mzML B2_WU350-062_d7_polar_neg.mzML B2_WU350-062_d7_lipid_pos.mzML B2_WU350-062_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=34.4; Age at Symptom onset (years)=62; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=213.7; D-dimer=793; Neutrophil %=94; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=62; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.3; Lymphocyte absolute=0.1; Lymphocyte %=1.2; IL1b=2.614118562; IL10=10.6839287; IL6=661.9173467; RANTES=1262.081076; MIP1a=19.28731485; GMCSF=1.673090394; MCP1=1532.292663; IL15=24.96558976; HGF=769.2021487; VEGF=2.233367234; IL1Ra=1492.16428; IL2R=174.7212879; MIG=33.45670222; IL8=8.776936134 SUBJECT_SAMPLE_FACTORS WU350-079 B2_WU350-079_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-079_d7_polar_pos.mzML B2_WU350-079_d7_polar_neg.mzML B2_WU350-079_d7_lipid_pos.mzML B2_WU350-079_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=45.1; Age at Symptom onset (years)=68.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.3; D-dimer=2229; Neutrophil %=79.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.8; Lymphocyte absolute=1.2; Lymphocyte %=12.4; IL1b=2.164688413; IL10=17.90368863; IL6=63.04259341; RANTES=494.6370146; MIP1a=7.667219129; GMCSF=4.324616579; MCP1=822.9573518; IL15=9.189439848; HGF=676.7304519; VEGF=0.661612925; IL1Ra=178.9436532; IL2R=52.40497342; MIG=92.04905808; IL8=21.88090924 SUBJECT_SAMPLE_FACTORS WU350-080 B2_WU350-080_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-080_d7_polar_pos.mzML B2_WU350-080_d7_polar_neg.mzML B2_WU350-080_d7_lipid_pos.mzML B2_WU350-080_d7_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=19.6; Age at Symptom onset (years)=87.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=16790; Neutrophil %=73.3; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=87.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.2; Lymphocyte absolute=1.7; Lymphocyte %=17; IL1b=0.922582019; IL10=6.403032128; IL6=15.66307323; RANTES=840.0323603; MIP1a=3.791859394; GMCSF=1.612737717; MCP1=94.84414466; IL15=5.042690989; HGF=108.5231566; VEGF=0.201045355; IL1Ra=155.6968477; IL2R=36.57564637; MIG=55.5807632; IL8=5.979249658 SUBJECT_SAMPLE_FACTORS WU350-084 B2_WU350-084_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-084_d7_polar_pos.mzML B2_WU350-084_d7_polar_neg.mzML B2_WU350-084_d7_lipid_pos.mzML B2_WU350-084_d7_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=27.1; Age at Symptom onset (years)=67.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=219.7; D-dimer=2033; Neutrophil %=76.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.8; Lymphocyte %=13.1; IL1b=238.2129151; IL10=2201.236727; IL6=276.3383023; RANTES=720.2523791; MIP1a=646.1002223; GMCSF=1559.239466; MCP1=3629.373646; IL15=2351.382129; HGF=5483.775688; VEGF=5.87145547; IL1Ra=697.6247535; IL2R=10069.44052; MIG=474.8651929; IL8=27.55799909 SUBJECT_SAMPLE_FACTORS WU350-097 B2_WU350-097_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-097_d7_polar_pos.mzML B2_WU350-097_d7_polar_neg.mzML B2_WU350-097_d7_lipid_pos.mzML B2_WU350-097_d7_lipid_neg.mzML; Days post symptom onset=22; Sex=Female; BMI=30.1; Age at Symptom onset (years)=72.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=254.2; D-dimer=28184; Neutrophil %=88.4; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=72.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=0.9; Lymphocyte %=7.1; IL1b=0.87; IL10=32.23; IL6=48; RANTES=829.58; MIP1a=14.5; GMCSF=9.73; MCP1=647.14; IL15=8.12; HGF=604.95; VEGF=1.9; IL1Ra=99.79; IL2R=148.09; MIG=70.77; IL8=17.54 SUBJECT_SAMPLE_FACTORS WU350-098 B2_WU350-098_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-098_d7_polar_pos.mzML B2_WU350-098_d7_polar_neg.mzML B2_WU350-098_d7_lipid_pos.mzML B2_WU350-098_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=39.8; Age at Symptom onset (years)=74; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=74.4; D-dimer=1474; Neutrophil %=84.5; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=74; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.4; Lymphocyte %=8.6; IL1b=1.43; IL10=28.65; IL6=47.09; RANTES=1165.14; MIP1a=60.19; GMCSF=0.82; MCP1=1866.18; IL15=589.07; HGF=541.55; VEGF=1.87; IL1Ra=196.55; IL2R=62.03; MIG=53.08; IL8=56.92 SUBJECT_SAMPLE_FACTORS WU350-099 B2_WU350-099_d7 batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B2_WU350-099_d7_polar_pos.mzML B2_WU350-099_d7_polar_neg.mzML B2_WU350-099_d7_lipid_pos.mzML B2_WU350-099_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=27.5; Age at Symptom onset (years)=90.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=83.4; D-dimer=524; Neutrophil %=68.7; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=90.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.8; Lymphocyte absolute=1.6; Lymphocyte %=19.6; IL1b=1.32; IL10=20.9; IL6=102.06; RANTES=755.92; MIP1a=14.5; GMCSF=1.85; MCP1=543.03; IL15=33.56; HGF=160.46; VEGF=1.55; IL1Ra=88.95; IL2R=131.15; MIG=76.38; IL8=22.62 SUBJECT_SAMPLE_FACTORS WU350-078 B3_WU350-078_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-078_d0_polar_pos.mzML B3_WU350-078_d0_polar_neg.mzML B3_WU350-078_d0_lipid_pos.mzML B3_WU350-078_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=-; Age at Symptom onset (years)=28.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=316; Neutrophil %=46.4; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=28.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.3; Lymphocyte absolute=3; Lymphocyte %=42; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-114 B3_WU350-114_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-114_d0_polar_pos.mzML B3_WU350-114_d0_polar_neg.mzML B3_WU350-114_d0_lipid_pos.mzML B3_WU350-114_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=22.4; Age at Symptom onset (years)=42.4; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=84; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=42.4; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=12.3; Lymphocyte absolute=1.4; Lymphocyte %=9.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-070 B3_WU350-070_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-070_d0_polar_pos.mzML B3_WU350-070_d0_polar_neg.mzML B3_WU350-070_d0_lipid_pos.mzML B3_WU350-070_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=35.4; Age at Symptom onset (years)=52.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=50.7; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=3; Lymphocyte %=36; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-082 B3_WU350-082_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-082_d0_polar_pos.mzML B3_WU350-082_d0_polar_neg.mzML B3_WU350-082_d0_lipid_pos.mzML B3_WU350-082_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=25; Age at Symptom onset (years)=87.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10; D-dimer=1400; Neutrophil %=49.6; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=87.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=3.3; Lymphocyte %=29.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-095 B3_WU350-095_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-095_d0_polar_pos.mzML B3_WU350-095_d0_polar_neg.mzML B3_WU350-095_d0_lipid_pos.mzML B3_WU350-095_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=26.2; Age at Symptom onset (years)=43.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=161.3; D-dimer=4562; Neutrophil %=83.6; CO2=20; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=8.3; Lymphocyte absolute=0.6; Lymphocyte %=6.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-056 B3_WU350-056_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-056_d0_polar_pos.mzML B3_WU350-056_d0_polar_neg.mzML B3_WU350-056_d0_lipid_pos.mzML B3_WU350-056_d0_lipid_neg.mzML; Days post symptom onset=27; Sex=Male; BMI=30.9; Age at Symptom onset (years)=61.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=60.5; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6; Lymphocyte absolute=2.5; Lymphocyte %=25.6; IL1b=0.683271006; IL10=35.85869352; IL6=2.926580303; RANTES=559.9591839; MIP1a=0.838283948; GMCSF=2.212546337; MCP1=194.326935; IL15=17.24107611; HGF=254.6560233; VEGF=1.892099477; IL1Ra=84.3069994; IL2R=27.84664369; MIG=6.803555177; IL8=8.523702193 SUBJECT_SAMPLE_FACTORS WU350-102 B3_WU350-102_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-102_d0_polar_pos.mzML B3_WU350-102_d0_polar_neg.mzML B3_WU350-102_d0_lipid_pos.mzML B3_WU350-102_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=29.8; Age at Symptom onset (years)=22.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=69.1; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=22.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.8; Lymphocyte absolute=0.4; Lymphocyte %=16.2; IL1b=1.54; IL10=25; IL6=13.21; RANTES=1094.95; MIP1a=14.5; GMCSF=3.51; MCP1=516.98; IL15=44.77; HGF=147.11; VEGF=1; IL1Ra=35.48; IL2R=94.62; MIG=20.57; IL8=16.9 SUBJECT_SAMPLE_FACTORS WU350-103 B3_WU350-103_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-103_d0_polar_pos.mzML B3_WU350-103_d0_polar_neg.mzML B3_WU350-103_d0_lipid_pos.mzML B3_WU350-103_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=21.5; Age at Symptom onset (years)=19.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=51.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=19.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.9; Lymphocyte absolute=1.4; Lymphocyte %=39.5; IL1b=1.82; IL10=2929.81; IL6=234.66; RANTES=1181.9; MIP1a=429.28; GMCSF=454.1; MCP1=156.55; IL15=98.69; HGF=187.7; VEGF=1.85; IL1Ra=58.78; IL2R=89.67; MIG=0.74; IL8=8.47 SUBJECT_SAMPLE_FACTORS WU350-104 B3_WU350-104_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-104_d0_polar_pos.mzML B3_WU350-104_d0_polar_neg.mzML B3_WU350-104_d0_lipid_pos.mzML B3_WU350-104_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=22.5; Age at Symptom onset (years)=70.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.4; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=70.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3; Lymphocyte absolute=1; Lymphocyte %=17.4; IL1b=0.58; IL10=0.8; IL6=6.51; RANTES=1404.7; MIP1a=99.91; GMCSF=1.74; MCP1=422.84; IL15=3.81; HGF=140.19; VEGF=0.95; IL1Ra=55.72; IL2R=52.14; MIG=15.17; IL8=12.91 SUBJECT_SAMPLE_FACTORS WU350-067 B3_WU350-067_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-067_d0_polar_pos.mzML B3_WU350-067_d0_polar_neg.mzML B3_WU350-067_d0_lipid_pos.mzML B3_WU350-067_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=28.8; Age at Symptom onset (years)=36.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=69.6; D-dimer=353; Neutrophil %=84.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.2; Lymphocyte absolute=0.8; Lymphocyte %=9.2; IL1b=1.171561893; IL10=1.578214064; IL6=36.7587046; RANTES=633.767352; MIP1a=<0.22; GMCSF=0.76012704; MCP1=174.1257391; IL15=27.62857721; HGF=465.2651539; VEGF=3.635129351; IL1Ra=66.66193476; IL2R=29.75261188; MIG=6.753922437; IL8=22.96113222 SUBJECT_SAMPLE_FACTORS WU350-068 B3_WU350-068_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-068_d0_polar_pos.mzML B3_WU350-068_d0_polar_neg.mzML B3_WU350-068_d0_lipid_pos.mzML B3_WU350-068_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=23.9; Age at Symptom onset (years)=60.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=205.3; D-dimer=706; Neutrophil %=82.1; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=60.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=0.9; Lymphocyte %=13.6; IL1b=4.403735376; IL10=570.3101638; IL6=149.2710998; RANTES=853.8578084; MIP1a=459.4581213; GMCSF=68.64461359; MCP1=2206.167992; IL15=2128.361324; HGF=1551.551334; VEGF=8.146755609; IL1Ra=110.9368655; IL2R=169.8674661; MIG=118.5102804; IL8=20.24190991 SUBJECT_SAMPLE_FACTORS WU350-069 B3_WU350-069_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-069_d0_polar_pos.mzML B3_WU350-069_d0_polar_neg.mzML B3_WU350-069_d0_lipid_pos.mzML B3_WU350-069_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=30.8; Age at Symptom onset (years)=43.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1; D-dimer=1089; Neutrophil %=67; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=2; Lymphocyte %=26.4; IL1b=0.686761812; IL10=4.082357887; IL6=3.607455246; RANTES=691.9023795; MIP1a=<0.22; GMCSF=1.418727451; MCP1=58.76700561; IL15=16.58525869; HGF=229.1384265; VEGF=0.427646815; IL1Ra=40.74421749; IL2R=46.57995809; MIG=35.51615823; IL8=14.68742499 SUBJECT_SAMPLE_FACTORS WU350-071 B3_WU350-071_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-071_d0_polar_pos.mzML B3_WU350-071_d0_polar_neg.mzML B3_WU350-071_d0_lipid_pos.mzML B3_WU350-071_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=48.1; Age at Symptom onset (years)=36; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=45.2; D-dimer=855; Neutrophil %=58.9; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.1; Lymphocyte %=26.7; IL1b=0.822436108; IL10=32.6002509; IL6=13.09950617; RANTES=646.3163018; MIP1a=13.36903435; GMCSF=2.134611906; MCP1=181.509934; IL15=102.7557238; HGF=135.9807728; VEGF=0.035866519; IL1Ra=20.32231275; IL2R=20.83502925; MIG=6.636105798; IL8=8.43826013 SUBJECT_SAMPLE_FACTORS WU350-073 B3_WU350-073_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-073_d0_polar_pos.mzML B3_WU350-073_d0_polar_neg.mzML B3_WU350-073_d0_lipid_pos.mzML B3_WU350-073_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=34.8; Age at Symptom onset (years)=60.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=116; D-dimer=-1; Neutrophil %=54.4; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=60.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=1.4; Lymphocyte %=18; IL1b=1.620425809; IL10=2.939118337; IL6=14.22846135; RANTES=475.0675516; MIP1a=239.2549133; GMCSF=2.25934565; MCP1=966.19177; IL15=910.1830713; HGF=1546.954788; VEGF=3.537525318; IL1Ra=93.07862965; IL2R=127.9505548; MIG=47.91347673; IL8=17.71522903 SUBJECT_SAMPLE_FACTORS WU350-086 B3_WU350-086_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-086_d0_polar_pos.mzML B3_WU350-086_d0_polar_neg.mzML B3_WU350-086_d0_lipid_pos.mzML B3_WU350-086_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=42.8; Age at Symptom onset (years)=44.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=138.6; D-dimer=1199; Neutrophil %=71.8; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=44.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=1.8; Lymphocyte %=23.8; IL1b=1.03; IL10=42.12; IL6=11.57; RANTES=355.93; MIP1a=14.5; GMCSF=5.34; MCP1=313.19; IL15=51.92; HGF=216.01; VEGF=0.91; IL1Ra=57.5; IL2R=52.24; MIG=34.42; IL8=13.57 SUBJECT_SAMPLE_FACTORS WU350-090 B3_WU350-090_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-090_d0_polar_pos.mzML B3_WU350-090_d0_polar_neg.mzML B3_WU350-090_d0_lipid_pos.mzML B3_WU350-090_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=18.4; Age at Symptom onset (years)=61.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=44.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.7; Lymphocyte %=32.1; IL1b=0.51; IL10=10.98; IL6=8.18; RANTES=1177.62; MIP1a=14.5; GMCSF=3.18; MCP1=110.08; IL15=5.59; HGF=116.15; VEGF=0.61; IL1Ra=31.31; IL2R=42.56; MIG=37.59; IL8=7.84 SUBJECT_SAMPLE_FACTORS WU350-091 B3_WU350-091_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-091_d0_polar_pos.mzML B3_WU350-091_d0_polar_neg.mzML B3_WU350-091_d0_lipid_pos.mzML B3_WU350-091_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=25.4; Age at Symptom onset (years)=92.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=279; D-dimer=877; Neutrophil %=86; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=92.7; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.6; Lymphocyte absolute=1; Lymphocyte %=8.6; IL1b=0.83; IL10=25.74; IL6=158.01; RANTES=759.58; MIP1a=14.5; GMCSF=1.9; MCP1=1224.4; IL15=18.19; HGF=920.84; VEGF=0.23; IL1Ra=89.87; IL2R=109.26; MIG=54.31; IL8=21.46 SUBJECT_SAMPLE_FACTORS WU350-100 B3_WU350-100_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-100_d0_polar_pos.mzML B3_WU350-100_d0_polar_neg.mzML B3_WU350-100_d0_lipid_pos.mzML B3_WU350-100_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=33.2; Age at Symptom onset (years)=44.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=70.9; D-dimer=423; Neutrophil %=75.9; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=44.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1; Lymphocyte %=18.2; IL1b=0.92; IL10=12.49; IL6=9.93; RANTES=676.38; MIP1a=14.5; GMCSF=4.08; MCP1=174.36; IL15=23.6; HGF=169.68; VEGF=0.89; IL1Ra=57.81; IL2R=52.54; MIG=32.16; IL8=12.21 SUBJECT_SAMPLE_FACTORS WU350-101 B3_WU350-101_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-101_d0_polar_pos.mzML B3_WU350-101_d0_polar_neg.mzML B3_WU350-101_d0_lipid_pos.mzML B3_WU350-101_d0_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=34.8; Age at Symptom onset (years)=36.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=17.6; D-dimer=648; Neutrophil %=62.5; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=1.8; Lymphocyte %=28; IL1b=1.11; IL10=57.85; IL6=13.49; RANTES=593.54; MIP1a=14.5; GMCSF=4.33; MCP1=177.74; IL15=47.75; HGF=240.45; VEGF=0.49; IL1Ra=31.83; IL2R=68.75; MIG=40.7; IL8=17.02 SUBJECT_SAMPLE_FACTORS WU350-105 B3_WU350-105_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-105_d0_polar_pos.mzML B3_WU350-105_d0_polar_neg.mzML B3_WU350-105_d0_lipid_pos.mzML B3_WU350-105_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=30.2; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=104.2; D-dimer=1871; Neutrophil %=76.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=18.5; IL1b=0.6; IL10=37.86; IL6=9.49; RANTES=801.22; MIP1a=10.89; GMCSF=1.9; MCP1=139.37; IL15=11.74; HGF=115.16; VEGF=5.29; IL1Ra=86.23; IL2R=17.43; MIG=14.62; IL8=3.06 SUBJECT_SAMPLE_FACTORS WU350-107 B3_WU350-107_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-107_d0_polar_pos.mzML B3_WU350-107_d0_polar_neg.mzML B3_WU350-107_d0_lipid_pos.mzML B3_WU350-107_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=23.9; Age at Symptom onset (years)=64.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=108.4; D-dimer=427; Neutrophil %=67.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=1; Lymphocyte %=26; IL1b=1.41; IL10=12.69; IL6=56.41; RANTES=1160.65; MIP1a=10.89; GMCSF=1.04; MCP1=285.87; IL15=25.47; HGF=125.24; VEGF=10.66; IL1Ra=83.56; IL2R=42.17; MIG=27.16; IL8=18.58 SUBJECT_SAMPLE_FACTORS WU350-108 B3_WU350-108_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-108_d0_polar_pos.mzML B3_WU350-108_d0_polar_neg.mzML B3_WU350-108_d0_lipid_pos.mzML B3_WU350-108_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=26.9; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=97.7; D-dimer=2483; Neutrophil %=56.6; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=54.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.3; Lymphocyte absolute=0.6; Lymphocyte %=25.8; IL1b=1.94; IL10=16.92; IL6=217.54; RANTES=1607.09; MIP1a=10.89; GMCSF=1.97; MCP1=416.58; IL15=73.76; HGF=290.74; VEGF=0.78; IL1Ra=622.26; IL2R=787.1; MIG=338.38; IL8=138.58 SUBJECT_SAMPLE_FACTORS WU350-109 B3_WU350-109_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-109_d0_polar_pos.mzML B3_WU350-109_d0_polar_neg.mzML B3_WU350-109_d0_lipid_pos.mzML B3_WU350-109_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=19.4; Age at Symptom onset (years)=70.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1086; Neutrophil %=73.8; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=70.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=1.1; Lymphocyte %=21.2; IL1b=0.76; IL10=2.43; IL6=42.55; RANTES=697.32; MIP1a=25.73; GMCSF=1.01; MCP1=1069.3; IL15=11.41; HGF=329.45; VEGF=0.5; IL1Ra=66.34; IL2R=88.32; MIG=55.68; IL8=30.97 SUBJECT_SAMPLE_FACTORS WU350-110 B3_WU350-110_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-110_d0_polar_pos.mzML B3_WU350-110_d0_polar_neg.mzML B3_WU350-110_d0_lipid_pos.mzML B3_WU350-110_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=29; Age at Symptom onset (years)=26.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=8.8; D-dimer=508; Neutrophil %=68.5; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=26.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.6; Lymphocyte absolute=1.3; Lymphocyte %=23.9; IL1b=2.25; IL10=1201.34; IL6=80.49; RANTES=19021.39; MIP1a=37.91; GMCSF=686.09; MCP1=318.37; IL15=84.44; HGF=100.99; VEGF=0.75; IL1Ra=40.4; IL2R=26.83; MIG=27.97; IL8=6.02 SUBJECT_SAMPLE_FACTORS WU350-112 B3_WU350-112_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-112_d0_polar_pos.mzML B3_WU350-112_d0_polar_neg.mzML B3_WU350-112_d0_lipid_pos.mzML B3_WU350-112_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=37.9; Age at Symptom onset (years)=24.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=561; Neutrophil %=55.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=24.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=2.1; Lymphocyte %=33.9; IL1b=0.45; IL10=14.24; IL6=11.06; RANTES=767.53; MIP1a=10.89; GMCSF=1.45; MCP1=144.63; IL15=3.81; HGF=143.33; VEGF=0.57; IL1Ra=43.96; IL2R=26.99; MIG=20.87; IL8=11.11 SUBJECT_SAMPLE_FACTORS WU350-113 B3_WU350-113_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-113_d0_polar_pos.mzML B3_WU350-113_d0_polar_neg.mzML B3_WU350-113_d0_lipid_pos.mzML B3_WU350-113_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=32; Age at Symptom onset (years)=39.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=60.1; D-dimer=626; Neutrophil %=68.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=0.9; Lymphocyte %=16.3; IL1b=1.28; IL10=19.47; IL6=15.18; RANTES=1062.45; MIP1a=10.89; GMCSF=7.76; MCP1=120.23; IL15=3.81; HGF=230.91; VEGF=1.43; IL1Ra=63.77; IL2R=25.8; MIG=24.21; IL8=18.35 SUBJECT_SAMPLE_FACTORS WU350-117 B3_WU350-117_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-117_d0_polar_pos.mzML B3_WU350-117_d0_polar_neg.mzML B3_WU350-117_d0_lipid_pos.mzML B3_WU350-117_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-066 B3_WU350-066_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-066_d0_polar_pos.mzML B3_WU350-066_d0_polar_neg.mzML B3_WU350-066_d0_lipid_pos.mzML B3_WU350-066_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=33; Age at Symptom onset (years)=78.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=56.1; D-dimer=7530; Neutrophil %=77.8; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=78.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=0.8; Lymphocyte %=8.3; IL1b=0.506239542; IL10=42.12479483; IL6=539.3767004; RANTES=551.8982022; MIP1a=13.31823221; GMCSF=0.255281731; MCP1=1608.628052; IL15=113.4319001; HGF=1201.455195; VEGF=2.175378355; IL1Ra=255.4277944; IL2R=1053.501117; MIG=45.04891946; IL8=153.9742537 SUBJECT_SAMPLE_FACTORS WU350-072 B3_WU350-072_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-072_d0_polar_pos.mzML B3_WU350-072_d0_polar_neg.mzML B3_WU350-072_d0_lipid_pos.mzML B3_WU350-072_d0_lipid_neg.mzML; Days post symptom onset=17; Sex=Female; BMI=21.3; Age at Symptom onset (years)=67.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.4; D-dimer=3738; Neutrophil %=86.1; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=67.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.1; Lymphocyte absolute=1.1; Lymphocyte %=9.3; IL1b=0.963949583; IL10=77.97420703; IL6=13.96370065; RANTES=681.4308192; MIP1a=12.79575172; GMCSF=4.877538; MCP1=270.8415139; IL15=31.40843919; HGF=210.5168437; VEGF=3.856480788; IL1Ra=42.9332641; IL2R=127.091718; MIG=103.8567413; IL8=12.49578438 SUBJECT_SAMPLE_FACTORS WU350-074 B3_WU350-074_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-074_d0_polar_pos.mzML B3_WU350-074_d0_polar_neg.mzML B3_WU350-074_d0_lipid_pos.mzML B3_WU350-074_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=41.7; Age at Symptom onset (years)=56.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=187.5; D-dimer=3388; Neutrophil %=88.5; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=56.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=8.8; IL1b=0.257980243; IL10=16.21207497; IL6=27.52503112; RANTES=806.2575664; MIP1a=<0.22; GMCSF=0.414226173; MCP1=364.8302458; IL15=22.406341; HGF=8733.703795; VEGF=0.19258002; IL1Ra=117.0960047; IL2R=416.9873133; MIG=38.48497883; IL8=30.65561761 SUBJECT_SAMPLE_FACTORS WU350-075 B3_WU350-075_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-075_d0_polar_pos.mzML B3_WU350-075_d0_polar_neg.mzML B3_WU350-075_d0_lipid_pos.mzML B3_WU350-075_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=29.7; Age at Symptom onset (years)=68.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=50.1; D-dimer=1349; Neutrophil %=76.3; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.2; IL1b=2.645579979; IL10=830.3448631; IL6=66.89600902; RANTES=8300.207348; MIP1a=427.9377316; GMCSF=2.23242763; MCP1=1410.619273; IL15=171.6701414; HGF=686.0749079; VEGF=17.77486454; IL1Ra=372.4106983; IL2R=79.00644588; MIG=254.9832011; IL8=26.40764502 SUBJECT_SAMPLE_FACTORS WU350-076 B3_WU350-076_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-076_d0_polar_pos.mzML B3_WU350-076_d0_polar_neg.mzML B3_WU350-076_d0_lipid_pos.mzML B3_WU350-076_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=36.9; Age at Symptom onset (years)=50; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=96.1; D-dimer=518; Neutrophil %=52.3; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=50; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.6; Lymphocyte %=36.1; IL1b=3.175610975; IL10=22.52571526; IL6=33.35742769; RANTES=632.8259236; MIP1a=20.71027662; GMCSF=1.708529825; MCP1=235.9220974; IL15=29.066628; HGF=224.0691619; VEGF=0.172747728; IL1Ra=41.06468254; IL2R=95.86256942; MIG=32.44417707; IL8=16.44967789 SUBJECT_SAMPLE_FACTORS WU350-077 B3_WU350-077_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-077_d0_polar_pos.mzML B3_WU350-077_d0_polar_neg.mzML B3_WU350-077_d0_lipid_pos.mzML B3_WU350-077_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=33; Age at Symptom onset (years)=76.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=129.2; D-dimer=2219; Neutrophil %=66.2; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=76.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3; Lymphocyte absolute=1.5; Lymphocyte %=25; IL1b=1.949788268; IL10=9.149842338; IL6=87.74746165; RANTES=876.7250321; MIP1a=8.525710039; GMCSF=1.584995761; MCP1=715.3933889; IL15=40.39106379; HGF=303.6853309; VEGF=2.211056796; IL1Ra=229.9927583; IL2R=163.2981023; MIG=68.66223216; IL8=123.7668564 SUBJECT_SAMPLE_FACTORS WU350-081 B3_WU350-081_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-081_d0_polar_pos.mzML B3_WU350-081_d0_polar_neg.mzML B3_WU350-081_d0_lipid_pos.mzML B3_WU350-081_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=43.3; Age at Symptom onset (years)=63.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=102.9; D-dimer=1853; Neutrophil %=70.9; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=63.8; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.3; Lymphocyte absolute=0.7; Lymphocyte %=15.1; IL1b=1.652803812; IL10=49.70047981; IL6=71.7893179; RANTES=1044.622366; MIP1a=9.510842052; GMCSF=10.65662636; MCP1=614.9844175; IL15=53.12436805; HGF=251.4861667; VEGF=2.603620169; IL1Ra=254.5109469; IL2R=309.9206468; MIG=92.16998918; IL8=45.97587435 SUBJECT_SAMPLE_FACTORS WU350-083 B3_WU350-083_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-083_d0_polar_pos.mzML B3_WU350-083_d0_polar_neg.mzML B3_WU350-083_d0_lipid_pos.mzML B3_WU350-083_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=21.4; Age at Symptom onset (years)=76.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=235.5; D-dimer=3130; Neutrophil %=78.3; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=76.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.8; Lymphocyte absolute=0.8; Lymphocyte %=12.5; IL1b=1.757169325; IL10=15.73397701; IL6=76.23830887; RANTES=314.4701821; MIP1a=3.454829041; GMCSF=0.561185095; MCP1=199.5106623; IL15=49.9960684; HGF=2314.514201; VEGF=4.950342053; IL1Ra=210.724445; IL2R=95.34663057; MIG=126.4401954; IL8=16.90667178 SUBJECT_SAMPLE_FACTORS WU350-085 B3_WU350-085_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-085_d0_polar_pos.mzML B3_WU350-085_d0_polar_neg.mzML B3_WU350-085_d0_lipid_pos.mzML B3_WU350-085_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=39.2; Age at Symptom onset (years)=77.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=203.7; D-dimer=3351; Neutrophil %=72.9; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=77.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=1.5; Lymphocyte %=16.5; IL1b=0.99248081; IL10=21.31129537; IL6=56.76525997; RANTES=488.7568524; MIP1a=6.061502294; GMCSF=1.745429593; MCP1=693.4912039; IL15=29.77027358; HGF=418.6779789; VEGF=2.247215749; IL1Ra=254.554167; IL2R=87.30009344; MIG=68.30613004; IL8=19.05509097 SUBJECT_SAMPLE_FACTORS WU350-087 B3_WU350-087_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-087_d0_polar_pos.mzML B3_WU350-087_d0_polar_neg.mzML B3_WU350-087_d0_lipid_pos.mzML B3_WU350-087_d0_lipid_neg.mzML; Days post symptom onset=27; Sex=Male; BMI=38.2; Age at Symptom onset (years)=69.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=17; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=215.7; D-dimer=5760; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.89; IL10=21.24; IL6=65.06; RANTES=14110; MIP1a=14.5; GMCSF=1.84; MCP1=445.67; IL15=20.83; HGF=11195.44; VEGF=2.65; IL1Ra=279.5; IL2R=127.96; MIG=355.82; IL8=42.25 SUBJECT_SAMPLE_FACTORS WU350-088 B3_WU350-088_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-088_d0_polar_pos.mzML B3_WU350-088_d0_polar_neg.mzML B3_WU350-088_d0_lipid_pos.mzML B3_WU350-088_d0_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=290; D-dimer=31308; Neutrophil %=88.8; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=0.4; Lymphocyte %=3.8; IL1b=0.92; IL10=34.59; IL6=288.69; RANTES=812.7; MIP1a=14.5; GMCSF=2.21; MCP1=3091.83; IL15=30.38; HGF=1072.26; VEGF=5.27; IL1Ra=174.1; IL2R=180.41; MIG=-; IL8=47.58 SUBJECT_SAMPLE_FACTORS WU350-089 B3_WU350-089_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-089_d0_polar_pos.mzML B3_WU350-089_d0_polar_neg.mzML B3_WU350-089_d0_lipid_pos.mzML B3_WU350-089_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=28.4; Age at Symptom onset (years)=55.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=38.4; D-dimer=-1; Neutrophil %=47.6; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.9; Lymphocyte %=39.8; IL1b=1.32; IL10=105.21; IL6=32.85; RANTES=912.49; MIP1a=74.01; GMCSF=2.13; MCP1=1017.09; IL15=769.58; HGF=829.71; VEGF=8.79; IL1Ra=77.84; IL2R=163.2; MIG=21.98; IL8=51.01 SUBJECT_SAMPLE_FACTORS WU350-092 B3_WU350-092_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-092_d0_polar_pos.mzML B3_WU350-092_d0_polar_neg.mzML B3_WU350-092_d0_lipid_pos.mzML B3_WU350-092_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=27.4; Age at Symptom onset (years)=72; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=173.3; D-dimer=4316; Neutrophil %=81.3; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=1.7; Lymphocyte %=11.4; IL1b=1.47; IL10=16.15; IL6=60.26; RANTES=825.37; MIP1a=14.5; GMCSF=2.14; MCP1=136.77; IL15=66.09; HGF=1394.37; VEGF=1.33; IL1Ra=411.28; IL2R=112.82; MIG=36.02; IL8=12.41 SUBJECT_SAMPLE_FACTORS WU350-093 B3_WU350-093_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-093_d0_polar_pos.mzML B3_WU350-093_d0_polar_neg.mzML B3_WU350-093_d0_lipid_pos.mzML B3_WU350-093_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=28.3; Age at Symptom onset (years)=84.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=158.3; D-dimer=1406; Neutrophil %=89.2; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=84.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.1; Lymphocyte %=2.4; IL1b=1.42; IL10=32.88; IL6=80.32; RANTES=894.94; MIP1a=14.5; GMCSF=1.78; MCP1=271.9; IL15=40.05; HGF=204.89; VEGF=1.05; IL1Ra=119.84; IL2R=143.6; MIG=292.72; IL8=32.33 SUBJECT_SAMPLE_FACTORS WU350-094 B3_WU350-094_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-094_d0_polar_pos.mzML B3_WU350-094_d0_polar_neg.mzML B3_WU350-094_d0_lipid_pos.mzML B3_WU350-094_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=33.1; Age at Symptom onset (years)=37.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=42.5; D-dimer=1975; Neutrophil %=66.9; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=37.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.7; Lymphocyte absolute=1.7; Lymphocyte %=30; IL1b=0.99; IL10=516.35; IL6=17.62; RANTES=713.3; MIP1a=14.5; GMCSF=48.31; MCP1=445.04; IL15=0.96; HGF=356.33; VEGF=0.46; IL1Ra=49.52; IL2R=53.41; MIG=27.01; IL8=13.89 SUBJECT_SAMPLE_FACTORS WU350-096 B3_WU350-096_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-096_d0_polar_pos.mzML B3_WU350-096_d0_polar_neg.mzML B3_WU350-096_d0_lipid_pos.mzML B3_WU350-096_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=28.1; Age at Symptom onset (years)=90; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=5131; Neutrophil %=78.8; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=90; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.6; Lymphocyte absolute=1.8; Lymphocyte %=14.4; IL1b=0.92; IL10=24.17; IL6=20.49; RANTES=601.48; MIP1a=14.5; GMCSF=1.4; MCP1=616.67; IL15=21.57; HGF=2938.13; VEGF=1.17; IL1Ra=73.44; IL2R=50.56; MIG=113.7; IL8=11.27 SUBJECT_SAMPLE_FACTORS WU350-106 B3_WU350-106_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-106_d0_polar_pos.mzML B3_WU350-106_d0_polar_neg.mzML B3_WU350-106_d0_lipid_pos.mzML B3_WU350-106_d0_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=31.7; Age at Symptom onset (years)=57.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=196.4; D-dimer=1164; Neutrophil %=77.4; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1.1; Lymphocyte %=13.7; IL1b=0.6; IL10=10.01; IL6=37.52; RANTES=1826.2; MIP1a=10.89; GMCSF=0.27; MCP1=229.01; IL15=131.62; HGF=112.06; VEGF=0.21; IL1Ra=20.76; IL2R=36.88; MIG=14.71; IL8=5.44 SUBJECT_SAMPLE_FACTORS WU350-111 B3_WU350-111_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-111_d0_polar_pos.mzML B3_WU350-111_d0_polar_neg.mzML B3_WU350-111_d0_lipid_pos.mzML B3_WU350-111_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=40.1; Age at Symptom onset (years)=71; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=171.1; D-dimer=1557; Neutrophil %=56.2; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=71; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=1.3; Lymphocyte %=26.5; IL1b=1.81; IL10=19315.06; IL6=4723.81; RANTES=1400.03; MIP1a=10.89; GMCSF=1245.73; MCP1=305.08; IL15=248.81; HGF=2480.88; VEGF=6.66; IL1Ra=259.63; IL2R=156.45; MIG=57.67; IL8=14.17 SUBJECT_SAMPLE_FACTORS WU350-115 B3_WU350-115_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-115_d0_polar_pos.mzML B3_WU350-115_d0_polar_neg.mzML B3_WU350-115_d0_lipid_pos.mzML B3_WU350-115_d0_lipid_neg.mzML; Days post symptom onset=25; Sex=Male; BMI=19.9; Age at Symptom onset (years)=87.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=25; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=242.3; D-dimer=1238; Neutrophil %=88.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=87.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=26.1; Lymphocyte absolute=0.7; Lymphocyte %=3.5; IL1b=1.37; IL10=57.36; IL6=340.48; RANTES=1605; MIP1a=10.89; GMCSF=26.17; MCP1=80.73; IL15=7.72; HGF=6993.84; VEGF=5.87; IL1Ra=1456.62; IL2R=113.3; MIG=16.97; IL8=18.8 SUBJECT_SAMPLE_FACTORS WU350-120 B3_WU350-120_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-120_d0_polar_pos.mzML B3_WU350-120_d0_polar_neg.mzML B3_WU350-120_d0_lipid_pos.mzML B3_WU350-120_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=25.3; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=114; D-dimer=2563; Neutrophil %=78.3; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=14.3; IL1b=2.23; IL10=25.64; IL6=139.91; RANTES=1284.8; MIP1a=10.89; GMCSF=0.23; MCP1=1917.63; IL15=12.66; HGF=6337.89; VEGF=3.34; IL1Ra=234.58; IL2R=113.32; MIG=60.67; IL8=24.21 SUBJECT_SAMPLE_FACTORS WU350-121 B3_WU350-121_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-121_d0_polar_pos.mzML B3_WU350-121_d0_polar_neg.mzML B3_WU350-121_d0_lipid_pos.mzML B3_WU350-121_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=26.9; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=198.5; D-dimer=1069; Neutrophil %=89.1; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=15.7; Lymphocyte absolute=1.2; Lymphocyte %=6.8; IL1b=1.29; IL10=0.8; IL6=51.14; RANTES=651.27; MIP1a=10.89; GMCSF=0.07; MCP1=590.86; IL15=3.81; HGF=2229.49; VEGF=5.56; IL1Ra=217.35; IL2R=32.94; MIG=18.77; IL8=11.27 SUBJECT_SAMPLE_FACTORS WU350-124 B3_WU350-124_d0 batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-124_d0_polar_pos.mzML B3_WU350-124_d0_polar_neg.mzML B3_WU350-124_d0_lipid_pos.mzML B3_WU350-124_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=23.3; Age at Symptom onset (years)=72.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50.5; D-dimer=17479; Neutrophil %=63.8; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.5; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=1.5; Lymphocyte absolute=0.7; Lymphocyte %=31.4; IL1b=1.28; IL10=25.5; IL6=51.74; RANTES=909.5; MIP1a=10.89; GMCSF=12.09; MCP1=760.94; IL15=106.76; HGF=359.68; VEGF=0.7; IL1Ra=73.1; IL2R=55.72; MIG=25.32; IL8=27.68 SUBJECT_SAMPLE_FACTORS WU350-089 B3_WU350-089_d14 batch:3 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-089_d14_polar_pos.mzML B3_WU350-089_d14_polar_neg.mzML B3_WU350-089_d14_lipid_pos.mzML B3_WU350-089_d14_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=28.4; Age at Symptom onset (years)=55.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=38.4; D-dimer=-1; Neutrophil %=47.6; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.9; Lymphocyte %=39.8; IL1b=1.32; IL10=105.21; IL6=32.85; RANTES=912.49; MIP1a=74.01; GMCSF=2.13; MCP1=1017.09; IL15=769.58; HGF=829.71; VEGF=8.79; IL1Ra=77.84; IL2R=163.2; MIG=21.98; IL8=51.01 SUBJECT_SAMPLE_FACTORS WU350-092 B3_WU350-092_d14 batch:3 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-092_d14_polar_pos.mzML B3_WU350-092_d14_polar_neg.mzML B3_WU350-092_d14_lipid_pos.mzML B3_WU350-092_d14_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=27.4; Age at Symptom onset (years)=72; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=173.3; D-dimer=4316; Neutrophil %=81.3; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=1.7; Lymphocyte %=11.4; IL1b=1.47; IL10=16.15; IL6=60.26; RANTES=825.37; MIP1a=14.5; GMCSF=2.14; MCP1=136.77; IL15=66.09; HGF=1394.37; VEGF=1.33; IL1Ra=411.28; IL2R=112.82; MIG=36.02; IL8=12.41 SUBJECT_SAMPLE_FACTORS WU350-086 B3_WU350-086_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-086_d3_polar_pos.mzML B3_WU350-086_d3_polar_neg.mzML B3_WU350-086_d3_lipid_pos.mzML B3_WU350-086_d3_lipid_neg.mzML; Days post symptom onset=17; Sex=Female; BMI=42.8; Age at Symptom onset (years)=44.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=138.6; D-dimer=1199; Neutrophil %=71.8; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=44.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=1.8; Lymphocyte %=23.8; IL1b=1.03; IL10=42.12; IL6=11.57; RANTES=355.93; MIP1a=14.5; GMCSF=5.34; MCP1=313.19; IL15=51.92; HGF=216.01; VEGF=0.91; IL1Ra=57.5; IL2R=52.24; MIG=34.42; IL8=13.57 SUBJECT_SAMPLE_FACTORS WU350-091 B3_WU350-091_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-091_d3_polar_pos.mzML B3_WU350-091_d3_polar_neg.mzML B3_WU350-091_d3_lipid_pos.mzML B3_WU350-091_d3_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=25.4; Age at Symptom onset (years)=92.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=279; D-dimer=877; Neutrophil %=86; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=92.7; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.6; Lymphocyte absolute=1; Lymphocyte %=8.6; IL1b=0.83; IL10=25.74; IL6=158.01; RANTES=759.58; MIP1a=14.5; GMCSF=1.9; MCP1=1224.4; IL15=18.19; HGF=920.84; VEGF=0.23; IL1Ra=89.87; IL2R=109.26; MIG=54.31; IL8=21.46 SUBJECT_SAMPLE_FACTORS WU350-100 B3_WU350-100_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-100_d3_polar_pos.mzML B3_WU350-100_d3_polar_neg.mzML B3_WU350-100_d3_lipid_pos.mzML B3_WU350-100_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=33.2; Age at Symptom onset (years)=44.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=70.9; D-dimer=423; Neutrophil %=75.9; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=44.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1; Lymphocyte %=18.2; IL1b=0.92; IL10=12.49; IL6=9.93; RANTES=676.38; MIP1a=14.5; GMCSF=4.08; MCP1=174.36; IL15=23.6; HGF=169.68; VEGF=0.89; IL1Ra=57.81; IL2R=52.54; MIG=32.16; IL8=12.21 SUBJECT_SAMPLE_FACTORS WU350-107 B3_WU350-107_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-107_d3_polar_pos.mzML B3_WU350-107_d3_polar_neg.mzML B3_WU350-107_d3_lipid_pos.mzML B3_WU350-107_d3_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=23.9; Age at Symptom onset (years)=64.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=108.4; D-dimer=427; Neutrophil %=67.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=1; Lymphocyte %=26; IL1b=1.41; IL10=12.69; IL6=56.41; RANTES=1160.65; MIP1a=10.89; GMCSF=1.04; MCP1=285.87; IL15=25.47; HGF=125.24; VEGF=10.66; IL1Ra=83.56; IL2R=42.17; MIG=27.16; IL8=18.58 SUBJECT_SAMPLE_FACTORS WU350-108 B3_WU350-108_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-108_d3_polar_pos.mzML B3_WU350-108_d3_polar_neg.mzML B3_WU350-108_d3_lipid_pos.mzML B3_WU350-108_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=26.9; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=97.7; D-dimer=2483; Neutrophil %=56.6; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=54.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.3; Lymphocyte absolute=0.6; Lymphocyte %=25.8; IL1b=1.94; IL10=16.92; IL6=217.54; RANTES=1607.09; MIP1a=10.89; GMCSF=1.97; MCP1=416.58; IL15=73.76; HGF=290.74; VEGF=0.78; IL1Ra=622.26; IL2R=787.1; MIG=338.38; IL8=138.58 SUBJECT_SAMPLE_FACTORS WU350-109 B3_WU350-109_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-109_d3_polar_pos.mzML B3_WU350-109_d3_polar_neg.mzML B3_WU350-109_d3_lipid_pos.mzML B3_WU350-109_d3_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=19.4; Age at Symptom onset (years)=70.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1086; Neutrophil %=73.8; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=70.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=1.1; Lymphocyte %=21.2; IL1b=0.76; IL10=2.43; IL6=42.55; RANTES=697.32; MIP1a=25.73; GMCSF=1.01; MCP1=1069.3; IL15=11.41; HGF=329.45; VEGF=0.5; IL1Ra=66.34; IL2R=88.32; MIG=55.68; IL8=30.97 SUBJECT_SAMPLE_FACTORS WU350-113 B3_WU350-113_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-113_d3_polar_pos.mzML B3_WU350-113_d3_polar_neg.mzML B3_WU350-113_d3_lipid_pos.mzML B3_WU350-113_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=32; Age at Symptom onset (years)=39.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=60.1; D-dimer=626; Neutrophil %=68.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=0.9; Lymphocyte %=16.3; IL1b=1.28; IL10=19.47; IL6=15.18; RANTES=1062.45; MIP1a=10.89; GMCSF=7.76; MCP1=120.23; IL15=3.81; HGF=230.91; VEGF=1.43; IL1Ra=63.77; IL2R=25.8; MIG=24.21; IL8=18.35 SUBJECT_SAMPLE_FACTORS WU350-117 B3_WU350-117_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-117_d3_polar_pos.mzML B3_WU350-117_d3_polar_neg.mzML B3_WU350-117_d3_lipid_pos.mzML B3_WU350-117_d3_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-066 B3_WU350-066_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-066_d3_polar_pos.mzML B3_WU350-066_d3_polar_neg.mzML B3_WU350-066_d3_lipid_pos.mzML B3_WU350-066_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=33; Age at Symptom onset (years)=78.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=56.1; D-dimer=7530; Neutrophil %=77.8; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=78.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=0.8; Lymphocyte %=8.3; IL1b=0.506239542; IL10=42.12479483; IL6=539.3767004; RANTES=551.8982022; MIP1a=13.31823221; GMCSF=0.255281731; MCP1=1608.628052; IL15=113.4319001; HGF=1201.455195; VEGF=2.175378355; IL1Ra=255.4277944; IL2R=1053.501117; MIG=45.04891946; IL8=153.9742537 SUBJECT_SAMPLE_FACTORS WU350-072 B3_WU350-072_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-072_d3_polar_pos.mzML B3_WU350-072_d3_polar_neg.mzML B3_WU350-072_d3_lipid_pos.mzML B3_WU350-072_d3_lipid_neg.mzML; Days post symptom onset=20; Sex=Female; BMI=21.3; Age at Symptom onset (years)=67.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.4; D-dimer=3738; Neutrophil %=86.1; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=67.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.1; Lymphocyte absolute=1.1; Lymphocyte %=9.3; IL1b=0.963949583; IL10=77.97420703; IL6=13.96370065; RANTES=681.4308192; MIP1a=12.79575172; GMCSF=4.877538; MCP1=270.8415139; IL15=31.40843919; HGF=210.5168437; VEGF=3.856480788; IL1Ra=42.9332641; IL2R=127.091718; MIG=103.8567413; IL8=12.49578438 SUBJECT_SAMPLE_FACTORS WU350-074 B3_WU350-074_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-074_d3_polar_pos.mzML B3_WU350-074_d3_polar_neg.mzML B3_WU350-074_d3_lipid_pos.mzML B3_WU350-074_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=41.7; Age at Symptom onset (years)=56.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=187.5; D-dimer=3388; Neutrophil %=88.5; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=56.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=8.8; IL1b=0.257980243; IL10=16.21207497; IL6=27.52503112; RANTES=806.2575664; MIP1a=<0.22; GMCSF=0.414226173; MCP1=364.8302458; IL15=22.406341; HGF=8733.703795; VEGF=0.19258002; IL1Ra=117.0960047; IL2R=416.9873133; MIG=38.48497883; IL8=30.65561761 SUBJECT_SAMPLE_FACTORS WU350-075 B3_WU350-075_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-075_d3_polar_pos.mzML B3_WU350-075_d3_polar_neg.mzML B3_WU350-075_d3_lipid_pos.mzML B3_WU350-075_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=29.7; Age at Symptom onset (years)=68.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=50.1; D-dimer=1349; Neutrophil %=76.3; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.2; IL1b=2.645579979; IL10=830.3448631; IL6=66.89600902; RANTES=8300.207348; MIP1a=427.9377316; GMCSF=2.23242763; MCP1=1410.619273; IL15=171.6701414; HGF=686.0749079; VEGF=17.77486454; IL1Ra=372.4106983; IL2R=79.00644588; MIG=254.9832011; IL8=26.40764502 SUBJECT_SAMPLE_FACTORS WU350-085 B3_WU350-085_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-085_d3_polar_pos.mzML B3_WU350-085_d3_polar_neg.mzML B3_WU350-085_d3_lipid_pos.mzML B3_WU350-085_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=39.2; Age at Symptom onset (years)=77.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=203.7; D-dimer=3351; Neutrophil %=72.9; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=77.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=1.5; Lymphocyte %=16.5; IL1b=0.99248081; IL10=21.31129537; IL6=56.76525997; RANTES=488.7568524; MIP1a=6.061502294; GMCSF=1.745429593; MCP1=693.4912039; IL15=29.77027358; HGF=418.6779789; VEGF=2.247215749; IL1Ra=254.554167; IL2R=87.30009344; MIG=68.30613004; IL8=19.05509097 SUBJECT_SAMPLE_FACTORS WU350-087 B3_WU350-087_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-087_d3_polar_pos.mzML B3_WU350-087_d3_polar_neg.mzML B3_WU350-087_d3_lipid_pos.mzML B3_WU350-087_d3_lipid_neg.mzML; Days post symptom onset=30; Sex=Male; BMI=38.2; Age at Symptom onset (years)=69.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=17; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=215.7; D-dimer=5760; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.89; IL10=21.24; IL6=65.06; RANTES=14110; MIP1a=14.5; GMCSF=1.84; MCP1=445.67; IL15=20.83; HGF=11195.44; VEGF=2.65; IL1Ra=279.5; IL2R=127.96; MIG=355.82; IL8=42.25 SUBJECT_SAMPLE_FACTORS WU350-088 B3_WU350-088_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-088_d3_polar_pos.mzML B3_WU350-088_d3_polar_neg.mzML B3_WU350-088_d3_lipid_pos.mzML B3_WU350-088_d3_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=290; D-dimer=31308; Neutrophil %=88.8; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=0.4; Lymphocyte %=3.8; IL1b=0.92; IL10=34.59; IL6=288.69; RANTES=812.7; MIP1a=14.5; GMCSF=2.21; MCP1=3091.83; IL15=30.38; HGF=1072.26; VEGF=5.27; IL1Ra=174.1; IL2R=180.41; MIG=-; IL8=47.58 SUBJECT_SAMPLE_FACTORS WU350-089 B3_WU350-089_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-089_d3_polar_pos.mzML B3_WU350-089_d3_polar_neg.mzML B3_WU350-089_d3_lipid_pos.mzML B3_WU350-089_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=28.4; Age at Symptom onset (years)=55.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=38.4; D-dimer=-1; Neutrophil %=47.6; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.9; Lymphocyte %=39.8; IL1b=1.32; IL10=105.21; IL6=32.85; RANTES=912.49; MIP1a=74.01; GMCSF=2.13; MCP1=1017.09; IL15=769.58; HGF=829.71; VEGF=8.79; IL1Ra=77.84; IL2R=163.2; MIG=21.98; IL8=51.01 SUBJECT_SAMPLE_FACTORS WU350-093 B3_WU350-093_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-093_d3_polar_pos.mzML B3_WU350-093_d3_polar_neg.mzML B3_WU350-093_d3_lipid_pos.mzML B3_WU350-093_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=28.3; Age at Symptom onset (years)=84.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=158.3; D-dimer=1406; Neutrophil %=89.2; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=84.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.1; Lymphocyte %=2.4; IL1b=1.42; IL10=32.88; IL6=80.32; RANTES=894.94; MIP1a=14.5; GMCSF=1.78; MCP1=271.9; IL15=40.05; HGF=204.89; VEGF=1.05; IL1Ra=119.84; IL2R=143.6; MIG=292.72; IL8=32.33 SUBJECT_SAMPLE_FACTORS WU350-096 B3_WU350-096_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-096_d3_polar_pos.mzML B3_WU350-096_d3_polar_neg.mzML B3_WU350-096_d3_lipid_pos.mzML B3_WU350-096_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=28.1; Age at Symptom onset (years)=90; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=5131; Neutrophil %=78.8; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=90; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.6; Lymphocyte absolute=1.8; Lymphocyte %=14.4; IL1b=0.92; IL10=24.17; IL6=20.49; RANTES=601.48; MIP1a=14.5; GMCSF=1.4; MCP1=616.67; IL15=21.57; HGF=2938.13; VEGF=1.17; IL1Ra=73.44; IL2R=50.56; MIG=113.7; IL8=11.27 SUBJECT_SAMPLE_FACTORS WU350-106 B3_WU350-106_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-106_d3_polar_pos.mzML B3_WU350-106_d3_polar_neg.mzML B3_WU350-106_d3_lipid_pos.mzML B3_WU350-106_d3_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=31.7; Age at Symptom onset (years)=57.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=196.4; D-dimer=1164; Neutrophil %=77.4; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1.1; Lymphocyte %=13.7; IL1b=0.6; IL10=10.01; IL6=37.52; RANTES=1826.2; MIP1a=10.89; GMCSF=0.27; MCP1=229.01; IL15=131.62; HGF=112.06; VEGF=0.21; IL1Ra=20.76; IL2R=36.88; MIG=14.71; IL8=5.44 SUBJECT_SAMPLE_FACTORS WU350-115 B3_WU350-115_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-115_d3_polar_pos.mzML B3_WU350-115_d3_polar_neg.mzML B3_WU350-115_d3_lipid_pos.mzML B3_WU350-115_d3_lipid_neg.mzML; Days post symptom onset=28; Sex=Male; BMI=19.9; Age at Symptom onset (years)=87.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=25; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=242.3; D-dimer=1238; Neutrophil %=88.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=87.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=26.1; Lymphocyte absolute=0.7; Lymphocyte %=3.5; IL1b=1.37; IL10=57.36; IL6=340.48; RANTES=1605; MIP1a=10.89; GMCSF=26.17; MCP1=80.73; IL15=7.72; HGF=6993.84; VEGF=5.87; IL1Ra=1456.62; IL2R=113.3; MIG=16.97; IL8=18.8 SUBJECT_SAMPLE_FACTORS WU350-120 B3_WU350-120_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-120_d3_polar_pos.mzML B3_WU350-120_d3_polar_neg.mzML B3_WU350-120_d3_lipid_pos.mzML B3_WU350-120_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=25.3; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=114; D-dimer=2563; Neutrophil %=78.3; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=14.3; IL1b=2.23; IL10=25.64; IL6=139.91; RANTES=1284.8; MIP1a=10.89; GMCSF=0.23; MCP1=1917.63; IL15=12.66; HGF=6337.89; VEGF=3.34; IL1Ra=234.58; IL2R=113.32; MIG=60.67; IL8=24.21 SUBJECT_SAMPLE_FACTORS WU350-121 B3_WU350-121_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-121_d3_polar_pos.mzML B3_WU350-121_d3_polar_neg.mzML B3_WU350-121_d3_lipid_pos.mzML B3_WU350-121_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=26.9; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=198.5; D-dimer=1069; Neutrophil %=89.1; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=15.7; Lymphocyte absolute=1.2; Lymphocyte %=6.8; IL1b=1.29; IL10=0.8; IL6=51.14; RANTES=651.27; MIP1a=10.89; GMCSF=0.07; MCP1=590.86; IL15=3.81; HGF=2229.49; VEGF=5.56; IL1Ra=217.35; IL2R=32.94; MIG=18.77; IL8=11.27 SUBJECT_SAMPLE_FACTORS WU350-124 B3_WU350-124_d3 batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-124_d3_polar_pos.mzML B3_WU350-124_d3_polar_neg.mzML B3_WU350-124_d3_lipid_pos.mzML B3_WU350-124_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=23.3; Age at Symptom onset (years)=72.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50.5; D-dimer=17479; Neutrophil %=63.8; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.5; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=1.5; Lymphocyte absolute=0.7; Lymphocyte %=31.4; IL1b=1.28; IL10=25.5; IL6=51.74; RANTES=909.5; MIP1a=10.89; GMCSF=12.09; MCP1=760.94; IL15=106.76; HGF=359.68; VEGF=0.7; IL1Ra=73.1; IL2R=55.72; MIG=25.32; IL8=27.68 SUBJECT_SAMPLE_FACTORS WU350-107 B3_WU350-107_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-107_d7_polar_pos.mzML B3_WU350-107_d7_polar_neg.mzML B3_WU350-107_d7_lipid_pos.mzML B3_WU350-107_d7_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=23.9; Age at Symptom onset (years)=64.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=108.4; D-dimer=427; Neutrophil %=67.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=1; Lymphocyte %=26; IL1b=1.41; IL10=12.69; IL6=56.41; RANTES=1160.65; MIP1a=10.89; GMCSF=1.04; MCP1=285.87; IL15=25.47; HGF=125.24; VEGF=10.66; IL1Ra=83.56; IL2R=42.17; MIG=27.16; IL8=18.58 SUBJECT_SAMPLE_FACTORS WU350-108 B3_WU350-108_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-108_d7_polar_pos.mzML B3_WU350-108_d7_polar_neg.mzML B3_WU350-108_d7_lipid_pos.mzML B3_WU350-108_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=26.9; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=97.7; D-dimer=2483; Neutrophil %=56.6; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=54.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.3; Lymphocyte absolute=0.6; Lymphocyte %=25.8; IL1b=1.94; IL10=16.92; IL6=217.54; RANTES=1607.09; MIP1a=10.89; GMCSF=1.97; MCP1=416.58; IL15=73.76; HGF=290.74; VEGF=0.78; IL1Ra=622.26; IL2R=787.1; MIG=338.38; IL8=138.58 SUBJECT_SAMPLE_FACTORS WU350-117 B3_WU350-117_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-117_d7_polar_pos.mzML B3_WU350-117_d7_polar_neg.mzML B3_WU350-117_d7_lipid_pos.mzML B3_WU350-117_d7_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-072 B3_WU350-072_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-072_d7_polar_pos.mzML B3_WU350-072_d7_polar_neg.mzML B3_WU350-072_d7_lipid_pos.mzML B3_WU350-072_d7_lipid_neg.mzML; Days post symptom onset=24; Sex=Female; BMI=21.3; Age at Symptom onset (years)=67.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.4; D-dimer=3738; Neutrophil %=86.1; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=67.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.1; Lymphocyte absolute=1.1; Lymphocyte %=9.3; IL1b=0.963949583; IL10=77.97420703; IL6=13.96370065; RANTES=681.4308192; MIP1a=12.79575172; GMCSF=4.877538; MCP1=270.8415139; IL15=31.40843919; HGF=210.5168437; VEGF=3.856480788; IL1Ra=42.9332641; IL2R=127.091718; MIG=103.8567413; IL8=12.49578438 SUBJECT_SAMPLE_FACTORS WU350-074 B3_WU350-074_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-074_d7_polar_pos.mzML B3_WU350-074_d7_polar_neg.mzML B3_WU350-074_d7_lipid_pos.mzML B3_WU350-074_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=41.7; Age at Symptom onset (years)=56.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=187.5; D-dimer=3388; Neutrophil %=88.5; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=56.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=8.8; IL1b=0.257980243; IL10=16.21207497; IL6=27.52503112; RANTES=806.2575664; MIP1a=<0.22; GMCSF=0.414226173; MCP1=364.8302458; IL15=22.406341; HGF=8733.703795; VEGF=0.19258002; IL1Ra=117.0960047; IL2R=416.9873133; MIG=38.48497883; IL8=30.65561761 SUBJECT_SAMPLE_FACTORS WU350-075 B3_WU350-075_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-075_d7_polar_pos.mzML B3_WU350-075_d7_polar_neg.mzML B3_WU350-075_d7_lipid_pos.mzML B3_WU350-075_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=29.7; Age at Symptom onset (years)=68.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=50.1; D-dimer=1349; Neutrophil %=76.3; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.2; IL1b=2.645579979; IL10=830.3448631; IL6=66.89600902; RANTES=8300.207348; MIP1a=427.9377316; GMCSF=2.23242763; MCP1=1410.619273; IL15=171.6701414; HGF=686.0749079; VEGF=17.77486454; IL1Ra=372.4106983; IL2R=79.00644588; MIG=254.9832011; IL8=26.40764502 SUBJECT_SAMPLE_FACTORS WU350-085 B3_WU350-085_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-085_d7_polar_pos.mzML B3_WU350-085_d7_polar_neg.mzML B3_WU350-085_d7_lipid_pos.mzML B3_WU350-085_d7_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=39.2; Age at Symptom onset (years)=77.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=203.7; D-dimer=3351; Neutrophil %=72.9; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=77.1; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=1.5; Lymphocyte %=16.5; IL1b=0.99248081; IL10=21.31129537; IL6=56.76525997; RANTES=488.7568524; MIP1a=6.061502294; GMCSF=1.745429593; MCP1=693.4912039; IL15=29.77027358; HGF=418.6779789; VEGF=2.247215749; IL1Ra=254.554167; IL2R=87.30009344; MIG=68.30613004; IL8=19.05509097 SUBJECT_SAMPLE_FACTORS WU350-087 B3_WU350-087_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-087_d7_polar_pos.mzML B3_WU350-087_d7_polar_neg.mzML B3_WU350-087_d7_lipid_pos.mzML B3_WU350-087_d7_lipid_neg.mzML; Days post symptom onset=34; Sex=Male; BMI=38.2; Age at Symptom onset (years)=69.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=17; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=215.7; D-dimer=5760; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.89; IL10=21.24; IL6=65.06; RANTES=14110; MIP1a=14.5; GMCSF=1.84; MCP1=445.67; IL15=20.83; HGF=11195.44; VEGF=2.65; IL1Ra=279.5; IL2R=127.96; MIG=355.82; IL8=42.25 SUBJECT_SAMPLE_FACTORS WU350-092 B3_WU350-092_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-092_d7_polar_pos.mzML B3_WU350-092_d7_polar_neg.mzML B3_WU350-092_d7_lipid_pos.mzML B3_WU350-092_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=27.4; Age at Symptom onset (years)=72; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=173.3; D-dimer=4316; Neutrophil %=81.3; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=1.7; Lymphocyte %=11.4; IL1b=1.47; IL10=16.15; IL6=60.26; RANTES=825.37; MIP1a=14.5; GMCSF=2.14; MCP1=136.77; IL15=66.09; HGF=1394.37; VEGF=1.33; IL1Ra=411.28; IL2R=112.82; MIG=36.02; IL8=12.41 SUBJECT_SAMPLE_FACTORS WU350-093 B3_WU350-093_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-093_d7_polar_pos.mzML B3_WU350-093_d7_polar_neg.mzML B3_WU350-093_d7_lipid_pos.mzML B3_WU350-093_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=28.3; Age at Symptom onset (years)=84.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=158.3; D-dimer=1406; Neutrophil %=89.2; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=84.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.1; Lymphocyte %=2.4; IL1b=1.42; IL10=32.88; IL6=80.32; RANTES=894.94; MIP1a=14.5; GMCSF=1.78; MCP1=271.9; IL15=40.05; HGF=204.89; VEGF=1.05; IL1Ra=119.84; IL2R=143.6; MIG=292.72; IL8=32.33 SUBJECT_SAMPLE_FACTORS WU350-111 B3_WU350-111_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-111_d7_polar_pos.mzML B3_WU350-111_d7_polar_neg.mzML B3_WU350-111_d7_lipid_pos.mzML B3_WU350-111_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Female; BMI=40.1; Age at Symptom onset (years)=71; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=171.1; D-dimer=1557; Neutrophil %=56.2; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=71; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=1.3; Lymphocyte %=26.5; IL1b=1.81; IL10=19315.06; IL6=4723.81; RANTES=1400.03; MIP1a=10.89; GMCSF=1245.73; MCP1=305.08; IL15=248.81; HGF=2480.88; VEGF=6.66; IL1Ra=259.63; IL2R=156.45; MIG=57.67; IL8=14.17 SUBJECT_SAMPLE_FACTORS WU350-115 B3_WU350-115_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-115_d7_polar_pos.mzML B3_WU350-115_d7_polar_neg.mzML B3_WU350-115_d7_lipid_pos.mzML B3_WU350-115_d7_lipid_neg.mzML; Days post symptom onset=32; Sex=Male; BMI=19.9; Age at Symptom onset (years)=87.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=25; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=242.3; D-dimer=1238; Neutrophil %=88.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=87.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=26.1; Lymphocyte absolute=0.7; Lymphocyte %=3.5; IL1b=1.37; IL10=57.36; IL6=340.48; RANTES=1605; MIP1a=10.89; GMCSF=26.17; MCP1=80.73; IL15=7.72; HGF=6993.84; VEGF=5.87; IL1Ra=1456.62; IL2R=113.3; MIG=16.97; IL8=18.8 SUBJECT_SAMPLE_FACTORS WU350-120 B3_WU350-120_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-120_d7_polar_pos.mzML B3_WU350-120_d7_polar_neg.mzML B3_WU350-120_d7_lipid_pos.mzML B3_WU350-120_d7_lipid_neg.mzML; Days post symptom onset=12; Sex=Female; BMI=25.3; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=114; D-dimer=2563; Neutrophil %=78.3; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=14.3; IL1b=2.23; IL10=25.64; IL6=139.91; RANTES=1284.8; MIP1a=10.89; GMCSF=0.23; MCP1=1917.63; IL15=12.66; HGF=6337.89; VEGF=3.34; IL1Ra=234.58; IL2R=113.32; MIG=60.67; IL8=24.21 SUBJECT_SAMPLE_FACTORS WU350-121 B3_WU350-121_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-121_d7_polar_pos.mzML B3_WU350-121_d7_polar_neg.mzML B3_WU350-121_d7_lipid_pos.mzML B3_WU350-121_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=26.9; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=198.5; D-dimer=1069; Neutrophil %=89.1; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=15.7; Lymphocyte absolute=1.2; Lymphocyte %=6.8; IL1b=1.29; IL10=0.8; IL6=51.14; RANTES=651.27; MIP1a=10.89; GMCSF=0.07; MCP1=590.86; IL15=3.81; HGF=2229.49; VEGF=5.56; IL1Ra=217.35; IL2R=32.94; MIG=18.77; IL8=11.27 SUBJECT_SAMPLE_FACTORS WU350-124 B3_WU350-124_d7 batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B3_WU350-124_d7_polar_pos.mzML B3_WU350-124_d7_polar_neg.mzML B3_WU350-124_d7_lipid_pos.mzML B3_WU350-124_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Female; BMI=23.3; Age at Symptom onset (years)=72.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50.5; D-dimer=17479; Neutrophil %=63.8; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.5; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=1.5; Lymphocyte absolute=0.7; Lymphocyte %=31.4; IL1b=1.28; IL10=25.5; IL6=51.74; RANTES=909.5; MIP1a=10.89; GMCSF=12.09; MCP1=760.94; IL15=106.76; HGF=359.68; VEGF=0.7; IL1Ra=73.1; IL2R=55.72; MIG=25.32; IL8=27.68 SUBJECT_SAMPLE_FACTORS WU350-118 B4_WU350-118_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-118_d0_polar_pos.mzML B4_WU350-118_d0_polar_neg.mzML B4_WU350-118_d0_lipid_pos.mzML B4_WU350-118_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=28.2; Age at Symptom onset (years)=19.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=19.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-133 B4_WU350-133_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-133_d0_polar_pos.mzML B4_WU350-133_d0_polar_neg.mzML B4_WU350-133_d0_lipid_pos.mzML B4_WU350-133_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=39.1; Age at Symptom onset (years)=25.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=25.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-136 B4_WU350-136_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-136_d0_polar_pos.mzML B4_WU350-136_d0_polar_neg.mzML B4_WU350-136_d0_lipid_pos.mzML B4_WU350-136_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=24.3; Age at Symptom onset (years)=22; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=22; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.2; Lymphocyte absolute=1.5; Lymphocyte %=36.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-141 B4_WU350-141_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-141_d0_polar_pos.mzML B4_WU350-141_d0_polar_neg.mzML B4_WU350-141_d0_lipid_pos.mzML B4_WU350-141_d0_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=41.7; Age at Symptom onset (years)=33.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=65.1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=33.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.9; Lymphocyte %=21.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-144 B4_WU350-144_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-144_d0_polar_pos.mzML B4_WU350-144_d0_polar_neg.mzML B4_WU350-144_d0_lipid_pos.mzML B4_WU350-144_d0_lipid_neg.mzML; Days post symptom onset=38; Sex=Female; BMI=18.1; Age at Symptom onset (years)=56.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=63.8; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=56.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=1.5; Lymphocyte %=23.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-150 B4_WU350-150_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-150_d0_polar_pos.mzML B4_WU350-150_d0_polar_neg.mzML B4_WU350-150_d0_lipid_pos.mzML B4_WU350-150_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=28.3; Age at Symptom onset (years)=49.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=56.9; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=49.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.8; Lymphocyte absolute=2.3; Lymphocyte %=34; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-162 B4_WU350-162_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-162_d0_polar_pos.mzML B4_WU350-162_d0_polar_neg.mzML B4_WU350-162_d0_lipid_pos.mzML B4_WU350-162_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=34.2; Age at Symptom onset (years)=57.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=54.9; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=1.7; Lymphocyte %=28.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-168 B4_WU350-168_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-168_d0_polar_pos.mzML B4_WU350-168_d0_polar_neg.mzML B4_WU350-168_d0_lipid_pos.mzML B4_WU350-168_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=34.9; Age at Symptom onset (years)=32.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-170 B4_WU350-170_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-170_d0_polar_pos.mzML B4_WU350-170_d0_polar_neg.mzML B4_WU350-170_d0_lipid_pos.mzML B4_WU350-170_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=-; Age at Symptom onset (years)=25.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.1; D-dimer=-1; Neutrophil %=66.8; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=25.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.2; Lymphocyte absolute=2.1; Lymphocyte %=26.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-177 B4_WU350-177_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-177_d0_polar_pos.mzML B4_WU350-177_d0_polar_neg.mzML B4_WU350-177_d0_lipid_pos.mzML B4_WU350-177_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=27.2; Age at Symptom onset (years)=40.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=68.4; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=40.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=3.1; Lymphocyte %=21.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-123 B4_WU350-123_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-123_d0_polar_pos.mzML B4_WU350-123_d0_polar_neg.mzML B4_WU350-123_d0_lipid_pos.mzML B4_WU350-123_d0_lipid_neg.mzML; Days post symptom onset=35; Sex=Female; BMI=33.3; Age at Symptom onset (years)=53.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=333; Neutrophil %=44.3; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=2.3; Lymphocyte %=42.6; IL1b=0.66; IL10=87.15; IL6=18.81; RANTES=1142.83; MIP1a=10.89; GMCSF=1.61; MCP1=84.01; IL15=3.81; HGF=31.1; VEGF=0.72; IL1Ra=37.04; IL2R=31.95; MIG=12.79; IL8=8.6 SUBJECT_SAMPLE_FACTORS WU350-122 B4_WU350-122_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-122_d0_polar_pos.mzML B4_WU350-122_d0_polar_neg.mzML B4_WU350-122_d0_lipid_pos.mzML B4_WU350-122_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=17.3; Age at Symptom onset (years)=74.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=193.7; D-dimer=-1; Neutrophil %=78.6; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=74.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.8; Lymphocyte absolute=1.9; Lymphocyte %=11.6; IL1b=4.68; IL10=95.68; IL6=76.89; RANTES=971.39; MIP1a=172.37; GMCSF=6.89; MCP1=765.88; IL15=1136.38; HGF=2620.81; VEGF=2.88; IL1Ra=87.82; IL2R=90.9; MIG=60.01; IL8=8.11 SUBJECT_SAMPLE_FACTORS WU350-127 B4_WU350-127_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-127_d0_polar_pos.mzML B4_WU350-127_d0_polar_neg.mzML B4_WU350-127_d0_lipid_pos.mzML B4_WU350-127_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=32.1; Age at Symptom onset (years)=27.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=60.3; D-dimer=3604; Neutrophil %=74.3; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=27.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=1.1; Lymphocyte %=19.2; IL1b=0.49; IL10=4.05; IL6=57.4; RANTES=1630.39; MIP1a=10.89; GMCSF=0.37; MCP1=101.2; IL15=5.88; HGF=144.96; VEGF=0.21; IL1Ra=41.43; IL2R=26.17; MIG=5.99; IL8=7.32 SUBJECT_SAMPLE_FACTORS WU350-128 B4_WU350-128_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-128_d0_polar_pos.mzML B4_WU350-128_d0_polar_neg.mzML B4_WU350-128_d0_lipid_pos.mzML B4_WU350-128_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=43.9; Age at Symptom onset (years)=27.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=78.1; D-dimer=1295; Neutrophil %=81.6; CO2=18; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=27.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=0.6; Lymphocyte %=9.7; IL1b=1.5; IL10=13.32; IL6=50.98; RANTES=951.68; MIP1a=10.89; GMCSF=1.79; MCP1=155.12; IL15=19.13; HGF=333.56; VEGF=5.71; IL1Ra=248.62; IL2R=11.41; MIG=12.51; IL8=14.02 SUBJECT_SAMPLE_FACTORS WU350-130 B4_WU350-130_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-130_d0_polar_pos.mzML B4_WU350-130_d0_polar_neg.mzML B4_WU350-130_d0_lipid_pos.mzML B4_WU350-130_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=26.6; Age at Symptom onset (years)=64.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=146; D-dimer=1196; Neutrophil %=76.7; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.4; IL1b=0.3; IL10=41.6; IL6=218.67; RANTES=596.22; MIP1a=10.89; GMCSF=13.93; MCP1=248.79; IL15=37.72; HGF=235.94; VEGF=1.35; IL1Ra=20.68; IL2R=15.46; MIG=14.99; IL8=11.81 SUBJECT_SAMPLE_FACTORS WU350-131 B4_WU350-131_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-131_d0_polar_pos.mzML B4_WU350-131_d0_polar_neg.mzML B4_WU350-131_d0_lipid_pos.mzML B4_WU350-131_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=32.9; Age at Symptom onset (years)=55.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=802; Neutrophil %=79.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.1; IL1b=1.37; IL10=37.53; IL6=39.84; RANTES=754.25; MIP1a=10.89; GMCSF=35.69; MCP1=165.72; IL15=8.45; HGF=966.84; VEGF=3.85; IL1Ra=70.66; IL2R=25.62; MIG=32.41; IL8=6.66 SUBJECT_SAMPLE_FACTORS WU350-132 B4_WU350-132_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-132_d0_polar_pos.mzML B4_WU350-132_d0_polar_neg.mzML B4_WU350-132_d0_lipid_pos.mzML B4_WU350-132_d0_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=22.1; Age at Symptom onset (years)=68.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.96; IL10=56.58; IL6=15.28; RANTES=468.77; MIP1a=2.27; GMCSF=3.43; MCP1=384.96; IL15=23.59; HGF=531.55; VEGF=2.9; IL1Ra=40.04; IL2R=117.27; MIG=55.08; IL8=8.16 SUBJECT_SAMPLE_FACTORS WU350-135 B4_WU350-135_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-135_d0_polar_pos.mzML B4_WU350-135_d0_polar_neg.mzML B4_WU350-135_d0_lipid_pos.mzML B4_WU350-135_d0_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=41.8; Age at Symptom onset (years)=58.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=64.5; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.9; Lymphocyte absolute=3.4; Lymphocyte %=27.8; IL1b=1.12; IL10=218.18; IL6=7.71; RANTES=335.51; MIP1a=95.61; GMCSF=1.75; MCP1=456.36; IL15=229.55; HGF=426.96; VEGF=3.41; IL1Ra=72.38; IL2R=98.38; MIG=8.24; IL8=25.12 SUBJECT_SAMPLE_FACTORS WU350-138 B4_WU350-138_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-138_d0_polar_pos.mzML B4_WU350-138_d0_polar_neg.mzML B4_WU350-138_d0_lipid_pos.mzML B4_WU350-138_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=41.5; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=176.6; D-dimer=1452; Neutrophil %=-1; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.24; IL10=15.92; IL6=29.31; RANTES=342.12; MIP1a=2.27; GMCSF=1.93; MCP1=307.79; IL15=7.86; HGF=2085.25; VEGF=8; IL1Ra=163.13; IL2R=162.69; MIG=36.85; IL8=95.52 SUBJECT_SAMPLE_FACTORS WU350-139 B4_WU350-139_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-139_d0_polar_pos.mzML B4_WU350-139_d0_polar_neg.mzML B4_WU350-139_d0_lipid_pos.mzML B4_WU350-139_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=30.2; Age at Symptom onset (years)=82.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=65.1; D-dimer=374; Neutrophil %=80.7; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=82.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=0.4; Lymphocyte %=10.6; IL1b=2.29; IL10=45.59; IL6=55.63; RANTES=565.73; MIP1a=2.27; GMCSF=0.87; MCP1=739.73; IL15=25.17; HGF=317.78; VEGF=3.29; IL1Ra=315.48; IL2R=214.63; MIG=66.88; IL8=30.85 SUBJECT_SAMPLE_FACTORS WU350-147 B4_WU350-147_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-147_d0_polar_pos.mzML B4_WU350-147_d0_polar_neg.mzML B4_WU350-147_d0_lipid_pos.mzML B4_WU350-147_d0_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=41.1; Age at Symptom onset (years)=76.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=202.3; D-dimer=22918; Neutrophil %=86.8; CO2=31; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=76.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.8; Lymphocyte absolute=0.8; Lymphocyte %=9.8; IL1b=1.32; IL10=17.22; IL6=115.84; RANTES=700.34; MIP1a=57.31; GMCSF=0.99; MCP1=1192.98; IL15=0.06; HGF=380.16; VEGF=1.53; IL1Ra=192.53; IL2R=61.16; MIG=110.69; IL8=41.21 SUBJECT_SAMPLE_FACTORS WU350-148 B4_WU350-148_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-148_d0_polar_pos.mzML B4_WU350-148_d0_polar_neg.mzML B4_WU350-148_d0_lipid_pos.mzML B4_WU350-148_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=24.9; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.4; D-dimer=1251; Neutrophil %=51.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=2.5; Lymphocyte %=40.7; IL1b=4.42; IL10=25.43; IL6=30.73; RANTES=1153.49; MIP1a=98.6; GMCSF=0.9; MCP1=487.04; IL15=67.82; HGF=364.74; VEGF=4.01; IL1Ra=126.76; IL2R=57.82; MIG=66.4; IL8=10.18 SUBJECT_SAMPLE_FACTORS WU350-151 B4_WU350-151_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-151_d0_polar_pos.mzML B4_WU350-151_d0_polar_neg.mzML B4_WU350-151_d0_lipid_pos.mzML B4_WU350-151_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=36.1; Age at Symptom onset (years)=62.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.4; D-dimer=629; Neutrophil %=80.9; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=62.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.3; Lymphocyte absolute=0.7; Lymphocyte %=11.3; IL1b=1.16; IL10=54.32; IL6=36.12; RANTES=537.01; MIP1a=2.27; GMCSF=0.86; MCP1=836.91; IL15=0.06; HGF=3234.35; VEGF=0.55; IL1Ra=144.82; IL2R=20.51; MIG=30.16; IL8=41.26 SUBJECT_SAMPLE_FACTORS WU350-153 B4_WU350-153_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-153_d0_polar_pos.mzML B4_WU350-153_d0_polar_neg.mzML B4_WU350-153_d0_lipid_pos.mzML B4_WU350-153_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=45.5; Age at Symptom onset (years)=59.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=168.3; D-dimer=7191; Neutrophil %=81.7; CO2=31; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=59.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.9; Lymphocyte absolute=1; Lymphocyte %=10; IL1b=3.51; IL10=2810.46; IL6=369.81; RANTES=601.84; MIP1a=577.82; GMCSF=731.35; MCP1=3406.98; IL15=6836.47; HGF=4892.58; VEGF=7.29; IL1Ra=638.89; IL2R=577.54; MIG=26.91; IL8=63.38 SUBJECT_SAMPLE_FACTORS WU350-156 B4_WU350-156_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-156_d0_polar_pos.mzML B4_WU350-156_d0_polar_neg.mzML B4_WU350-156_d0_lipid_pos.mzML B4_WU350-156_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=36.3; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=59.1; D-dimer=599; Neutrophil %=73.7; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.3; Lymphocyte absolute=1.7; Lymphocyte %=15.8; IL1b=0.97; IL10=57.18; IL6=32.22; RANTES=869.61; MIP1a=1.66; GMCSF=42; MCP1=150.43; IL15=6.86; HGF=2189.15; VEGF=12.22; IL1Ra=97.41; IL2R=55.99; MIG=49.2; IL8=11.82 SUBJECT_SAMPLE_FACTORS WU350-157 B4_WU350-157_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-157_d0_polar_pos.mzML B4_WU350-157_d0_polar_neg.mzML B4_WU350-157_d0_lipid_pos.mzML B4_WU350-157_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=32.7; Age at Symptom onset (years)=72.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=43.4; D-dimer=1921; Neutrophil %=53.4; CO2=30; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=2.6; Lymphocyte %=34.3; IL1b=1.57; IL10=3.47; IL6=14.82; RANTES=706.33; MIP1a=1.66; GMCSF=1.5; MCP1=353.62; IL15=3.41; HGF=675.36; VEGF=8.19; IL1Ra=118.33; IL2R=48.57; MIG=19.43; IL8=28 SUBJECT_SAMPLE_FACTORS WU350-158 B4_WU350-158_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-158_d0_polar_pos.mzML B4_WU350-158_d0_polar_neg.mzML B4_WU350-158_d0_lipid_pos.mzML B4_WU350-158_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=28; Age at Symptom onset (years)=65.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2090; Neutrophil %=67.5; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.8; Lymphocyte %=25.8; IL1b=1.31; IL10=29.85; IL6=15.1; RANTES=734.64; MIP1a=1.66; GMCSF=0.43; MCP1=137.77; IL15=22.6; HGF=6398.24; VEGF=0.49; IL1Ra=63.18; IL2R=619.06; MIG=205.42; IL8=20.25 SUBJECT_SAMPLE_FACTORS WU350-159 B4_WU350-159_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-159_d0_polar_pos.mzML B4_WU350-159_d0_polar_neg.mzML B4_WU350-159_d0_lipid_pos.mzML B4_WU350-159_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=25.9; Age at Symptom onset (years)=60.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=1012; Neutrophil %=64.4; CO2=17; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=60.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6.2; Lymphocyte absolute=2; Lymphocyte %=20.2; IL1b=0.27; IL10=1.12; IL6=12.03; RANTES=634.83; MIP1a=1.66; GMCSF=9.75; MCP1=301.53; IL15=39.93; HGF=325.73; VEGF=0.12; IL1Ra=48.46; IL2R=110.11; MIG=38.85; IL8=22.68 SUBJECT_SAMPLE_FACTORS WU350-164 B4_WU350-164_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-164_d0_polar_pos.mzML B4_WU350-164_d0_polar_neg.mzML B4_WU350-164_d0_lipid_pos.mzML B4_WU350-164_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=18.5; Age at Symptom onset (years)=38.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=11.8; D-dimer=706; Neutrophil %=74.8; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=38.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=1.2; Lymphocyte %=16.5; IL1b=1.31; IL10=4.34; IL6=9.7; RANTES=1017.03; MIP1a=1.66; GMCSF=0.02; MCP1=327.22; IL15=4.78; HGF=830.77; VEGF=4.47; IL1Ra=884.51; IL2R=44.91; MIG=7.92; IL8=225.88 SUBJECT_SAMPLE_FACTORS WU350-175 B4_WU350-175_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-175_d0_polar_pos.mzML B4_WU350-175_d0_polar_neg.mzML B4_WU350-175_d0_lipid_pos.mzML B4_WU350-175_d0_lipid_neg.mzML; Days post symptom onset=20; Sex=Male; BMI=28.9; Age at Symptom onset (years)=58.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2415; Neutrophil %=81.7; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=58.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=0.7; Lymphocyte %=9.9; IL1b=4.51; IL10=394.02; IL6=42.61; RANTES=746.78; MIP1a=92.94; GMCSF=2.14; MCP1=182.51; IL15=262.77; HGF=356.41; VEGF=2.19; IL1Ra=198.93; IL2R=86.58; MIG=8.91; IL8=25.92 SUBJECT_SAMPLE_FACTORS WU350-116 B4_WU350-116_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-116_d0_polar_pos.mzML B4_WU350-116_d0_polar_neg.mzML B4_WU350-116_d0_lipid_pos.mzML B4_WU350-116_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=21.6; Age at Symptom onset (years)=85.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=6540; Neutrophil %=81.9; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=85.2; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.3; Lymphocyte absolute=0.7; Lymphocyte %=7.2; IL1b=2.02; IL10=7.62; IL6=46.37; RANTES=1025.28; MIP1a=10.89; GMCSF=0.09; MCP1=1091.85; IL15=50.48; HGF=638.85; VEGF=1.57; IL1Ra=264.22; IL2R=7.38; MIG=29.12; IL8=27.7 SUBJECT_SAMPLE_FACTORS WU350-119 B4_WU350-119_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-119_d0_polar_pos.mzML B4_WU350-119_d0_polar_neg.mzML B4_WU350-119_d0_lipid_pos.mzML B4_WU350-119_d0_lipid_neg.mzML; Days post symptom onset=33; Sex=Female; BMI=35.7; Age at Symptom onset (years)=37.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=16.1; D-dimer=43531; Neutrophil %=91.2; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=37.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.2; Lymphocyte absolute=0.6; Lymphocyte %=4.1; IL1b=3.86; IL10=9.89; IL6=689.59; RANTES=1029.39; MIP1a=10.89; GMCSF=0.31; MCP1=2172.21; IL15=54.92; HGF=1154.46; VEGF=3.18; IL1Ra=2042.47; IL2R=84.89; MIG=51.83; IL8=139.78 SUBJECT_SAMPLE_FACTORS WU350-126 B4_WU350-126_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-126_d0_polar_pos.mzML B4_WU350-126_d0_polar_neg.mzML B4_WU350-126_d0_lipid_pos.mzML B4_WU350-126_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-129 B4_WU350-129_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-129_d0_polar_pos.mzML B4_WU350-129_d0_polar_neg.mzML B4_WU350-129_d0_lipid_pos.mzML B4_WU350-129_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=27.2; Age at Symptom onset (years)=78.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=145.9; D-dimer=2333; Neutrophil %=69.3; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.9; Lymphocyte absolute=1; Lymphocyte %=24; IL1b=0.9; IL10=33.53; IL6=202.02; RANTES=1403.17; MIP1a=10.89; GMCSF=0.18; MCP1=1228.43; IL15=13.1; HGF=271.94; VEGF=3.29; IL1Ra=104.49; IL2R=105.96; MIG=38.45; IL8=42.67 SUBJECT_SAMPLE_FACTORS WU350-134 B4_WU350-134_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-134_d0_polar_pos.mzML B4_WU350-134_d0_polar_neg.mzML B4_WU350-134_d0_lipid_pos.mzML B4_WU350-134_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=37.5; Age at Symptom onset (years)=60.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=130.2; D-dimer=695; Neutrophil %=82; CO2=20; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=60.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=0.5; Lymphocyte %=11.2; IL1b=1.32; IL10=181.41; IL6=48.12; RANTES=464.3; MIP1a=2.27; GMCSF=4.13; MCP1=440.22; IL15=22.54; HGF=250.83; VEGF=2.56; IL1Ra=241.07; IL2R=143.36; MIG=60.17; IL8=31.81 SUBJECT_SAMPLE_FACTORS WU350-137 B4_WU350-137_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-137_d0_polar_pos.mzML B4_WU350-137_d0_polar_neg.mzML B4_WU350-137_d0_lipid_pos.mzML B4_WU350-137_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=23; Age at Symptom onset (years)=68.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=369.2; D-dimer=5922; Neutrophil %=78.7; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=9.4; Lymphocyte absolute=1.8; Lymphocyte %=15; IL1b=1.26; IL10=64.63; IL6=176.87; RANTES=700.21; MIP1a=2.27; GMCSF=1.36; MCP1=906.83; IL15=42.18; HGF=4259.29; VEGF=5.25; IL1Ra=76.51; IL2R=33.49; MIG=93.06; IL8=48.52 SUBJECT_SAMPLE_FACTORS WU350-142 B4_WU350-142_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-142_d0_polar_pos.mzML B4_WU350-142_d0_polar_neg.mzML B4_WU350-142_d0_lipid_pos.mzML B4_WU350-142_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=23.4; Age at Symptom onset (years)=68.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=68.7; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=0.9; Lymphocyte %=13.1; IL1b=0.63; IL10=12.44; IL6=29.16; RANTES=2358.61; MIP1a=2.27; GMCSF=0.68; MCP1=283.4; IL15=28.95; HGF=384.13; VEGF=1.88; IL1Ra=91.54; IL2R=189.63; MIG=11.79; IL8=13.57 SUBJECT_SAMPLE_FACTORS WU350-143 B4_WU350-143_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-143_d0_polar_pos.mzML B4_WU350-143_d0_polar_neg.mzML B4_WU350-143_d0_lipid_pos.mzML B4_WU350-143_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=28.8; Age at Symptom onset (years)=81.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=269.8; D-dimer=1352; Neutrophil %=77.8; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=81.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=1.3; Lymphocyte %=17.6; IL1b=3.04; IL10=188.2; IL6=647.24; RANTES=766.15; MIP1a=2.27; GMCSF=27.16; MCP1=950.95; IL15=64.85; HGF=2702.27; VEGF=5.81; IL1Ra=1000.01; IL2R=390.7; MIG=122.49; IL8=52.46 SUBJECT_SAMPLE_FACTORS WU350-145 B4_WU350-145_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-145_d0_polar_pos.mzML B4_WU350-145_d0_polar_neg.mzML B4_WU350-145_d0_lipid_pos.mzML B4_WU350-145_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=31; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.7; D-dimer=65085; Neutrophil %=62.5; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.2; Lymphocyte %=17.6; IL1b=2.51; IL10=38.35; IL6=53.04; RANTES=875.58; MIP1a=2.27; GMCSF=0.71; MCP1=223.42; IL15=20.8; HGF=5427.58; VEGF=1.5; IL1Ra=148.37; IL2R=83.14; MIG=399.6; IL8=16.49 SUBJECT_SAMPLE_FACTORS WU350-146 B4_WU350-146_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-146_d0_polar_pos.mzML B4_WU350-146_d0_polar_neg.mzML B4_WU350-146_d0_lipid_pos.mzML B4_WU350-146_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=27.3; Age at Symptom onset (years)=76; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=4327; Neutrophil %=96.7; CO2=20; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=76; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=18.1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.66; IL10=50.2; IL6=1176.76; RANTES=1020.54; MIP1a=220.26; GMCSF=0.4; MCP1=1093.35; IL15=40.29; HGF=1384.85; VEGF=18.19; IL1Ra=128.96; IL2R=259.81; MIG=63.2; IL8=81.66 SUBJECT_SAMPLE_FACTORS WU350-152 B4_WU350-152_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-152_d0_polar_pos.mzML B4_WU350-152_d0_polar_neg.mzML B4_WU350-152_d0_lipid_pos.mzML B4_WU350-152_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=24.2; Age at Symptom onset (years)=60.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=348.8; D-dimer=4282; Neutrophil %=60.8; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=60.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.6; Lymphocyte absolute=2.2; Lymphocyte %=28.7; IL1b=3.34; IL10=114.97; IL6=17336.9; RANTES=494.55; MIP1a=28.73; GMCSF=2.76; MCP1=1711.67; IL15=95.31; HGF=65999.23; VEGF=3.59; IL1Ra=1119.1; IL2R=222.73; MIG=126.54; IL8=443.76 SUBJECT_SAMPLE_FACTORS WU350-154 B4_WU350-154_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-154_d0_polar_pos.mzML B4_WU350-154_d0_polar_neg.mzML B4_WU350-154_d0_lipid_pos.mzML B4_WU350-154_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=16.3; Age at Symptom onset (years)=71.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=63.4; D-dimer=1222; Neutrophil %=79.4; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.3; Lymphocyte absolute=1.6; Lymphocyte %=12.2; IL1b=2.08; IL10=4.3; IL6=62.72; RANTES=1083; MIP1a=42.78; GMCSF=2.23; MCP1=406.74; IL15=34.9; HGF=1205.42; VEGF=10.2; IL1Ra=128.21; IL2R=93.39; MIG=32.38; IL8=14.11 SUBJECT_SAMPLE_FACTORS WU350-155 B4_WU350-155_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-155_d0_polar_pos.mzML B4_WU350-155_d0_polar_neg.mzML B4_WU350-155_d0_lipid_pos.mzML B4_WU350-155_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=21.1; Age at Symptom onset (years)=66.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=18.5; D-dimer=4407; Neutrophil %=55.7; CO2=20; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.2; Lymphocyte absolute=0.8; Lymphocyte %=31.3; IL1b=0.71; IL10=14; IL6=22.86; RANTES=1145.04; MIP1a=141.03; GMCSF=2.17; MCP1=469.86; IL15=207.18; HGF=154.43; VEGF=2.2; IL1Ra=35.48; IL2R=44.73; MIG=25.08; IL8=25.21 SUBJECT_SAMPLE_FACTORS WU350-163 B4_WU350-163_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-163_d0_polar_pos.mzML B4_WU350-163_d0_polar_neg.mzML B4_WU350-163_d0_lipid_pos.mzML B4_WU350-163_d0_lipid_neg.mzML; Days post symptom onset=20; Sex=Male; BMI=27.4; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=285.7; D-dimer=-1; Neutrophil %=85.6; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=7.2; IL1b=2.71; IL10=401.2; IL6=316.57; RANTES=703.06; MIP1a=737.67; GMCSF=4.1; MCP1=1992.8; IL15=344.74; HGF=4261.87; VEGF=68.92; IL1Ra=365.56; IL2R=1774.31; MIG=339.44; IL8=55.76 SUBJECT_SAMPLE_FACTORS WU350-165 B4_WU350-165_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-165_d0_polar_pos.mzML B4_WU350-165_d0_polar_neg.mzML B4_WU350-165_d0_lipid_pos.mzML B4_WU350-165_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=23.8; Age at Symptom onset (years)=68.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=173.2; D-dimer=1828; Neutrophil %=88.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=68.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.8; Lymphocyte %=4.4; IL1b=0.51; IL10=20.27; IL6=228.64; RANTES=1245.13; MIP1a=1.66; GMCSF=1.83; MCP1=535.19; IL15=3.41; HGF=723.18; VEGF=9.13; IL1Ra=304.21; IL2R=302.53; MIG=58.26; IL8=43.73 SUBJECT_SAMPLE_FACTORS WU350-166 B4_WU350-166_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-166_d0_polar_pos.mzML B4_WU350-166_d0_polar_neg.mzML B4_WU350-166_d0_lipid_pos.mzML B4_WU350-166_d0_lipid_neg.mzML; Days post symptom onset=28; Sex=Male; BMI=20.6; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=21; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=12.1; D-dimer=447; Neutrophil %=66.3; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.8; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=6.5; Lymphocyte absolute=2.2; Lymphocyte %=22; IL1b=0.28; IL10=62.46; IL6=6.73; RANTES=1026.81; MIP1a=435.1; GMCSF=1.28; MCP1=162.09; IL15=3.81; HGF=295.47; VEGF=9.54; IL1Ra=35.7; IL2R=234.3; MIG=25.3; IL8=12.71 SUBJECT_SAMPLE_FACTORS WU350-172 B4_WU350-172_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-172_d0_polar_pos.mzML B4_WU350-172_d0_polar_neg.mzML B4_WU350-172_d0_lipid_pos.mzML B4_WU350-172_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=22.1; Age at Symptom onset (years)=36.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295.7; D-dimer=6934; Neutrophil %=87.3; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=28; Lymphocyte absolute=0.9; Lymphocyte %=2.9; IL1b=10.82; IL10=45.24; IL6=2386.31; RANTES=1237.44; MIP1a=47.66; GMCSF=2.17; MCP1=1132.57; IL15=63.49; HGF=1258.92; VEGF=15.38; IL1Ra=1393.98; IL2R=78.74; MIG=29.62; IL8=37.43 SUBJECT_SAMPLE_FACTORS WU350-174 B4_WU350-174_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-174_d0_polar_pos.mzML B4_WU350-174_d0_polar_neg.mzML B4_WU350-174_d0_lipid_pos.mzML B4_WU350-174_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=20; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=216.8; D-dimer=1130; Neutrophil %=91; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=0.7; Lymphocyte %=5.6; IL1b=0.47; IL10=7.42; IL6=16.48; RANTES=1383.99; MIP1a=1.66; GMCSF=1.04; MCP1=358.56; IL15=71.25; HGF=2053.09; VEGF=1.65; IL1Ra=153.16; IL2R=231.47; MIG=26.95; IL8=12.63 SUBJECT_SAMPLE_FACTORS WU350-176 B4_WU350-176_d0 batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-176_d0_polar_pos.mzML B4_WU350-176_d0_polar_neg.mzML B4_WU350-176_d0_lipid_pos.mzML B4_WU350-176_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=25.1; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=178.2; D-dimer=55831; Neutrophil %=90.8; CO2=15; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=13.2; Lymphocyte absolute=0.8; Lymphocyte %=5.8; IL1b=12.95; IL10=134.87; IL6=11223.41; RANTES=678.35; MIP1a=113.48; GMCSF=0.63; MCP1=681.19; IL15=93.87; HGF=4236.1; VEGF=5.93; IL1Ra=2738.59; IL2R=117.59; MIG=8.47; IL8=62.18 SUBJECT_SAMPLE_FACTORS WU350-117 B4_WU350-117_d14 batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-117_d14_polar_pos.mzML B4_WU350-117_d14_polar_neg.mzML B4_WU350-117_d14_lipid_pos.mzML B4_WU350-117_d14_lipid_neg.mzML; Days post symptom onset=24; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-120 B4_WU350-120_d14 batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-120_d14_polar_pos.mzML B4_WU350-120_d14_polar_neg.mzML B4_WU350-120_d14_lipid_pos.mzML B4_WU350-120_d14_lipid_neg.mzML; Days post symptom onset=19; Sex=Female; BMI=25.3; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=114; D-dimer=2563; Neutrophil %=78.3; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=14.3; IL1b=2.23; IL10=25.64; IL6=139.91; RANTES=1284.8; MIP1a=10.89; GMCSF=0.23; MCP1=1917.63; IL15=12.66; HGF=6337.89; VEGF=3.34; IL1Ra=234.58; IL2R=113.32; MIG=60.67; IL8=24.21 SUBJECT_SAMPLE_FACTORS WU350-124 B4_WU350-124_d14 batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-124_d14_polar_pos.mzML B4_WU350-124_d14_polar_neg.mzML B4_WU350-124_d14_lipid_pos.mzML B4_WU350-124_d14_lipid_neg.mzML; Days post symptom onset=20; Sex=Female; BMI=23.3; Age at Symptom onset (years)=72.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50.5; D-dimer=17479; Neutrophil %=63.8; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.5; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=1.5; Lymphocyte absolute=0.7; Lymphocyte %=31.4; IL1b=1.28; IL10=25.5; IL6=51.74; RANTES=909.5; MIP1a=10.89; GMCSF=12.09; MCP1=760.94; IL15=106.76; HGF=359.68; VEGF=0.7; IL1Ra=73.1; IL2R=55.72; MIG=25.32; IL8=27.68 SUBJECT_SAMPLE_FACTORS WU350-126 B4_WU350-126_d14 batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-126_d14_polar_pos.mzML B4_WU350-126_d14_polar_neg.mzML B4_WU350-126_d14_lipid_pos.mzML B4_WU350-126_d14_lipid_neg.mzML; Days post symptom onset=22; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-058 B4_WU350-058_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-058_d28_polar_pos.mzML B4_WU350-058_d28_polar_neg.mzML B4_WU350-058_d28_lipid_pos.mzML B4_WU350-058_d28_lipid_neg.mzML; Days post symptom onset=42; Sex=Female; BMI=29.6; Age at Symptom onset (years)=53.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=55.5; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=3.6; Lymphocyte %=36.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-025 B4_WU350-025_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-025_d28_polar_pos.mzML B4_WU350-025_d28_polar_neg.mzML B4_WU350-025_d28_lipid_pos.mzML B4_WU350-025_d28_lipid_neg.mzML; Days post symptom onset=40; Sex=Male; BMI=24.8; Age at Symptom onset (years)=64.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=77; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=0.5; Lymphocyte %=15.3; IL1b=0.334111293; IL10=12.28156552; IL6=26.47902453; RANTES=774.9869506; MIP1a=<1; GMCSF=0.694132102; MCP1=212.7214972; IL15=<8.3; HGF=104.1175127; VEGF=5.027117086; IL1Ra=37.97530185; IL2R=40.96344227; MIG=48.78528622; IL8=12.16369395 SUBJECT_SAMPLE_FACTORS WU350-059 B4_WU350-059_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-059_d28_polar_pos.mzML B4_WU350-059_d28_polar_neg.mzML B4_WU350-059_d28_lipid_pos.mzML B4_WU350-059_d28_lipid_neg.mzML; Days post symptom onset=38; Sex=Male; BMI=27.1; Age at Symptom onset (years)=51.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.1; D-dimer=443; Neutrophil %=64.6; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=0.9; Lymphocyte %=21.7; IL1b=0.973059682; IL10=5.819472912; IL6=21.01243452; RANTES=1035.565165; MIP1a=0.946296474; GMCSF=1.167691272; MCP1=366.5020672; IL15=<2.77; HGF=74.08510034; VEGF=0.795015097; IL1Ra=68.43571516; IL2R=60.66993446; MIG=21.28021373; IL8=12.44605834 SUBJECT_SAMPLE_FACTORS WU350-050 B4_WU350-050_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-050_d28_polar_pos.mzML B4_WU350-050_d28_polar_neg.mzML B4_WU350-050_d28_lipid_pos.mzML B4_WU350-050_d28_lipid_neg.mzML; Days post symptom onset=38; Sex=Male; BMI=24.4; Age at Symptom onset (years)=61.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=379; D-dimer=2352; Neutrophil %=87; CO2=44; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=61.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=13.6; Lymphocyte absolute=0.7; Lymphocyte %=4.6; IL1b=2.848917758; IL10=153.5725103; IL6=267.1820298; RANTES=959.9618241; MIP1a=27.91900928; GMCSF=2.449666442; MCP1=1898.04711; IL15=135.3076684; HGF=11714.84867; VEGF=1.285622707; IL1Ra=199.1739012; IL2R=60.11581187; MIG=224.7485143; IL8=43.13522009 SUBJECT_SAMPLE_FACTORS WU350-055 B4_WU350-055_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-055_d28_polar_pos.mzML B4_WU350-055_d28_polar_neg.mzML B4_WU350-055_d28_lipid_pos.mzML B4_WU350-055_d28_lipid_neg.mzML; Days post symptom onset=35; Sex=Male; BMI=24.3; Age at Symptom onset (years)=79.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.4; D-dimer=936; Neutrophil %=37.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=79.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=0.7; Lymphocyte absolute=0.7; Lymphocyte %=39.5; IL1b=2.330575872; IL10=13.87728587; IL6=31.41294916; RANTES=1243.058906; MIP1a=1.630441719; GMCSF=0.996461633; MCP1=439.4720124; IL15=27.46931093; HGF=233.537326; VEGF=0.76763317; IL1Ra=214.0162865; IL2R=145.7396059; MIG=44.60888737; IL8=180.7444869 SUBJECT_SAMPLE_FACTORS WU350-065 B4_WU350-065_d28 batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-065_d28_polar_pos.mzML B4_WU350-065_d28_polar_neg.mzML B4_WU350-065_d28_lipid_pos.mzML B4_WU350-065_d28_lipid_neg.mzML; Days post symptom onset=36; Sex=Male; BMI=32.4; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.1; D-dimer=372; Neutrophil %=88.9; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=73.7; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=5.6; Lymphocyte absolute=0.3; Lymphocyte %=5.2; IL1b=1.933800515; IL10=1454.559414; IL6=379.5929623; RANTES=652.2572197; MIP1a=2.953122527; GMCSF=575.3349883; MCP1=627.1981562; IL15=51.69292859; HGF=2306.20299; VEGF=2.947989887; IL1Ra=121.6108625; IL2R=55.01694945; MIG=66.37774287; IL8=25.34769801 SUBJECT_SAMPLE_FACTORS WU350-125 B4_WU350-125_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-125_d3_polar_pos.mzML B4_WU350-125_d3_polar_neg.mzML B4_WU350-125_d3_lipid_pos.mzML B4_WU350-125_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=25.8; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6; D-dimer=496; Neutrophil %=59.6; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=1.7; Lymphocyte %=29.4; IL1b=176.03; IL10=141.42; IL6=195.3; RANTES=19021.39; MIP1a=1434.31; GMCSF=17.31; MCP1=11267.7; IL15=17510.51; HGF=9535.78; VEGF=4.4; IL1Ra=428.64; IL2R=1789.25; MIG=153.36; IL8=89.9 SUBJECT_SAMPLE_FACTORS WU350-130 B4_WU350-130_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-130_d3_polar_pos.mzML B4_WU350-130_d3_polar_neg.mzML B4_WU350-130_d3_lipid_pos.mzML B4_WU350-130_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=26.6; Age at Symptom onset (years)=64.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=146; D-dimer=1196; Neutrophil %=76.7; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.4; IL1b=0.3; IL10=41.6; IL6=218.67; RANTES=596.22; MIP1a=10.89; GMCSF=13.93; MCP1=248.79; IL15=37.72; HGF=235.94; VEGF=1.35; IL1Ra=20.68; IL2R=15.46; MIG=14.99; IL8=11.81 SUBJECT_SAMPLE_FACTORS WU350-131 B4_WU350-131_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-131_d3_polar_pos.mzML B4_WU350-131_d3_polar_neg.mzML B4_WU350-131_d3_lipid_pos.mzML B4_WU350-131_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=32.9; Age at Symptom onset (years)=55.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=802; Neutrophil %=79.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.1; IL1b=1.37; IL10=37.53; IL6=39.84; RANTES=754.25; MIP1a=10.89; GMCSF=35.69; MCP1=165.72; IL15=8.45; HGF=966.84; VEGF=3.85; IL1Ra=70.66; IL2R=25.62; MIG=32.41; IL8=6.66 SUBJECT_SAMPLE_FACTORS WU350-132 B4_WU350-132_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-132_d3_polar_pos.mzML B4_WU350-132_d3_polar_neg.mzML B4_WU350-132_d3_lipid_pos.mzML B4_WU350-132_d3_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=22.1; Age at Symptom onset (years)=68.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.96; IL10=56.58; IL6=15.28; RANTES=468.77; MIP1a=2.27; GMCSF=3.43; MCP1=384.96; IL15=23.59; HGF=531.55; VEGF=2.9; IL1Ra=40.04; IL2R=117.27; MIG=55.08; IL8=8.16 SUBJECT_SAMPLE_FACTORS WU350-138 B4_WU350-138_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-138_d3_polar_pos.mzML B4_WU350-138_d3_polar_neg.mzML B4_WU350-138_d3_lipid_pos.mzML B4_WU350-138_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=41.5; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=176.6; D-dimer=1452; Neutrophil %=-1; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.24; IL10=15.92; IL6=29.31; RANTES=342.12; MIP1a=2.27; GMCSF=1.93; MCP1=307.79; IL15=7.86; HGF=2085.25; VEGF=8; IL1Ra=163.13; IL2R=162.69; MIG=36.85; IL8=95.52 SUBJECT_SAMPLE_FACTORS WU350-147 B4_WU350-147_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-147_d3_polar_pos.mzML B4_WU350-147_d3_polar_neg.mzML B4_WU350-147_d3_lipid_pos.mzML B4_WU350-147_d3_lipid_neg.mzML; Days post symptom onset=24; Sex=Male; BMI=41.1; Age at Symptom onset (years)=76.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=202.3; D-dimer=22918; Neutrophil %=86.8; CO2=31; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=76.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.8; Lymphocyte absolute=0.8; Lymphocyte %=9.8; IL1b=1.32; IL10=17.22; IL6=115.84; RANTES=700.34; MIP1a=57.31; GMCSF=0.99; MCP1=1192.98; IL15=0.06; HGF=380.16; VEGF=1.53; IL1Ra=192.53; IL2R=61.16; MIG=110.69; IL8=41.21 SUBJECT_SAMPLE_FACTORS WU350-148 B4_WU350-148_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-148_d3_polar_pos.mzML B4_WU350-148_d3_polar_neg.mzML B4_WU350-148_d3_lipid_pos.mzML B4_WU350-148_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=24.9; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.4; D-dimer=1251; Neutrophil %=51.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=2.5; Lymphocyte %=40.7; IL1b=4.42; IL10=25.43; IL6=30.73; RANTES=1153.49; MIP1a=98.6; GMCSF=0.9; MCP1=487.04; IL15=67.82; HGF=364.74; VEGF=4.01; IL1Ra=126.76; IL2R=57.82; MIG=66.4; IL8=10.18 SUBJECT_SAMPLE_FACTORS WU350-151 B4_WU350-151_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-151_d3_polar_pos.mzML B4_WU350-151_d3_polar_neg.mzML B4_WU350-151_d3_lipid_pos.mzML B4_WU350-151_d3_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=36.1; Age at Symptom onset (years)=62.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.4; D-dimer=629; Neutrophil %=80.9; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=62.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.3; Lymphocyte absolute=0.7; Lymphocyte %=11.3; IL1b=1.16; IL10=54.32; IL6=36.12; RANTES=537.01; MIP1a=2.27; GMCSF=0.86; MCP1=836.91; IL15=0.06; HGF=3234.35; VEGF=0.55; IL1Ra=144.82; IL2R=20.51; MIG=30.16; IL8=41.26 SUBJECT_SAMPLE_FACTORS WU350-153 B4_WU350-153_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-153_d3_polar_pos.mzML B4_WU350-153_d3_polar_neg.mzML B4_WU350-153_d3_lipid_pos.mzML B4_WU350-153_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=45.5; Age at Symptom onset (years)=59.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=168.3; D-dimer=7191; Neutrophil %=81.7; CO2=31; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=59.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.9; Lymphocyte absolute=1; Lymphocyte %=10; IL1b=3.51; IL10=2810.46; IL6=369.81; RANTES=601.84; MIP1a=577.82; GMCSF=731.35; MCP1=3406.98; IL15=6836.47; HGF=4892.58; VEGF=7.29; IL1Ra=638.89; IL2R=577.54; MIG=26.91; IL8=63.38 SUBJECT_SAMPLE_FACTORS WU350-158 B4_WU350-158_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-158_d3_polar_pos.mzML B4_WU350-158_d3_polar_neg.mzML B4_WU350-158_d3_lipid_pos.mzML B4_WU350-158_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=28; Age at Symptom onset (years)=65.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2090; Neutrophil %=67.5; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.8; Lymphocyte %=25.8; IL1b=1.31; IL10=29.85; IL6=15.1; RANTES=734.64; MIP1a=1.66; GMCSF=0.43; MCP1=137.77; IL15=22.6; HGF=6398.24; VEGF=0.49; IL1Ra=63.18; IL2R=619.06; MIG=205.42; IL8=20.25 SUBJECT_SAMPLE_FACTORS WU350-159 B4_WU350-159_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-159_d3_polar_pos.mzML B4_WU350-159_d3_polar_neg.mzML B4_WU350-159_d3_lipid_pos.mzML B4_WU350-159_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=25.9; Age at Symptom onset (years)=60.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=1012; Neutrophil %=64.4; CO2=17; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=60.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6.2; Lymphocyte absolute=2; Lymphocyte %=20.2; IL1b=0.27; IL10=1.12; IL6=12.03; RANTES=634.83; MIP1a=1.66; GMCSF=9.75; MCP1=301.53; IL15=39.93; HGF=325.73; VEGF=0.12; IL1Ra=48.46; IL2R=110.11; MIG=38.85; IL8=22.68 SUBJECT_SAMPLE_FACTORS WU350-087 B4_WU350-087_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-087_d3_polar_pos.mzML B4_WU350-087_d3_polar_neg.mzML B4_WU350-087_d3_lipid_pos.mzML B4_WU350-087_d3_lipid_neg.mzML; Days post symptom onset=32; Sex=Male; BMI=38.2; Age at Symptom onset (years)=69.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=17; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=215.7; D-dimer=5760; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.89; IL10=21.24; IL6=65.06; RANTES=14110; MIP1a=14.5; GMCSF=1.84; MCP1=445.67; IL15=20.83; HGF=11195.44; VEGF=2.65; IL1Ra=279.5; IL2R=127.96; MIG=355.82; IL8=42.25 SUBJECT_SAMPLE_FACTORS WU350-116 B4_WU350-116_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-116_d3_polar_pos.mzML B4_WU350-116_d3_polar_neg.mzML B4_WU350-116_d3_lipid_pos.mzML B4_WU350-116_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=21.6; Age at Symptom onset (years)=85.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=6540; Neutrophil %=81.9; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=85.2; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.3; Lymphocyte absolute=0.7; Lymphocyte %=7.2; IL1b=2.02; IL10=7.62; IL6=46.37; RANTES=1025.28; MIP1a=10.89; GMCSF=0.09; MCP1=1091.85; IL15=50.48; HGF=638.85; VEGF=1.57; IL1Ra=264.22; IL2R=7.38; MIG=29.12; IL8=27.7 SUBJECT_SAMPLE_FACTORS WU350-126 B4_WU350-126_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-126_d3_polar_pos.mzML B4_WU350-126_d3_polar_neg.mzML B4_WU350-126_d3_lipid_pos.mzML B4_WU350-126_d3_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-134 B4_WU350-134_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-134_d3_polar_pos.mzML B4_WU350-134_d3_polar_neg.mzML B4_WU350-134_d3_lipid_pos.mzML B4_WU350-134_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=37.5; Age at Symptom onset (years)=60.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=130.2; D-dimer=695; Neutrophil %=82; CO2=20; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=60.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=0.5; Lymphocyte %=11.2; IL1b=1.32; IL10=181.41; IL6=48.12; RANTES=464.3; MIP1a=2.27; GMCSF=4.13; MCP1=440.22; IL15=22.54; HGF=250.83; VEGF=2.56; IL1Ra=241.07; IL2R=143.36; MIG=60.17; IL8=31.81 SUBJECT_SAMPLE_FACTORS WU350-137 B4_WU350-137_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-137_d3_polar_pos.mzML B4_WU350-137_d3_polar_neg.mzML B4_WU350-137_d3_lipid_pos.mzML B4_WU350-137_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=23; Age at Symptom onset (years)=68.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=369.2; D-dimer=5922; Neutrophil %=78.7; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=68.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=9.4; Lymphocyte absolute=1.8; Lymphocyte %=15; IL1b=1.26; IL10=64.63; IL6=176.87; RANTES=700.21; MIP1a=2.27; GMCSF=1.36; MCP1=906.83; IL15=42.18; HGF=4259.29; VEGF=5.25; IL1Ra=76.51; IL2R=33.49; MIG=93.06; IL8=48.52 SUBJECT_SAMPLE_FACTORS WU350-143 B4_WU350-143_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-143_d3_polar_pos.mzML B4_WU350-143_d3_polar_neg.mzML B4_WU350-143_d3_lipid_pos.mzML B4_WU350-143_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=28.8; Age at Symptom onset (years)=81.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=269.8; D-dimer=1352; Neutrophil %=77.8; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=81.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=1.3; Lymphocyte %=17.6; IL1b=3.04; IL10=188.2; IL6=647.24; RANTES=766.15; MIP1a=2.27; GMCSF=27.16; MCP1=950.95; IL15=64.85; HGF=2702.27; VEGF=5.81; IL1Ra=1000.01; IL2R=390.7; MIG=122.49; IL8=52.46 SUBJECT_SAMPLE_FACTORS WU350-145 B4_WU350-145_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-145_d3_polar_pos.mzML B4_WU350-145_d3_polar_neg.mzML B4_WU350-145_d3_lipid_pos.mzML B4_WU350-145_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=31; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.7; D-dimer=65085; Neutrophil %=62.5; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.2; Lymphocyte %=17.6; IL1b=2.51; IL10=38.35; IL6=53.04; RANTES=875.58; MIP1a=2.27; GMCSF=0.71; MCP1=223.42; IL15=20.8; HGF=5427.58; VEGF=1.5; IL1Ra=148.37; IL2R=83.14; MIG=399.6; IL8=16.49 SUBJECT_SAMPLE_FACTORS WU350-146 B4_WU350-146_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-146_d3_polar_pos.mzML B4_WU350-146_d3_polar_neg.mzML B4_WU350-146_d3_lipid_pos.mzML B4_WU350-146_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=27.3; Age at Symptom onset (years)=76; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=4327; Neutrophil %=96.7; CO2=20; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=76; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=18.1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.66; IL10=50.2; IL6=1176.76; RANTES=1020.54; MIP1a=220.26; GMCSF=0.4; MCP1=1093.35; IL15=40.29; HGF=1384.85; VEGF=18.19; IL1Ra=128.96; IL2R=259.81; MIG=63.2; IL8=81.66 SUBJECT_SAMPLE_FACTORS WU350-154 B4_WU350-154_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-154_d3_polar_pos.mzML B4_WU350-154_d3_polar_neg.mzML B4_WU350-154_d3_lipid_pos.mzML B4_WU350-154_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=16.3; Age at Symptom onset (years)=71.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=63.4; D-dimer=1222; Neutrophil %=79.4; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.3; Lymphocyte absolute=1.6; Lymphocyte %=12.2; IL1b=2.08; IL10=4.3; IL6=62.72; RANTES=1083; MIP1a=42.78; GMCSF=2.23; MCP1=406.74; IL15=34.9; HGF=1205.42; VEGF=10.2; IL1Ra=128.21; IL2R=93.39; MIG=32.38; IL8=14.11 SUBJECT_SAMPLE_FACTORS WU350-163 B4_WU350-163_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-163_d3_polar_pos.mzML B4_WU350-163_d3_polar_neg.mzML B4_WU350-163_d3_lipid_pos.mzML B4_WU350-163_d3_lipid_neg.mzML; Days post symptom onset=23; Sex=Male; BMI=27.4; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=285.7; D-dimer=-1; Neutrophil %=85.6; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=7.2; IL1b=2.71; IL10=401.2; IL6=316.57; RANTES=703.06; MIP1a=737.67; GMCSF=4.1; MCP1=1992.8; IL15=344.74; HGF=4261.87; VEGF=68.92; IL1Ra=365.56; IL2R=1774.31; MIG=339.44; IL8=55.76 SUBJECT_SAMPLE_FACTORS WU350-165 B4_WU350-165_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-165_d3_polar_pos.mzML B4_WU350-165_d3_polar_neg.mzML B4_WU350-165_d3_lipid_pos.mzML B4_WU350-165_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=23.8; Age at Symptom onset (years)=68.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=173.2; D-dimer=1828; Neutrophil %=88.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=68.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.8; Lymphocyte %=4.4; IL1b=0.51; IL10=20.27; IL6=228.64; RANTES=1245.13; MIP1a=1.66; GMCSF=1.83; MCP1=535.19; IL15=3.41; HGF=723.18; VEGF=9.13; IL1Ra=304.21; IL2R=302.53; MIG=58.26; IL8=43.73 SUBJECT_SAMPLE_FACTORS WU350-129 B4_WU350-129_d3 batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B4_WU350-129_d3_polar_pos.mzML B4_WU350-129_d3_polar_neg.mzML B4_WU350-129_d3_lipid_pos.mzML B4_WU350-129_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=27.2; Age at Symptom onset (years)=78.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=145.9; D-dimer=2333; Neutrophil %=69.3; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.9; Lymphocyte absolute=1; Lymphocyte %=24; IL1b=0.9; IL10=33.53; IL6=202.02; RANTES=1403.17; MIP1a=10.89; GMCSF=0.18; MCP1=1228.43; IL15=13.1; HGF=271.94; VEGF=3.29; IL1Ra=104.49; IL2R=105.96; MIG=38.45; IL8=42.67 SUBJECT_SAMPLE_FACTORS WU350-125 B4_WU350-125_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-125_d7_polar_pos.mzML B4_WU350-125_d7_polar_neg.mzML B4_WU350-125_d7_lipid_pos.mzML B4_WU350-125_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=25.8; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6; D-dimer=496; Neutrophil %=59.6; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=1.7; Lymphocyte %=29.4; IL1b=176.03; IL10=141.42; IL6=195.3; RANTES=19021.39; MIP1a=1434.31; GMCSF=17.31; MCP1=11267.7; IL15=17510.51; HGF=9535.78; VEGF=4.4; IL1Ra=428.64; IL2R=1789.25; MIG=153.36; IL8=89.9 SUBJECT_SAMPLE_FACTORS WU350-130 B4_WU350-130_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-130_d7_polar_pos.mzML B4_WU350-130_d7_polar_neg.mzML B4_WU350-130_d7_lipid_pos.mzML B4_WU350-130_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=26.6; Age at Symptom onset (years)=64.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=146; D-dimer=1196; Neutrophil %=76.7; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.4; IL1b=0.3; IL10=41.6; IL6=218.67; RANTES=596.22; MIP1a=10.89; GMCSF=13.93; MCP1=248.79; IL15=37.72; HGF=235.94; VEGF=1.35; IL1Ra=20.68; IL2R=15.46; MIG=14.99; IL8=11.81 SUBJECT_SAMPLE_FACTORS WU350-131 B4_WU350-131_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-131_d7_polar_pos.mzML B4_WU350-131_d7_polar_neg.mzML B4_WU350-131_d7_lipid_pos.mzML B4_WU350-131_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=32.9; Age at Symptom onset (years)=55.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=802; Neutrophil %=79.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=0.8; Lymphocyte %=15.1; IL1b=1.37; IL10=37.53; IL6=39.84; RANTES=754.25; MIP1a=10.89; GMCSF=35.69; MCP1=165.72; IL15=8.45; HGF=966.84; VEGF=3.85; IL1Ra=70.66; IL2R=25.62; MIG=32.41; IL8=6.66 SUBJECT_SAMPLE_FACTORS WU350-138 B4_WU350-138_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-138_d7_polar_pos.mzML B4_WU350-138_d7_polar_neg.mzML B4_WU350-138_d7_lipid_pos.mzML B4_WU350-138_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Female; BMI=41.5; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=176.6; D-dimer=1452; Neutrophil %=-1; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.24; IL10=15.92; IL6=29.31; RANTES=342.12; MIP1a=2.27; GMCSF=1.93; MCP1=307.79; IL15=7.86; HGF=2085.25; VEGF=8; IL1Ra=163.13; IL2R=162.69; MIG=36.85; IL8=95.52 SUBJECT_SAMPLE_FACTORS WU350-148 B4_WU350-148_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-148_d7_polar_pos.mzML B4_WU350-148_d7_polar_neg.mzML B4_WU350-148_d7_lipid_pos.mzML B4_WU350-148_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=24.9; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.4; D-dimer=1251; Neutrophil %=51.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=2.5; Lymphocyte %=40.7; IL1b=4.42; IL10=25.43; IL6=30.73; RANTES=1153.49; MIP1a=98.6; GMCSF=0.9; MCP1=487.04; IL15=67.82; HGF=364.74; VEGF=4.01; IL1Ra=126.76; IL2R=57.82; MIG=66.4; IL8=10.18 SUBJECT_SAMPLE_FACTORS WU350-126 B4_WU350-126_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-126_d7_polar_pos.mzML B4_WU350-126_d7_polar_neg.mzML B4_WU350-126_d7_lipid_pos.mzML B4_WU350-126_d7_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-145 B4_WU350-145_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-145_d7_polar_pos.mzML B4_WU350-145_d7_polar_neg.mzML B4_WU350-145_d7_lipid_pos.mzML B4_WU350-145_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=31; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.7; D-dimer=65085; Neutrophil %=62.5; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.2; Lymphocyte %=17.6; IL1b=2.51; IL10=38.35; IL6=53.04; RANTES=875.58; MIP1a=2.27; GMCSF=0.71; MCP1=223.42; IL15=20.8; HGF=5427.58; VEGF=1.5; IL1Ra=148.37; IL2R=83.14; MIG=399.6; IL8=16.49 SUBJECT_SAMPLE_FACTORS WU350-146 B4_WU350-146_d7 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B4_WU350-146_d7_polar_pos.mzML B4_WU350-146_d7_polar_neg.mzML B4_WU350-146_d7_lipid_pos.mzML B4_WU350-146_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=27.3; Age at Symptom onset (years)=76; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=4327; Neutrophil %=96.7; CO2=20; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=76; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=18.1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=1.66; IL10=50.2; IL6=1176.76; RANTES=1020.54; MIP1a=220.26; GMCSF=0.4; MCP1=1093.35; IL15=40.29; HGF=1384.85; VEGF=18.19; IL1Ra=128.96; IL2R=259.81; MIG=63.2; IL8=81.66 SUBJECT_SAMPLE_FACTORS WU350-179 B5_WU350-179_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-179_d0_polar_pos.mzML B5_WU350-179_d0_polar_neg.mzML B5_WU350-179_d0_lipid_pos.mzML B5_WU350-179_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=31.3; Age at Symptom onset (years)=59.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=63.8; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=1.7; Lymphocyte %=24.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-189 B5_WU350-189_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-189_d0_polar_pos.mzML B5_WU350-189_d0_polar_neg.mzML B5_WU350-189_d0_lipid_pos.mzML B5_WU350-189_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=27.4; Age at Symptom onset (years)=49.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=74.4; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=49.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.7; Lymphocyte absolute=1.4; Lymphocyte %=14; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-194 B5_WU350-194_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-194_d0_polar_pos.mzML B5_WU350-194_d0_polar_neg.mzML B5_WU350-194_d0_lipid_pos.mzML B5_WU350-194_d0_lipid_neg.mzML; Days post symptom onset=25; Sex=Female; BMI=28; Age at Symptom onset (years)=80.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=63.2; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=80.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=1.3; Lymphocyte %=20.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-196 B5_WU350-196_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-196_d0_polar_pos.mzML B5_WU350-196_d0_polar_neg.mzML B5_WU350-196_d0_lipid_pos.mzML B5_WU350-196_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=29; Age at Symptom onset (years)=62.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=84.4; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=62.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.8; Lymphocyte absolute=0.1; Lymphocyte %=2.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-199 B5_WU350-199_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-199_d0_polar_pos.mzML B5_WU350-199_d0_polar_neg.mzML B5_WU350-199_d0_lipid_pos.mzML B5_WU350-199_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=29.5; Age at Symptom onset (years)=51.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=58.4; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2; Lymphocyte absolute=1.2; Lymphocyte %=33.7; IL1b=1.07; IL10=58.95; IL6=43.25; RANTES=783.14; MIP1a=1.66; GMCSF=8.12; MCP1=749.85; IL15=22.31; HGF=204.62; VEGF=0.78; IL1Ra=95.63; IL2R=114.02; MIG=56.96; IL8=74.71 SUBJECT_SAMPLE_FACTORS WU350-192 B5_WU350-192_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-192_d0_polar_pos.mzML B5_WU350-192_d0_polar_neg.mzML B5_WU350-192_d0_lipid_pos.mzML B5_WU350-192_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=25; Age at Symptom onset (years)=91.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=664; Neutrophil %=76.2; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=91.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.5; Lymphocyte absolute=0.9; Lymphocyte %=15.1; IL1b=1.99; IL10=1.34; IL6=11.39; RANTES=949.57; MIP1a=63.34; GMCSF=0.66; MCP1=539.61; IL15=180.66; HGF=290.23; VEGF=0.56; IL1Ra=48.21; IL2R=188.56; MIG=51.84; IL8=9.28 SUBJECT_SAMPLE_FACTORS WU350-198 B5_WU350-198_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-198_d0_polar_pos.mzML B5_WU350-198_d0_polar_neg.mzML B5_WU350-198_d0_lipid_pos.mzML B5_WU350-198_d0_lipid_neg.mzML; Days post symptom onset=36; Sex=Male; BMI=17.3; Age at Symptom onset (years)=78.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2374; Neutrophil %=70.5; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=78.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=16.6; IL1b=0.36; IL10=2.1; IL6=15.68; RANTES=740.81; MIP1a=1.66; GMCSF=0.42; MCP1=93.79; IL15=4.02; HGF=1185.2; VEGF=0.18; IL1Ra=17.76; IL2R=33.4; MIG=162; IL8=7.23 SUBJECT_SAMPLE_FACTORS WU350-190 B5_WU350-190_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-190_d0_polar_pos.mzML B5_WU350-190_d0_polar_neg.mzML B5_WU350-190_d0_lipid_pos.mzML B5_WU350-190_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=30.2; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=397.5; D-dimer=977; Neutrophil %=83.3; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=1.69; IL10=8.38; IL6=423.6; RANTES=713.32; MIP1a=1.66; GMCSF=0.21; MCP1=1077.76; IL15=17.72; HGF=21353.12; VEGF=5.25; IL1Ra=198.05; IL2R=1330.19; MIG=143.13; IL8=48.18 SUBJECT_SAMPLE_FACTORS WU350-178 B5_WU350-178_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-178_d0_polar_pos.mzML B5_WU350-178_d0_polar_neg.mzML B5_WU350-178_d0_lipid_pos.mzML B5_WU350-178_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=28; Age at Symptom onset (years)=76.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=64.6; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=76.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=0.21; IL10=50.63; IL6=61.76; RANTES=786.6; MIP1a=1.66; GMCSF=2.83; MCP1=113.47; IL15=250.04; HGF=1831.18; VEGF=0.15; IL1Ra=71.09; IL2R=33.29; MIG=28.51; IL8=18.77 SUBJECT_SAMPLE_FACTORS WU350-184 B5_WU350-184_d0 batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-184_d0_polar_pos.mzML B5_WU350-184_d0_polar_neg.mzML B5_WU350-184_d0_lipid_pos.mzML B5_WU350-184_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=19.6; Age at Symptom onset (years)=73.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=249; D-dimer=5078; Neutrophil %=93.5; CO2=21; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=73.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.9; Lymphocyte absolute=0.3; Lymphocyte %=4.1; IL1b=4.96; IL10=44.35; IL6=35176.66; RANTES=937.55; MIP1a=44.63; GMCSF=0.75; MCP1=1049.16; IL15=238.59; HGF=1251.86; VEGF=11.5; IL1Ra=1376.97; IL2R=128.26; MIG=50.11; IL8=805.13 SUBJECT_SAMPLE_FACTORS WU350-145 B5_WU350-145_d14 batch:5 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-145_d14_polar_pos.mzML B5_WU350-145_d14_polar_neg.mzML B5_WU350-145_d14_lipid_pos.mzML B5_WU350-145_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=31; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.7; D-dimer=65085; Neutrophil %=62.5; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.2; Lymphocyte %=17.6; IL1b=2.51; IL10=38.35; IL6=53.04; RANTES=875.58; MIP1a=2.27; GMCSF=0.71; MCP1=223.42; IL15=20.8; HGF=5427.58; VEGF=1.5; IL1Ra=148.37; IL2R=83.14; MIG=399.6; IL8=16.49 SUBJECT_SAMPLE_FACTORS WU350-154 B5_WU350-154_d14 batch:5 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-154_d14_polar_pos.mzML B5_WU350-154_d14_polar_neg.mzML B5_WU350-154_d14_lipid_pos.mzML B5_WU350-154_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=16.3; Age at Symptom onset (years)=71.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=63.4; D-dimer=1222; Neutrophil %=79.4; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.3; Lymphocyte absolute=1.6; Lymphocyte %=12.2; IL1b=2.08; IL10=4.3; IL6=62.72; RANTES=1083; MIP1a=42.78; GMCSF=2.23; MCP1=406.74; IL15=34.9; HGF=1205.42; VEGF=10.2; IL1Ra=128.21; IL2R=93.39; MIG=32.38; IL8=14.11 SUBJECT_SAMPLE_FACTORS WU350-105 B5_WU350-105_d28 batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-105_d28_polar_pos.mzML B5_WU350-105_d28_polar_neg.mzML B5_WU350-105_d28_lipid_pos.mzML B5_WU350-105_d28_lipid_neg.mzML; Days post symptom onset=44; Sex=Female; BMI=30.2; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=104.2; D-dimer=1871; Neutrophil %=76.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=18.5; IL1b=0.6; IL10=37.86; IL6=9.49; RANTES=801.22; MIP1a=10.89; GMCSF=1.9; MCP1=139.37; IL15=11.74; HGF=115.16; VEGF=5.29; IL1Ra=86.23; IL2R=17.43; MIG=14.62; IL8=3.06 SUBJECT_SAMPLE_FACTORS WU350-113 B5_WU350-113_d28 batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-113_d28_polar_pos.mzML B5_WU350-113_d28_polar_neg.mzML B5_WU350-113_d28_lipid_pos.mzML B5_WU350-113_d28_lipid_neg.mzML; Days post symptom onset=37; Sex=Male; BMI=32; Age at Symptom onset (years)=39.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=60.1; D-dimer=626; Neutrophil %=68.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.9; Lymphocyte absolute=0.9; Lymphocyte %=16.3; IL1b=1.28; IL10=19.47; IL6=15.18; RANTES=1062.45; MIP1a=10.89; GMCSF=7.76; MCP1=120.23; IL15=3.81; HGF=230.91; VEGF=1.43; IL1Ra=63.77; IL2R=25.8; MIG=24.21; IL8=18.35 SUBJECT_SAMPLE_FACTORS WU350-117 B5_WU350-117_d28 batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-117_d28_polar_pos.mzML B5_WU350-117_d28_polar_neg.mzML B5_WU350-117_d28_lipid_pos.mzML B5_WU350-117_d28_lipid_neg.mzML; Days post symptom onset=32; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-080 B5_WU350-080_d28 batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-080_d28_polar_pos.mzML B5_WU350-080_d28_polar_neg.mzML B5_WU350-080_d28_lipid_pos.mzML B5_WU350-080_d28_lipid_neg.mzML; Days post symptom onset=28; Sex=Male; BMI=19.6; Age at Symptom onset (years)=87.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=16790; Neutrophil %=73.3; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=87.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.2; Lymphocyte absolute=1.7; Lymphocyte %=17; IL1b=0.922582019; IL10=6.403032128; IL6=15.66307323; RANTES=840.0323603; MIP1a=3.791859394; GMCSF=1.612737717; MCP1=94.84414466; IL15=5.042690989; HGF=108.5231566; VEGF=0.201045355; IL1Ra=155.6968477; IL2R=36.57564637; MIG=55.5807632; IL8=5.979249658 SUBJECT_SAMPLE_FACTORS WU350-084 B5_WU350-084_d28 batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-084_d28_polar_pos.mzML B5_WU350-084_d28_polar_neg.mzML B5_WU350-084_d28_lipid_pos.mzML B5_WU350-084_d28_lipid_neg.mzML; Days post symptom onset=33; Sex=Male; BMI=27.1; Age at Symptom onset (years)=67.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=219.7; D-dimer=2033; Neutrophil %=76.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.5; Lymphocyte absolute=0.8; Lymphocyte %=13.1; IL1b=238.2129151; IL10=2201.236727; IL6=276.3383023; RANTES=720.2523791; MIP1a=646.1002223; GMCSF=1559.239466; MCP1=3629.373646; IL15=2351.382129; HGF=5483.775688; VEGF=5.87145547; IL1Ra=697.6247535; IL2R=10069.44052; MIG=474.8651929; IL8=27.55799909 SUBJECT_SAMPLE_FACTORS WU350-175 B5_WU350-175_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-175_d3_polar_pos.mzML B5_WU350-175_d3_polar_neg.mzML B5_WU350-175_d3_lipid_pos.mzML B5_WU350-175_d3_lipid_neg.mzML; Days post symptom onset=23; Sex=Male; BMI=28.9; Age at Symptom onset (years)=58.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2415; Neutrophil %=81.7; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=58.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=0.7; Lymphocyte %=9.9; IL1b=4.51; IL10=394.02; IL6=42.61; RANTES=746.78; MIP1a=92.94; GMCSF=2.14; MCP1=182.51; IL15=262.77; HGF=356.41; VEGF=2.19; IL1Ra=198.93; IL2R=86.58; MIG=8.91; IL8=25.92 SUBJECT_SAMPLE_FACTORS WU350-192 B5_WU350-192_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-192_d3_polar_pos.mzML B5_WU350-192_d3_polar_neg.mzML B5_WU350-192_d3_lipid_pos.mzML B5_WU350-192_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=25; Age at Symptom onset (years)=91.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=664; Neutrophil %=76.2; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=91.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.5; Lymphocyte absolute=0.9; Lymphocyte %=15.1; IL1b=1.99; IL10=1.34; IL6=11.39; RANTES=949.57; MIP1a=63.34; GMCSF=0.66; MCP1=539.61; IL15=180.66; HGF=290.23; VEGF=0.56; IL1Ra=48.21; IL2R=188.56; MIG=51.84; IL8=9.28 SUBJECT_SAMPLE_FACTORS WU350-198 B5_WU350-198_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-198_d3_polar_pos.mzML B5_WU350-198_d3_polar_neg.mzML B5_WU350-198_d3_lipid_pos.mzML B5_WU350-198_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=17.3; Age at Symptom onset (years)=78.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2374; Neutrophil %=70.5; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=78.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=16.6; IL1b=0.36; IL10=2.1; IL6=15.68; RANTES=740.81; MIP1a=1.66; GMCSF=0.42; MCP1=93.79; IL15=4.02; HGF=1185.2; VEGF=0.18; IL1Ra=17.76; IL2R=33.4; MIG=162; IL8=7.23 SUBJECT_SAMPLE_FACTORS WU350-190 B5_WU350-190_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-190_d3_polar_pos.mzML B5_WU350-190_d3_polar_neg.mzML B5_WU350-190_d3_lipid_pos.mzML B5_WU350-190_d3_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=30.2; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=397.5; D-dimer=977; Neutrophil %=83.3; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=1.69; IL10=8.38; IL6=423.6; RANTES=713.32; MIP1a=1.66; GMCSF=0.21; MCP1=1077.76; IL15=17.72; HGF=21353.12; VEGF=5.25; IL1Ra=198.05; IL2R=1330.19; MIG=143.13; IL8=48.18 SUBJECT_SAMPLE_FACTORS WU350-172 B5_WU350-172_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-172_d3_polar_pos.mzML B5_WU350-172_d3_polar_neg.mzML B5_WU350-172_d3_lipid_pos.mzML B5_WU350-172_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=22.1; Age at Symptom onset (years)=36.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295.7; D-dimer=6934; Neutrophil %=87.3; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=28; Lymphocyte absolute=0.9; Lymphocyte %=2.9; IL1b=10.82; IL10=45.24; IL6=2386.31; RANTES=1237.44; MIP1a=47.66; GMCSF=2.17; MCP1=1132.57; IL15=63.49; HGF=1258.92; VEGF=15.38; IL1Ra=1393.98; IL2R=78.74; MIG=29.62; IL8=37.43 SUBJECT_SAMPLE_FACTORS WU350-174 B5_WU350-174_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-174_d3_polar_pos.mzML B5_WU350-174_d3_polar_neg.mzML B5_WU350-174_d3_lipid_pos.mzML B5_WU350-174_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=20; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=216.8; D-dimer=1130; Neutrophil %=91; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=0.7; Lymphocyte %=5.6; IL1b=0.47; IL10=7.42; IL6=16.48; RANTES=1383.99; MIP1a=1.66; GMCSF=1.04; MCP1=358.56; IL15=71.25; HGF=2053.09; VEGF=1.65; IL1Ra=153.16; IL2R=231.47; MIG=26.95; IL8=12.63 SUBJECT_SAMPLE_FACTORS WU350-176 B5_WU350-176_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-176_d3_polar_pos.mzML B5_WU350-176_d3_polar_neg.mzML B5_WU350-176_d3_lipid_pos.mzML B5_WU350-176_d3_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=25.1; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=178.2; D-dimer=55831; Neutrophil %=90.8; CO2=15; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=13.2; Lymphocyte absolute=0.8; Lymphocyte %=5.8; IL1b=12.95; IL10=134.87; IL6=11223.41; RANTES=678.35; MIP1a=113.48; GMCSF=0.63; MCP1=681.19; IL15=93.87; HGF=4236.1; VEGF=5.93; IL1Ra=2738.59; IL2R=117.59; MIG=8.47; IL8=62.18 SUBJECT_SAMPLE_FACTORS WU350-178 B5_WU350-178_d3 batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-178_d3_polar_pos.mzML B5_WU350-178_d3_polar_neg.mzML B5_WU350-178_d3_lipid_pos.mzML B5_WU350-178_d3_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=28; Age at Symptom onset (years)=76.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=64.6; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=76.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=0.21; IL10=50.63; IL6=61.76; RANTES=786.6; MIP1a=1.66; GMCSF=2.83; MCP1=113.47; IL15=250.04; HGF=1831.18; VEGF=0.15; IL1Ra=71.09; IL2R=33.29; MIG=28.51; IL8=18.77 SUBJECT_SAMPLE_FACTORS WU350-159 B5_WU350-159_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-159_d7_polar_pos.mzML B5_WU350-159_d7_polar_neg.mzML B5_WU350-159_d7_lipid_pos.mzML B5_WU350-159_d7_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=25.9; Age at Symptom onset (years)=60.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.5; D-dimer=1012; Neutrophil %=64.4; CO2=17; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=60.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6.2; Lymphocyte absolute=2; Lymphocyte %=20.2; IL1b=0.27; IL10=1.12; IL6=12.03; RANTES=634.83; MIP1a=1.66; GMCSF=9.75; MCP1=301.53; IL15=39.93; HGF=325.73; VEGF=0.12; IL1Ra=48.46; IL2R=110.11; MIG=38.85; IL8=22.68 SUBJECT_SAMPLE_FACTORS WU350-175 B5_WU350-175_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-175_d7_polar_pos.mzML B5_WU350-175_d7_polar_neg.mzML B5_WU350-175_d7_lipid_pos.mzML B5_WU350-175_d7_lipid_neg.mzML; Days post symptom onset=27; Sex=Male; BMI=28.9; Age at Symptom onset (years)=58.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2415; Neutrophil %=81.7; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=58.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=0.7; Lymphocyte %=9.9; IL1b=4.51; IL10=394.02; IL6=42.61; RANTES=746.78; MIP1a=92.94; GMCSF=2.14; MCP1=182.51; IL15=262.77; HGF=356.41; VEGF=2.19; IL1Ra=198.93; IL2R=86.58; MIG=8.91; IL8=25.92 SUBJECT_SAMPLE_FACTORS WU350-154 B5_WU350-154_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-154_d7_polar_pos.mzML B5_WU350-154_d7_polar_neg.mzML B5_WU350-154_d7_lipid_pos.mzML B5_WU350-154_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=16.3; Age at Symptom onset (years)=71.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=63.4; D-dimer=1222; Neutrophil %=79.4; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.1; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=10.3; Lymphocyte absolute=1.6; Lymphocyte %=12.2; IL1b=2.08; IL10=4.3; IL6=62.72; RANTES=1083; MIP1a=42.78; GMCSF=2.23; MCP1=406.74; IL15=34.9; HGF=1205.42; VEGF=10.2; IL1Ra=128.21; IL2R=93.39; MIG=32.38; IL8=14.11 SUBJECT_SAMPLE_FACTORS WU350-163 B5_WU350-163_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-163_d7_polar_pos.mzML B5_WU350-163_d7_polar_neg.mzML B5_WU350-163_d7_lipid_pos.mzML B5_WU350-163_d7_lipid_neg.mzML; Days post symptom onset=27; Sex=Male; BMI=27.4; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=285.7; D-dimer=-1; Neutrophil %=85.6; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=7.2; IL1b=2.71; IL10=401.2; IL6=316.57; RANTES=703.06; MIP1a=737.67; GMCSF=4.1; MCP1=1992.8; IL15=344.74; HGF=4261.87; VEGF=68.92; IL1Ra=365.56; IL2R=1774.31; MIG=339.44; IL8=55.76 SUBJECT_SAMPLE_FACTORS WU350-165 B5_WU350-165_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-165_d7_polar_pos.mzML B5_WU350-165_d7_polar_neg.mzML B5_WU350-165_d7_lipid_pos.mzML B5_WU350-165_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=23.8; Age at Symptom onset (years)=68.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=173.2; D-dimer=1828; Neutrophil %=88.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=68.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.8; Lymphocyte %=4.4; IL1b=0.51; IL10=20.27; IL6=228.64; RANTES=1245.13; MIP1a=1.66; GMCSF=1.83; MCP1=535.19; IL15=3.41; HGF=723.18; VEGF=9.13; IL1Ra=304.21; IL2R=302.53; MIG=58.26; IL8=43.73 SUBJECT_SAMPLE_FACTORS WU350-172 B5_WU350-172_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-172_d7_polar_pos.mzML B5_WU350-172_d7_polar_neg.mzML B5_WU350-172_d7_lipid_pos.mzML B5_WU350-172_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=22.1; Age at Symptom onset (years)=36.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295.7; D-dimer=6934; Neutrophil %=87.3; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=36.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=28; Lymphocyte absolute=0.9; Lymphocyte %=2.9; IL1b=10.82; IL10=45.24; IL6=2386.31; RANTES=1237.44; MIP1a=47.66; GMCSF=2.17; MCP1=1132.57; IL15=63.49; HGF=1258.92; VEGF=15.38; IL1Ra=1393.98; IL2R=78.74; MIG=29.62; IL8=37.43 SUBJECT_SAMPLE_FACTORS WU350-174 B5_WU350-174_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-174_d7_polar_pos.mzML B5_WU350-174_d7_polar_neg.mzML B5_WU350-174_d7_lipid_pos.mzML B5_WU350-174_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=20; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=216.8; D-dimer=1130; Neutrophil %=91; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=0.7; Lymphocyte %=5.6; IL1b=0.47; IL10=7.42; IL6=16.48; RANTES=1383.99; MIP1a=1.66; GMCSF=1.04; MCP1=358.56; IL15=71.25; HGF=2053.09; VEGF=1.65; IL1Ra=153.16; IL2R=231.47; MIG=26.95; IL8=12.63 SUBJECT_SAMPLE_FACTORS WU350-176 B5_WU350-176_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-176_d7_polar_pos.mzML B5_WU350-176_d7_polar_neg.mzML B5_WU350-176_d7_lipid_pos.mzML B5_WU350-176_d7_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=25.1; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=178.2; D-dimer=55831; Neutrophil %=90.8; CO2=15; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=13.2; Lymphocyte absolute=0.8; Lymphocyte %=5.8; IL1b=12.95; IL10=134.87; IL6=11223.41; RANTES=678.35; MIP1a=113.48; GMCSF=0.63; MCP1=681.19; IL15=93.87; HGF=4236.1; VEGF=5.93; IL1Ra=2738.59; IL2R=117.59; MIG=8.47; IL8=62.18 SUBJECT_SAMPLE_FACTORS WU350-178 B5_WU350-178_d7 batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B5_WU350-178_d7_polar_pos.mzML B5_WU350-178_d7_polar_neg.mzML B5_WU350-178_d7_lipid_pos.mzML B5_WU350-178_d7_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=28; Age at Symptom onset (years)=76.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=64.6; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=76.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=0.21; IL10=50.63; IL6=61.76; RANTES=786.6; MIP1a=1.66; GMCSF=2.83; MCP1=113.47; IL15=250.04; HGF=1831.18; VEGF=0.15; IL1Ra=71.09; IL2R=33.29; MIG=28.51; IL8=18.77 SUBJECT_SAMPLE_FACTORS WU350-201 B6_WU350-201_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-201_d0_polar_pos.mzML B6_WU350-201_d0_polar_neg.mzML B6_WU350-201_d0_lipid_pos.mzML B6_WU350-201_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=26.9; Age at Symptom onset (years)=80.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=71.2; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=80.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.6; Lymphocyte absolute=0.7; Lymphocyte %=11.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-215 B6_WU350-215_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-215_d0_polar_pos.mzML B6_WU350-215_d0_polar_neg.mzML B6_WU350-215_d0_lipid_pos.mzML B6_WU350-215_d0_lipid_neg.mzML; Days post symptom onset=62; Sex=Male; BMI=26.8; Age at Symptom onset (years)=25.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=389; Neutrophil %=54; CO2=30; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=25.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=1.8; Lymphocyte %=36.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-221 B6_WU350-221_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-221_d0_polar_pos.mzML B6_WU350-221_d0_polar_neg.mzML B6_WU350-221_d0_lipid_pos.mzML B6_WU350-221_d0_lipid_neg.mzML; Days post symptom onset=107; Sex=Female; BMI=40.9; Age at Symptom onset (years)=43.1; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-225 B6_WU350-225_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-225_d0_polar_pos.mzML B6_WU350-225_d0_polar_neg.mzML B6_WU350-225_d0_lipid_pos.mzML B6_WU350-225_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=22.6; Age at Symptom onset (years)=59.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=59.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-228 B6_WU350-228_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-228_d0_polar_pos.mzML B6_WU350-228_d0_polar_neg.mzML B6_WU350-228_d0_lipid_pos.mzML B6_WU350-228_d0_lipid_neg.mzML; Days post symptom onset=28; Sex=Female; BMI=40.7; Age at Symptom onset (years)=47.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.6; D-dimer=-1; Neutrophil %=67; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=47.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=9.3; Lymphocyte absolute=3.4; Lymphocyte %=24.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-233 B6_WU350-233_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-233_d0_polar_pos.mzML B6_WU350-233_d0_polar_neg.mzML B6_WU350-233_d0_lipid_pos.mzML B6_WU350-233_d0_lipid_neg.mzML; Days post symptom onset=57; Sex=Male; BMI=33.7; Age at Symptom onset (years)=53; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=951; Neutrophil %=58.4; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=2.1; Lymphocyte %=28; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-202 B6_WU350-202_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-202_d0_polar_pos.mzML B6_WU350-202_d0_polar_neg.mzML B6_WU350-202_d0_lipid_pos.mzML B6_WU350-202_d0_lipid_neg.mzML; Days post symptom onset=21; Sex=Female; BMI=29.7; Age at Symptom onset (years)=39.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1426; Neutrophil %=58.7; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=1.9; Lymphocyte %=33.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-200 B6_WU350-200_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-200_d0_polar_pos.mzML B6_WU350-200_d0_polar_neg.mzML B6_WU350-200_d0_lipid_pos.mzML B6_WU350-200_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=22.7; Age at Symptom onset (years)=63.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=55.3; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=63.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6.1; Lymphocyte absolute=3.9; Lymphocyte %=34.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-247 B6_WU350-247_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-247_d0_polar_pos.mzML B6_WU350-247_d0_polar_neg.mzML B6_WU350-247_d0_lipid_pos.mzML B6_WU350-247_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=25.8; Age at Symptom onset (years)=56.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=39.5; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=56.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.5; Lymphocyte absolute=1.9; Lymphocyte %=51.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-204 B6_WU350-204_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-204_d0_polar_pos.mzML B6_WU350-204_d0_polar_neg.mzML B6_WU350-204_d0_lipid_pos.mzML B6_WU350-204_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=35.1; Age at Symptom onset (years)=71.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=113.9; D-dimer=397; Neutrophil %=62.2; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=2.5; Lymphocyte %=32.4; IL1b=1.16; IL10=99.78; IL6=43.27; RANTES=547.97; MIP1a=50.38; GMCSF=5.77; MCP1=665.13; IL15=12.97; HGF=377.06; VEGF=1.44; IL1Ra=111.97; IL2R=142.46; MIG=58.28; IL8=37.47 SUBJECT_SAMPLE_FACTORS WU350-206 B6_WU350-206_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-206_d0_polar_pos.mzML B6_WU350-206_d0_polar_neg.mzML B6_WU350-206_d0_lipid_pos.mzML B6_WU350-206_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=31.9; Age at Symptom onset (years)=65; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=54.6; D-dimer=1038; Neutrophil %=63.9; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=65; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.8; Lymphocyte absolute=1.7; Lymphocyte %=22.1; IL1b=1.75; IL10=2.15; IL6=20.66; RANTES=870.82; MIP1a=1.66; GMCSF=1.02; MCP1=673.25; IL15=32.54; HGF=300.11; VEGF=3.2; IL1Ra=288.53; IL2R=60.04; MIG=29.24; IL8=15.92 SUBJECT_SAMPLE_FACTORS WU350-207 B6_WU350-207_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-207_d0_polar_pos.mzML B6_WU350-207_d0_polar_neg.mzML B6_WU350-207_d0_lipid_pos.mzML B6_WU350-207_d0_lipid_neg.mzML; Days post symptom onset=33; Sex=Female; BMI=37.6; Age at Symptom onset (years)=58.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=56.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=2.1; Lymphocyte %=29.2; IL1b=2.27; IL10=18.31; IL6=3.94; RANTES=907.44; MIP1a=2.19; GMCSF=0.51; MCP1=481.98; IL15=75.66; HGF=368.52; VEGF=1.41; IL1Ra=86.35; IL2R=80.56; MIG=59.35; IL8=10.76 SUBJECT_SAMPLE_FACTORS WU350-219 B6_WU350-219_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-219_d0_polar_pos.mzML B6_WU350-219_d0_polar_neg.mzML B6_WU350-219_d0_lipid_pos.mzML B6_WU350-219_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=28; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.2; D-dimer=860; Neutrophil %=57.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=1.1; Lymphocyte %=15.6; IL1b=2.11; IL10=145.78; IL6=9.18; RANTES=1111.1; MIP1a=1.66; GMCSF=6.97; MCP1=784.73; IL15=13.83; HGF=213.3; VEGF=2.9; IL1Ra=656.28; IL2R=48.18; MIG=38.67; IL8=13.26 SUBJECT_SAMPLE_FACTORS WU350-227 B6_WU350-227_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-227_d0_polar_pos.mzML B6_WU350-227_d0_polar_neg.mzML B6_WU350-227_d0_lipid_pos.mzML B6_WU350-227_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=51.5; Age at Symptom onset (years)=39.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=86.3; D-dimer=528; Neutrophil %=69.9; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=39.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=1.5; Lymphocyte %=16.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-231 B6_WU350-231_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-231_d0_polar_pos.mzML B6_WU350-231_d0_polar_neg.mzML B6_WU350-231_d0_lipid_pos.mzML B6_WU350-231_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.5; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=47.7; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=1.7; Lymphocyte %=24.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-238 B6_WU350-238_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-238_d0_polar_pos.mzML B6_WU350-238_d0_polar_neg.mzML B6_WU350-238_d0_lipid_pos.mzML B6_WU350-238_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=17.9; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1252; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-239 B6_WU350-239_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-239_d0_polar_pos.mzML B6_WU350-239_d0_polar_neg.mzML B6_WU350-239_d0_lipid_pos.mzML B6_WU350-239_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=41.5; Age at Symptom onset (years)=52.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=122.3; D-dimer=693; Neutrophil %=62.2; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=1.8; Lymphocyte %=22.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-241 B6_WU350-241_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-241_d0_polar_pos.mzML B6_WU350-241_d0_polar_neg.mzML B6_WU350-241_d0_lipid_pos.mzML B6_WU350-241_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=33.7; Age at Symptom onset (years)=85.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.5; D-dimer=6517; Neutrophil %=62.2; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=85.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.9; Lymphocyte absolute=2.5; Lymphocyte %=26.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-242 B6_WU350-242_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-242_d0_polar_pos.mzML B6_WU350-242_d0_polar_neg.mzML B6_WU350-242_d0_lipid_pos.mzML B6_WU350-242_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=54.6; Age at Symptom onset (years)=62.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2019; Neutrophil %=77; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=62.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=1; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-243 B6_WU350-243_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-243_d0_polar_pos.mzML B6_WU350-243_d0_polar_neg.mzML B6_WU350-243_d0_lipid_pos.mzML B6_WU350-243_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=49.3; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=18.3; D-dimer=1996; Neutrophil %=69.8; CO2=18; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=54.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=1.1; Lymphocyte %=17.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-244 B6_WU350-244_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-244_d0_polar_pos.mzML B6_WU350-244_d0_polar_neg.mzML B6_WU350-244_d0_lipid_pos.mzML B6_WU350-244_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=22; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.6; D-dimer=-1; Neutrophil %=56.7; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=1.5; Lymphocyte %=33; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-259 B6_WU350-259_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-259_d0_polar_pos.mzML B6_WU350-259_d0_polar_neg.mzML B6_WU350-259_d0_lipid_pos.mzML B6_WU350-259_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=25.4; Age at Symptom onset (years)=83.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=32.6; D-dimer=2152; Neutrophil %=74.6; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=83.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.6; Lymphocyte %=12.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-260 B6_WU350-260_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-260_d0_polar_pos.mzML B6_WU350-260_d0_polar_neg.mzML B6_WU350-260_d0_lipid_pos.mzML B6_WU350-260_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=33.9; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=108.3; D-dimer=31765; Neutrophil %=73.4; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=1.1; Lymphocyte %=19.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-261 B6_WU350-261_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-261_d0_polar_pos.mzML B6_WU350-261_d0_polar_neg.mzML B6_WU350-261_d0_lipid_pos.mzML B6_WU350-261_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=28.9; Age at Symptom onset (years)=52.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.1; D-dimer=738; Neutrophil %=70.8; CO2=20; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.8; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-218 B6_WU350-218_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B6_WU350-218_d0_polar_pos.mzML B6_WU350-218_d0_polar_neg.mzML B6_WU350-218_d0_lipid_pos.mzML B6_WU350-218_d0_lipid_neg.mzML; Days post symptom onset=30; Sex=Female; BMI=47.6; Age at Symptom onset (years)=48.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=13.7; D-dimer=492; Neutrophil %=62.3; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=48.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.7; Lymphocyte absolute=3; Lymphocyte %=27.4; IL1b=0.89; IL10=450.67; IL6=4.84; RANTES=817.65; MIP1a=1.66; GMCSF=12.16; MCP1=200.29; IL15=63.75; HGF=219.29; VEGF=2.42; IL1Ra=33.52; IL2R=55.57; MIG=12.66; IL8=6.6 SUBJECT_SAMPLE_FACTORS WU350-209 B6_WU350-209_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-209_d0_polar_pos.mzML B6_WU350-209_d0_polar_neg.mzML B6_WU350-209_d0_lipid_pos.mzML B6_WU350-209_d0_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=40.3; Age at Symptom onset (years)=59.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=382; D-dimer=1295; Neutrophil %=85; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=14.5; Lymphocyte absolute=1.1; Lymphocyte %=5.3; IL1b=2.51; IL10=197.21; IL6=396.75; RANTES=642.66; MIP1a=51.46; GMCSF=2.82; MCP1=746.58; IL15=434.17; HGF=26136.39; VEGF=1.62; IL1Ra=1419.08; IL2R=148.34; MIG=176.83; IL8=37.11 SUBJECT_SAMPLE_FACTORS WU350-205 B6_WU350-205_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-205_d0_polar_pos.mzML B6_WU350-205_d0_polar_neg.mzML B6_WU350-205_d0_lipid_pos.mzML B6_WU350-205_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=21.1; Age at Symptom onset (years)=69; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=122.2; D-dimer=6376; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.26; IL10=111.89; IL6=839.25; RANTES=771.79; MIP1a=1.66; GMCSF=10.84; MCP1=347.56; IL15=19.37; HGF=2592.31; VEGF=5.33; IL1Ra=139.06; IL2R=35.83; MIG=1.05; IL8=213.16 SUBJECT_SAMPLE_FACTORS WU350-208 B6_WU350-208_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-208_d0_polar_pos.mzML B6_WU350-208_d0_polar_neg.mzML B6_WU350-208_d0_lipid_pos.mzML B6_WU350-208_d0_lipid_neg.mzML; Days post symptom onset=37; Sex=Female; BMI=31.1; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295; D-dimer=1787; Neutrophil %=78.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=12.6; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=0.83; IL10=21.93; IL6=242.8; RANTES=1091.06; MIP1a=1.66; GMCSF=2.09; MCP1=650.13; IL15=40.08; HGF=5370.78; VEGF=2.33; IL1Ra=151.39; IL2R=48.48; MIG=20.71; IL8=24.38 SUBJECT_SAMPLE_FACTORS WU350-210 B6_WU350-210_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-210_d0_polar_pos.mzML B6_WU350-210_d0_polar_neg.mzML B6_WU350-210_d0_lipid_pos.mzML B6_WU350-210_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=21.9; Age at Symptom onset (years)=73.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=6.4; D-dimer=5001; Neutrophil %=78.5; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=73.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=11; Lymphocyte absolute=1.6; Lymphocyte %=11.1; IL1b=0.35; IL10=55.54; IL6=8.69; RANTES=637.83; MIP1a=1.66; GMCSF=1.69; MCP1=316.55; IL15=3.41; HGF=1521.21; VEGF=2.36; IL1Ra=37.73; IL2R=21.42; MIG=12.86; IL8=19.42 SUBJECT_SAMPLE_FACTORS WU350-217 B6_WU350-217_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-217_d0_polar_pos.mzML B6_WU350-217_d0_polar_neg.mzML B6_WU350-217_d0_lipid_pos.mzML B6_WU350-217_d0_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=18.2; Age at Symptom onset (years)=71.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=94.8; D-dimer=2281; Neutrophil %=67.2; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=71.8; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=1.3; Lymphocyte %=21.9; IL1b=123.69; IL10=47.25; IL6=27.87; RANTES=2799.18; MIP1a=1093.87; GMCSF=0.89; MCP1=4549.52; IL15=4431.43; HGF=6907.71; VEGF=1.43; IL1Ra=545.82; IL2R=3248.93; MIG=446.98; IL8=27.95 SUBJECT_SAMPLE_FACTORS WU350-226 B6_WU350-226_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-226_d0_polar_pos.mzML B6_WU350-226_d0_polar_neg.mzML B6_WU350-226_d0_lipid_pos.mzML B6_WU350-226_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=40.4; Age at Symptom onset (years)=54.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=15.7; D-dimer=1063; Neutrophil %=35.4; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1; Lymphocyte absolute=1.3; Lymphocyte %=44.2; IL1b=0.92; IL10=18.01; IL6=14.02; RANTES=600.22; MIP1a=84.99; GMCSF=8.55; MCP1=274.21; IL15=306.6; HGF=380.95; VEGF=1.51; IL1Ra=33.66; IL2R=46.04; MIG=18.35; IL8=17 SUBJECT_SAMPLE_FACTORS WU350-232 B6_WU350-232_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-232_d0_polar_pos.mzML B6_WU350-232_d0_polar_neg.mzML B6_WU350-232_d0_lipid_pos.mzML B6_WU350-232_d0_lipid_neg.mzML; Days post symptom onset=15; Sex=Female; BMI=43.1; Age at Symptom onset (years)=64.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=387.8; D-dimer=14397; Neutrophil %=89.6; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=26.1; Lymphocyte absolute=1; Lymphocyte %=2.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-246 B6_WU350-246_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-246_d0_polar_pos.mzML B6_WU350-246_d0_polar_neg.mzML B6_WU350-246_d0_lipid_pos.mzML B6_WU350-246_d0_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=19.8; Age at Symptom onset (years)=78.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=23055; Neutrophil %=89.8; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.3; Lymphocyte absolute=0.5; Lymphocyte %=5.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-248 B6_WU350-248_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-248_d0_polar_pos.mzML B6_WU350-248_d0_polar_neg.mzML B6_WU350-248_d0_lipid_pos.mzML B6_WU350-248_d0_lipid_neg.mzML; Days post symptom onset=12; Sex=Female; BMI=40.2; Age at Symptom onset (years)=71.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=12; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=245.6; D-dimer=509; Neutrophil %=77.9; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=0.8; Lymphocyte %=11.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-249 B6_WU350-249_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-249_d0_polar_pos.mzML B6_WU350-249_d0_polar_neg.mzML B6_WU350-249_d0_lipid_pos.mzML B6_WU350-249_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=22.5; Age at Symptom onset (years)=28.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=104.4; D-dimer=6570; Neutrophil %=72.8; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=28.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=6.6; Lymphocyte absolute=1.9; Lymphocyte %=21; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-251 B6_WU350-251_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-251_d0_polar_pos.mzML B6_WU350-251_d0_polar_neg.mzML B6_WU350-251_d0_lipid_pos.mzML B6_WU350-251_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=24.7; Age at Symptom onset (years)=86.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=86; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86.6; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=14.7; Lymphocyte absolute=0.6; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-255 B6_WU350-255_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-255_d0_polar_pos.mzML B6_WU350-255_d0_polar_neg.mzML B6_WU350-255_d0_lipid_pos.mzML B6_WU350-255_d0_lipid_neg.mzML; Days post symptom onset=36; Sex=Female; BMI=20.8; Age at Symptom onset (years)=70.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=79.2; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=70.2; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-256 B6_WU350-256_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-256_d0_polar_pos.mzML B6_WU350-256_d0_polar_neg.mzML B6_WU350-256_d0_lipid_pos.mzML B6_WU350-256_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=20.4; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=84.8; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-257 B6_WU350-257_d0 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-257_d0_polar_pos.mzML B6_WU350-257_d0_polar_neg.mzML B6_WU350-257_d0_lipid_pos.mzML B6_WU350-257_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=32; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.1; D-dimer=6558; Neutrophil %=89.6; CO2=12; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=66.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.3; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-238 B6_WU350-238_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-238_d14_polar_pos.mzML B6_WU350-238_d14_polar_neg.mzML B6_WU350-238_d14_lipid_pos.mzML B6_WU350-238_d14_lipid_neg.mzML; Days post symptom onset=15; Sex=Female; BMI=17.9; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1252; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-174 B6_WU350-174_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-174_d14_polar_pos.mzML B6_WU350-174_d14_polar_neg.mzML B6_WU350-174_d14_lipid_pos.mzML B6_WU350-174_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=20; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=216.8; D-dimer=1130; Neutrophil %=91; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=0.7; Lymphocyte %=5.6; IL1b=0.47; IL10=7.42; IL6=16.48; RANTES=1383.99; MIP1a=1.66; GMCSF=1.04; MCP1=358.56; IL15=71.25; HGF=2053.09; VEGF=1.65; IL1Ra=153.16; IL2R=231.47; MIG=26.95; IL8=12.63 SUBJECT_SAMPLE_FACTORS WU350-163 B6_WU350-163_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-163_d14_polar_pos.mzML B6_WU350-163_d14_polar_neg.mzML B6_WU350-163_d14_lipid_pos.mzML B6_WU350-163_d14_lipid_neg.mzML; Days post symptom onset=34; Sex=Male; BMI=27.4; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=285.7; D-dimer=-1; Neutrophil %=85.6; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=5.3; Lymphocyte absolute=0.5; Lymphocyte %=7.2; IL1b=2.71; IL10=401.2; IL6=316.57; RANTES=703.06; MIP1a=737.67; GMCSF=4.1; MCP1=1992.8; IL15=344.74; HGF=4261.87; VEGF=68.92; IL1Ra=365.56; IL2R=1774.31; MIG=339.44; IL8=55.76 SUBJECT_SAMPLE_FACTORS WU350-165 B6_WU350-165_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-165_d14_polar_pos.mzML B6_WU350-165_d14_polar_neg.mzML B6_WU350-165_d14_lipid_pos.mzML B6_WU350-165_d14_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=23.8; Age at Symptom onset (years)=68.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=173.2; D-dimer=1828; Neutrophil %=88.5; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=68.4; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.8; Lymphocyte %=4.4; IL1b=0.51; IL10=20.27; IL6=228.64; RANTES=1245.13; MIP1a=1.66; GMCSF=1.83; MCP1=535.19; IL15=3.41; HGF=723.18; VEGF=9.13; IL1Ra=304.21; IL2R=302.53; MIG=58.26; IL8=43.73 SUBJECT_SAMPLE_FACTORS WU350-176 B6_WU350-176_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-176_d14_polar_pos.mzML B6_WU350-176_d14_polar_neg.mzML B6_WU350-176_d14_lipid_pos.mzML B6_WU350-176_d14_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=25.1; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=178.2; D-dimer=55831; Neutrophil %=90.8; CO2=15; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=13.2; Lymphocyte absolute=0.8; Lymphocyte %=5.8; IL1b=12.95; IL10=134.87; IL6=11223.41; RANTES=678.35; MIP1a=113.48; GMCSF=0.63; MCP1=681.19; IL15=93.87; HGF=4236.1; VEGF=5.93; IL1Ra=2738.59; IL2R=117.59; MIG=8.47; IL8=62.18 SUBJECT_SAMPLE_FACTORS WU350-190 B6_WU350-190_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-190_d14_polar_pos.mzML B6_WU350-190_d14_polar_neg.mzML B6_WU350-190_d14_lipid_pos.mzML B6_WU350-190_d14_lipid_neg.mzML; Days post symptom onset=28; Sex=Male; BMI=30.2; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=397.5; D-dimer=977; Neutrophil %=83.3; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=1.69; IL10=8.38; IL6=423.6; RANTES=713.32; MIP1a=1.66; GMCSF=0.21; MCP1=1077.76; IL15=17.72; HGF=21353.12; VEGF=5.25; IL1Ra=198.05; IL2R=1330.19; MIG=143.13; IL8=48.18 SUBJECT_SAMPLE_FACTORS WU350-205 B6_WU350-205_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-205_d14_polar_pos.mzML B6_WU350-205_d14_polar_neg.mzML B6_WU350-205_d14_lipid_pos.mzML B6_WU350-205_d14_lipid_neg.mzML; Days post symptom onset=28; Sex=Female; BMI=21.1; Age at Symptom onset (years)=69; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=122.2; D-dimer=6376; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.26; IL10=111.89; IL6=839.25; RANTES=771.79; MIP1a=1.66; GMCSF=10.84; MCP1=347.56; IL15=19.37; HGF=2592.31; VEGF=5.33; IL1Ra=139.06; IL2R=35.83; MIG=1.05; IL8=213.16 SUBJECT_SAMPLE_FACTORS WU350-209 B6_WU350-209_d14 batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-209_d14_polar_pos.mzML B6_WU350-209_d14_polar_neg.mzML B6_WU350-209_d14_lipid_pos.mzML B6_WU350-209_d14_lipid_neg.mzML; Days post symptom onset=25; Sex=Female; BMI=40.3; Age at Symptom onset (years)=59.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=382; D-dimer=1295; Neutrophil %=85; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=14.5; Lymphocyte absolute=1.1; Lymphocyte %=5.3; IL1b=2.51; IL10=197.21; IL6=396.75; RANTES=642.66; MIP1a=51.46; GMCSF=2.82; MCP1=746.58; IL15=434.17; HGF=26136.39; VEGF=1.62; IL1Ra=1419.08; IL2R=148.34; MIG=176.83; IL8=37.11 SUBJECT_SAMPLE_FACTORS WU350-141 B6_WU350-141_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-141_d28_polar_pos.mzML B6_WU350-141_d28_polar_neg.mzML B6_WU350-141_d28_lipid_pos.mzML B6_WU350-141_d28_lipid_neg.mzML; Days post symptom onset=49; Sex=Male; BMI=41.7; Age at Symptom onset (years)=33.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=65.1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=33.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.9; Lymphocyte %=21.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-149 B6_WU350-149_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-149_d28_polar_pos.mzML B6_WU350-149_d28_polar_neg.mzML B6_WU350-149_d28_lipid_pos.mzML B6_WU350-149_d28_lipid_neg.mzML; Days post symptom onset=41; Sex=Male; BMI=31.8; Age at Symptom onset (years)=66.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-179 B6_WU350-179_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-179_d28_polar_pos.mzML B6_WU350-179_d28_polar_neg.mzML B6_WU350-179_d28_lipid_pos.mzML B6_WU350-179_d28_lipid_neg.mzML; Days post symptom onset=33; Sex=Male; BMI=31.3; Age at Symptom onset (years)=59.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=63.8; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=1.7; Lymphocyte %=24.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-125 B6_WU350-125_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-125_d28_polar_pos.mzML B6_WU350-125_d28_polar_neg.mzML B6_WU350-125_d28_lipid_pos.mzML B6_WU350-125_d28_lipid_neg.mzML; Days post symptom onset=32; Sex=Male; BMI=25.8; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6; D-dimer=496; Neutrophil %=59.6; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=1.7; Lymphocyte %=29.4; IL1b=176.03; IL10=141.42; IL6=195.3; RANTES=19021.39; MIP1a=1434.31; GMCSF=17.31; MCP1=11267.7; IL15=17510.51; HGF=9535.78; VEGF=4.4; IL1Ra=428.64; IL2R=1789.25; MIG=153.36; IL8=89.9 SUBJECT_SAMPLE_FACTORS WU350-120 B6_WU350-120_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-120_d28_polar_pos.mzML B6_WU350-120_d28_polar_neg.mzML B6_WU350-120_d28_lipid_pos.mzML B6_WU350-120_d28_lipid_neg.mzML; Days post symptom onset=33; Sex=Female; BMI=25.3; Age at Symptom onset (years)=57.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=114; D-dimer=2563; Neutrophil %=78.3; CO2=23; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=57.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=14.3; IL1b=2.23; IL10=25.64; IL6=139.91; RANTES=1284.8; MIP1a=10.89; GMCSF=0.23; MCP1=1917.63; IL15=12.66; HGF=6337.89; VEGF=3.34; IL1Ra=234.58; IL2R=113.32; MIG=60.67; IL8=24.21 SUBJECT_SAMPLE_FACTORS WU350-126 B6_WU350-126_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-126_d28_polar_pos.mzML B6_WU350-126_d28_polar_neg.mzML B6_WU350-126_d28_lipid_pos.mzML B6_WU350-126_d28_lipid_neg.mzML; Days post symptom onset=35; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-145 B6_WU350-145_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-145_d28_polar_pos.mzML B6_WU350-145_d28_polar_neg.mzML B6_WU350-145_d28_lipid_pos.mzML B6_WU350-145_d28_lipid_neg.mzML; Days post symptom onset=31; Sex=Male; BMI=31; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.7; D-dimer=65085; Neutrophil %=62.5; CO2=29; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.2; Lymphocyte %=17.6; IL1b=2.51; IL10=38.35; IL6=53.04; RANTES=875.58; MIP1a=2.27; GMCSF=0.71; MCP1=223.42; IL15=20.8; HGF=5427.58; VEGF=1.5; IL1Ra=148.37; IL2R=83.14; MIG=399.6; IL8=16.49 SUBJECT_SAMPLE_FACTORS WU350-174 B6_WU350-174_d28 batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-174_d28_polar_pos.mzML B6_WU350-174_d28_polar_neg.mzML B6_WU350-174_d28_lipid_pos.mzML B6_WU350-174_d28_lipid_neg.mzML; Days post symptom onset=30; Sex=Male; BMI=20; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=216.8; D-dimer=1130; Neutrophil %=91; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=9.9; Lymphocyte absolute=0.7; Lymphocyte %=5.6; IL1b=0.47; IL10=7.42; IL6=16.48; RANTES=1383.99; MIP1a=1.66; GMCSF=1.04; MCP1=358.56; IL15=71.25; HGF=2053.09; VEGF=1.65; IL1Ra=153.16; IL2R=231.47; MIG=26.95; IL8=12.63 SUBJECT_SAMPLE_FACTORS WU350-206 B6_WU350-206_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-206_d3_polar_pos.mzML B6_WU350-206_d3_polar_neg.mzML B6_WU350-206_d3_lipid_pos.mzML B6_WU350-206_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=31.9; Age at Symptom onset (years)=65; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=54.6; D-dimer=1038; Neutrophil %=63.9; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=65; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.8; Lymphocyte absolute=1.7; Lymphocyte %=22.1; IL1b=1.75; IL10=2.15; IL6=20.66; RANTES=870.82; MIP1a=1.66; GMCSF=1.02; MCP1=673.25; IL15=32.54; HGF=300.11; VEGF=3.2; IL1Ra=288.53; IL2R=60.04; MIG=29.24; IL8=15.92 SUBJECT_SAMPLE_FACTORS WU350-218 B6_WU350-218_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-218_d3_polar_pos.mzML B6_WU350-218_d3_polar_neg.mzML B6_WU350-218_d3_lipid_pos.mzML B6_WU350-218_d3_lipid_neg.mzML; Days post symptom onset=32; Sex=Female; BMI=47.6; Age at Symptom onset (years)=48.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=13.7; D-dimer=492; Neutrophil %=62.3; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=48.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.7; Lymphocyte absolute=3; Lymphocyte %=27.4; IL1b=0.89; IL10=450.67; IL6=4.84; RANTES=817.65; MIP1a=1.66; GMCSF=12.16; MCP1=200.29; IL15=63.75; HGF=219.29; VEGF=2.42; IL1Ra=33.52; IL2R=55.57; MIG=12.66; IL8=6.6 SUBJECT_SAMPLE_FACTORS WU350-219 B6_WU350-219_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-219_d3_polar_pos.mzML B6_WU350-219_d3_polar_neg.mzML B6_WU350-219_d3_lipid_pos.mzML B6_WU350-219_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=28; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.2; D-dimer=860; Neutrophil %=57.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=1.1; Lymphocyte %=15.6; IL1b=2.11; IL10=145.78; IL6=9.18; RANTES=1111.1; MIP1a=1.66; GMCSF=6.97; MCP1=784.73; IL15=13.83; HGF=213.3; VEGF=2.9; IL1Ra=656.28; IL2R=48.18; MIG=38.67; IL8=13.26 SUBJECT_SAMPLE_FACTORS WU350-238 B6_WU350-238_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-238_d3_polar_pos.mzML B6_WU350-238_d3_polar_neg.mzML B6_WU350-238_d3_lipid_pos.mzML B6_WU350-238_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=17.9; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1252; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-241 B6_WU350-241_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-241_d3_polar_pos.mzML B6_WU350-241_d3_polar_neg.mzML B6_WU350-241_d3_lipid_pos.mzML B6_WU350-241_d3_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=33.7; Age at Symptom onset (years)=85.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.5; D-dimer=6517; Neutrophil %=62.2; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=85.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.9; Lymphocyte absolute=2.5; Lymphocyte %=26.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-242 B6_WU350-242_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-242_d3_polar_pos.mzML B6_WU350-242_d3_polar_neg.mzML B6_WU350-242_d3_lipid_pos.mzML B6_WU350-242_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=54.6; Age at Symptom onset (years)=62.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2019; Neutrophil %=77; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=62.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=1; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-244 B6_WU350-244_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-244_d3_polar_pos.mzML B6_WU350-244_d3_polar_neg.mzML B6_WU350-244_d3_lipid_pos.mzML B6_WU350-244_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=22; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.6; D-dimer=-1; Neutrophil %=56.7; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=1.5; Lymphocyte %=33; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-209 B6_WU350-209_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-209_d3_polar_pos.mzML B6_WU350-209_d3_polar_neg.mzML B6_WU350-209_d3_lipid_pos.mzML B6_WU350-209_d3_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=40.3; Age at Symptom onset (years)=59.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=382; D-dimer=1295; Neutrophil %=85; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=14.5; Lymphocyte absolute=1.1; Lymphocyte %=5.3; IL1b=2.51; IL10=197.21; IL6=396.75; RANTES=642.66; MIP1a=51.46; GMCSF=2.82; MCP1=746.58; IL15=434.17; HGF=26136.39; VEGF=1.62; IL1Ra=1419.08; IL2R=148.34; MIG=176.83; IL8=37.11 SUBJECT_SAMPLE_FACTORS WU350-205 B6_WU350-205_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-205_d3_polar_pos.mzML B6_WU350-205_d3_polar_neg.mzML B6_WU350-205_d3_lipid_pos.mzML B6_WU350-205_d3_lipid_neg.mzML; Days post symptom onset=17; Sex=Female; BMI=21.1; Age at Symptom onset (years)=69; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=122.2; D-dimer=6376; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.26; IL10=111.89; IL6=839.25; RANTES=771.79; MIP1a=1.66; GMCSF=10.84; MCP1=347.56; IL15=19.37; HGF=2592.31; VEGF=5.33; IL1Ra=139.06; IL2R=35.83; MIG=1.05; IL8=213.16 SUBJECT_SAMPLE_FACTORS WU350-208 B6_WU350-208_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-208_d3_polar_pos.mzML B6_WU350-208_d3_polar_neg.mzML B6_WU350-208_d3_lipid_pos.mzML B6_WU350-208_d3_lipid_neg.mzML; Days post symptom onset=40; Sex=Female; BMI=31.1; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295; D-dimer=1787; Neutrophil %=78.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=12.6; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=0.83; IL10=21.93; IL6=242.8; RANTES=1091.06; MIP1a=1.66; GMCSF=2.09; MCP1=650.13; IL15=40.08; HGF=5370.78; VEGF=2.33; IL1Ra=151.39; IL2R=48.48; MIG=20.71; IL8=24.38 SUBJECT_SAMPLE_FACTORS WU350-232 B6_WU350-232_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-232_d3_polar_pos.mzML B6_WU350-232_d3_polar_neg.mzML B6_WU350-232_d3_lipid_pos.mzML B6_WU350-232_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=43.1; Age at Symptom onset (years)=64.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=387.8; D-dimer=14397; Neutrophil %=89.6; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=26.1; Lymphocyte absolute=1; Lymphocyte %=2.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-246 B6_WU350-246_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-246_d3_polar_pos.mzML B6_WU350-246_d3_polar_neg.mzML B6_WU350-246_d3_lipid_pos.mzML B6_WU350-246_d3_lipid_neg.mzML; Days post symptom onset=19; Sex=Male; BMI=19.8; Age at Symptom onset (years)=78.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=23055; Neutrophil %=89.8; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.3; Lymphocyte absolute=0.5; Lymphocyte %=5.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-248 B6_WU350-248_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-248_d3_polar_pos.mzML B6_WU350-248_d3_polar_neg.mzML B6_WU350-248_d3_lipid_pos.mzML B6_WU350-248_d3_lipid_neg.mzML; Days post symptom onset=15; Sex=Female; BMI=40.2; Age at Symptom onset (years)=71.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=12; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=245.6; D-dimer=509; Neutrophil %=77.9; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=0.8; Lymphocyte %=11.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-251 B6_WU350-251_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-251_d3_polar_pos.mzML B6_WU350-251_d3_polar_neg.mzML B6_WU350-251_d3_lipid_pos.mzML B6_WU350-251_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=24.7; Age at Symptom onset (years)=86.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=86; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86.6; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=14.7; Lymphocyte absolute=0.6; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-255 B6_WU350-255_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-255_d3_polar_pos.mzML B6_WU350-255_d3_polar_neg.mzML B6_WU350-255_d3_lipid_pos.mzML B6_WU350-255_d3_lipid_neg.mzML; Days post symptom onset=39; Sex=Female; BMI=20.8; Age at Symptom onset (years)=70.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=79.2; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=70.2; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-256 B6_WU350-256_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-256_d3_polar_pos.mzML B6_WU350-256_d3_polar_neg.mzML B6_WU350-256_d3_lipid_pos.mzML B6_WU350-256_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=20.4; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=84.8; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-257 B6_WU350-257_d3 batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-257_d3_polar_pos.mzML B6_WU350-257_d3_polar_neg.mzML B6_WU350-257_d3_lipid_pos.mzML B6_WU350-257_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=32; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.1; D-dimer=6558; Neutrophil %=89.6; CO2=12; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=66.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.3; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-233 B6_WU350-233_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-233_d7_polar_pos.mzML B6_WU350-233_d7_polar_neg.mzML B6_WU350-233_d7_lipid_pos.mzML B6_WU350-233_d7_lipid_neg.mzML; Days post symptom onset=63; Sex=Male; BMI=33.7; Age at Symptom onset (years)=53; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=951; Neutrophil %=58.4; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=2.1; Lymphocyte %=28; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-198 B6_WU350-198_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-198_d7_polar_pos.mzML B6_WU350-198_d7_polar_neg.mzML B6_WU350-198_d7_lipid_pos.mzML B6_WU350-198_d7_lipid_neg.mzML; Days post symptom onset=43; Sex=Male; BMI=17.3; Age at Symptom onset (years)=78.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2374; Neutrophil %=70.5; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=78.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=16.6; IL1b=0.36; IL10=2.1; IL6=15.68; RANTES=740.81; MIP1a=1.66; GMCSF=0.42; MCP1=93.79; IL15=4.02; HGF=1185.2; VEGF=0.18; IL1Ra=17.76; IL2R=33.4; MIG=162; IL8=7.23 SUBJECT_SAMPLE_FACTORS WU350-204 B6_WU350-204_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-204_d7_polar_pos.mzML B6_WU350-204_d7_polar_neg.mzML B6_WU350-204_d7_lipid_pos.mzML B6_WU350-204_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=35.1; Age at Symptom onset (years)=71.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=113.9; D-dimer=397; Neutrophil %=62.2; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=2.5; Lymphocyte %=32.4; IL1b=1.16; IL10=99.78; IL6=43.27; RANTES=547.97; MIP1a=50.38; GMCSF=5.77; MCP1=665.13; IL15=12.97; HGF=377.06; VEGF=1.44; IL1Ra=111.97; IL2R=142.46; MIG=58.28; IL8=37.47 SUBJECT_SAMPLE_FACTORS WU350-219 B6_WU350-219_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-219_d7_polar_pos.mzML B6_WU350-219_d7_polar_neg.mzML B6_WU350-219_d7_lipid_pos.mzML B6_WU350-219_d7_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=28; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=4.2; D-dimer=860; Neutrophil %=57.9; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=1.1; Lymphocyte %=15.6; IL1b=2.11; IL10=145.78; IL6=9.18; RANTES=1111.1; MIP1a=1.66; GMCSF=6.97; MCP1=784.73; IL15=13.83; HGF=213.3; VEGF=2.9; IL1Ra=656.28; IL2R=48.18; MIG=38.67; IL8=13.26 SUBJECT_SAMPLE_FACTORS WU350-238 B6_WU350-238_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-238_d7_polar_pos.mzML B6_WU350-238_d7_polar_neg.mzML B6_WU350-238_d7_lipid_pos.mzML B6_WU350-238_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=17.9; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1252; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-242 B6_WU350-242_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-242_d7_polar_pos.mzML B6_WU350-242_d7_polar_neg.mzML B6_WU350-242_d7_lipid_pos.mzML B6_WU350-242_d7_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=54.6; Age at Symptom onset (years)=62.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=2019; Neutrophil %=77; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=62.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.6; Lymphocyte absolute=1; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-244 B6_WU350-244_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-244_d7_polar_pos.mzML B6_WU350-244_d7_polar_neg.mzML B6_WU350-244_d7_lipid_pos.mzML B6_WU350-244_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=22; Age at Symptom onset (years)=78.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.6; D-dimer=-1; Neutrophil %=56.7; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=1.5; Lymphocyte %=33; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-190 B6_WU350-190_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-190_d7_polar_pos.mzML B6_WU350-190_d7_polar_neg.mzML B6_WU350-190_d7_lipid_pos.mzML B6_WU350-190_d7_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=30.2; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=397.5; D-dimer=977; Neutrophil %=83.3; CO2=29; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.9; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=1.69; IL10=8.38; IL6=423.6; RANTES=713.32; MIP1a=1.66; GMCSF=0.21; MCP1=1077.76; IL15=17.72; HGF=21353.12; VEGF=5.25; IL1Ra=198.05; IL2R=1330.19; MIG=143.13; IL8=48.18 SUBJECT_SAMPLE_FACTORS WU350-205 B6_WU350-205_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-205_d7_polar_pos.mzML B6_WU350-205_d7_polar_neg.mzML B6_WU350-205_d7_lipid_pos.mzML B6_WU350-205_d7_lipid_neg.mzML; Days post symptom onset=20; Sex=Female; BMI=21.1; Age at Symptom onset (years)=69; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=122.2; D-dimer=6376; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.26; IL10=111.89; IL6=839.25; RANTES=771.79; MIP1a=1.66; GMCSF=10.84; MCP1=347.56; IL15=19.37; HGF=2592.31; VEGF=5.33; IL1Ra=139.06; IL2R=35.83; MIG=1.05; IL8=213.16 SUBJECT_SAMPLE_FACTORS WU350-208 B6_WU350-208_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-208_d7_polar_pos.mzML B6_WU350-208_d7_polar_neg.mzML B6_WU350-208_d7_lipid_pos.mzML B6_WU350-208_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=31.1; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295; D-dimer=1787; Neutrophil %=78.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=12.6; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=0.83; IL10=21.93; IL6=242.8; RANTES=1091.06; MIP1a=1.66; GMCSF=2.09; MCP1=650.13; IL15=40.08; HGF=5370.78; VEGF=2.33; IL1Ra=151.39; IL2R=48.48; MIG=20.71; IL8=24.38 SUBJECT_SAMPLE_FACTORS WU350-209 B6_WU350-209_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-209_d7_polar_pos.mzML B6_WU350-209_d7_polar_neg.mzML B6_WU350-209_d7_lipid_pos.mzML B6_WU350-209_d7_lipid_neg.mzML; Days post symptom onset=19; Sex=Female; BMI=40.3; Age at Symptom onset (years)=59.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=382; D-dimer=1295; Neutrophil %=85; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=14.5; Lymphocyte absolute=1.1; Lymphocyte %=5.3; IL1b=2.51; IL10=197.21; IL6=396.75; RANTES=642.66; MIP1a=51.46; GMCSF=2.82; MCP1=746.58; IL15=434.17; HGF=26136.39; VEGF=1.62; IL1Ra=1419.08; IL2R=148.34; MIG=176.83; IL8=37.11 SUBJECT_SAMPLE_FACTORS WU350-246 B6_WU350-246_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-246_d7_polar_pos.mzML B6_WU350-246_d7_polar_neg.mzML B6_WU350-246_d7_lipid_pos.mzML B6_WU350-246_d7_lipid_neg.mzML; Days post symptom onset=22; Sex=Male; BMI=19.8; Age at Symptom onset (years)=78.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=23055; Neutrophil %=89.8; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.3; Lymphocyte absolute=0.5; Lymphocyte %=5.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-251 B6_WU350-251_d7 batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-251_d7_polar_pos.mzML B6_WU350-251_d7_polar_neg.mzML B6_WU350-251_d7_lipid_pos.mzML B6_WU350-251_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=24.7; Age at Symptom onset (years)=86.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=86; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86.6; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=14.7; Lymphocyte absolute=0.6; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-006 B6_WU350-006_d84 batch:6 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B6_WU350-006_d84_polar_pos.mzML B6_WU350-006_d84_polar_neg.mzML B6_WU350-006_d84_lipid_pos.mzML B6_WU350-006_d84_lipid_neg.mzML; Days post symptom onset=66; Sex=Male; BMI=29.1; Age at Symptom onset (years)=74.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=273.3; D-dimer=7279; Neutrophil %=64.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=1; Age=74.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2; Lymphocyte absolute=1; Lymphocyte %=30.7; IL1b=6.407101377; IL10=630.2442659; IL6=512.5536265; RANTES=939.3844282; MIP1a=14.33099844; GMCSF=446.8787402; MCP1=877.7866027; IL15=10.66807132; HGF=329.1129911; VEGF=0.673823306; IL1Ra=126.097449; IL2R=60.07848135; MIG=22.21072098; IL8=38.48142042 SUBJECT_SAMPLE_FACTORS WU350-281 B7_WU350-281_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-281_d0_polar_pos.mzML B7_WU350-281_d0_polar_neg.mzML B7_WU350-281_d0_lipid_pos.mzML B7_WU350-281_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=18.7; Age at Symptom onset (years)=59.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=41.8; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.9; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.5; Lymphocyte absolute=2.2; Lymphocyte %=37.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-284 B7_WU350-284_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-284_d0_polar_pos.mzML B7_WU350-284_d0_polar_neg.mzML B7_WU350-284_d0_lipid_pos.mzML B7_WU350-284_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=25.1; Age at Symptom onset (years)=35.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=47.9; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=35.8; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.2; Lymphocyte absolute=1.8; Lymphocyte %=39.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-293 B7_WU350-293_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-293_d0_polar_pos.mzML B7_WU350-293_d0_polar_neg.mzML B7_WU350-293_d0_lipid_pos.mzML B7_WU350-293_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=50.2; Age at Symptom onset (years)=44.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=52.5; CO2=29; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=44.2; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=2.5; Lymphocyte %=38.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-296 B7_WU350-296_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-296_d0_polar_pos.mzML B7_WU350-296_d0_polar_neg.mzML B7_WU350-296_d0_lipid_pos.mzML B7_WU350-296_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=20.5; Age at Symptom onset (years)=27.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=<215; Neutrophil %=64.8; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=27.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=1.3; Lymphocyte %=25.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-285 B7_WU350-285_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-285_d0_polar_pos.mzML B7_WU350-285_d0_polar_neg.mzML B7_WU350-285_d0_lipid_pos.mzML B7_WU350-285_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=33.8; Age at Symptom onset (years)=56.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=68; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=56.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=1.1; Lymphocyte %=19.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-287 B7_WU350-287_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-287_d0_polar_pos.mzML B7_WU350-287_d0_polar_neg.mzML B7_WU350-287_d0_lipid_pos.mzML B7_WU350-287_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.3; Age at Symptom onset (years)=46.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=66.9; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=46.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=3.6; Lymphocyte %=22.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-294 B7_WU350-294_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-294_d0_polar_pos.mzML B7_WU350-294_d0_polar_neg.mzML B7_WU350-294_d0_lipid_pos.mzML B7_WU350-294_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=31.6; Age at Symptom onset (years)=40.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=34.9; D-dimer=730; Neutrophil %=69; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=40.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=1.6; Lymphocyte %=22.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-282 B7_WU350-282_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-282_d0_polar_pos.mzML B7_WU350-282_d0_polar_neg.mzML B7_WU350-282_d0_lipid_pos.mzML B7_WU350-282_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=22.7; Age at Symptom onset (years)=51.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1021; Neutrophil %=82.8; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.8; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=14.4; Lymphocyte absolute=1.1; Lymphocyte %=6.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-286 B7_WU350-286_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-286_d0_polar_pos.mzML B7_WU350-286_d0_polar_neg.mzML B7_WU350-286_d0_lipid_pos.mzML B7_WU350-286_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=37.5; Age at Symptom onset (years)=52.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=65.9; CO2=34; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.3; Lymphocyte absolute=2.2; Lymphocyte %=23.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-295 B7_WU350-295_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-295_d0_polar_pos.mzML B7_WU350-295_d0_polar_neg.mzML B7_WU350-295_d0_lipid_pos.mzML B7_WU350-295_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=29; Age at Symptom onset (years)=42.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=640; Neutrophil %=74.7; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=42.4; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=7.8; Lymphocyte absolute=1.6; Lymphocyte %=15.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-274 B7_WU350-274_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-274_d0_polar_pos.mzML B7_WU350-274_d0_polar_neg.mzML B7_WU350-274_d0_lipid_pos.mzML B7_WU350-274_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=37.1; Age at Symptom onset (years)=20.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=64.4; CO2=31; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=20.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.9; Lymphocyte absolute=2.7; Lymphocyte %=24.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-300 B7_WU350-300_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-300_d0_polar_pos.mzML B7_WU350-300_d0_polar_neg.mzML B7_WU350-300_d0_lipid_pos.mzML B7_WU350-300_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=-; Age at Symptom onset (years)=74.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=67.5; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.9; Lymphocyte absolute=1.4; Lymphocyte %=19.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-262 B7_WU350-262_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-262_d0_polar_pos.mzML B7_WU350-262_d0_polar_neg.mzML B7_WU350-262_d0_lipid_pos.mzML B7_WU350-262_d0_lipid_neg.mzML; Days post symptom onset=26; Sex=Male; BMI=28.9; Age at Symptom onset (years)=21.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.1; D-dimer=-1; Neutrophil %=70.9; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=21.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.5; Lymphocyte absolute=1.6; Lymphocyte %=17.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-277 B7_WU350-277_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-277_d0_polar_pos.mzML B7_WU350-277_d0_polar_neg.mzML B7_WU350-277_d0_lipid_pos.mzML B7_WU350-277_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=19.4; Age at Symptom onset (years)=73.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.4; D-dimer=5114; Neutrophil %=75; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=73.3; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-278 B7_WU350-278_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-278_d0_polar_pos.mzML B7_WU350-278_d0_polar_neg.mzML B7_WU350-278_d0_lipid_pos.mzML B7_WU350-278_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=42; Age at Symptom onset (years)=76.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=3116; Neutrophil %=79.6; CO2=35; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=76.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.1; Lymphocyte absolute=0.6; Lymphocyte %=14.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-279 B7_WU350-279_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-279_d0_polar_pos.mzML B7_WU350-279_d0_polar_neg.mzML B7_WU350-279_d0_lipid_pos.mzML B7_WU350-279_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=36.4; Age at Symptom onset (years)=67.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=70.9; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=1.2; Lymphocyte %=16.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-288 B7_WU350-288_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-288_d0_polar_pos.mzML B7_WU350-288_d0_polar_neg.mzML B7_WU350-288_d0_lipid_pos.mzML B7_WU350-288_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=42.5; Age at Symptom onset (years)=32.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=46.9; D-dimer=573; Neutrophil %=38.7; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3; Lymphocyte absolute=4.1; Lymphocyte %=53.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-290 B7_WU350-290_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-290_d0_polar_pos.mzML B7_WU350-290_d0_polar_neg.mzML B7_WU350-290_d0_lipid_pos.mzML B7_WU350-290_d0_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=39.7; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=54.3; D-dimer=1233; Neutrophil %=59.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.2; Lymphocyte absolute=0.9; Lymphocyte %=23.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-298 B7_WU350-298_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-298_d0_polar_pos.mzML B7_WU350-298_d0_polar_neg.mzML B7_WU350-298_d0_lipid_pos.mzML B7_WU350-298_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=39.8; Age at Symptom onset (years)=26.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=18.2; D-dimer=397; Neutrophil %=67.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=26.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.8; Lymphocyte absolute=1.2; Lymphocyte %=22.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-299 B7_WU350-299_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-299_d0_polar_pos.mzML B7_WU350-299_d0_polar_neg.mzML B7_WU350-299_d0_lipid_pos.mzML B7_WU350-299_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=53.6; Age at Symptom onset (years)=39.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=107.2; D-dimer=1025; Neutrophil %=61.8; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=1.7; Lymphocyte %=31.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-280 B7_WU350-280_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-280_d0_polar_pos.mzML B7_WU350-280_d0_polar_neg.mzML B7_WU350-280_d0_lipid_pos.mzML B7_WU350-280_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=24.1; Age at Symptom onset (years)=55.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=80.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=55.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=0.8; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-297 B7_WU350-297_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-297_d0_polar_pos.mzML B7_WU350-297_d0_polar_neg.mzML B7_WU350-297_d0_lipid_pos.mzML B7_WU350-297_d0_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=30.7; Age at Symptom onset (years)=65; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=132.5; D-dimer=349; Neutrophil %=79; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=1.2; Lymphocyte %=15.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-266 B7_WU350-266_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-266_d0_polar_pos.mzML B7_WU350-266_d0_polar_neg.mzML B7_WU350-266_d0_lipid_pos.mzML B7_WU350-266_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=45.1; Age at Symptom onset (years)=39.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=248.7; D-dimer=794; Neutrophil %=74.5; CO2=32; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=5.1; Lymphocyte absolute=1.1; Lymphocyte %=15.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-275 B7_WU350-275_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-275_d0_polar_pos.mzML B7_WU350-275_d0_polar_neg.mzML B7_WU350-275_d0_lipid_pos.mzML B7_WU350-275_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=36.4; Age at Symptom onset (years)=51.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=185.4; D-dimer=700; Neutrophil %=81.3; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=51.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1; Lymphocyte %=12.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-292 B7_WU350-292_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-292_d0_polar_pos.mzML B7_WU350-292_d0_polar_neg.mzML B7_WU350-292_d0_lipid_pos.mzML B7_WU350-292_d0_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=28.5; Age at Symptom onset (years)=63; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=256.6; D-dimer=8160; Neutrophil %=84.5; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.5; Lymphocyte absolute=1.3; Lymphocyte %=11.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-263 B7_WU350-263_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-263_d0_polar_pos.mzML B7_WU350-263_d0_polar_neg.mzML B7_WU350-263_d0_lipid_pos.mzML B7_WU350-263_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=29.5; Age at Symptom onset (years)=32.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=77.5; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.7; Lymphocyte absolute=0.8; Lymphocyte %=13.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-267 B7_WU350-267_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-267_d0_polar_pos.mzML B7_WU350-267_d0_polar_neg.mzML B7_WU350-267_d0_lipid_pos.mzML B7_WU350-267_d0_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=28.8; Age at Symptom onset (years)=69.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=90.6; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=23.8; Lymphocyte absolute=1.3; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-268 B7_WU350-268_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-268_d0_polar_pos.mzML B7_WU350-268_d0_polar_neg.mzML B7_WU350-268_d0_lipid_pos.mzML B7_WU350-268_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=31.3; Age at Symptom onset (years)=84.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.9; D-dimer=33841; Neutrophil %=67.8; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=84.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.3; Lymphocyte absolute=2.3; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-272 B7_WU350-272_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-272_d0_polar_pos.mzML B7_WU350-272_d0_polar_neg.mzML B7_WU350-272_d0_lipid_pos.mzML B7_WU350-272_d0_lipid_neg.mzML; Days post symptom onset=66; Sex=Female; BMI=28.4; Age at Symptom onset (years)=82.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=64; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=57; CO2=36; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=82.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=2.1; Lymphocyte %=29.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-276 B7_WU350-276_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-276_d0_polar_pos.mzML B7_WU350-276_d0_polar_neg.mzML B7_WU350-276_d0_lipid_pos.mzML B7_WU350-276_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=20.3; Age at Symptom onset (years)=54.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=398.6; D-dimer=15579; Neutrophil %=82.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=54.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=21.4; Lymphocyte absolute=0.9; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-283 B7_WU350-283_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-283_d0_polar_pos.mzML B7_WU350-283_d0_polar_neg.mzML B7_WU350-283_d0_lipid_pos.mzML B7_WU350-283_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.2; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=3.1; D-dimer=1147; Neutrophil %=66.1; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.1; Lymphocyte absolute=0.7; Lymphocyte %=22.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-289 B7_WU350-289_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-289_d0_polar_pos.mzML B7_WU350-289_d0_polar_neg.mzML B7_WU350-289_d0_lipid_pos.mzML B7_WU350-289_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=39; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=440.4; D-dimer=5592; Neutrophil %=83.7; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=11.1; Lymphocyte absolute=1.1; Lymphocyte %=8.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-291 B7_WU350-291_d0 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-291_d0_polar_pos.mzML B7_WU350-291_d0_polar_neg.mzML B7_WU350-291_d0_lipid_pos.mzML B7_WU350-291_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=21.7; Age at Symptom onset (years)=19.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=83.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=19.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6; Lymphocyte absolute=0.8; Lymphocyte %=10.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-279 B7_WU350-279_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-279_d14_polar_pos.mzML B7_WU350-279_d14_polar_neg.mzML B7_WU350-279_d14_lipid_pos.mzML B7_WU350-279_d14_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=36.4; Age at Symptom onset (years)=67.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=70.9; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=1.2; Lymphocyte %=16.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-232 B7_WU350-232_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-232_d14_polar_pos.mzML B7_WU350-232_d14_polar_neg.mzML B7_WU350-232_d14_lipid_pos.mzML B7_WU350-232_d14_lipid_neg.mzML; Days post symptom onset=23; Sex=Female; BMI=43.1; Age at Symptom onset (years)=64.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=387.8; D-dimer=14397; Neutrophil %=89.6; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=64.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=26.1; Lymphocyte absolute=1; Lymphocyte %=2.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-246 B7_WU350-246_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-246_d14_polar_pos.mzML B7_WU350-246_d14_polar_neg.mzML B7_WU350-246_d14_lipid_pos.mzML B7_WU350-246_d14_lipid_neg.mzML; Days post symptom onset=29; Sex=Male; BMI=19.8; Age at Symptom onset (years)=78.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=23055; Neutrophil %=89.8; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=78.3; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.3; Lymphocyte absolute=0.5; Lymphocyte %=5.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-257 B7_WU350-257_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-257_d14_polar_pos.mzML B7_WU350-257_d14_polar_neg.mzML B7_WU350-257_d14_lipid_pos.mzML B7_WU350-257_d14_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=32; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.1; D-dimer=6558; Neutrophil %=89.6; CO2=12; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=66.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.3; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-272 B7_WU350-272_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-272_d14_polar_pos.mzML B7_WU350-272_d14_polar_neg.mzML B7_WU350-272_d14_lipid_pos.mzML B7_WU350-272_d14_lipid_neg.mzML; Days post symptom onset=81; Sex=Female; BMI=28.4; Age at Symptom onset (years)=82.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=64; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=57; CO2=36; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=82.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=2.1; Lymphocyte %=29.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-292 B7_WU350-292_d14 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-292_d14_polar_pos.mzML B7_WU350-292_d14_polar_neg.mzML B7_WU350-292_d14_lipid_pos.mzML B7_WU350-292_d14_lipid_neg.mzML; Days post symptom onset=24; Sex=Female; BMI=28.5; Age at Symptom onset (years)=63; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=256.6; D-dimer=8160; Neutrophil %=84.5; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.5; Lymphocyte absolute=1.3; Lymphocyte %=11.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-229 B7_WU350-229_d28 batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-229_d28_polar_pos.mzML B7_WU350-229_d28_polar_neg.mzML B7_WU350-229_d28_lipid_pos.mzML B7_WU350-229_d28_lipid_neg.mzML; Days post symptom onset=48; Sex=Female; BMI=19.4; Age at Symptom onset (years)=39.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-252 B7_WU350-252_d28 batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-252_d28_polar_pos.mzML B7_WU350-252_d28_polar_neg.mzML B7_WU350-252_d28_lipid_pos.mzML B7_WU350-252_d28_lipid_neg.mzML; Days post symptom onset=47; Sex=Male; BMI=35.4; Age at Symptom onset (years)=63.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-238 B7_WU350-238_d28 batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-238_d28_polar_pos.mzML B7_WU350-238_d28_polar_neg.mzML B7_WU350-238_d28_lipid_pos.mzML B7_WU350-238_d28_lipid_neg.mzML; Days post symptom onset=34; Sex=Female; BMI=17.9; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1252; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-205 B7_WU350-205_d28 batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-205_d28_polar_pos.mzML B7_WU350-205_d28_polar_neg.mzML B7_WU350-205_d28_lipid_pos.mzML B7_WU350-205_d28_lipid_neg.mzML; Days post symptom onset=41; Sex=Female; BMI=21.1; Age at Symptom onset (years)=69; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=122.2; D-dimer=6376; Neutrophil %=-1; CO2=23; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=0.26; IL10=111.89; IL6=839.25; RANTES=771.79; MIP1a=1.66; GMCSF=10.84; MCP1=347.56; IL15=19.37; HGF=2592.31; VEGF=5.33; IL1Ra=139.06; IL2R=35.83; MIG=1.05; IL8=213.16 SUBJECT_SAMPLE_FACTORS WU350-208 B7_WU350-208_d28 batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-208_d28_polar_pos.mzML B7_WU350-208_d28_polar_neg.mzML B7_WU350-208_d28_lipid_pos.mzML B7_WU350-208_d28_lipid_neg.mzML; Days post symptom onset=44; Sex=Female; BMI=31.1; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=295; D-dimer=1787; Neutrophil %=78.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=12.6; Lymphocyte absolute=1.2; Lymphocyte %=12.8; IL1b=0.83; IL10=21.93; IL6=242.8; RANTES=1091.06; MIP1a=1.66; GMCSF=2.09; MCP1=650.13; IL15=40.08; HGF=5370.78; VEGF=2.33; IL1Ra=151.39; IL2R=48.48; MIG=20.71; IL8=24.38 SUBJECT_SAMPLE_FACTORS WU350-261 B7_WU350-261_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-261_d3_polar_pos.mzML B7_WU350-261_d3_polar_neg.mzML B7_WU350-261_d3_lipid_pos.mzML B7_WU350-261_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=28.9; Age at Symptom onset (years)=52.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.1; D-dimer=738; Neutrophil %=70.8; CO2=20; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.8; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-277 B7_WU350-277_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-277_d3_polar_pos.mzML B7_WU350-277_d3_polar_neg.mzML B7_WU350-277_d3_lipid_pos.mzML B7_WU350-277_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=19.4; Age at Symptom onset (years)=73.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.4; D-dimer=5114; Neutrophil %=75; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=73.3; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-278 B7_WU350-278_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-278_d3_polar_pos.mzML B7_WU350-278_d3_polar_neg.mzML B7_WU350-278_d3_lipid_pos.mzML B7_WU350-278_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=42; Age at Symptom onset (years)=76.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=3116; Neutrophil %=79.6; CO2=35; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=76.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.1; Lymphocyte absolute=0.6; Lymphocyte %=14.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-279 B7_WU350-279_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-279_d3_polar_pos.mzML B7_WU350-279_d3_polar_neg.mzML B7_WU350-279_d3_lipid_pos.mzML B7_WU350-279_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=36.4; Age at Symptom onset (years)=67.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=70.9; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=67.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=1.2; Lymphocyte %=16.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-280 B7_WU350-280_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-280_d3_polar_pos.mzML B7_WU350-280_d3_polar_neg.mzML B7_WU350-280_d3_lipid_pos.mzML B7_WU350-280_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=24.1; Age at Symptom onset (years)=55.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=80.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=55.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=0.8; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-290 B7_WU350-290_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-290_d3_polar_pos.mzML B7_WU350-290_d3_polar_neg.mzML B7_WU350-290_d3_lipid_pos.mzML B7_WU350-290_d3_lipid_neg.mzML; Days post symptom onset=21; Sex=Female; BMI=39.7; Age at Symptom onset (years)=53; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=54.3; D-dimer=1233; Neutrophil %=59.5; CO2=22; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.2; Lymphocyte absolute=0.9; Lymphocyte %=23.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-298 B7_WU350-298_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-298_d3_polar_pos.mzML B7_WU350-298_d3_polar_neg.mzML B7_WU350-298_d3_lipid_pos.mzML B7_WU350-298_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=39.8; Age at Symptom onset (years)=26.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=18.2; D-dimer=397; Neutrophil %=67.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=26.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.8; Lymphocyte absolute=1.2; Lymphocyte %=22.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-267 B7_WU350-267_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-267_d3_polar_pos.mzML B7_WU350-267_d3_polar_neg.mzML B7_WU350-267_d3_lipid_pos.mzML B7_WU350-267_d3_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=28.8; Age at Symptom onset (years)=69.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=90.6; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=23.8; Lymphocyte absolute=1.3; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-268 B7_WU350-268_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-268_d3_polar_pos.mzML B7_WU350-268_d3_polar_neg.mzML B7_WU350-268_d3_lipid_pos.mzML B7_WU350-268_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=31.3; Age at Symptom onset (years)=84.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.9; D-dimer=33841; Neutrophil %=67.8; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=84.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.3; Lymphocyte absolute=2.3; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-272 B7_WU350-272_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-272_d3_polar_pos.mzML B7_WU350-272_d3_polar_neg.mzML B7_WU350-272_d3_lipid_pos.mzML B7_WU350-272_d3_lipid_neg.mzML; Days post symptom onset=69; Sex=Female; BMI=28.4; Age at Symptom onset (years)=82.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=64; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=57; CO2=36; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=82.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=2.1; Lymphocyte %=29.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-276 B7_WU350-276_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-276_d3_polar_pos.mzML B7_WU350-276_d3_polar_neg.mzML B7_WU350-276_d3_lipid_pos.mzML B7_WU350-276_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=20.3; Age at Symptom onset (years)=54.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=398.6; D-dimer=15579; Neutrophil %=82.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=54.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=21.4; Lymphocyte absolute=0.9; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-283 B7_WU350-283_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-283_d3_polar_pos.mzML B7_WU350-283_d3_polar_neg.mzML B7_WU350-283_d3_lipid_pos.mzML B7_WU350-283_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.2; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=3.1; D-dimer=1147; Neutrophil %=66.1; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.1; Lymphocyte absolute=0.7; Lymphocyte %=22.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-291 B7_WU350-291_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-291_d3_polar_pos.mzML B7_WU350-291_d3_polar_neg.mzML B7_WU350-291_d3_lipid_pos.mzML B7_WU350-291_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=21.7; Age at Symptom onset (years)=19.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=83.2; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=19.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6; Lymphocyte absolute=0.8; Lymphocyte %=10.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-289 B7_WU350-289_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-289_d3_polar_pos.mzML B7_WU350-289_d3_polar_neg.mzML B7_WU350-289_d3_lipid_pos.mzML B7_WU350-289_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=39; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=440.4; D-dimer=5592; Neutrophil %=83.7; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=11.1; Lymphocyte absolute=1.1; Lymphocyte %=8.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-292 B7_WU350-292_d3 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-292_d3_polar_pos.mzML B7_WU350-292_d3_polar_neg.mzML B7_WU350-292_d3_lipid_pos.mzML B7_WU350-292_d3_lipid_neg.mzML; Days post symptom onset=17; Sex=Female; BMI=28.5; Age at Symptom onset (years)=63; Hospitalized?=Yes; Time from symptom onset to ICU (days)=10; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=256.6; D-dimer=8160; Neutrophil %=84.5; CO2=28; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=9.5; Lymphocyte absolute=1.3; Lymphocyte %=11.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-259 B7_WU350-259_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-259_d7_polar_pos.mzML B7_WU350-259_d7_polar_neg.mzML B7_WU350-259_d7_lipid_pos.mzML B7_WU350-259_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=25.4; Age at Symptom onset (years)=83.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=32.6; D-dimer=2152; Neutrophil %=74.6; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=83.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=0.6; Lymphocyte %=12.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-261 B7_WU350-261_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-261_d7_polar_pos.mzML B7_WU350-261_d7_polar_neg.mzML B7_WU350-261_d7_lipid_pos.mzML B7_WU350-261_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=28.9; Age at Symptom onset (years)=52.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.1; D-dimer=738; Neutrophil %=70.8; CO2=20; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.8; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-280 B7_WU350-280_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-280_d7_polar_pos.mzML B7_WU350-280_d7_polar_neg.mzML B7_WU350-280_d7_lipid_pos.mzML B7_WU350-280_d7_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=24.1; Age at Symptom onset (years)=55.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=80.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=55.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=0.8; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-255 B7_WU350-255_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-255_d7_polar_pos.mzML B7_WU350-255_d7_polar_neg.mzML B7_WU350-255_d7_lipid_pos.mzML B7_WU350-255_d7_lipid_neg.mzML; Days post symptom onset=43; Sex=Female; BMI=20.8; Age at Symptom onset (years)=70.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=79.2; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=1; Age=70.2; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=4.4; Lymphocyte absolute=0.8; Lymphocyte %=13.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-256 B7_WU350-256_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-256_d7_polar_pos.mzML B7_WU350-256_d7_polar_neg.mzML B7_WU350-256_d7_lipid_pos.mzML B7_WU350-256_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=20.4; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=84.8; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.2; Lymphocyte absolute=0.8; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-257 B7_WU350-257_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-257_d7_polar_pos.mzML B7_WU350-257_d7_polar_neg.mzML B7_WU350-257_d7_lipid_pos.mzML B7_WU350-257_d7_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=32; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.1; D-dimer=6558; Neutrophil %=89.6; CO2=12; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=66.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.3; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-268 B7_WU350-268_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-268_d7_polar_pos.mzML B7_WU350-268_d7_polar_neg.mzML B7_WU350-268_d7_lipid_pos.mzML B7_WU350-268_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Female; BMI=31.3; Age at Symptom onset (years)=84.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=37.9; D-dimer=33841; Neutrophil %=67.8; CO2=19; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=84.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.3; Lymphocyte absolute=2.3; Lymphocyte %=21.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-272 B7_WU350-272_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-272_d7_polar_pos.mzML B7_WU350-272_d7_polar_neg.mzML B7_WU350-272_d7_lipid_pos.mzML B7_WU350-272_d7_lipid_neg.mzML; Days post symptom onset=73; Sex=Female; BMI=28.4; Age at Symptom onset (years)=82.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=64; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=57; CO2=36; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=82.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.1; Lymphocyte absolute=2.1; Lymphocyte %=29.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-275 B7_WU350-275_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-275_d7_polar_pos.mzML B7_WU350-275_d7_polar_neg.mzML B7_WU350-275_d7_lipid_pos.mzML B7_WU350-275_d7_lipid_neg.mzML; Days post symptom onset=21; Sex=Female; BMI=36.4; Age at Symptom onset (years)=51.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=185.4; D-dimer=700; Neutrophil %=81.3; CO2=19; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=51.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=6.4; Lymphocyte absolute=1; Lymphocyte %=12.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-276 B7_WU350-276_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-276_d7_polar_pos.mzML B7_WU350-276_d7_polar_neg.mzML B7_WU350-276_d7_lipid_pos.mzML B7_WU350-276_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=20.3; Age at Symptom onset (years)=54.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=398.6; D-dimer=15579; Neutrophil %=82.1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=54.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=21.4; Lymphocyte absolute=0.9; Lymphocyte %=3.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-289 B7_WU350-289_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-289_d7_polar_pos.mzML B7_WU350-289_d7_polar_neg.mzML B7_WU350-289_d7_lipid_pos.mzML B7_WU350-289_d7_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=39; Age at Symptom onset (years)=32.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=440.4; D-dimer=5592; Neutrophil %=83.7; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=32.5; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=11.1; Lymphocyte absolute=1.1; Lymphocyte %=8.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-283 B7_WU350-283_d7 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B7_WU350-283_d7_polar_pos.mzML B7_WU350-283_d7_polar_neg.mzML B7_WU350-283_d7_lipid_pos.mzML B7_WU350-283_d7_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=27.2; Age at Symptom onset (years)=51.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=3.1; D-dimer=1147; Neutrophil %=66.1; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.1; Lymphocyte absolute=0.7; Lymphocyte %=22.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-058 B7_WU350-058_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-058_d84_polar_pos.mzML B7_WU350-058_d84_polar_neg.mzML B7_WU350-058_d84_lipid_pos.mzML B7_WU350-058_d84_lipid_neg.mzML; Days post symptom onset=98; Sex=Female; BMI=29.6; Age at Symptom onset (years)=53.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=55.5; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=3.6; Lymphocyte %=36.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-078 B7_WU350-078_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-078_d84_polar_pos.mzML B7_WU350-078_d84_polar_neg.mzML B7_WU350-078_d84_lipid_pos.mzML B7_WU350-078_d84_lipid_neg.mzML; Days post symptom onset=101; Sex=Female; BMI=-; Age at Symptom onset (years)=28.9; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=316; Neutrophil %=46.4; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=28.9; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.3; Lymphocyte absolute=3; Lymphocyte %=42; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-193 B7_WU350-193_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-193_d84_polar_pos.mzML B7_WU350-193_d84_polar_neg.mzML B7_WU350-193_d84_lipid_pos.mzML B7_WU350-193_d84_lipid_neg.mzML; Days post symptom onset=75; Sex=Female; BMI=22.8; Age at Symptom onset (years)=49.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=49.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-012 B7_WU350-012_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-012_d84_polar_pos.mzML B7_WU350-012_d84_polar_neg.mzML B7_WU350-012_d84_lipid_pos.mzML B7_WU350-012_d84_lipid_neg.mzML; Days post symptom onset=81; Sex=Male; BMI=44.1; Age at Symptom onset (years)=62.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=105.9; D-dimer=991; Neutrophil %=89.3; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=62.8; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.4; Lymphocyte absolute=0.2; Lymphocyte %=2.7; IL1b=7.474523333; IL10=11.55916841; IL6=110.2863586; RANTES=1322.830764; MIP1a=36.73113405; GMCSF=11.59301025; MCP1=388.8769742; IL15=28.29446947; HGF=485.4034952; VEGF=1.300736432; IL1Ra=94.47152335; IL2R=126.9379408; MIG=58.85782435; IL8=19.52026042 SUBJECT_SAMPLE_FACTORS WU350-025 B7_WU350-025_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-025_d84_polar_pos.mzML B7_WU350-025_d84_polar_neg.mzML B7_WU350-025_d84_lipid_pos.mzML B7_WU350-025_d84_lipid_neg.mzML; Days post symptom onset=91; Sex=Male; BMI=24.8; Age at Symptom onset (years)=64.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=77; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=0.5; Lymphocyte %=15.3; IL1b=0.334111293; IL10=12.28156552; IL6=26.47902453; RANTES=774.9869506; MIP1a=<1; GMCSF=0.694132102; MCP1=212.7214972; IL15=<8.3; HGF=104.1175127; VEGF=5.027117086; IL1Ra=37.97530185; IL2R=40.96344227; MIG=48.78528622; IL8=12.16369395 SUBJECT_SAMPLE_FACTORS WU350-059 B7_WU350-059_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-059_d84_polar_pos.mzML B7_WU350-059_d84_polar_neg.mzML B7_WU350-059_d84_lipid_pos.mzML B7_WU350-059_d84_lipid_neg.mzML; Days post symptom onset=94; Sex=Male; BMI=27.1; Age at Symptom onset (years)=51.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=62.1; D-dimer=443; Neutrophil %=64.6; CO2=28; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.6; Lymphocyte absolute=0.9; Lymphocyte %=21.7; IL1b=0.973059682; IL10=5.819472912; IL6=21.01243452; RANTES=1035.565165; MIP1a=0.946296474; GMCSF=1.167691272; MCP1=366.5020672; IL15=<2.77; HGF=74.08510034; VEGF=0.795015097; IL1Ra=68.43571516; IL2R=60.66993446; MIG=21.28021373; IL8=12.44605834 SUBJECT_SAMPLE_FACTORS WU350-105 B7_WU350-105_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-105_d84_polar_pos.mzML B7_WU350-105_d84_polar_neg.mzML B7_WU350-105_d84_lipid_pos.mzML B7_WU350-105_d84_lipid_neg.mzML; Days post symptom onset=96; Sex=Female; BMI=30.2; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=104.2; D-dimer=1871; Neutrophil %=76.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.8; Lymphocyte %=18.5; IL1b=0.6; IL10=37.86; IL6=9.49; RANTES=801.22; MIP1a=10.89; GMCSF=1.9; MCP1=139.37; IL15=11.74; HGF=115.16; VEGF=5.29; IL1Ra=86.23; IL2R=17.43; MIG=14.62; IL8=3.06 SUBJECT_SAMPLE_FACTORS WU350-117 B7_WU350-117_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-117_d84_polar_pos.mzML B7_WU350-117_d84_polar_neg.mzML B7_WU350-117_d84_lipid_pos.mzML B7_WU350-117_d84_lipid_neg.mzML; Days post symptom onset=94; Sex=Male; BMI=18.3; Age at Symptom onset (years)=53.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.7; D-dimer=2277; Neutrophil %=89.5; CO2=11; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=53.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=12.9; Lymphocyte absolute=0.5; Lymphocyte %=3.7; IL1b=0.59; IL10=0.8; IL6=5.02; RANTES=2240.37; MIP1a=10.89; GMCSF=0.55; MCP1=132.62; IL15=3.81; HGF=495.34; VEGF=0.21; IL1Ra=18.14; IL2R=63.9; MIG=17.91; IL8=5.73 SUBJECT_SAMPLE_FACTORS WU350-148 B7_WU350-148_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-148_d84_polar_pos.mzML B7_WU350-148_d84_polar_neg.mzML B7_WU350-148_d84_lipid_pos.mzML B7_WU350-148_d84_lipid_neg.mzML; Days post symptom onset=77; Sex=Female; BMI=24.9; Age at Symptom onset (years)=64.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=30.4; D-dimer=1251; Neutrophil %=51.1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.2; Lymphocyte absolute=2.5; Lymphocyte %=40.7; IL1b=4.42; IL10=25.43; IL6=30.73; RANTES=1153.49; MIP1a=98.6; GMCSF=0.9; MCP1=487.04; IL15=67.82; HGF=364.74; VEGF=4.01; IL1Ra=126.76; IL2R=57.82; MIG=66.4; IL8=10.18 SUBJECT_SAMPLE_FACTORS WU350-007 B7_WU350-007_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-007_d84_polar_pos.mzML B7_WU350-007_d84_polar_neg.mzML B7_WU350-007_d84_lipid_pos.mzML B7_WU350-007_d84_lipid_neg.mzML; Days post symptom onset=113; Sex=Male; BMI=24.7; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=292.4; D-dimer=727; Neutrophil %=84.2; CO2=28; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=10.4; Lymphocyte absolute=0.9; Lymphocyte %=7; IL1b=6.534484849; IL10=19.10967038; IL6=486.5806279; RANTES=1018.907336; MIP1a=34.58397542; GMCSF=11.03248171; MCP1=1332.399745; IL15=44.61366715; HGF=1582.715841; VEGF=1.860819849; IL1Ra=261.0672563; IL2R=102.2135046; MIG=66.78111724; IL8=28.80814927 SUBJECT_SAMPLE_FACTORS WU350-013 B7_WU350-013_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-013_d84_polar_pos.mzML B7_WU350-013_d84_polar_neg.mzML B7_WU350-013_d84_lipid_pos.mzML B7_WU350-013_d84_lipid_neg.mzML; Days post symptom onset=89; Sex=Male; BMI=30.6; Age at Symptom onset (years)=80.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=225.9; D-dimer=1670; Neutrophil %=93.1; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=80.8; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.2; Lymphocyte absolute=0.3; Lymphocyte %=3; IL1b=4.976974182; IL10=54.92686871; IL6=296.9066773; RANTES=585.4003056; MIP1a=10.0981817; GMCSF=10.04841148; MCP1=1303.844512; IL15=22.82324687; HGF=726.5621765; VEGF=6.876694719; IL1Ra=1048.239677; IL2R=124.3491115; MIG=84.900486; IL8=25.72906886 SUBJECT_SAMPLE_FACTORS WU350-014 B7_WU350-014_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-014_d84_polar_pos.mzML B7_WU350-014_d84_polar_neg.mzML B7_WU350-014_d84_lipid_pos.mzML B7_WU350-014_d84_lipid_neg.mzML; Days post symptom onset=87; Sex=Male; BMI=25.5; Age at Symptom onset (years)=66.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=41.5; D-dimer=1530; Neutrophil %=52.2; CO2=25; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=66.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=0.9; Lymphocyte absolute=0.7; Lymphocyte %=37.4; IL1b=0.811503836; IL10=23.88846397; IL6=25.96411109; RANTES=693.3801726; MIP1a=27.25334281; GMCSF=1.497099241; MCP1=505.525744; IL15=61.77101181; HGF=66.59597601; VEGF=0.975492592; IL1Ra=54.78235533; IL2R=35.01993895; MIG=43.56103392; IL8=26.27460047 SUBJECT_SAMPLE_FACTORS WU350-126 B7_WU350-126_d84 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B7_WU350-126_d84_polar_pos.mzML B7_WU350-126_d84_polar_neg.mzML B7_WU350-126_d84_lipid_pos.mzML B7_WU350-126_d84_lipid_neg.mzML; Days post symptom onset=87; Sex=Male; BMI=28.4; Age at Symptom onset (years)=67.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=7; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=201.4; D-dimer=2597; Neutrophil %=83.5; CO2=17; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=67.2; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.3; Lymphocyte absolute=1; Lymphocyte %=13.1; IL1b=2.87; IL10=38.27; IL6=556.12; RANTES=680.05; MIP1a=30.32; GMCSF=0.28; MCP1=2852.1; IL15=41.13; HGF=14356.2; VEGF=3.62; IL1Ra=141.82; IL2R=92.91; MIG=290.87; IL8=74.14 SUBJECT_SAMPLE_FACTORS WU350-335 B8_WU350-335_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-335_d0_polar_pos.mzML B8_WU350-335_d0_polar_neg.mzML B8_WU350-335_d0_lipid_pos.mzML B8_WU350-335_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=37.4; Age at Symptom onset (years)=27.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=27.3; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-346 B8_WU350-346_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-346_d0_polar_pos.mzML B8_WU350-346_d0_polar_neg.mzML B8_WU350-346_d0_lipid_pos.mzML B8_WU350-346_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=26.9; Age at Symptom onset (years)=38.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=38.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-348 B8_WU350-348_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-348_d0_polar_pos.mzML B8_WU350-348_d0_polar_neg.mzML B8_WU350-348_d0_lipid_pos.mzML B8_WU350-348_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=57.6; Age at Symptom onset (years)=34.4; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=62; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=34.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.9; Lymphocyte absolute=2.3; Lymphocyte %=29.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-350 B8_WU350-350_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-350_d0_polar_pos.mzML B8_WU350-350_d0_polar_neg.mzML B8_WU350-350_d0_lipid_pos.mzML B8_WU350-350_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=27.5; Age at Symptom onset (years)=29; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=87.9; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=29; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=21; Lymphocyte absolute=1.4; Lymphocyte %=4.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-302 B8_WU350-302_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-302_d0_polar_pos.mzML B8_WU350-302_d0_polar_neg.mzML B8_WU350-302_d0_lipid_pos.mzML B8_WU350-302_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Female; BMI=40.1; Age at Symptom onset (years)=64.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=120.6; D-dimer=-1; Neutrophil %=90.8; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=18.6; Lymphocyte absolute=0.6; Lymphocyte %=2.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-303 B8_WU350-303_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-303_d0_polar_pos.mzML B8_WU350-303_d0_polar_neg.mzML B8_WU350-303_d0_lipid_pos.mzML B8_WU350-303_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=26.9; Age at Symptom onset (years)=63.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=90.4; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=63.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.8; Lymphocyte absolute=0.2; Lymphocyte %=2.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-314 B8_WU350-314_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-314_d0_polar_pos.mzML B8_WU350-314_d0_polar_neg.mzML B8_WU350-314_d0_lipid_pos.mzML B8_WU350-314_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=33.6; Age at Symptom onset (years)=26.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.6; D-dimer=1985; Neutrophil %=58.7; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=26.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=2.1; Lymphocyte %=27.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-344 B8_WU350-344_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-344_d0_polar_pos.mzML B8_WU350-344_d0_polar_neg.mzML B8_WU350-344_d0_lipid_pos.mzML B8_WU350-344_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=39.3; Age at Symptom onset (years)=29.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=46.3; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=29.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.8; Lymphocyte absolute=3.2; Lymphocyte %=39; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-313 B8_WU350-313_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-313_d0_polar_pos.mzML B8_WU350-313_d0_polar_neg.mzML B8_WU350-313_d0_lipid_pos.mzML B8_WU350-313_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=27.4; Age at Symptom onset (years)=31.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=394; D-dimer=1004; Neutrophil %=93.9; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=31.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=22.3; Lymphocyte absolute=0.8; Lymphocyte %=3.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-315 B8_WU350-315_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-315_d0_polar_pos.mzML B8_WU350-315_d0_polar_neg.mzML B8_WU350-315_d0_lipid_pos.mzML B8_WU350-315_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=18.8; Age at Symptom onset (years)=30.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=368.8; D-dimer=5037; Neutrophil %=85; CO2=27; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=30.4; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=11; Lymphocyte absolute=0.6; Lymphocyte %=4.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-310 B8_WU350-310_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-310_d0_polar_pos.mzML B8_WU350-310_d0_polar_neg.mzML B8_WU350-310_d0_lipid_pos.mzML B8_WU350-310_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=27.4; Age at Symptom onset (years)=55; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.9; D-dimer=2037; Neutrophil %=63.4; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=1.5; Lymphocyte %=21.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-319 B8_WU350-319_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-319_d0_polar_pos.mzML B8_WU350-319_d0_polar_neg.mzML B8_WU350-319_d0_lipid_pos.mzML B8_WU350-319_d0_lipid_neg.mzML; Days post symptom onset=13; Sex=Female; BMI=24.4; Age at Symptom onset (years)=66.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=50.9; CO2=39; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.7; Lymphocyte %=37; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-324 B8_WU350-324_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-324_d0_polar_pos.mzML B8_WU350-324_d0_polar_neg.mzML B8_WU350-324_d0_lipid_pos.mzML B8_WU350-324_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=27.8; Age at Symptom onset (years)=58.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=89.2; D-dimer=833; Neutrophil %=60.9; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.2; Lymphocyte absolute=1.1; Lymphocyte %=30.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-329 B8_WU350-329_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-329_d0_polar_pos.mzML B8_WU350-329_d0_polar_neg.mzML B8_WU350-329_d0_lipid_pos.mzML B8_WU350-329_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=29.2; Age at Symptom onset (years)=33.1; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.9; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=33.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.6; Lymphocyte %=36.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-334 B8_WU350-334_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-334_d0_polar_pos.mzML B8_WU350-334_d0_polar_neg.mzML B8_WU350-334_d0_lipid_pos.mzML B8_WU350-334_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=25.8; Age at Symptom onset (years)=20.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=20.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-353 B8_WU350-353_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-353_d0_polar_pos.mzML B8_WU350-353_d0_polar_neg.mzML B8_WU350-353_d0_lipid_pos.mzML B8_WU350-353_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=40.5; Age at Symptom onset (years)=65.1; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=33.2; D-dimer=-1; Neutrophil %=86.4; CO2=31; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.9; Lymphocyte absolute=0.4; Lymphocyte %=7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-330 B8_WU350-330_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-330_d0_polar_pos.mzML B8_WU350-330_d0_polar_neg.mzML B8_WU350-330_d0_lipid_pos.mzML B8_WU350-330_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=40.1; Age at Symptom onset (years)=53.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.2; D-dimer=321; Neutrophil %=76.1; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1; Lymphocyte %=18.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-341 B8_WU350-341_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-341_d0_polar_pos.mzML B8_WU350-341_d0_polar_neg.mzML B8_WU350-341_d0_lipid_pos.mzML B8_WU350-341_d0_lipid_neg.mzML; Days post symptom onset=87; Sex=Male; BMI=29; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1.9; D-dimer=489; Neutrophil %=68.4; CO2=43; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=0.7; Lymphocyte %=18.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-355 B8_WU350-355_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-355_d0_polar_pos.mzML B8_WU350-355_d0_polar_neg.mzML B8_WU350-355_d0_lipid_pos.mzML B8_WU350-355_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=47; Age at Symptom onset (years)=47.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=180.6; D-dimer=622; Neutrophil %=82.1; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=47.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=0.7; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-301 B8_WU350-301_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-301_d0_polar_pos.mzML B8_WU350-301_d0_polar_neg.mzML B8_WU350-301_d0_lipid_pos.mzML B8_WU350-301_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=53.8; Age at Symptom onset (years)=47.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6.5; D-dimer=732; Neutrophil %=55.3; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=47.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.7; Lymphocyte absolute=2.2; Lymphocyte %=33.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-305 B8_WU350-305_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-305_d0_polar_pos.mzML B8_WU350-305_d0_polar_neg.mzML B8_WU350-305_d0_lipid_pos.mzML B8_WU350-305_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=53.5; Age at Symptom onset (years)=43.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=7.9; D-dimer=565; Neutrophil %=72; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.9; Lymphocyte absolute=1.4; Lymphocyte %=14.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-307 B8_WU350-307_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-307_d0_polar_pos.mzML B8_WU350-307_d0_polar_neg.mzML B8_WU350-307_d0_lipid_pos.mzML B8_WU350-307_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=42.6; Age at Symptom onset (years)=44.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1046; Neutrophil %=50.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=44.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.4; Lymphocyte absolute=2.7; Lymphocyte %=40; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-311 B8_WU350-311_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-311_d0_polar_pos.mzML B8_WU350-311_d0_polar_neg.mzML B8_WU350-311_d0_lipid_pos.mzML B8_WU350-311_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=24.4; Age at Symptom onset (years)=76.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=69.1; D-dimer=4806; Neutrophil %=64.7; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=76.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1.1; Lymphocyte %=19.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-316 B8_WU350-316_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-316_d0_polar_pos.mzML B8_WU350-316_d0_polar_neg.mzML B8_WU350-316_d0_lipid_pos.mzML B8_WU350-316_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Female; BMI=36.4; Age at Symptom onset (years)=57.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=123.8; D-dimer=641; Neutrophil %=86.1; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=0.8; Lymphocyte %=8.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-317 B8_WU350-317_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-317_d0_polar_pos.mzML B8_WU350-317_d0_polar_neg.mzML B8_WU350-317_d0_lipid_pos.mzML B8_WU350-317_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=44.3; Age at Symptom onset (years)=52; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=75.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=8; Lymphocyte absolute=1.8; Lymphocyte %=17; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-318 B8_WU350-318_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-318_d0_polar_pos.mzML B8_WU350-318_d0_polar_neg.mzML B8_WU350-318_d0_lipid_pos.mzML B8_WU350-318_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=33.2; Age at Symptom onset (years)=27.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=73; D-dimer=-1; Neutrophil %=76; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=27.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=10.9; Lymphocyte absolute=2.4; Lymphocyte %=16.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-320 B8_WU350-320_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-320_d0_polar_pos.mzML B8_WU350-320_d0_polar_neg.mzML B8_WU350-320_d0_lipid_pos.mzML B8_WU350-320_d0_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=41.7; Age at Symptom onset (years)=85.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=53053; Neutrophil %=65.1; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=85.9; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.3; Lymphocyte %=17.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-321 B8_WU350-321_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-321_d0_polar_pos.mzML B8_WU350-321_d0_polar_neg.mzML B8_WU350-321_d0_lipid_pos.mzML B8_WU350-321_d0_lipid_neg.mzML; Days post symptom onset=113; Sex=Male; BMI=23; Age at Symptom onset (years)=54.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=88.3; CO2=31; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=54.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=16.3; Lymphocyte absolute=1; Lymphocyte %=5.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-323 B8_WU350-323_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-323_d0_polar_pos.mzML B8_WU350-323_d0_polar_neg.mzML B8_WU350-323_d0_lipid_pos.mzML B8_WU350-323_d0_lipid_neg.mzML; Days post symptom onset=22; Sex=Female; BMI=37.4; Age at Symptom onset (years)=30.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=73.8; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=30.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.3; Lymphocyte absolute=0.8; Lymphocyte %=11; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-325 B8_WU350-325_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-325_d0_polar_pos.mzML B8_WU350-325_d0_polar_neg.mzML B8_WU350-325_d0_lipid_pos.mzML B8_WU350-325_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=39.6; Age at Symptom onset (years)=34.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6.9; D-dimer=1062; Neutrophil %=50.4; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=34.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=2.1; Lymphocyte %=36.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-326 B8_WU350-326_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-326_d0_polar_pos.mzML B8_WU350-326_d0_polar_neg.mzML B8_WU350-326_d0_lipid_pos.mzML B8_WU350-326_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=31.5; Age at Symptom onset (years)=68.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.6; D-dimer=607; Neutrophil %=86.8; CO2=21; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=68.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.5; Lymphocyte absolute=0.4; Lymphocyte %=6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-327 B8_WU350-327_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-327_d0_polar_pos.mzML B8_WU350-327_d0_polar_neg.mzML B8_WU350-327_d0_lipid_pos.mzML B8_WU350-327_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=23.8; Age at Symptom onset (years)=37.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.7; D-dimer=323; Neutrophil %=45.3; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=37.7; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.9; Lymphocyte absolute=1.6; Lymphocyte %=38.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-331 B8_WU350-331_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-331_d0_polar_pos.mzML B8_WU350-331_d0_polar_neg.mzML B8_WU350-331_d0_lipid_pos.mzML B8_WU350-331_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=22.5; Age at Symptom onset (years)=75; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.9; D-dimer=570; Neutrophil %=56.3; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=75; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=2.1; Lymphocyte %=33.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-332 B8_WU350-332_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-332_d0_polar_pos.mzML B8_WU350-332_d0_polar_neg.mzML B8_WU350-332_d0_lipid_pos.mzML B8_WU350-332_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=24.7; Age at Symptom onset (years)=61.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=162.4; D-dimer=370; Neutrophil %=74.1; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=61.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5; Lymphocyte absolute=0.8; Lymphocyte %=12.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-336 B8_WU350-336_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-336_d0_polar_pos.mzML B8_WU350-336_d0_polar_neg.mzML B8_WU350-336_d0_lipid_pos.mzML B8_WU350-336_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=39.1; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=35; D-dimer=544; Neutrophil %=57.6; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.9; Lymphocyte absolute=1.1; Lymphocyte %=21.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-340 B8_WU350-340_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-340_d0_polar_pos.mzML B8_WU350-340_d0_polar_neg.mzML B8_WU350-340_d0_lipid_pos.mzML B8_WU350-340_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=32.3; Age at Symptom onset (years)=46.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=109.2; D-dimer=-1; Neutrophil %=73.8; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=46.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.4; Lymphocyte absolute=1.2; Lymphocyte %=20.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-343 B8_WU350-343_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-343_d0_polar_pos.mzML B8_WU350-343_d0_polar_neg.mzML B8_WU350-343_d0_lipid_pos.mzML B8_WU350-343_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=22.2; Age at Symptom onset (years)=28.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50; D-dimer=-1; Neutrophil %=68.7; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=28.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.5; Lymphocyte %=11; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-345 B8_WU350-345_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-345_d0_polar_pos.mzML B8_WU350-345_d0_polar_neg.mzML B8_WU350-345_d0_lipid_pos.mzML B8_WU350-345_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=18.8; Age at Symptom onset (years)=68.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=1; CRP=14.7; D-dimer=-1; Neutrophil %=65; CO2=18; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=68.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.7; Lymphocyte %=18.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-349 B8_WU350-349_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-349_d0_polar_pos.mzML B8_WU350-349_d0_polar_neg.mzML B8_WU350-349_d0_lipid_pos.mzML B8_WU350-349_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=32.9; Age at Symptom onset (years)=59.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=643; Neutrophil %=65.5; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.8; Lymphocyte absolute=1.8; Lymphocyte %=24.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-352 B8_WU350-352_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-352_d0_polar_pos.mzML B8_WU350-352_d0_polar_neg.mzML B8_WU350-352_d0_lipid_pos.mzML B8_WU350-352_d0_lipid_neg.mzML; Days post symptom onset=19; Sex=Male; BMI=30.2; Age at Symptom onset (years)=69.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=51.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=69.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=1.5; Lymphocyte absolute=1.1; Lymphocyte %=37.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-354 B8_WU350-354_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-354_d0_polar_pos.mzML B8_WU350-354_d0_polar_neg.mzML B8_WU350-354_d0_lipid_pos.mzML B8_WU350-354_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=27.8; Age at Symptom onset (years)=84.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=61; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=84.3; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=1.2; Lymphocyte %=26.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-309 B8_WU350-309_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-309_d0_polar_pos.mzML B8_WU350-309_d0_polar_neg.mzML B8_WU350-309_d0_lipid_pos.mzML B8_WU350-309_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=32.3; Age at Symptom onset (years)=50.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=98.1; D-dimer=1329; Neutrophil %=85.3; CO2=16; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=50.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=0.9; Lymphocyte %=9.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-322 B8_WU350-322_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-322_d0_polar_pos.mzML B8_WU350-322_d0_polar_neg.mzML B8_WU350-322_d0_lipid_pos.mzML B8_WU350-322_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=48.5; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=289.5; D-dimer=691; Neutrophil %=81.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.6; Lymphocyte absolute=0.9; Lymphocyte %=9.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-338 B8_WU350-338_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-338_d0_polar_pos.mzML B8_WU350-338_d0_polar_neg.mzML B8_WU350-338_d0_lipid_pos.mzML B8_WU350-338_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=25.1; Age at Symptom onset (years)=51.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1313; Neutrophil %=89.6; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=51.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.3; Lymphocyte %=3.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-351 B8_WU350-351_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-351_d0_polar_pos.mzML B8_WU350-351_d0_polar_neg.mzML B8_WU350-351_d0_lipid_pos.mzML B8_WU350-351_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=73.9; Age at Symptom onset (years)=69.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=152.8; D-dimer=1874; Neutrophil %=88.9; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.7; Lymphocyte %=8.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-304 B8_WU350-304_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-304_d0_polar_pos.mzML B8_WU350-304_d0_polar_neg.mzML B8_WU350-304_d0_lipid_pos.mzML B8_WU350-304_d0_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=29.2; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.1; D-dimer=1007; Neutrophil %=66; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.3; Lymphocyte absolute=0.5; Lymphocyte %=23.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-306 B8_WU350-306_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-306_d0_polar_pos.mzML B8_WU350-306_d0_polar_neg.mzML B8_WU350-306_d0_lipid_pos.mzML B8_WU350-306_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=21.8; Age at Symptom onset (years)=30.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=30.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-312 B8_WU350-312_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-312_d0_polar_pos.mzML B8_WU350-312_d0_polar_neg.mzML B8_WU350-312_d0_lipid_pos.mzML B8_WU350-312_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=52.7; Age at Symptom onset (years)=50.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.5; D-dimer=411; Neutrophil %=65.1; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=50.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.5; Lymphocyte absolute=1.2; Lymphocyte %=23.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-337 B8_WU350-337_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-337_d0_polar_pos.mzML B8_WU350-337_d0_polar_neg.mzML B8_WU350-337_d0_lipid_pos.mzML B8_WU350-337_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=35.9; Age at Symptom onset (years)=61.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=80; D-dimer=490; Neutrophil %=74.8; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=61.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.1; Lymphocyte %=19.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-347 B8_WU350-347_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-347_d0_polar_pos.mzML B8_WU350-347_d0_polar_neg.mzML B8_WU350-347_d0_lipid_pos.mzML B8_WU350-347_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=26.4; Age at Symptom onset (years)=46.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=61.1; D-dimer=5511; Neutrophil %=85.2; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=46.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5; Lymphocyte absolute=0.6; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-339 B8_WU350-339_d0 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-339_d0_polar_pos.mzML B8_WU350-339_d0_polar_neg.mzML B8_WU350-339_d0_lipid_pos.mzML B8_WU350-339_d0_lipid_neg.mzML; Days post symptom onset=15; Sex=Female; BMI=35.7; Age at Symptom onset (years)=57.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=31.4; D-dimer=458; Neutrophil %=89; CO2=32; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=57.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=11.2; Lymphocyte absolute=1; Lymphocyte %=7.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-305 B8_WU350-305_d14 batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-305_d14_polar_pos.mzML B8_WU350-305_d14_polar_neg.mzML B8_WU350-305_d14_lipid_pos.mzML B8_WU350-305_d14_lipid_neg.mzML; Days post symptom onset=19; Sex=Female; BMI=53.5; Age at Symptom onset (years)=43.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=7.9; D-dimer=565; Neutrophil %=72; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.9; Lymphocyte absolute=1.4; Lymphocyte %=14.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-309 B8_WU350-309_d14 batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-309_d14_polar_pos.mzML B8_WU350-309_d14_polar_neg.mzML B8_WU350-309_d14_lipid_pos.mzML B8_WU350-309_d14_lipid_neg.mzML; Days post symptom onset=20; Sex=Male; BMI=32.3; Age at Symptom onset (years)=50.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=98.1; D-dimer=1329; Neutrophil %=85.3; CO2=16; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=50.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=0.9; Lymphocyte %=9.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-312 B8_WU350-312_d14 batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-312_d14_polar_pos.mzML B8_WU350-312_d14_polar_neg.mzML B8_WU350-312_d14_lipid_pos.mzML B8_WU350-312_d14_lipid_neg.mzML; Days post symptom onset=19; Sex=Female; BMI=52.7; Age at Symptom onset (years)=50.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.5; D-dimer=411; Neutrophil %=65.1; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=50.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.5; Lymphocyte absolute=1.2; Lymphocyte %=23.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-254 B8_WU350-254_d28 batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-254_d28_polar_pos.mzML B8_WU350-254_d28_polar_neg.mzML B8_WU350-254_d28_lipid_pos.mzML B8_WU350-254_d28_lipid_neg.mzML; Days post symptom onset=85; Sex=Male; BMI=31; Age at Symptom onset (years)=59.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-264 B8_WU350-264_d28 batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-264_d28_polar_pos.mzML B8_WU350-264_d28_polar_neg.mzML B8_WU350-264_d28_lipid_pos.mzML B8_WU350-264_d28_lipid_neg.mzML; Days post symptom onset=41; Sex=Male; BMI=34.1; Age at Symptom onset (years)=51.2; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-280 B8_WU350-280_d28 batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-280_d28_polar_pos.mzML B8_WU350-280_d28_polar_neg.mzML B8_WU350-280_d28_lipid_pos.mzML B8_WU350-280_d28_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=24.1; Age at Symptom onset (years)=55.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=80.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=55.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.4; Lymphocyte absolute=0.8; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-320 B8_WU350-320_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-320_d3_polar_pos.mzML B8_WU350-320_d3_polar_neg.mzML B8_WU350-320_d3_lipid_pos.mzML B8_WU350-320_d3_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=41.7; Age at Symptom onset (years)=85.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=53053; Neutrophil %=65.1; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=85.9; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.3; Lymphocyte %=17.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-336 B8_WU350-336_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-336_d3_polar_pos.mzML B8_WU350-336_d3_polar_neg.mzML B8_WU350-336_d3_lipid_pos.mzML B8_WU350-336_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=39.1; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=35; D-dimer=544; Neutrophil %=57.6; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.9; Lymphocyte absolute=1.1; Lymphocyte %=21.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-316 B8_WU350-316_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-316_d3_polar_pos.mzML B8_WU350-316_d3_polar_neg.mzML B8_WU350-316_d3_lipid_pos.mzML B8_WU350-316_d3_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=36.4; Age at Symptom onset (years)=57.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=123.8; D-dimer=641; Neutrophil %=86.1; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=0.8; Lymphocyte %=8.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-330 B8_WU350-330_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-330_d3_polar_pos.mzML B8_WU350-330_d3_polar_neg.mzML B8_WU350-330_d3_lipid_pos.mzML B8_WU350-330_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=40.1; Age at Symptom onset (years)=53.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=106.2; D-dimer=321; Neutrophil %=76.1; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1; Lymphocyte %=18.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-355 B8_WU350-355_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-355_d3_polar_pos.mzML B8_WU350-355_d3_polar_neg.mzML B8_WU350-355_d3_lipid_pos.mzML B8_WU350-355_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=47; Age at Symptom onset (years)=47.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=180.6; D-dimer=622; Neutrophil %=82.1; CO2=24; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=47.9; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=0.7; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-301 B8_WU350-301_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-301_d3_polar_pos.mzML B8_WU350-301_d3_polar_neg.mzML B8_WU350-301_d3_lipid_pos.mzML B8_WU350-301_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=53.8; Age at Symptom onset (years)=47.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=6.5; D-dimer=732; Neutrophil %=55.3; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=47.2; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=3.7; Lymphocyte absolute=2.2; Lymphocyte %=33.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-305 B8_WU350-305_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-305_d3_polar_pos.mzML B8_WU350-305_d3_polar_neg.mzML B8_WU350-305_d3_lipid_pos.mzML B8_WU350-305_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=53.5; Age at Symptom onset (years)=43.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=7.9; D-dimer=565; Neutrophil %=72; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.9; Lymphocyte absolute=1.4; Lymphocyte %=14.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-311 B8_WU350-311_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-311_d3_polar_pos.mzML B8_WU350-311_d3_polar_neg.mzML B8_WU350-311_d3_lipid_pos.mzML B8_WU350-311_d3_lipid_neg.mzML; Days post symptom onset=7; Sex=Male; BMI=24.4; Age at Symptom onset (years)=76.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=69.1; D-dimer=4806; Neutrophil %=64.7; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=76.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1.1; Lymphocyte %=19.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-317 B8_WU350-317_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-317_d3_polar_pos.mzML B8_WU350-317_d3_polar_neg.mzML B8_WU350-317_d3_lipid_pos.mzML B8_WU350-317_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=44.3; Age at Symptom onset (years)=52; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=75.3; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=52; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=8; Lymphocyte absolute=1.8; Lymphocyte %=17; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-323 B8_WU350-323_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-323_d3_polar_pos.mzML B8_WU350-323_d3_polar_neg.mzML B8_WU350-323_d3_lipid_pos.mzML B8_WU350-323_d3_lipid_neg.mzML; Days post symptom onset=25; Sex=Female; BMI=37.4; Age at Symptom onset (years)=30.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=73.8; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=30.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.3; Lymphocyte absolute=0.8; Lymphocyte %=11; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-327 B8_WU350-327_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-327_d3_polar_pos.mzML B8_WU350-327_d3_polar_neg.mzML B8_WU350-327_d3_lipid_pos.mzML B8_WU350-327_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=23.8; Age at Symptom onset (years)=37.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.7; D-dimer=323; Neutrophil %=45.3; CO2=22; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=37.7; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.9; Lymphocyte absolute=1.6; Lymphocyte %=38.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-331 B8_WU350-331_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-331_d3_polar_pos.mzML B8_WU350-331_d3_polar_neg.mzML B8_WU350-331_d3_lipid_pos.mzML B8_WU350-331_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=22.5; Age at Symptom onset (years)=75; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=0.9; D-dimer=570; Neutrophil %=56.3; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=75; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.5; Lymphocyte absolute=2.1; Lymphocyte %=33.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-332 B8_WU350-332_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-332_d3_polar_pos.mzML B8_WU350-332_d3_polar_neg.mzML B8_WU350-332_d3_lipid_pos.mzML B8_WU350-332_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=24.7; Age at Symptom onset (years)=61.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=162.4; D-dimer=370; Neutrophil %=74.1; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=61.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5; Lymphocyte absolute=0.8; Lymphocyte %=12.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-343 B8_WU350-343_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-343_d3_polar_pos.mzML B8_WU350-343_d3_polar_neg.mzML B8_WU350-343_d3_lipid_pos.mzML B8_WU350-343_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=22.2; Age at Symptom onset (years)=28.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=50; D-dimer=-1; Neutrophil %=68.7; CO2=24; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=28.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=1.5; Lymphocyte %=11; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-341 B8_WU350-341_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-341_d3_polar_pos.mzML B8_WU350-341_d3_polar_neg.mzML B8_WU350-341_d3_lipid_pos.mzML B8_WU350-341_d3_lipid_neg.mzML; Days post symptom onset=91; Sex=Male; BMI=29; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1.9; D-dimer=489; Neutrophil %=68.4; CO2=43; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=0.7; Lymphocyte %=18.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-309 B8_WU350-309_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-309_d3_polar_pos.mzML B8_WU350-309_d3_polar_neg.mzML B8_WU350-309_d3_lipid_pos.mzML B8_WU350-309_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=32.3; Age at Symptom onset (years)=50.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=98.1; D-dimer=1329; Neutrophil %=85.3; CO2=16; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=50.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=0.9; Lymphocyte %=9.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-322 B8_WU350-322_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-322_d3_polar_pos.mzML B8_WU350-322_d3_polar_neg.mzML B8_WU350-322_d3_lipid_pos.mzML B8_WU350-322_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=48.5; Age at Symptom onset (years)=41.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=289.5; D-dimer=691; Neutrophil %=81.5; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=41.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.6; Lymphocyte absolute=0.9; Lymphocyte %=9.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-337 B8_WU350-337_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-337_d3_polar_pos.mzML B8_WU350-337_d3_polar_neg.mzML B8_WU350-337_d3_lipid_pos.mzML B8_WU350-337_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=35.9; Age at Symptom onset (years)=61.2; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=80; D-dimer=490; Neutrophil %=74.8; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=61.2; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=1.1; Lymphocyte %=19.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-338 B8_WU350-338_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-338_d3_polar_pos.mzML B8_WU350-338_d3_polar_neg.mzML B8_WU350-338_d3_lipid_pos.mzML B8_WU350-338_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=25.1; Age at Symptom onset (years)=51.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1313; Neutrophil %=89.6; CO2=22; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=51.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.3; Lymphocyte %=3.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-351 B8_WU350-351_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-351_d3_polar_pos.mzML B8_WU350-351_d3_polar_neg.mzML B8_WU350-351_d3_lipid_pos.mzML B8_WU350-351_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=73.9; Age at Symptom onset (years)=69.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=152.8; D-dimer=1874; Neutrophil %=88.9; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.7; Lymphocyte %=8.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-339 B8_WU350-339_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-339_d3_polar_pos.mzML B8_WU350-339_d3_polar_neg.mzML B8_WU350-339_d3_lipid_pos.mzML B8_WU350-339_d3_lipid_neg.mzML; Days post symptom onset=18; Sex=Female; BMI=35.7; Age at Symptom onset (years)=57.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=31.4; D-dimer=458; Neutrophil %=89; CO2=32; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=57.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=11.2; Lymphocyte absolute=1; Lymphocyte %=7.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-347 B8_WU350-347_d3 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-347_d3_polar_pos.mzML B8_WU350-347_d3_polar_neg.mzML B8_WU350-347_d3_lipid_pos.mzML B8_WU350-347_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=26.4; Age at Symptom onset (years)=46.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=61.1; D-dimer=5511; Neutrophil %=85.2; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=46.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5; Lymphocyte absolute=0.6; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-311 B8_WU350-311_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-311_d7_polar_pos.mzML B8_WU350-311_d7_polar_neg.mzML B8_WU350-311_d7_lipid_pos.mzML B8_WU350-311_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=24.4; Age at Symptom onset (years)=76.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=69.1; D-dimer=4806; Neutrophil %=64.7; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=76.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.2; Lymphocyte absolute=1.1; Lymphocyte %=19.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-305 B8_WU350-305_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-305_d7_polar_pos.mzML B8_WU350-305_d7_polar_neg.mzML B8_WU350-305_d7_lipid_pos.mzML B8_WU350-305_d7_lipid_neg.mzML; Days post symptom onset=12; Sex=Female; BMI=53.5; Age at Symptom onset (years)=43.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=7.9; D-dimer=565; Neutrophil %=72; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=43.5; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.9; Lymphocyte absolute=1.4; Lymphocyte %=14.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-336 B8_WU350-336_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-336_d7_polar_pos.mzML B8_WU350-336_d7_polar_neg.mzML B8_WU350-336_d7_lipid_pos.mzML B8_WU350-336_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=39.1; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=35; D-dimer=544; Neutrophil %=57.6; CO2=27; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.9; Lymphocyte absolute=1.1; Lymphocyte %=21.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-316 B8_WU350-316_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-316_d7_polar_pos.mzML B8_WU350-316_d7_polar_neg.mzML B8_WU350-316_d7_lipid_pos.mzML B8_WU350-316_d7_lipid_neg.mzML; Days post symptom onset=21; Sex=Female; BMI=36.4; Age at Symptom onset (years)=57.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=123.8; D-dimer=641; Neutrophil %=86.1; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.3; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7.5; Lymphocyte absolute=0.8; Lymphocyte %=8.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-304 B8_WU350-304_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-304_d7_polar_pos.mzML B8_WU350-304_d7_polar_neg.mzML B8_WU350-304_d7_lipid_pos.mzML B8_WU350-304_d7_lipid_neg.mzML; Days post symptom onset=21; Sex=Male; BMI=29.2; Age at Symptom onset (years)=74.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=15; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=19.1; D-dimer=1007; Neutrophil %=66; CO2=24; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=74.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=1.3; Lymphocyte absolute=0.5; Lymphocyte %=23.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-312 B8_WU350-312_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-312_d7_polar_pos.mzML B8_WU350-312_d7_polar_neg.mzML B8_WU350-312_d7_lipid_pos.mzML B8_WU350-312_d7_lipid_neg.mzML; Days post symptom onset=12; Sex=Female; BMI=52.7; Age at Symptom onset (years)=50.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.5; D-dimer=411; Neutrophil %=65.1; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=50.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.5; Lymphocyte absolute=1.2; Lymphocyte %=23.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-309 B8_WU350-309_d7 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B8_WU350-309_d7_polar_pos.mzML B8_WU350-309_d7_polar_neg.mzML B8_WU350-309_d7_lipid_pos.mzML B8_WU350-309_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=32.3; Age at Symptom onset (years)=50.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=6; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=98.1; D-dimer=1329; Neutrophil %=85.3; CO2=16; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=50.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.1; Lymphocyte absolute=0.9; Lymphocyte %=9.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-149 B8_WU350-149_d84 batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-149_d84_polar_pos.mzML B8_WU350-149_d84_polar_neg.mzML B8_WU350-149_d84_lipid_pos.mzML B8_WU350-149_d84_lipid_neg.mzML; Days post symptom onset=91; Sex=Male; BMI=31.8; Age at Symptom onset (years)=66.7; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-173 B8_WU350-173_d84 batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-173_d84_polar_pos.mzML B8_WU350-173_d84_polar_neg.mzML B8_WU350-173_d84_lipid_pos.mzML B8_WU350-173_d84_lipid_neg.mzML; Days post symptom onset=88; Sex=Male; BMI=29; Age at Symptom onset (years)=51.8; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=51.8; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-203 B8_WU350-203_d84 batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-203_d84_polar_pos.mzML B8_WU350-203_d84_polar_neg.mzML B8_WU350-203_d84_lipid_pos.mzML B8_WU350-203_d84_lipid_neg.mzML; Days post symptom onset=77; Sex=Female; BMI=24.1; Age at Symptom onset (years)=57.4; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=57.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-041 B8_WU350-041_d84 batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B8_WU350-041_d84_polar_pos.mzML B8_WU350-041_d84_polar_neg.mzML B8_WU350-041_d84_lipid_pos.mzML B8_WU350-041_d84_lipid_neg.mzML; Days post symptom onset=106; Sex=Male; BMI=30.3; Age at Symptom onset (years)=75.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=82.7; D-dimer=4752; Neutrophil %=74.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=75.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.3; Lymphocyte absolute=0.6; Lymphocyte %=13.2; IL1b=0.760294705; IL10=2.196532189; IL6=12.54552719; RANTES=659.9494775; MIP1a=<1; GMCSF=0.888897678; MCP1=546.0734817; IL15=30.01173681; HGF=685.9359253; VEGF=1.682410164; IL1Ra=53.83351701; IL2R=12.36250909; MIG=60.64036826; IL8=30.84288681 SUBJECT_SAMPLE_FACTORS WU350-378 B9_WU350-378_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-378_d0_polar_pos.mzML B9_WU350-378_d0_polar_neg.mzML B9_WU350-378_d0_lipid_pos.mzML B9_WU350-378_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=19.9; Age at Symptom onset (years)=29.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=77.5; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=29.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=9.5; Lymphocyte absolute=1.5; Lymphocyte %=12.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-392 B9_WU350-392_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-392_d0_polar_pos.mzML B9_WU350-392_d0_polar_neg.mzML B9_WU350-392_d0_lipid_pos.mzML B9_WU350-392_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=42.9; Age at Symptom onset (years)=65.6; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=89.2; CO2=22; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=7; Lymphocyte absolute=0.3; Lymphocyte %=4.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-371 B9_WU350-371_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-371_d0_polar_pos.mzML B9_WU350-371_d0_polar_neg.mzML B9_WU350-371_d0_lipid_pos.mzML B9_WU350-371_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=26.6; Age at Symptom onset (years)=57.3; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=46.9; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=57.3; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=1.9; Lymphocyte absolute=1.4; Lymphocyte %=34.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-368 B9_WU350-368_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-368_d0_polar_pos.mzML B9_WU350-368_d0_polar_neg.mzML B9_WU350-368_d0_lipid_pos.mzML B9_WU350-368_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=44.7; Age at Symptom onset (years)=75.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=140.8; D-dimer=1215; Neutrophil %=59.7; CO2=31; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=75.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.1; Lymphocyte absolute=1.1; Lymphocyte %=22.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-369 B9_WU350-369_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-369_d0_polar_pos.mzML B9_WU350-369_d0_polar_neg.mzML B9_WU350-369_d0_lipid_pos.mzML B9_WU350-369_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=32; Age at Symptom onset (years)=62.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=87.2; D-dimer=453; Neutrophil %=53.6; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=62.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=3.1; Lymphocyte absolute=1.8; Lymphocyte %=31.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-400 B9_WU350-400_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-400_d0_polar_pos.mzML B9_WU350-400_d0_polar_neg.mzML B9_WU350-400_d0_lipid_pos.mzML B9_WU350-400_d0_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=29.3; Age at Symptom onset (years)=65.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=86.8; D-dimer=12288; Neutrophil %=87.3; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.9; Lymphocyte absolute=0.6; Lymphocyte %=5.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-356 B9_WU350-356_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-356_d0_polar_pos.mzML B9_WU350-356_d0_polar_neg.mzML B9_WU350-356_d0_lipid_pos.mzML B9_WU350-356_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=21.9; Age at Symptom onset (years)=86; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=27.6; D-dimer=5883; Neutrophil %=82.9; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=10.6; Lymphocyte absolute=1.1; Lymphocyte %=8.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-361 B9_WU350-361_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-361_d0_polar_pos.mzML B9_WU350-361_d0_polar_neg.mzML B9_WU350-361_d0_lipid_pos.mzML B9_WU350-361_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=35.6; Age at Symptom onset (years)=55.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=65; D-dimer=695; Neutrophil %=52.5; CO2=18; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=55.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.7; Lymphocyte %=36.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-375 B9_WU350-375_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-375_d0_polar_pos.mzML B9_WU350-375_d0_polar_neg.mzML B9_WU350-375_d0_lipid_pos.mzML B9_WU350-375_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Female; BMI=33.6; Age at Symptom onset (years)=37.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.9; D-dimer=<215; Neutrophil %=52; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=37.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.5; Lymphocyte %=32.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-380 B9_WU350-380_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-380_d0_polar_pos.mzML B9_WU350-380_d0_polar_neg.mzML B9_WU350-380_d0_lipid_pos.mzML B9_WU350-380_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=26.5; Age at Symptom onset (years)=91.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=46.8; D-dimer=835; Neutrophil %=60.5; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=91.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.1; Lymphocyte %=27.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-382 B9_WU350-382_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-382_d0_polar_pos.mzML B9_WU350-382_d0_polar_neg.mzML B9_WU350-382_d0_lipid_pos.mzML B9_WU350-382_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=37.1; Age at Symptom onset (years)=24.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=24.4; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=6.5; Lymphocyte %=54.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-385 B9_WU350-385_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-385_d0_polar_pos.mzML B9_WU350-385_d0_polar_neg.mzML B9_WU350-385_d0_lipid_pos.mzML B9_WU350-385_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=23.2; Age at Symptom onset (years)=63.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=141; D-dimer=2149; Neutrophil %=71.3; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=63.7; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=5.1; Lymphocyte absolute=1; Lymphocyte %=13.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-386 B9_WU350-386_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-386_d0_polar_pos.mzML B9_WU350-386_d0_polar_neg.mzML B9_WU350-386_d0_lipid_pos.mzML B9_WU350-386_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=26; Age at Symptom onset (years)=29; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=29; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=2.1; Lymphocyte %=26.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-387 B9_WU350-387_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-387_d0_polar_pos.mzML B9_WU350-387_d0_polar_neg.mzML B9_WU350-387_d0_lipid_pos.mzML B9_WU350-387_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=20.7; Age at Symptom onset (years)=42.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=80; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=42.6; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=9; Lymphocyte absolute=1.2; Lymphocyte %=11.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-388 B9_WU350-388_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-388_d0_polar_pos.mzML B9_WU350-388_d0_polar_neg.mzML B9_WU350-388_d0_lipid_pos.mzML B9_WU350-388_d0_lipid_neg.mzML; Days post symptom onset=8; Sex=Female; BMI=32.2; Age at Symptom onset (years)=42.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=126.7; D-dimer=1385; Neutrophil %=74; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=42.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=6.8; Lymphocyte absolute=1.7; Lymphocyte %=18.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-395 B9_WU350-395_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-395_d0_polar_pos.mzML B9_WU350-395_d0_polar_neg.mzML B9_WU350-395_d0_lipid_pos.mzML B9_WU350-395_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=20; Age at Symptom onset (years)=20.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=82.1; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=20.9; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=12.6; Lymphocyte absolute=1.4; Lymphocyte %=8.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-360 B9_WU350-360_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-360_d0_polar_pos.mzML B9_WU350-360_d0_polar_neg.mzML B9_WU350-360_d0_lipid_pos.mzML B9_WU350-360_d0_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=23.8; Age at Symptom onset (years)=26.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=82.5; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=26.6; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=11.6; Lymphocyte absolute=1.7; Lymphocyte %=12.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-379 B9_WU350-379_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-379_d0_polar_pos.mzML B9_WU350-379_d0_polar_neg.mzML B9_WU350-379_d0_lipid_pos.mzML B9_WU350-379_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=57.3; Age at Symptom onset (years)=58.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=2.9; D-dimer=375; Neutrophil %=83.7; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=58.1; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=4; Lymphocyte absolute=0.5; Lymphocyte %=11.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-383 B9_WU350-383_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-383_d0_polar_pos.mzML B9_WU350-383_d0_polar_neg.mzML B9_WU350-383_d0_lipid_pos.mzML B9_WU350-383_d0_lipid_neg.mzML; Days post symptom onset=7; Sex=Female; BMI=40.2; Age at Symptom onset (years)=33.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=34.2; D-dimer=433; Neutrophil %=76.3; CO2=19; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=33.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.3; Lymphocyte %=20.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-364 B9_WU350-364_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-364_d0_polar_pos.mzML B9_WU350-364_d0_polar_neg.mzML B9_WU350-364_d0_lipid_pos.mzML B9_WU350-364_d0_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=68.7; Age at Symptom onset (years)=21.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=92; D-dimer=1359; Neutrophil %=77.8; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=21.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.2; Lymphocyte %=15.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-366 B9_WU350-366_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-366_d0_polar_pos.mzML B9_WU350-366_d0_polar_neg.mzML B9_WU350-366_d0_lipid_pos.mzML B9_WU350-366_d0_lipid_neg.mzML; Days post symptom onset=12; Sex=Male; BMI=27.8; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=169.4; D-dimer=2194; Neutrophil %=89.2; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.6; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-367 B9_WU350-367_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-367_d0_polar_pos.mzML B9_WU350-367_d0_polar_neg.mzML B9_WU350-367_d0_lipid_pos.mzML B9_WU350-367_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=41.9; Age at Symptom onset (years)=61.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=200.2; D-dimer=845; Neutrophil %=89.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=61.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.4; Lymphocyte absolute=0.5; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-374 B9_WU350-374_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-374_d0_polar_pos.mzML B9_WU350-374_d0_polar_neg.mzML B9_WU350-374_d0_lipid_pos.mzML B9_WU350-374_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Female; BMI=27.2; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=>80000; Neutrophil %=84.4; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.3; Lymphocyte absolute=1; Lymphocyte %=11.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-377 B9_WU350-377_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-377_d0_polar_pos.mzML B9_WU350-377_d0_polar_neg.mzML B9_WU350-377_d0_lipid_pos.mzML B9_WU350-377_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=54; Age at Symptom onset (years)=63.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=135.4; D-dimer=1318; Neutrophil %=82.1; CO2=30; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=0.9; Lymphocyte %=10.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-389 B9_WU350-389_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-389_d0_polar_pos.mzML B9_WU350-389_d0_polar_neg.mzML B9_WU350-389_d0_lipid_pos.mzML B9_WU350-389_d0_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=21.9; Age at Symptom onset (years)=59.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=36.8; D-dimer=3546; Neutrophil %=90.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.6; Lymphocyte absolute=0.3; Lymphocyte %=4.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-394 B9_WU350-394_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-394_d0_polar_pos.mzML B9_WU350-394_d0_polar_neg.mzML B9_WU350-394_d0_lipid_pos.mzML B9_WU350-394_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=29.5; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.5; D-dimer=2442; Neutrophil %=81.8; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=0.4; Lymphocyte %=3.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-398 B9_WU350-398_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-398_d0_polar_pos.mzML B9_WU350-398_d0_polar_neg.mzML B9_WU350-398_d0_lipid_pos.mzML B9_WU350-398_d0_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=27.9; Age at Symptom onset (years)=53.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=98.7; D-dimer=994; Neutrophil %=61.7; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=1.7; Lymphocyte absolute=0.8; Lymphocyte %=29.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-359 B9_WU350-359_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-359_d0_polar_pos.mzML B9_WU350-359_d0_polar_neg.mzML B9_WU350-359_d0_lipid_pos.mzML B9_WU350-359_d0_lipid_neg.mzML; Days post symptom onset=1; Sex=Male; BMI=37.2; Age at Symptom onset (years)=59.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=91.9; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.8; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=25; Lymphocyte absolute=0.9; Lymphocyte %=3.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-365 B9_WU350-365_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-365_d0_polar_pos.mzML B9_WU350-365_d0_polar_neg.mzML B9_WU350-365_d0_lipid_pos.mzML B9_WU350-365_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=26.3; Age at Symptom onset (years)=68.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=80.1; CO2=23; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=68.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=3.5; Lymphocyte absolute=0.5; Lymphocyte %=12.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-372 B9_WU350-372_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-372_d0_polar_pos.mzML B9_WU350-372_d0_polar_neg.mzML B9_WU350-372_d0_lipid_pos.mzML B9_WU350-372_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=33.9; Age at Symptom onset (years)=71.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=49.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2.1; Lymphocyte absolute=1.1; Lymphocyte %=26.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-373 B9_WU350-373_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-373_d0_polar_pos.mzML B9_WU350-373_d0_polar_neg.mzML B9_WU350-373_d0_lipid_pos.mzML B9_WU350-373_d0_lipid_neg.mzML; Days post symptom onset=23; Sex=Male; BMI=31.3; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=20; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=183.6; D-dimer=17764; Neutrophil %=-1; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-390 B9_WU350-390_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-390_d0_polar_pos.mzML B9_WU350-390_d0_polar_neg.mzML B9_WU350-390_d0_lipid_pos.mzML B9_WU350-390_d0_lipid_neg.mzML; Days post symptom onset=26; Sex=Female; BMI=32.5; Age at Symptom onset (years)=75.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=12; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=75.6; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-391 B9_WU350-391_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-391_d0_polar_pos.mzML B9_WU350-391_d0_polar_neg.mzML B9_WU350-391_d0_lipid_pos.mzML B9_WU350-391_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=28; Age at Symptom onset (years)=67.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=75.4; D-dimer=683; Neutrophil %=87.8; CO2=21; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=67.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.3; Lymphocyte %=6.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-362 B9_WU350-362_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-362_d0_polar_pos.mzML B9_WU350-362_d0_polar_neg.mzML B9_WU350-362_d0_lipid_pos.mzML B9_WU350-362_d0_lipid_neg.mzML; Days post symptom onset=2; Sex=Female; BMI=29.5; Age at Symptom onset (years)=84.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=259.1; D-dimer=7302; Neutrophil %=88.1; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=84.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=11.9; Lymphocyte absolute=1; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-363 B9_WU350-363_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-363_d0_polar_pos.mzML B9_WU350-363_d0_polar_neg.mzML B9_WU350-363_d0_lipid_pos.mzML B9_WU350-363_d0_lipid_neg.mzML; Days post symptom onset=21; Sex=Female; BMI=31.9; Age at Symptom onset (years)=64.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=18; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=17.6; D-dimer=738; Neutrophil %=74.2; CO2=32; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=1.5; Lymphocyte %=16; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-376 B9_WU350-376_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-376_d0_polar_pos.mzML B9_WU350-376_d0_polar_neg.mzML B9_WU350-376_d0_lipid_pos.mzML B9_WU350-376_d0_lipid_neg.mzML; Days post symptom onset=3; Sex=Male; BMI=24.1; Age at Symptom onset (years)=70.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=198.6; D-dimer=14582; Neutrophil %=86.4; CO2=18; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=70.3; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=7; Lymphocyte absolute=0.6; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-393 B9_WU350-393_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-393_d0_polar_pos.mzML B9_WU350-393_d0_polar_neg.mzML B9_WU350-393_d0_lipid_pos.mzML B9_WU350-393_d0_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=23.9; Age at Symptom onset (years)=83.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=44.6; D-dimer=1866; Neutrophil %=72.8; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=83.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.5; Lymphocyte %=14.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-397 B9_WU350-397_d0 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-397_d0_polar_pos.mzML B9_WU350-397_d0_polar_neg.mzML B9_WU350-397_d0_lipid_pos.mzML B9_WU350-397_d0_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=36.5; Age at Symptom onset (years)=53.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1014; Neutrophil %=93.3; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=53.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.4; Lymphocyte %=5.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-356 B9_WU350-356_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-356_d14_polar_pos.mzML B9_WU350-356_d14_polar_neg.mzML B9_WU350-356_d14_lipid_pos.mzML B9_WU350-356_d14_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=21.9; Age at Symptom onset (years)=86; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=27.6; D-dimer=5883; Neutrophil %=82.9; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=10.6; Lymphocyte absolute=1.1; Lymphocyte %=8.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-339 B9_WU350-339_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-339_d14_polar_pos.mzML B9_WU350-339_d14_polar_neg.mzML B9_WU350-339_d14_lipid_pos.mzML B9_WU350-339_d14_lipid_neg.mzML; Days post symptom onset=27; Sex=Female; BMI=35.7; Age at Symptom onset (years)=57.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=31.4; D-dimer=458; Neutrophil %=89; CO2=32; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=57.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=11.2; Lymphocyte absolute=1; Lymphocyte %=7.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-351 B9_WU350-351_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-351_d14_polar_pos.mzML B9_WU350-351_d14_polar_neg.mzML B9_WU350-351_d14_lipid_pos.mzML B9_WU350-351_d14_lipid_neg.mzML; Days post symptom onset=16; Sex=Female; BMI=73.9; Age at Symptom onset (years)=69.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=152.8; D-dimer=1874; Neutrophil %=88.9; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.7; Lymphocyte %=8.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-363 B9_WU350-363_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-363_d14_polar_pos.mzML B9_WU350-363_d14_polar_neg.mzML B9_WU350-363_d14_lipid_pos.mzML B9_WU350-363_d14_lipid_neg.mzML; Days post symptom onset=35; Sex=Female; BMI=31.9; Age at Symptom onset (years)=64.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=18; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=17.6; D-dimer=738; Neutrophil %=74.2; CO2=32; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=1.5; Lymphocyte %=16; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-366 B9_WU350-366_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-366_d14_polar_pos.mzML B9_WU350-366_d14_polar_neg.mzML B9_WU350-366_d14_lipid_pos.mzML B9_WU350-366_d14_lipid_neg.mzML; Days post symptom onset=28; Sex=Male; BMI=27.8; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=169.4; D-dimer=2194; Neutrophil %=89.2; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.6; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-367 B9_WU350-367_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-367_d14_polar_pos.mzML B9_WU350-367_d14_polar_neg.mzML B9_WU350-367_d14_lipid_pos.mzML B9_WU350-367_d14_lipid_neg.mzML; Days post symptom onset=25; Sex=Male; BMI=41.9; Age at Symptom onset (years)=61.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=200.2; D-dimer=845; Neutrophil %=89.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=61.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.4; Lymphocyte absolute=0.5; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-376 B9_WU350-376_d14 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-376_d14_polar_pos.mzML B9_WU350-376_d14_polar_neg.mzML B9_WU350-376_d14_lipid_pos.mzML B9_WU350-376_d14_lipid_neg.mzML; Days post symptom onset=17; Sex=Male; BMI=24.1; Age at Symptom onset (years)=70.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=198.6; D-dimer=14582; Neutrophil %=86.4; CO2=18; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=70.3; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=7; Lymphocyte absolute=0.6; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-312 B9_WU350-312_d28 batch:9 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-312_d28_polar_pos.mzML B9_WU350-312_d28_polar_neg.mzML B9_WU350-312_d28_lipid_pos.mzML B9_WU350-312_d28_lipid_neg.mzML; Days post symptom onset=33; Sex=Female; BMI=52.7; Age at Symptom onset (years)=50.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=10.5; D-dimer=411; Neutrophil %=65.1; CO2=26; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=50.4; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.5; Lymphocyte absolute=1.2; Lymphocyte %=23.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-400 B9_WU350-400_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-400_d3_polar_pos.mzML B9_WU350-400_d3_polar_neg.mzML B9_WU350-400_d3_lipid_pos.mzML B9_WU350-400_d3_lipid_neg.mzML; Days post symptom onset=18; Sex=Male; BMI=29.3; Age at Symptom onset (years)=65.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=86.8; D-dimer=12288; Neutrophil %=87.3; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=65.4; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=9.9; Lymphocyte absolute=0.6; Lymphocyte %=5.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-368 B9_WU350-368_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-368_d3_polar_pos.mzML B9_WU350-368_d3_polar_neg.mzML B9_WU350-368_d3_lipid_pos.mzML B9_WU350-368_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=44.7; Age at Symptom onset (years)=75.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=140.8; D-dimer=1215; Neutrophil %=59.7; CO2=31; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=75.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.1; Lymphocyte absolute=1.1; Lymphocyte %=22.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-356 B9_WU350-356_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-356_d3_polar_pos.mzML B9_WU350-356_d3_polar_neg.mzML B9_WU350-356_d3_lipid_pos.mzML B9_WU350-356_d3_lipid_neg.mzML; Days post symptom onset=2; Sex=Male; BMI=21.9; Age at Symptom onset (years)=86; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=27.6; D-dimer=5883; Neutrophil %=82.9; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=10.6; Lymphocyte absolute=1.1; Lymphocyte %=8.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-375 B9_WU350-375_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-375_d3_polar_pos.mzML B9_WU350-375_d3_polar_neg.mzML B9_WU350-375_d3_lipid_pos.mzML B9_WU350-375_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=33.6; Age at Symptom onset (years)=37.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=5.9; D-dimer=<215; Neutrophil %=52; CO2=29; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=37.7; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.3; Lymphocyte absolute=1.5; Lymphocyte %=32.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-380 B9_WU350-380_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-380_d3_polar_pos.mzML B9_WU350-380_d3_polar_neg.mzML B9_WU350-380_d3_lipid_pos.mzML B9_WU350-380_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=26.5; Age at Symptom onset (years)=91.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=46.8; D-dimer=835; Neutrophil %=60.5; CO2=27; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=91.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=2.4; Lymphocyte absolute=1.1; Lymphocyte %=27.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-386 B9_WU350-386_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-386_d3_polar_pos.mzML B9_WU350-386_d3_polar_neg.mzML B9_WU350-386_d3_lipid_pos.mzML B9_WU350-386_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=26; Age at Symptom onset (years)=29; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=53.7; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=1; Age=29; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.3; Lymphocyte absolute=2.1; Lymphocyte %=26.5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-383 B9_WU350-383_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-383_d3_polar_pos.mzML B9_WU350-383_d3_polar_neg.mzML B9_WU350-383_d3_lipid_pos.mzML B9_WU350-383_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=40.2; Age at Symptom onset (years)=33.4; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=34.2; D-dimer=433; Neutrophil %=76.3; CO2=19; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=33.4; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=4.7; Lymphocyte absolute=1.3; Lymphocyte %=20.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-364 B9_WU350-364_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-364_d3_polar_pos.mzML B9_WU350-364_d3_polar_neg.mzML B9_WU350-364_d3_lipid_pos.mzML B9_WU350-364_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=68.7; Age at Symptom onset (years)=21.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=92; D-dimer=1359; Neutrophil %=77.8; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=21.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.2; Lymphocyte %=15.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-366 B9_WU350-366_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-366_d3_polar_pos.mzML B9_WU350-366_d3_polar_neg.mzML B9_WU350-366_d3_lipid_pos.mzML B9_WU350-366_d3_lipid_neg.mzML; Days post symptom onset=14; Sex=Male; BMI=27.8; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=169.4; D-dimer=2194; Neutrophil %=89.2; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.6; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-367 B9_WU350-367_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-367_d3_polar_pos.mzML B9_WU350-367_d3_polar_neg.mzML B9_WU350-367_d3_lipid_pos.mzML B9_WU350-367_d3_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=41.9; Age at Symptom onset (years)=61.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=200.2; D-dimer=845; Neutrophil %=89.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=61.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.4; Lymphocyte absolute=0.5; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-374 B9_WU350-374_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-374_d3_polar_pos.mzML B9_WU350-374_d3_polar_neg.mzML B9_WU350-374_d3_lipid_pos.mzML B9_WU350-374_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Female; BMI=27.2; Age at Symptom onset (years)=72.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=>80000; Neutrophil %=84.4; CO2=21; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=72.8; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=7.3; Lymphocyte absolute=1; Lymphocyte %=11.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-377 B9_WU350-377_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-377_d3_polar_pos.mzML B9_WU350-377_d3_polar_neg.mzML B9_WU350-377_d3_lipid_pos.mzML B9_WU350-377_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=54; Age at Symptom onset (years)=63.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=135.4; D-dimer=1318; Neutrophil %=82.1; CO2=30; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=0.9; Lymphocyte %=10.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-391 B9_WU350-391_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-391_d3_polar_pos.mzML B9_WU350-391_d3_polar_neg.mzML B9_WU350-391_d3_lipid_pos.mzML B9_WU350-391_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Male; BMI=28; Age at Symptom onset (years)=67.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=75.4; D-dimer=683; Neutrophil %=87.8; CO2=21; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=67.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.3; Lymphocyte %=6.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-394 B9_WU350-394_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-394_d3_polar_pos.mzML B9_WU350-394_d3_polar_neg.mzML B9_WU350-394_d3_lipid_pos.mzML B9_WU350-394_d3_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=29.5; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.5; D-dimer=2442; Neutrophil %=81.8; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=0.4; Lymphocyte %=3.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-398 B9_WU350-398_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-398_d3_polar_pos.mzML B9_WU350-398_d3_polar_neg.mzML B9_WU350-398_d3_lipid_pos.mzML B9_WU350-398_d3_lipid_neg.mzML; Days post symptom onset=6; Sex=Male; BMI=27.9; Age at Symptom onset (years)=53.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=98.7; D-dimer=994; Neutrophil %=61.7; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=1.7; Lymphocyte absolute=0.8; Lymphocyte %=29.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-359 B9_WU350-359_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-359_d3_polar_pos.mzML B9_WU350-359_d3_polar_neg.mzML B9_WU350-359_d3_lipid_pos.mzML B9_WU350-359_d3_lipid_neg.mzML; Days post symptom onset=4; Sex=Male; BMI=37.2; Age at Symptom onset (years)=59.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=91.9; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.8; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=25; Lymphocyte absolute=0.9; Lymphocyte %=3.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-363 B9_WU350-363_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-363_d3_polar_pos.mzML B9_WU350-363_d3_polar_neg.mzML B9_WU350-363_d3_lipid_pos.mzML B9_WU350-363_d3_lipid_neg.mzML; Days post symptom onset=24; Sex=Female; BMI=31.9; Age at Symptom onset (years)=64.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=18; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=17.6; D-dimer=738; Neutrophil %=74.2; CO2=32; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=1.5; Lymphocyte %=16; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-372 B9_WU350-372_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-372_d3_polar_pos.mzML B9_WU350-372_d3_polar_neg.mzML B9_WU350-372_d3_lipid_pos.mzML B9_WU350-372_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Male; BMI=33.9; Age at Symptom onset (years)=71.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=49.9; CO2=26; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=71.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=2.1; Lymphocyte absolute=1.1; Lymphocyte %=26.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-373 B9_WU350-373_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-373_d3_polar_pos.mzML B9_WU350-373_d3_polar_neg.mzML B9_WU350-373_d3_lipid_pos.mzML B9_WU350-373_d3_lipid_neg.mzML; Days post symptom onset=25; Sex=Male; BMI=31.3; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=20; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=183.6; D-dimer=17764; Neutrophil %=-1; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-390 B9_WU350-390_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-390_d3_polar_pos.mzML B9_WU350-390_d3_polar_neg.mzML B9_WU350-390_d3_lipid_pos.mzML B9_WU350-390_d3_lipid_neg.mzML; Days post symptom onset=30; Sex=Female; BMI=32.5; Age at Symptom onset (years)=75.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=12; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=25; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=75.6; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-362 B9_WU350-362_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-362_d3_polar_pos.mzML B9_WU350-362_d3_polar_neg.mzML B9_WU350-362_d3_lipid_pos.mzML B9_WU350-362_d3_lipid_neg.mzML; Days post symptom onset=5; Sex=Female; BMI=29.5; Age at Symptom onset (years)=84.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=259.1; D-dimer=7302; Neutrophil %=88.1; CO2=20; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=84.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=11.9; Lymphocyte absolute=1; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-389 B9_WU350-389_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-389_d3_polar_pos.mzML B9_WU350-389_d3_polar_neg.mzML B9_WU350-389_d3_lipid_pos.mzML B9_WU350-389_d3_lipid_neg.mzML; Days post symptom onset=13; Sex=Female; BMI=21.9; Age at Symptom onset (years)=59.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=9; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=36.8; D-dimer=3546; Neutrophil %=90.8; CO2=25; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=59.7; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=6.6; Lymphocyte absolute=0.3; Lymphocyte %=4.9; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-393 B9_WU350-393_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-393_d3_polar_pos.mzML B9_WU350-393_d3_polar_neg.mzML B9_WU350-393_d3_lipid_pos.mzML B9_WU350-393_d3_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=23.9; Age at Symptom onset (years)=83.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=44.6; D-dimer=1866; Neutrophil %=72.8; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=83.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.5; Lymphocyte %=14.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-397 B9_WU350-397_d3 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-397_d3_polar_pos.mzML B9_WU350-397_d3_polar_neg.mzML B9_WU350-397_d3_lipid_pos.mzML B9_WU350-397_d3_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=36.5; Age at Symptom onset (years)=53.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1014; Neutrophil %=93.3; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=53.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.4; Lymphocyte %=5.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-356 B9_WU350-356_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-356_d7_polar_pos.mzML B9_WU350-356_d7_polar_neg.mzML B9_WU350-356_d7_lipid_pos.mzML B9_WU350-356_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=21.9; Age at Symptom onset (years)=86; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=27.6; D-dimer=5883; Neutrophil %=82.9; CO2=23; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=86; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=10.6; Lymphocyte absolute=1.1; Lymphocyte %=8.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-341 B9_WU350-341_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-341_d7_polar_pos.mzML B9_WU350-341_d7_polar_neg.mzML B9_WU350-341_d7_lipid_pos.mzML B9_WU350-341_d7_lipid_neg.mzML; Days post symptom onset=94; Sex=Male; BMI=29; Age at Symptom onset (years)=55.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=1.9; D-dimer=489; Neutrophil %=68.4; CO2=43; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=55.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=2.8; Lymphocyte absolute=0.7; Lymphocyte %=18.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-368 B9_WU350-368_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-368_d7_polar_pos.mzML B9_WU350-368_d7_polar_neg.mzML B9_WU350-368_d7_lipid_pos.mzML B9_WU350-368_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Female; BMI=44.7; Age at Symptom onset (years)=75.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=140.8; D-dimer=1215; Neutrophil %=59.7; CO2=31; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=1; Age=75.3; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=3.1; Lymphocyte absolute=1.1; Lymphocyte %=22.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-364 B9_WU350-364_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-364_d7_polar_pos.mzML B9_WU350-364_d7_polar_neg.mzML B9_WU350-364_d7_lipid_pos.mzML B9_WU350-364_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=68.7; Age at Symptom onset (years)=21.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=92; D-dimer=1359; Neutrophil %=77.8; CO2=26; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=21.6; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5.8; Lymphocyte absolute=1.2; Lymphocyte %=15.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-397 B9_WU350-397_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-397_d7_polar_pos.mzML B9_WU350-397_d7_polar_neg.mzML B9_WU350-397_d7_lipid_pos.mzML B9_WU350-397_d7_lipid_neg.mzML; Days post symptom onset=13; Sex=Male; BMI=36.5; Age at Symptom onset (years)=53.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=5; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=Yes; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=1014; Neutrophil %=93.3; CO2=25; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=53.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.6; Lymphocyte absolute=0.4; Lymphocyte %=5.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-347 B9_WU350-347_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-347_d7_polar_pos.mzML B9_WU350-347_d7_polar_neg.mzML B9_WU350-347_d7_lipid_pos.mzML B9_WU350-347_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Male; BMI=26.4; Age at Symptom onset (years)=46.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=61.1; D-dimer=5511; Neutrophil %=85.2; CO2=21; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=46.1; Smoker=-1; High/Low arterial pH=-; Neutrophil absolute=5; Lymphocyte absolute=0.6; Lymphocyte %=10; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-359 B9_WU350-359_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-359_d7_polar_pos.mzML B9_WU350-359_d7_polar_neg.mzML B9_WU350-359_d7_lipid_pos.mzML B9_WU350-359_d7_lipid_neg.mzML; Days post symptom onset=8; Sex=Male; BMI=37.2; Age at Symptom onset (years)=59.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=-1; D-dimer=-1; Neutrophil %=91.9; CO2=19; Acute respiratory failure=1; Diabetes=-; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=59.8; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=25; Lymphocyte absolute=0.9; Lymphocyte %=3.2; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-363 B9_WU350-363_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-363_d7_polar_pos.mzML B9_WU350-363_d7_polar_neg.mzML B9_WU350-363_d7_lipid_pos.mzML B9_WU350-363_d7_lipid_neg.mzML; Days post symptom onset=29; Sex=Female; BMI=31.9; Age at Symptom onset (years)=64.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=18; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=17.6; D-dimer=738; Neutrophil %=74.2; CO2=32; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=64.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=1.5; Lymphocyte %=16; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-373 B9_WU350-373_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-373_d7_polar_pos.mzML B9_WU350-373_d7_polar_neg.mzML B9_WU350-373_d7_lipid_pos.mzML B9_WU350-373_d7_lipid_neg.mzML; Days post symptom onset=30; Sex=Male; BMI=31.3; Age at Symptom onset (years)=66.8; Hospitalized?=Yes; Time from symptom onset to ICU (days)=20; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=183.6; D-dimer=17764; Neutrophil %=-1; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=66.8; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=-1; Lymphocyte absolute=-; Lymphocyte %=-; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-391 B9_WU350-391_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-391_d7_polar_pos.mzML B9_WU350-391_d7_polar_neg.mzML B9_WU350-391_d7_lipid_pos.mzML B9_WU350-391_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=28; Age at Symptom onset (years)=67.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=3; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=Yes; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=75.4; D-dimer=683; Neutrophil %=87.8; CO2=21; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=67.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=4.2; Lymphocyte absolute=0.3; Lymphocyte %=6.4; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-394 B9_WU350-394_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-394_d7_polar_pos.mzML B9_WU350-394_d7_polar_neg.mzML B9_WU350-394_d7_lipid_pos.mzML B9_WU350-394_d7_lipid_neg.mzML; Days post symptom onset=15; Sex=Male; BMI=29.5; Age at Symptom onset (years)=64.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=-; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=185.5; D-dimer=2442; Neutrophil %=81.8; CO2=20; Acute respiratory failure=-; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=64.9; Smoker=-; High/Low arterial pH=1; Neutrophil absolute=8.6; Lymphocyte absolute=0.4; Lymphocyte %=3.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-351 B9_WU350-351_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-351_d7_polar_pos.mzML B9_WU350-351_d7_polar_neg.mzML B9_WU350-351_d7_lipid_pos.mzML B9_WU350-351_d7_lipid_neg.mzML; Days post symptom onset=9; Sex=Female; BMI=73.9; Age at Symptom onset (years)=69.1; Hospitalized?=Yes; Time from symptom onset to ICU (days)=2; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=152.8; D-dimer=1874; Neutrophil %=88.9; CO2=26; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=69.1; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.4; Lymphocyte absolute=0.7; Lymphocyte %=8.6; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-366 B9_WU350-366_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-366_d7_polar_pos.mzML B9_WU350-366_d7_polar_neg.mzML B9_WU350-366_d7_lipid_pos.mzML B9_WU350-366_d7_lipid_neg.mzML; Days post symptom onset=19; Sex=Male; BMI=27.8; Age at Symptom onset (years)=69.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=11; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=1; 60 day mortality=1; 90 day mortality=1; CRP=169.4; D-dimer=2194; Neutrophil %=89.2; CO2=24; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=69.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=15.2; Lymphocyte absolute=0.6; Lymphocyte %=3.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-367 B9_WU350-367_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-367_d7_polar_pos.mzML B9_WU350-367_d7_polar_neg.mzML B9_WU350-367_d7_lipid_pos.mzML B9_WU350-367_d7_lipid_neg.mzML; Days post symptom onset=16; Sex=Male; BMI=41.9; Age at Symptom onset (years)=61.6; Hospitalized?=Yes; Time from symptom onset to ICU (days)=8; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=200.2; D-dimer=845; Neutrophil %=89.5; CO2=27; Acute respiratory failure=1; Diabetes=1; Acute renal failure=1; Chronic kidney disease=1; Cancer=-; Age=61.6; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=8.4; Lymphocyte absolute=0.5; Lymphocyte %=5; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-376 B9_WU350-376_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-376_d7_polar_pos.mzML B9_WU350-376_d7_polar_neg.mzML B9_WU350-376_d7_lipid_pos.mzML B9_WU350-376_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=24.1; Age at Symptom onset (years)=70.3; Hospitalized?=Yes; Time from symptom onset to ICU (days)=14; Subject on ventilation at any point after d0=Yes; Mortality Status=Deceased; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=1; 30 day mortality=-; 60 day mortality=1; 90 day mortality=1; CRP=198.6; D-dimer=14582; Neutrophil %=86.4; CO2=18; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=1; Cancer=-; Age=70.3; Smoker=1; High/Low arterial pH=1; Neutrophil absolute=7; Lymphocyte absolute=0.6; Lymphocyte %=7.3; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-377 B9_WU350-377_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-377_d7_polar_pos.mzML B9_WU350-377_d7_polar_neg.mzML B9_WU350-377_d7_lipid_pos.mzML B9_WU350-377_d7_lipid_neg.mzML; Days post symptom onset=10; Sex=Male; BMI=54; Age at Symptom onset (years)=63.9; Hospitalized?=Yes; Time from symptom onset to ICU (days)=1; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=135.4; D-dimer=1318; Neutrophil %=82.1; CO2=30; Acute respiratory failure=1; Diabetes=1; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=63.9; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=7.1; Lymphocyte absolute=0.9; Lymphocyte %=10.1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-393 B9_WU350-393_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-393_d7_polar_pos.mzML B9_WU350-393_d7_polar_neg.mzML B9_WU350-393_d7_lipid_pos.mzML B9_WU350-393_d7_lipid_neg.mzML; Days post symptom onset=-; Sex=Female; BMI=23.9; Age at Symptom onset (years)=83.5; Hospitalized?=Yes; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=No; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=No; Symptom Shortness of breath=No; Symptom: Sore throat=No; Asymptomatic=Yes; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=44.6; D-dimer=1866; Neutrophil %=72.8; CO2=28; Acute respiratory failure=-; Diabetes=1; Acute renal failure=1; Chronic kidney disease=-; Cancer=-; Age=83.5; Smoker=-; High/Low arterial pH=-; Neutrophil absolute=2.7; Lymphocyte absolute=0.5; Lymphocyte %=14.7; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-398 B9_WU350-398_d7 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 RAW_FILE_NAME=B9_WU350-398_d7_polar_pos.mzML B9_WU350-398_d7_polar_neg.mzML B9_WU350-398_d7_lipid_pos.mzML B9_WU350-398_d7_lipid_neg.mzML; Days post symptom onset=11; Sex=Male; BMI=27.9; Age at Symptom onset (years)=53.7; Hospitalized?=Yes; Time from symptom onset to ICU (days)=4; Subject on ventilation at any point after d0=Yes; Mortality Status=Alive; Symptom Fever=No; Symptom Headache=No; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=No; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=98.7; D-dimer=994; Neutrophil %=61.7; CO2=30; Acute respiratory failure=1; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=53.7; Smoker=-1; High/Low arterial pH=1; Neutrophil absolute=1.7; Lymphocyte absolute=0.8; Lymphocyte %=29.8; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 SUBJECT_SAMPLE_FACTORS WU350-229 B9_WU350-229_d84 batch:9 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- RAW_FILE_NAME=B9_WU350-229_d84_polar_pos.mzML B9_WU350-229_d84_polar_neg.mzML B9_WU350-229_d84_lipid_pos.mzML B9_WU350-229_d84_lipid_neg.mzML; Days post symptom onset=101; Sex=Female; BMI=19.4; Age at Symptom onset (years)=39.5; Hospitalized?=No; Time from symptom onset to ICU (days)=None; Subject on ventilation at any point after d0=-; Mortality Status=Alive; Symptom Fever=Yes; Symptom Headache=Yes; Symptom Cough=Yes; Symptom Shortness of breath=Yes; Symptom: Sore throat=Yes; Asymptomatic=No; Death due to COVID-19?=-; 30 day mortality=-; 60 day mortality=-; 90 day mortality=-; CRP=-1; D-dimer=-1; Neutrophil %=-1; CO2=-1; Acute respiratory failure=-; Diabetes=-; Acute renal failure=-; Chronic kidney disease=-; Cancer=-; Age=39.5; Smoker=1; High/Low arterial pH=-; Neutrophil absolute=-1; Lymphocyte absolute=-1; Lymphocyte %=-1; IL1b=-1; IL10=-1; IL6=-1; RANTES=-1; MIP1a=-1; GMCSF=-1; MCP1=-1; IL15=-1; HGF=-1; VEGF=-1; IL1Ra=-1; IL2R=-1; MIG=-1; IL8=-1 #COLLECTION CO:COLLECTION_SUMMARY Over the period of March to August of 2020, blood specimens of 341 individuals CO:COLLECTION_SUMMARY who presented at Barnes Jewish Hospital or Christian Hospital located in Saint CO:COLLECTION_SUMMARY Louis, Missouri, USA were collected. Inclusion criteria were a physician-ordered CO:COLLECTION_SUMMARY SARS-CoV-2 nasopharyngeal swab polymerase chain reaction (PCR) test with a CO:COLLECTION_SUMMARY positive or negative outcome, availability of gender and age information, and an CO:COLLECTION_SUMMARY age greater than 18. Informed consent was obtained from all study participants. CO:COLLECTION_SUMMARY The clinical cohort consisted of 155 female and 186 184 male participants. Out CO:COLLECTION_SUMMARY of the 341 339 patients, 274 272 were considered SARS-CoV-2 positive (COV+) and CO:COLLECTION_SUMMARY 67 were considered SARS-CoV-2 negative (COV-). Two individuals included in the CO:COLLECTION_SUMMARY COV+ group were later determined to be infected with other coronaviruses (NL63, CO:COLLECTION_SUMMARY HKu1). Samples were collected at the time of enrollment (d0) to the study, and CO:COLLECTION_SUMMARY 3, 7, 14, 28, or 84 days post study entry. Clinically relevant medical CO:COLLECTION_SUMMARY information (e.g., patient-reported symptoms, date of symptom-onset, age, race, CO:COLLECTION_SUMMARY and BMI) was collected at the time of enrollment from the subject or the medical CO:COLLECTION_SUMMARY record. Participant plasma was stored at -80°C upon collection. CO:SAMPLE_TYPE Blood (plasma) #TREATMENT TR:TREATMENT_SUMMARY This observational study did not evaluate or apply any treatments or TR:TREATMENT_SUMMARY therapeutics. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Participant plasma, which had been stored at -80°C upon collection, was thawed SP:SAMPLEPREP_SUMMARY on ice. A 50 µL aliquot was transferred onto the solid-phase-extraction SP:SAMPLEPREP_SUMMARY (SPE)-system CAPTIVA-EMR Lipid 96-wellplate (Agilent Technologies) before SP:SAMPLEPREP_SUMMARY addition of 250 µL of acetonitrile containing 1% formic acid (v/v) and 10 µM SP:SAMPLEPREP_SUMMARY internal standard (consisting of uniformly 13C and 15N labeled amino acids from SP:SAMPLEPREP_SUMMARY Cambridge Isotope Laboratories, Inc). The samples were mixed for 1 min at 360 SP:SAMPLEPREP_SUMMARY rpm on an orbital shaker at room temperature prior to a 10 min incubation period SP:SAMPLEPREP_SUMMARY at 4°C. Afterwards, 200 µL 80% acetonitrile in water (v/v) were added to the SP:SAMPLEPREP_SUMMARY samples. The samples were mixed on an orbital shaker (360 rpm) for an additional SP:SAMPLEPREP_SUMMARY 10 min at room temperature. The samples were then eluted into a 96-deepwell SP:SAMPLEPREP_SUMMARY collection plate by centrifugation (10 min, 57 x g, 4°C followed by 2 min, 1000 SP:SAMPLEPREP_SUMMARY x g, 4°C). Polar eluates were stored at -80°C until the day of LC/MS analysis. SP:SAMPLEPREP_SUMMARY The SPE-plates were then washed twice with 500 µL 80% acetonitrile in water SP:SAMPLEPREP_SUMMARY (v/v). Lipids still bound to the SPE-material were then released into a second SP:SAMPLEPREP_SUMMARY elution plate, in two elution steps applying 2x 500 µL 1:1 methyl tert-butyl SP:SAMPLEPREP_SUMMARY ether:methanol (v/v) onto the SPE cartridge and centrifuging for 2 min at 1000 g SP:SAMPLEPREP_SUMMARY and 4°C. The combined eluates were dried under a stream of nitrogen (Biotage SP:SAMPLEPREP_SUMMARY SPE Dry Evaporation System) at room temperature and reconstituted with 100 µL SP:SAMPLEPREP_SUMMARY 1:1 2-propanol:methanol (v/v) prior to LC/MS analysis. SP:PROCESSING_STORAGE_CONDITIONS Described in summary SP:EXTRACT_STORAGE Described in summary #CHROMATOGRAPHY CH:CHROMATOGRAPHY_SUMMARY An aliquot of 2 µL of polar metabolite extract was subjected to LC/MS analysis CH:CHROMATOGRAPHY_SUMMARY by using an Agilent 1290 Infinity II liquid-chromatography (LC) system coupled CH:CHROMATOGRAPHY_SUMMARY to an Agilent 6540 Quadrupole-Time-of-Flight (Q-TOF) mass spectrometer with a CH:CHROMATOGRAPHY_SUMMARY dual Agilent Jet Stream electrospray ionization source. Polar metabolites were CH:CHROMATOGRAPHY_SUMMARY separated on a SeQuant® ZIC®-pHILIC column (100 x 2.1 mm, 5 µm, polymer, CH:CHROMATOGRAPHY_SUMMARY Merck-Millipore) including a ZIC®-pHILIC guard column (2.1 mm x 20 mm, 5 µm). CH:CHROMATOGRAPHY_SUMMARY The column compartment temperature was maintained at 40°C and the flow rate was CH:CHROMATOGRAPHY_SUMMARY set to 250 µL/min. The mobile phases consisted of A: 95% water, 5% CH:CHROMATOGRAPHY_SUMMARY acetonitrile, 20 mM ammonium bicarbonate, 0.1% ammonium hydroxide solution (25% CH:CHROMATOGRAPHY_SUMMARY ammonia in water), 2.5 µM medronic acid, and B: 95% acetonitrile, 5% water, 2.5 CH:CHROMATOGRAPHY_SUMMARY µM medronic acid. The following linear gradient was applied: 0 to 1 min, 90% B; CH:CHROMATOGRAPHY_SUMMARY 12 min, 35% B; 12.5 to 14.5 min, 25% B; 15 min, 90% B followed by a CH:CHROMATOGRAPHY_SUMMARY re-equilibration phase of 4 min at 400µL/min and 2 min at 250µL/min. CH:INSTRUMENT_NAME Agilent 1290 Infinity II CH:COLUMN_NAME SeQuant ZIC-pHILIC (100 x 2.1mm,5um) CH:COLUMN_TEMPERATURE 40 CH:FLOW_GRADIENT 0 to 1 min, 90% B; 12 min, 35% B; 12.5 to 14.5 min, 25% B; 15 min, 90% B CH:FLOW_GRADIENT followed by a re-equilibration phase of 4 min CH:FLOW_RATE 250ul/min CH:SOLVENT_A 95% water/5% acetonitrile; 20 mM ammonium bicarbonate; 0.1% ammonium hydroxide; CH:SOLVENT_A 2.5 µM medronic acid CH:SOLVENT_B 95% acetonitrile/5% water; 2.5 µM medronic acid CH:CHROMATOGRAPHY_TYPE HILIC #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:INSTRUMENT_NAME Agilent 6540 QTOF MS:INSTRUMENT_TYPE QTOF MS:MS_TYPE ESI MS:MS_COMMENTS gas temperature 200°C, drying gas flow 10 L/min, nebulizer pressure 44 psi, MS:MS_COMMENTS sheath gas temperature 300°C, sheath gas flow 12 L/min, VCap 3000 V, nozzle MS:MS_COMMENTS voltage 2000 V, Fragmentor 100 V, Skimmer 65 V, Oct 1 RF Vpp 750 V, and m/z MS:MS_COMMENTS range 50-1700. Data were acquired under continuous reference mass correction at MS:MS_COMMENTS m/z 121.0509 and 922.0890 for positive ion mode and m/z 119.0363 and 966.0007 MS:MS_COMMENTS for negative ion mode. Polar metabolite identifications were supported by MS:MS_COMMENTS matching the retention time, accurate mass, and MS/MS fragmentation data to our MS:MS_COMMENTS in-house retention time and MS/MS library created from authentic reference MS:MS_COMMENTS standards (Mass Spectrometry Metabolite Library supplied by IROA Technologies, MS:MS_COMMENTS Millipore Sigma, St. Louis, MO, USA) and online MS/MS libraries (Human MS:MS_COMMENTS Metabolome Database (HMDB, https://hmdb.ca), Mass Bank of North America (MoNA, MS:MS_COMMENTS https://mona.fiehnlab.ucdavis.edu/), and mzCloud (https://mzcloud.org). Lipid MS:MS_COMMENTS iterative MS/MS data were annotated with the Agilent Lipid Annotator software. MS:MS_COMMENTS All data files were then analyzed in Skyline (Version 20.1.0.155) to obtain peak MS:MS_COMMENTS areas. m/z values of the metabolite and lipid target lists obtained from the MS:MS_COMMENTS metabolite identification workflow, which had at least an MS/MS match to an MS:MS_COMMENTS online library, were extracted under consideration of retention times. MS:ION_MODE POSITIVE #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS Relative Intensity MS_METABOLITE_DATA_START Samples B1_WU350-013_d0 B1_WU350-014_d0 B1_WU350-021_d0 B1_WU350-029_d0 B1_WU350-031_d0 B1_WU350-041_d0 B1_WU350-047_d0 B1_WU350-050_d0 B1_WU350-055_d0 B1_WU350-065_d0 B1_WU350-008_d14 B1_WU350-005_d14 B1_WU350-006_d14 B1_WU350-007_d14 B1_WU350-009_d14 B1_WU350-011_d14 B1_WU350-013_d14 B1_WU350-014_d14 B1_WU350-021_d14 B1_WU350-029_d14 B1_WU350-031_d14 B1_WU350-041_d14 B1_WU350-047_d14 B1_WU350-050_d14 B1_WU350-055_d14 B1_WU350-065_d14 B1_WU350-006_d3 B1_WU350-007_d3 B1_WU350-009_d3 B1_WU350-011_d3 B1_WU350-013_d3 B1_WU350-014_d3 B1_WU350-021_d3 B1_WU350-029_d3 B1_WU350-031_d3 B1_WU350-041_d3 B1_WU350-047_d3 B1_WU350-050_d3 B1_WU350-055_d3 B1_WU350-065_d3 B1_WU350-004_d7 B1_WU350-005_d7 B1_WU350-006_d7 B1_WU350-007_d7 B1_WU350-009_d7 B1_WU350-011_d7 B1_WU350-013_d7 B1_WU350-014_d7 B1_WU350-021_d7 B1_WU350-029_d7 B1_WU350-031_d7 B1_WU350-041_d7 B1_WU350-047_d7 B1_WU350-050_d7 B1_WU350-055_d7 B1_WU350-065_d7 B2_WU350-024_d0 B2_WU350-026_d0 B2_WU350-058_d0 B2_WU350-017_d0 B2_WU350-044_d0 B2_WU350-045_d0 B2_WU350-019_d0 B2_WU350-020_d0 B2_WU350-022_d0 B2_WU350-040_d0 B2_WU350-016_d0 B2_WU350-035_d0 B2_WU350-036_d0 B2_WU350-063_d0 B2_WU350-025_d0 B2_WU350-030_d0 B2_WU350-032_d0 B2_WU350-038_d0 B2_WU350-039_d0 B2_WU350-042_d0 B2_WU350-043_d0 B2_WU350-051_d0 B2_WU350-052_d0 B2_WU350-054_d0 B2_WU350-057_d0 B2_WU350-059_d0 B2_WU350-060_d0 B2_WU350-061_d0 B2_WU350-015_d0 B2_WU350-018_d0 B2_WU350-023_d0 B2_WU350-027_d0 B2_WU350-028_d0 B2_WU350-037_d0 B2_WU350-048_d0 B2_WU350-053_d0 B2_WU350-062_d0 B2_WU350-079_d0 B2_WU350-080_d0 B2_WU350-084_d0 B2_WU350-097_d0 B2_WU350-098_d0 B2_WU350-099_d0 B2_WU350-079_d14 B2_WU350-080_d14 B2_WU350-084_d14 B2_WU350-097_d14 B2_WU350-098_d14 B2_WU350-099_d14 B2_WU350-012_d28 B2_WU350-013_d28 B2_WU350-029_d28 B2_WU350-030_d3 B2_WU350-032_d3 B2_WU350-038_d3 B2_WU350-039_d3 B2_WU350-042_d3 B2_WU350-043_d3 B2_WU350-060_d3 B2_WU350-061_d3 B2_WU350-015_d3 B2_WU350-027_d3 B2_WU350-037_d3 B2_WU350-062_d3 B2_WU350-079_d3 B2_WU350-080_d3 B2_WU350-084_d3 B2_WU350-097_d3 B2_WU350-098_d3 B2_WU350-099_d3 B2_WU350-032_d7 B2_WU350-039_d7 B2_WU350-042_d7 B2_WU350-015_d7 B2_WU350-053_d7 B2_WU350-062_d7 B2_WU350-079_d7 B2_WU350-080_d7 B2_WU350-084_d7 B2_WU350-097_d7 B2_WU350-098_d7 B2_WU350-099_d7 B3_WU350-078_d0 B3_WU350-114_d0 B3_WU350-070_d0 B3_WU350-082_d0 B3_WU350-095_d0 B3_WU350-056_d0 B3_WU350-102_d0 B3_WU350-103_d0 B3_WU350-104_d0 B3_WU350-067_d0 B3_WU350-068_d0 B3_WU350-069_d0 B3_WU350-071_d0 B3_WU350-073_d0 B3_WU350-086_d0 B3_WU350-090_d0 B3_WU350-091_d0 B3_WU350-100_d0 B3_WU350-101_d0 B3_WU350-105_d0 B3_WU350-107_d0 B3_WU350-108_d0 B3_WU350-109_d0 B3_WU350-110_d0 B3_WU350-112_d0 B3_WU350-113_d0 B3_WU350-117_d0 B3_WU350-066_d0 B3_WU350-072_d0 B3_WU350-074_d0 B3_WU350-075_d0 B3_WU350-076_d0 B3_WU350-077_d0 B3_WU350-081_d0 B3_WU350-083_d0 B3_WU350-085_d0 B3_WU350-087_d0 B3_WU350-088_d0 B3_WU350-089_d0 B3_WU350-092_d0 B3_WU350-093_d0 B3_WU350-094_d0 B3_WU350-096_d0 B3_WU350-106_d0 B3_WU350-111_d0 B3_WU350-115_d0 B3_WU350-120_d0 B3_WU350-121_d0 B3_WU350-124_d0 B3_WU350-089_d14 B3_WU350-092_d14 B3_WU350-086_d3 B3_WU350-091_d3 B3_WU350-100_d3 B3_WU350-107_d3 B3_WU350-108_d3 B3_WU350-109_d3 B3_WU350-113_d3 B3_WU350-117_d3 B3_WU350-066_d3 B3_WU350-072_d3 B3_WU350-074_d3 B3_WU350-075_d3 B3_WU350-085_d3 B3_WU350-087_d3 B3_WU350-088_d3 B3_WU350-089_d3 B3_WU350-093_d3 B3_WU350-096_d3 B3_WU350-106_d3 B3_WU350-115_d3 B3_WU350-120_d3 B3_WU350-121_d3 B3_WU350-124_d3 B3_WU350-107_d7 B3_WU350-108_d7 B3_WU350-117_d7 B3_WU350-072_d7 B3_WU350-074_d7 B3_WU350-075_d7 B3_WU350-085_d7 B3_WU350-087_d7 B3_WU350-092_d7 B3_WU350-093_d7 B3_WU350-111_d7 B3_WU350-115_d7 B3_WU350-120_d7 B3_WU350-121_d7 B3_WU350-124_d7 B4_WU350-118_d0 B4_WU350-133_d0 B4_WU350-136_d0 B4_WU350-141_d0 B4_WU350-144_d0 B4_WU350-150_d0 B4_WU350-162_d0 B4_WU350-168_d0 B4_WU350-170_d0 B4_WU350-177_d0 B4_WU350-123_d0 B4_WU350-122_d0 B4_WU350-127_d0 B4_WU350-128_d0 B4_WU350-130_d0 B4_WU350-131_d0 B4_WU350-132_d0 B4_WU350-135_d0 B4_WU350-138_d0 B4_WU350-139_d0 B4_WU350-147_d0 B4_WU350-148_d0 B4_WU350-151_d0 B4_WU350-153_d0 B4_WU350-156_d0 B4_WU350-157_d0 B4_WU350-158_d0 B4_WU350-159_d0 B4_WU350-164_d0 B4_WU350-175_d0 B4_WU350-116_d0 B4_WU350-119_d0 B4_WU350-126_d0 B4_WU350-129_d0 B4_WU350-134_d0 B4_WU350-137_d0 B4_WU350-142_d0 B4_WU350-143_d0 B4_WU350-145_d0 B4_WU350-146_d0 B4_WU350-152_d0 B4_WU350-154_d0 B4_WU350-155_d0 B4_WU350-163_d0 B4_WU350-165_d0 B4_WU350-166_d0 B4_WU350-172_d0 B4_WU350-174_d0 B4_WU350-176_d0 B4_WU350-117_d14 B4_WU350-120_d14 B4_WU350-124_d14 B4_WU350-126_d14 B4_WU350-058_d28 B4_WU350-025_d28 B4_WU350-059_d28 B4_WU350-050_d28 B4_WU350-055_d28 B4_WU350-065_d28 B4_WU350-125_d3 B4_WU350-130_d3 B4_WU350-131_d3 B4_WU350-132_d3 B4_WU350-138_d3 B4_WU350-147_d3 B4_WU350-148_d3 B4_WU350-151_d3 B4_WU350-153_d3 B4_WU350-158_d3 B4_WU350-159_d3 B4_WU350-087_d3 B4_WU350-116_d3 B4_WU350-126_d3 B4_WU350-134_d3 B4_WU350-137_d3 B4_WU350-143_d3 B4_WU350-145_d3 B4_WU350-146_d3 B4_WU350-154_d3 B4_WU350-163_d3 B4_WU350-165_d3 B4_WU350-129_d3 B4_WU350-125_d7 B4_WU350-130_d7 B4_WU350-131_d7 B4_WU350-138_d7 B4_WU350-148_d7 B4_WU350-126_d7 B4_WU350-145_d7 B4_WU350-146_d7 B5_WU350-179_d0 B5_WU350-189_d0 B5_WU350-194_d0 B5_WU350-196_d0 B5_WU350-199_d0 B5_WU350-192_d0 B5_WU350-198_d0 B5_WU350-190_d0 B5_WU350-178_d0 B5_WU350-184_d0 B5_WU350-145_d14 B5_WU350-154_d14 B5_WU350-105_d28 B5_WU350-113_d28 B5_WU350-117_d28 B5_WU350-080_d28 B5_WU350-084_d28 B5_WU350-175_d3 B5_WU350-192_d3 B5_WU350-198_d3 B5_WU350-190_d3 B5_WU350-172_d3 B5_WU350-174_d3 B5_WU350-176_d3 B5_WU350-178_d3 B5_WU350-159_d7 B5_WU350-175_d7 B5_WU350-154_d7 B5_WU350-163_d7 B5_WU350-165_d7 B5_WU350-172_d7 B5_WU350-174_d7 B5_WU350-176_d7 B5_WU350-178_d7 B6_WU350-201_d0 B6_WU350-215_d0 B6_WU350-221_d0 B6_WU350-225_d0 B6_WU350-228_d0 B6_WU350-233_d0 B6_WU350-202_d0 B6_WU350-200_d0 B6_WU350-247_d0 B6_WU350-204_d0 B6_WU350-206_d0 B6_WU350-207_d0 B6_WU350-219_d0 B6_WU350-227_d0 B6_WU350-231_d0 B6_WU350-238_d0 B6_WU350-239_d0 B6_WU350-241_d0 B6_WU350-242_d0 B6_WU350-243_d0 B6_WU350-244_d0 B6_WU350-259_d0 B6_WU350-260_d0 B6_WU350-261_d0 B6_WU350-218_d0 B6_WU350-209_d0 B6_WU350-205_d0 B6_WU350-208_d0 B6_WU350-210_d0 B6_WU350-217_d0 B6_WU350-226_d0 B6_WU350-232_d0 B6_WU350-246_d0 B6_WU350-248_d0 B6_WU350-249_d0 B6_WU350-251_d0 B6_WU350-255_d0 B6_WU350-256_d0 B6_WU350-257_d0 B6_WU350-238_d14 B6_WU350-174_d14 B6_WU350-163_d14 B6_WU350-165_d14 B6_WU350-176_d14 B6_WU350-190_d14 B6_WU350-205_d14 B6_WU350-209_d14 B6_WU350-141_d28 B6_WU350-149_d28 B6_WU350-179_d28 B6_WU350-125_d28 B6_WU350-120_d28 B6_WU350-126_d28 B6_WU350-145_d28 B6_WU350-174_d28 B6_WU350-206_d3 B6_WU350-218_d3 B6_WU350-219_d3 B6_WU350-238_d3 B6_WU350-241_d3 B6_WU350-242_d3 B6_WU350-244_d3 B6_WU350-209_d3 B6_WU350-205_d3 B6_WU350-208_d3 B6_WU350-232_d3 B6_WU350-246_d3 B6_WU350-248_d3 B6_WU350-251_d3 B6_WU350-255_d3 B6_WU350-256_d3 B6_WU350-257_d3 B6_WU350-233_d7 B6_WU350-198_d7 B6_WU350-204_d7 B6_WU350-219_d7 B6_WU350-238_d7 B6_WU350-242_d7 B6_WU350-244_d7 B6_WU350-190_d7 B6_WU350-205_d7 B6_WU350-208_d7 B6_WU350-209_d7 B6_WU350-246_d7 B6_WU350-251_d7 B6_WU350-006_d84 B7_WU350-281_d0 B7_WU350-284_d0 B7_WU350-293_d0 B7_WU350-296_d0 B7_WU350-285_d0 B7_WU350-287_d0 B7_WU350-294_d0 B7_WU350-282_d0 B7_WU350-286_d0 B7_WU350-295_d0 B7_WU350-274_d0 B7_WU350-300_d0 B7_WU350-262_d0 B7_WU350-277_d0 B7_WU350-278_d0 B7_WU350-279_d0 B7_WU350-288_d0 B7_WU350-290_d0 B7_WU350-298_d0 B7_WU350-299_d0 B7_WU350-280_d0 B7_WU350-297_d0 B7_WU350-266_d0 B7_WU350-275_d0 B7_WU350-292_d0 B7_WU350-263_d0 B7_WU350-267_d0 B7_WU350-268_d0 B7_WU350-272_d0 B7_WU350-276_d0 B7_WU350-283_d0 B7_WU350-289_d0 B7_WU350-291_d0 B7_WU350-279_d14 B7_WU350-232_d14 B7_WU350-246_d14 B7_WU350-257_d14 B7_WU350-272_d14 B7_WU350-292_d14 B7_WU350-229_d28 B7_WU350-252_d28 B7_WU350-238_d28 B7_WU350-205_d28 B7_WU350-208_d28 B7_WU350-261_d3 B7_WU350-277_d3 B7_WU350-278_d3 B7_WU350-279_d3 B7_WU350-280_d3 B7_WU350-290_d3 B7_WU350-298_d3 B7_WU350-267_d3 B7_WU350-268_d3 B7_WU350-272_d3 B7_WU350-276_d3 B7_WU350-283_d3 B7_WU350-291_d3 B7_WU350-289_d3 B7_WU350-292_d3 B7_WU350-259_d7 B7_WU350-261_d7 B7_WU350-280_d7 B7_WU350-255_d7 B7_WU350-256_d7 B7_WU350-257_d7 B7_WU350-268_d7 B7_WU350-272_d7 B7_WU350-275_d7 B7_WU350-276_d7 B7_WU350-289_d7 B7_WU350-283_d7 B7_WU350-058_d84 B7_WU350-078_d84 B7_WU350-193_d84 B7_WU350-012_d84 B7_WU350-025_d84 B7_WU350-059_d84 B7_WU350-105_d84 B7_WU350-117_d84 B7_WU350-148_d84 B7_WU350-007_d84 B7_WU350-013_d84 B7_WU350-014_d84 B7_WU350-126_d84 B8_WU350-335_d0 B8_WU350-346_d0 B8_WU350-348_d0 B8_WU350-350_d0 B8_WU350-302_d0 B8_WU350-303_d0 B8_WU350-314_d0 B8_WU350-344_d0 B8_WU350-313_d0 B8_WU350-315_d0 B8_WU350-310_d0 B8_WU350-319_d0 B8_WU350-324_d0 B8_WU350-329_d0 B8_WU350-334_d0 B8_WU350-353_d0 B8_WU350-330_d0 B8_WU350-341_d0 B8_WU350-355_d0 B8_WU350-301_d0 B8_WU350-305_d0 B8_WU350-307_d0 B8_WU350-311_d0 B8_WU350-316_d0 B8_WU350-317_d0 B8_WU350-318_d0 B8_WU350-320_d0 B8_WU350-321_d0 B8_WU350-323_d0 B8_WU350-325_d0 B8_WU350-326_d0 B8_WU350-327_d0 B8_WU350-331_d0 B8_WU350-332_d0 B8_WU350-336_d0 B8_WU350-340_d0 B8_WU350-343_d0 B8_WU350-345_d0 B8_WU350-349_d0 B8_WU350-352_d0 B8_WU350-354_d0 B8_WU350-309_d0 B8_WU350-322_d0 B8_WU350-338_d0 B8_WU350-351_d0 B8_WU350-304_d0 B8_WU350-306_d0 B8_WU350-312_d0 B8_WU350-337_d0 B8_WU350-347_d0 B8_WU350-339_d0 B8_WU350-305_d14 B8_WU350-309_d14 B8_WU350-312_d14 B8_WU350-254_d28 B8_WU350-264_d28 B8_WU350-280_d28 B8_WU350-320_d3 B8_WU350-336_d3 B8_WU350-316_d3 B8_WU350-330_d3 B8_WU350-355_d3 B8_WU350-301_d3 B8_WU350-305_d3 B8_WU350-311_d3 B8_WU350-317_d3 B8_WU350-323_d3 B8_WU350-327_d3 B8_WU350-331_d3 B8_WU350-332_d3 B8_WU350-343_d3 B8_WU350-341_d3 B8_WU350-309_d3 B8_WU350-322_d3 B8_WU350-337_d3 B8_WU350-338_d3 B8_WU350-351_d3 B8_WU350-339_d3 B8_WU350-347_d3 B8_WU350-311_d7 B8_WU350-305_d7 B8_WU350-336_d7 B8_WU350-316_d7 B8_WU350-304_d7 B8_WU350-312_d7 B8_WU350-309_d7 B8_WU350-149_d84 B8_WU350-173_d84 B8_WU350-203_d84 B8_WU350-041_d84 B9_WU350-378_d0 B9_WU350-392_d0 B9_WU350-371_d0 B9_WU350-368_d0 B9_WU350-369_d0 B9_WU350-400_d0 B9_WU350-356_d0 B9_WU350-361_d0 B9_WU350-375_d0 B9_WU350-380_d0 B9_WU350-382_d0 B9_WU350-385_d0 B9_WU350-386_d0 B9_WU350-387_d0 B9_WU350-388_d0 B9_WU350-395_d0 B9_WU350-360_d0 B9_WU350-379_d0 B9_WU350-383_d0 B9_WU350-364_d0 B9_WU350-366_d0 B9_WU350-367_d0 B9_WU350-374_d0 B9_WU350-377_d0 B9_WU350-389_d0 B9_WU350-394_d0 B9_WU350-398_d0 B9_WU350-359_d0 B9_WU350-365_d0 B9_WU350-372_d0 B9_WU350-373_d0 B9_WU350-390_d0 B9_WU350-391_d0 B9_WU350-362_d0 B9_WU350-363_d0 B9_WU350-376_d0 B9_WU350-393_d0 B9_WU350-397_d0 B9_WU350-356_d14 B9_WU350-339_d14 B9_WU350-351_d14 B9_WU350-363_d14 B9_WU350-366_d14 B9_WU350-367_d14 B9_WU350-376_d14 B9_WU350-312_d28 B9_WU350-400_d3 B9_WU350-368_d3 B9_WU350-356_d3 B9_WU350-375_d3 B9_WU350-380_d3 B9_WU350-386_d3 B9_WU350-383_d3 B9_WU350-364_d3 B9_WU350-366_d3 B9_WU350-367_d3 B9_WU350-374_d3 B9_WU350-377_d3 B9_WU350-391_d3 B9_WU350-394_d3 B9_WU350-398_d3 B9_WU350-359_d3 B9_WU350-363_d3 B9_WU350-372_d3 B9_WU350-373_d3 B9_WU350-390_d3 B9_WU350-362_d3 B9_WU350-389_d3 B9_WU350-393_d3 B9_WU350-397_d3 B9_WU350-356_d7 B9_WU350-341_d7 B9_WU350-368_d7 B9_WU350-364_d7 B9_WU350-397_d7 B9_WU350-347_d7 B9_WU350-359_d7 B9_WU350-363_d7 B9_WU350-373_d7 B9_WU350-391_d7 B9_WU350-394_d7 B9_WU350-351_d7 B9_WU350-366_d7 B9_WU350-367_d7 B9_WU350-376_d7 B9_WU350-377_d7 B9_WU350-393_d7 B9_WU350-398_d7 B9_WU350-229_d84 Factors batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:1 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:2 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:3 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:4 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:5 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:6 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:7 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:8 | WU day of presentation:d84 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d0 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d14 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d28 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d3 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:No | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:1 | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:- batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d7 | SARS-CoV-2 Positive:Yes | Admitted to the ICU:Yes | REMDESIVIR on:- | DEXAMETHOSONE on:1 batch:9 | WU day of presentation:d84 | SARS-CoV-2 Positive:No | Admitted to the ICU:None | REMDESIVIR on:- | DEXAMETHOSONE on:- 1 8 Diazabicyclo 5 4 0 undec 7 ene 393192.0025 570833.5975 461009.0210 571578.9154 480511.2131 456837.3984 316168.8439 390783.5308 484650.2127 663652.6443 210879.0611 475897.7333 546739.4503 419180.4130 608914.7501 252623.4622 373346.4128 368056.1232 478810.4391 496237.0543 544055.1795 445680.2910 516570.9307 500540.1490 496102.2058 463767.2123 514814.5199 281141.1668 543775.7558 540988.8733 689382.2934 452145.9570 450884.5932 365302.5122 526473.1699 440628.6260 494728.8894 186620.9884 425791.7096 311916.4700 494649.2406 532378.9141 507488.0016 427839.4457 304673.2810 478760.3243 631205.0702 749643.7048 455022.6785 372378.9137 562971.9616 403089.8700 589700.1839 625894.7821 447506.4805 480595.7147 479701.5805 646044.8229 420690.2547 631649.2188 560397.4431 318198.7397 691998.3074 466485.5034 454621.3944 480609.7349 339404.1677 445383.0305 384424.4008 226503.3060 646595.5032 486691.7759 413821.6071 503891.6083 497493.8339 369179.9333 442936.7696 439063.8898 381930.9571 527457.9969 427049.9803 663454.5277 369710.5223 410687.2640 615188.7039 556400.8636 561699.4623 461056.4424 892258.2224 401252.1462 258629.4807 494674.7397 351589.0391 432169.7290 505166.3104 505008.7626 522124.7932 483604.9488 386319.4392 282442.8091 531777.2763 428015.9481 568870.0661 560148.6980 554100.2209 395166.9098 511144.1680 404375.3208 718456.5417 411607.8572 253820.2121 454028.3286 250658.1017 391125.6962 453561.4446 399295.3881 468487.1262 601957.1739 333874.2841 398461.5541 415813.0831 363967.1834 405201.7558 380746.0114 444716.4142 369499.1414 509946.3518 477654.0725 393303.0709 391084.5967 521128.6995 482965.5200 357036.2010 486617.1606 582332.3270 656267.7829 503181.1631 426666.2695 427718.9643 313874.9373 536026.3510 399936.0619 373547.9989 576871.6516 586251.3551 301984.0797 397117.5243 480790.9415 449356.5763 434321.5696 549752.6013 488833.0666 430088.0152 606022.2082 362786.8744 382561.4812 562737.9070 439693.2590 316967.9235 342882.6293 439630.3018 447903.2362 469843.3528 367464.1848 375977.2493 482103.1172 601332.4873 532313.0475 669965.2155 586755.7841 356702.5205 426759.8987 525778.0228 575956.9771 536903.4788 421219.7750 593355.0719 448517.7688 499489.8316 373887.6183 317051.7228 315767.7855 539917.5420 457629.6336 362930.4767 427074.3498 514137.4111 455678.6565 458304.9877 443074.7749 435997.9339 506560.9303 292190.9015 494369.7093 437484.6210 568973.6419 444962.1167 406366.2509 460005.4496 611953.9353 391555.3141 403919.2533 418467.0128 463839.4551 485676.7039 413824.3354 337933.4171 394187.4445 511299.8535 428894.9154 444978.0843 285806.8277 407090.4759 432548.5412 485150.3608 332570.9390 480219.4977 329589.1323 386039.5968 419134.1695 552888.7884 531046.0040 490287.8206 617840.6018 521434.2022 781765.3525 587590.0338 648215.2671 434711.0589 481541.1806 771682.2844 330786.6541 439125.3741 407474.4597 503682.9500 515465.9406 624607.8086 466344.5357 284490.9017 569701.3410 566068.5081 424302.4950 381206.3615 370038.1938 707686.8881 494949.2219 415232.2011 537663.7161 380579.9840 328453.4858 343729.2974 357423.8086 413995.9122 423731.6528 376800.7791 346460.5246 529583.3437 534374.4686 584199.8223 604644.8135 625233.0122 397972.6150 377000.4222 422544.1939 335821.3395 382861.9760 250360.6108 291981.1928 526617.5283 550904.5955 400063.2852 364804.4799 498346.6190 427097.0928 749274.8654 756608.5939 465054.0028 289220.7007 602189.2812 510798.6196 448987.6400 583332.4405 517639.4882 438532.6963 383714.4582 415137.8229 709056.0729 363060.3158 436111.8999 313381.0375 368131.9563 657730.6920 425483.7875 488502.1994 378082.2400 388169.1084 383977.4011 556798.9582 539548.6523 360708.8437 516217.5290 368708.3476 338946.0361 508613.8252 444936.6201 549673.9645 516406.7363 444085.8835 412151.1970 553070.0857 394892.3138 421258.3892 370074.7875 690275.3849 273075.9694 575570.4352 438602.7716 531973.2782 430906.8331 446587.4884 540064.9072 519673.1197 462195.2533 633183.7339 425123.8461 443463.3691 508595.9412 353669.8973 317820.2870 547914.5494 737162.5011 531859.5031 553217.8701 691893.5467 481466.8926 247960.0306 373750.6395 320606.0621 501671.8169 391041.4372 464194.1249 572573.3120 496731.9482 448849.5995 562229.2465 518283.2671 391285.2194 375001.4671 231767.1930 339965.5339 348602.2160 551710.9631 423160.8627 487235.1397 460114.6476 405851.8425 332856.5309 392591.4125 527039.6207 463437.9185 414253.0211 456158.9494 377227.0029 651909.2270 540306.8713 455468.0796 436585.3213 444766.3882 937126.8784 513447.8273 361174.1429 492208.9685 688586.8607 755302.9998 378733.0094 552974.2418 354587.5837 575259.5376 428719.0814 586679.6790 416219.7535 507060.3591 280538.4210 414101.9908 395508.4420 371138.3371 372731.1143 667418.0779 505707.4504 398281.6382 554187.2143 752364.5593 481511.0845 261562.9596 261894.8651 456013.7226 533896.7222 430770.3150 364668.0226 726591.4693 505736.4744 365657.1532 432378.5593 387312.2020 310279.1948 420949.4583 550615.1432 368301.3501 417746.7855 331302.3512 352183.1087 346566.2343 354184.2615 654194.9701 671750.6053 556109.7528 394800.7092 347354.1413 353901.1388 436530.2652 468199.3809 399408.2052 420924.9388 267556.5617 746934.6659 379003.0128 365665.7945 465502.1310 445493.1190 510126.8226 442237.3064 248564.4778 342784.9349 258053.1319 390159.1165 503872.7302 297394.9187 455950.8647 734878.4715 330977.8162 338195.3361 395678.3843 387688.9974 246880.1736 512695.1074 479946.8417 268660.4881 348979.2144 535634.1563 709161.8082 486537.6832 528796.5913 415714.9590 446070.4469 380224.0644 517917.1230 547260.9825 202182.0290 395757.6268 320802.1539 530095.2759 377379.7791 524753.4593 411249.4672 598373.7209 529378.9797 517803.2378 367786.7216 460463.5220 333602.6869 640460.6728 410164.1001 311061.4392 744249.1084 289249.1469 514645.7128 396303.6395 460362.4939 285439.9964 540516.6264 361040.6489 419424.0791 362663.7470 387312.6029 362560.6328 517195.9683 496264.4112 452510.5355 337807.7349 574020.3577 478330.9008 560508.8331 485334.9436 445151.2382 348562.7086 341942.8903 517622.9340 595155.0676 445560.7213 467301.7845 475789.3415 477477.1096 529283.4940 504866.2713 619113.0206 1405379.6550 262955.2899 225525.2424 349242.7897 420453.5312 535710.7989 514550.9755 300752.3391 562440.4873 442033.5198 340481.3258 558801.9804 409230.6133 297380.9501 345413.6710 386061.6060 443461.2234 503629.3479 441565.9247 427652.5669 312307.5629 415299.5765 307843.2084 491550.8266 520994.2798 513856.6047 347030.0889 544188.5084 485932.8374 561165.8899 491366.0827 552375.5085 458152.6040 560005.8729 95846.4374 438682.4994 331962.7469 321695.8927 648565.2992 343297.1281 431237.8868 561353.7188 449252.7287 533216.4345 540562.0189 500643.7824 535977.4679 543830.4733 439193.0567 218356.9680 617866.8892 499015.7724 529529.5035 549106.1176 367547.2051 554160.2417 370295.4901 565124.9924 396004.7970 634416.3188 506557.4071 593091.9006 351051.1777 408249.7182 373435.2835 345829.5532 440889.5886 347030.0889 543602.4796 436718.4561 468296.5884 482734.4237 658352.4744 393576.5541 536706.3377 339512.8026 452707.9100 400186.2022 557739.9040 424473.2575 543928.1484 555145.1413 334423.4370 482961.0617 367865.6234 208628.9538 552726.6488 334841.3010 356839.5165 499088.2692 497672.2032 498834.4729 425668.9723 170971.0295 408715.1348 542885.1495 408109.9640 415481.8868 480460.6988 462482.7911 336328.3872 523323.7815 117913.8258 278559.9648 414569.3343 292953.7153 475828.3782 408055.4334 314511.1017 362313.5482 529807.8601 311556.6313 1011219.9140 461513.1791 329442.4111 317865.3420 478140.9409 381728.9091 612448.9233 293198.7889 364159.7952 350848.5611 684104.9783 273241.4472 365478.5011 500568.8268 452481.1857 507789.3285 802071.7435 442089.4956 846808.0502 341437.6208 391125.5252 395846.1670 347430.7432 442839.5592 359558.0969 624440.6549 332414.0501 457958.7717 409565.9992 490323.3396 687166.4706 436496.5603 625278.8332 333651.4348 330462.8348 321796.4665 425612.4523 818244.3771 339098.6442 464928.1854 415482.5212 781464.3797 663483.4230 346078.9301 393563.2635 490695.3954 279601.1800 442008.8169 427982.1432 282606.5035 387374.9125 555148.4078 366877.6740 342268.2973 389123.3440 506507.4731 363107.4945 439164.7031 582080.2978 407596.6720 745405.6898 424680.8834 327490.2126 356556.8017 471269.5387 755782.0339 422821.9363 378678.3534 772188.7166 401654.6445 591199.7363 343778.6934 554449.5784 408776.3198 508882.9419 438834.3329 323676.5661 425503.9063 289049.9307 481975.0923 329516.7689 866894.5840 324058.4315 1 Methyladenosine 585818.5338 318925.9148 1429717.0980 324341.4611 676972.4349 631237.3719 657574.2129 677491.4502 376146.1798 817131.8317 228244.8924 535148.6354 816070.9638 790333.9731 769357.6670 461806.2780 1001082.7930 400887.1255 870955.9114 899900.5774 818480.4663 453273.8635 634535.6165 427783.5479 484511.7932 893438.3806 667659.4723 331353.7856 495804.2734 606359.9096 941522.7684 297865.1299 861478.3633 453505.4105 849048.7779 437811.2283 675627.3280 803382.1686 533240.3222 769339.7104 441750.1014 819347.1439 873448.0266 599967.6053 779238.1925 608203.7515 1045577.5040 640660.8683 918994.9786 767562.4388 882951.9827 426733.8045 699928.5596 570209.6806 392917.4201 1186680.4680 830575.2087 372476.4615 422490.8099 523234.0332 434085.1901 431208.5174 388896.8277 774898.0592 1177680.9340 815832.3904 440958.3199 350836.0215 471104.5051 374717.0711 396268.2774 1107244.4620 816464.3130 664008.6286 406444.4467 630873.2316 273120.4821 469251.0377 606317.1127 409628.6118 409080.2295 484393.0420 468866.6450 587318.9424 1221702.6040 584019.0640 397246.5265 522282.8839 1875562.3060 1039674.2000 708428.4879 1124578.7430 789041.2434 660249.5669 567528.7557 510643.3872 612884.3916 906474.5394 646989.7827 635805.5173 459928.4863 796344.4803 384805.9856 688264.2844 592109.8181 561209.1848 1020707.1690 714170.5848 380498.1452 670912.0675 546545.3480 457602.7382 513683.2043 269609.0422 448542.3794 541218.8110 1045111.1840 617387.6339 1097775.1360 907189.1016 760407.5806 447874.8929 674994.2330 476342.9371 855303.5134 592089.1425 798025.5575 450734.9841 507704.8262 1305572.1020 1070455.9200 1188213.1040 636882.7621 419782.1012 1000679.1610 414109.9396 1032975.9320 697590.3811 448619.9886 575692.8093 243932.2218 396389.5096 524235.5008 236195.0849 421427.6688 277893.5471 649026.3313 329890.6548 686465.7865 216477.2581 474142.2176 408174.2702 300242.2752 516416.3662 682401.2092 405010.6285 434188.7337 502691.1938 602373.7308 922551.4537 324187.2050 384022.3511 426973.5461 469771.9300 934520.1218 564566.6038 729491.6098 1060513.0480 602657.9101 280857.3210 684245.9551 1134840.9090 666714.4872 614093.4441 1109705.6870 730931.9869 405714.4134 664702.0637 860570.4975 460125.4165 693780.6810 528448.5845 703427.2976 1051734.3310 870809.2823 905802.2785 300811.5423 496567.5941 1309766.6180 454210.6523 682969.0504 471143.2756 531379.1235 898097.8718 618456.4102 464382.6662 1166193.9030 855005.3302 886070.3746 915715.5889 1045026.3170 807325.9522 805047.4035 822384.1138 565736.4636 798942.4427 870139.2132 505109.5041 991499.4917 845962.0625 763300.7587 573456.1271 504037.6618 827711.1151 1122992.3060 775732.2131 1069142.6120 1372525.5750 775826.6545 1033978.0030 648598.1880 1206956.5900 609308.3048 432565.5291 541052.2807 1011348.7440 481404.4638 209275.9319 465696.3388 339931.7178 298699.7582 528567.5878 363299.7255 414767.8559 362414.6641 386999.7623 816793.7380 568042.0146 676370.6946 432311.8195 434137.1635 463064.1060 360824.3411 578817.1236 463947.9972 631033.7073 840363.4358 581690.8315 480071.8903 491850.8550 1003602.7320 347693.3474 522964.8914 661421.6455 900732.9591 267931.5211 1006005.2750 663197.6578 678643.6080 724400.0700 603914.9477 551490.6921 714334.3269 823470.9368 1061248.1630 447650.5162 960038.7645 838287.5441 918655.4781 586176.8567 827870.7521 1528556.1150 606513.3567 854955.4040 1009786.1040 1139165.0530 1199273.2150 592596.7738 553530.1855 513239.2640 449642.0525 418685.3861 461295.0747 781588.9570 717003.0380 871811.6777 372206.2942 389896.8074 472641.1029 517850.8149 536969.7388 604896.1822 514725.7282 520944.5323 986601.4332 457983.7165 759384.7070 1011105.4920 1380002.8050 905270.1054 588191.0143 586446.8922 1214428.2740 467050.6331 1266785.5120 789291.0341 1327004.5310 1228727.4050 790004.4148 479858.8575 365835.1216 389628.2340 538458.1826 533273.6372 934499.7392 682833.5128 942039.2774 387526.1749 344673.2751 389368.6117 591491.4005 477714.3200 508911.2968 517528.8638 597971.5567 652047.0566 1360476.9780 436901.6017 450885.6369 371630.7333 395997.8838 1236060.2290 419753.1316 659666.4712 867493.7838 592787.4060 437454.7359 776343.4998 604404.5574 926109.5614 1157231.3160 707213.6824 555322.2544 860150.9576 683492.8405 636715.1559 1110683.7300 370049.7100 1296452.0790 905658.4785 541644.6643 555770.7853 363620.1906 363347.9285 375345.0005 437306.2886 440887.8048 502657.6536 1160472.4100 389179.4209 717254.2928 600857.7842 514285.8220 473201.2982 670469.9799 327918.8724 406753.5982 412338.7369 483584.6905 974290.7198 330310.4537 512005.7218 1616221.9020 521615.7140 607740.9055 444721.6634 680947.8288 1017379.1040 899698.9839 515069.7855 634777.3612 445827.9606 1287105.5800 405712.0101 676604.2657 348518.1186 936832.2043 1088116.7790 560967.4179 847443.3605 432163.8045 1186602.4310 713562.2930 1049416.3060 614996.3822 600683.9832 1160191.8060 593702.8784 507046.0363 496813.9397 403561.5606 470794.8925 1156458.2930 996494.9537 382891.8828 815003.1196 656578.0034 372528.5887 489361.0917 351717.4477 679703.8776 610470.3670 422860.8734 839828.3780 1653529.8030 812983.4829 1171586.6940 555491.5560 584190.0031 754585.3808 624168.6807 458155.4849 974819.4431 1120888.6600 467340.0896 552838.0182 512230.8617 416933.0599 837642.3373 333408.7044 749859.0253 1204580.1340 460263.5947 830503.5716 507362.2169 424006.0439 566977.2436 385809.3242 517887.2352 482152.7854 477389.5662 524575.9625 427002.3282 567474.4935 691941.6840 600538.9892 520743.7212 347471.2057 493308.3217 861350.1727 932506.9210 1014912.3540 583816.0115 445113.4507 928762.3133 578283.0123 387105.5343 306037.4774 473755.8219 621150.6223 881090.2443 257160.6779 476307.2584 1219035.7360 611250.9920 909918.5797 595777.2616 439118.9114 447870.1530 413494.8209 518804.6744 2089745.3040 525164.1744 820451.0824 1233720.0400 525747.2083 418270.8495 391908.1713 416135.8407 1455712.9910 652219.4402 540520.6113 959061.1148 822857.5481 411492.1304 433610.5956 722676.6675 510566.6079 893022.6721 844396.5576 697102.4183 1193364.0210 454820.2689 682387.1623 496356.5794 609936.6879 1727257.7740 526747.2523 445329.2740 679447.9617 577298.6246 1392992.2700 826522.0773 830578.2840 967305.5687 1276483.3040 443348.7112 361450.5994 395121.5730 554696.5516 462651.5567 605980.5358 547890.6221 541957.3877 352117.9829 1103238.3730 823066.0302 385859.5434 489995.5769 603297.5098 737116.5642 549183.2720 431330.4018 333758.3680 480600.3334 669425.0434 680864.0837 459761.2320 455636.6660 532064.0235 732841.2319 387550.0734 620481.3219 568100.3884 242793.0820 354025.2902 607769.5171 444835.2454 645876.4037 492324.9590 905778.8898 752729.4861 490238.5018 1025618.0190 509546.7714 381232.4823 381304.2414 765050.8943 993719.0724 1152328.2460 510745.2455 929022.6505 341826.6192 426672.1044 1030846.0990 547029.2913 562542.2430 385763.8250 745119.2331 577431.0930 427302.6691 672809.1957 711492.3690 491804.3431 1247075.2690 1123774.1510 882244.2143 462923.5198 916160.1062 369163.1916 1280135.1430 384601.7546 574222.5902 578817.2853 759769.1889 517297.8405 448637.0410 775153.9678 727260.4341 482717.5856 378512.4060 363397.1397 737787.5158 1095633.4710 716322.5014 1203708.5150 386557.7301 1110319.1040 363292.8981 649428.0360 1100309.3710 471274.5091 585952.6007 638291.9800 515060.2719 649293.7879 954870.0492 1593641.5320 465025.0758 1371159.2210 1313087.9830 861059.1023 562657.4505 615049.6241 715434.0869 703293.7051 555480.8235 574766.9096 471434.5790 416870.7787 692406.3816 390841.8068 523589.7504 405188.9970 602557.2664 790572.2452 384653.8184 1098487.1340 703141.6708 385871.1211 426875.3788 587451.4916 365013.5177 673084.1881 279876.8680 382878.1332 327654.3915 569950.4402 463762.0662 347650.7920 603086.9335 464992.4125 694759.3362 959070.2796 525703.2610 1158458.2610 1075974.9670 451227.1831 844538.6700 328161.2101 525919.7429 423672.7444 805268.7237 477111.9678 888509.0023 438392.4345 897650.5441 939637.3196 824500.6297 770716.2365 509160.4893 789438.5119 544254.8208 993749.9500 1327065.6470 772132.9368 582195.1714 385761.1639 851291.1420 1203911.1480 494220.3921 392325.4454 460741.5460 460476.9736 528468.9746 315126.2974 696411.6492 490156.9079 688622.9687 445269.5940 1083251.9660 424882.8550 1408748.3650 358198.6900 711813.3481 668985.8777 478691.3420 1304131.5720 826780.0848 467680.5800 748246.9455 535858.9504 628691.5519 700395.8026 413759.7077 1354816.7030 894906.0849 1207798.8410 414359.3457 911332.8120 675546.8171 1703053.5290 997263.6009 453982.4607 803515.8801 550716.0184 402837.6717 540183.5150 742355.0667 367716.9282 1 Methylhistidine 762664.8490 217614.3781 1284006.5930 32695.8712 1602928.2840 719703.9439 1089087.2820 218340.5909 60421.3776 220461.8621 263515.0725 307509.1901 142345.7713 138474.1874 3878.1354 133779.9960 320886.0555 133327.8455 201065.2355 253212.0164 2501423.5940 689572.1523 5674488.4300 73964.5359 172396.5647 490589.4056 149520.1394 38097.8525 709951.7665 283760.4774 67237.9774 220203.2693 309924.8736 89358.1400 3670215.8360 471596.0754 931395.6283 259250.4529 206462.5351 387590.3121 86570.8541 369245.1502 253897.0379 98046.5100 306978.0448 513346.3928 144373.3512 8059.2751 391071.8975 214683.9400 1033571.5140 498119.4344 4410892.3650 91721.3283 220534.1122 759707.2266 358445.3499 249928.3110 742376.1580 63180.2498 38101.8242 1398954.2960 79635.4560 254260.6872 453496.9403 217805.9866 249435.6505 350525.1453 447855.7708 952219.4989 30890.3215 398839.8893 917610.4176 452845.7675 35319.4103 315435.8851 92821.4204 778872.0432 3211487.8110 55778.8415 396398.3957 69280.2268 205094.2387 2543662.0220 175607.6698 30411.4261 20979.1785 217078.5213 192371.2538 1156606.0500 2016910.1390 2103247.6610 604243.4683 880842.5344 104495.4049 58587.7833 66661.5075 16152.2938 219698.6713 5779906.8560 159132.8355 272521.3739 160300.5968 864789.4908 43212.1523 293108.7552 27479.0734 300679.5960 2337.1886 1251151.2480 500859.0336 110071.7083 178257.6864 481124.2581 354206.9174 2014848.6020 396839.0760 208191.1841 1079662.8090 622574.7410 276370.3292 181042.6095 630830.9055 252400.9602 505351.4121 184924.3151 127959.8744 176789.2811 199466.6297 455156.3941 40481.7546 270956.9539 3226582.9420 351908.9710 154390.7697 44240.0423 1009025.4300 41453.3063 95946.5586 374836.9468 344079.4490 1635468.7080 239950.5637 1116609.2490 439406.7136 1819438.9780 201445.8706 501434.1561 61017.9336 384463.0178 144097.8983 126222.9855 628814.0532 1398372.1810 66331.0818 50158.7829 260839.9703 20677.8888 173922.8987 3836884.7100 875325.9774 32047.6417 72117.3967 421237.7561 773164.4289 2881426.4510 588992.4033 371072.5771 1542436.3320 2783586.8900 1147068.3130 197636.4666 288727.0438 278868.4722 197534.4103 54835.4671 956773.0316 28015.4219 581140.3859 55983.0213 239747.4745 84671.1404 173922.8987 59141.0624 353062.2631 52839.8866 584706.5422 675012.3026 475989.3357 146045.4303 47476.2564 185422.6933 1246.7789 182767.1622 161976.7605 255456.5114 1457949.5540 1474598.2500 261739.8233 96763.4139 101258.6111 12951.8358 195607.1645 107519.4028 912245.5459 655069.9414 656729.2224 259290.5270 385071.2721 221363.1956 62086.1186 83238.1412 38285.8895 438320.2817 1083756.0170 466520.8063 61007.8317 223194.7405 16015.9817 34663.8825 461696.8383 3622950.9250 1476966.6480 4091139.4830 1361884.7870 2504236.4070 201657.5597 9160881.4250 50402.3705 342062.9067 2093101.1250 2666949.7820 476630.9988 127616.1459 44898.2115 49662.9298 174404.0922 505934.8764 1384922.9920 37799.0379 224111.1709 23937.8101 323998.0244 1707362.9520 214692.6361 124914.0780 571305.2531 177591.1326 48660.7943 6841.5401 3581160.9980 375627.4952 186794.7902 88209.6523 562143.7658 145801.6165 546902.1045 148340.4706 1279848.4320 1377437.9880 1961935.6660 429325.1011 489960.0067 397371.9899 594837.8632 2388.1698 2026174.9370 1626588.2610 478315.8751 37550.8670 265097.3240 224848.7068 536431.7610 241644.3887 1257539.9100 686771.1439 829024.9384 755129.5840 483920.4449 785188.9630 20590.7331 364784.5504 546410.6096 66358.9316 162557.5589 23154.9115 135787.5202 155728.1000 65102.4532 488417.4752 164552.2878 324345.1633 49286.3773 18987.9477 1193786.7150 295869.8642 783119.8864 128612.8704 354068.4893 576907.2883 247043.2761 380667.9567 154346.7910 424431.4512 394511.5662 261557.9044 197335.4810 355198.3962 432935.4824 82935.2045 2369640.6650 407419.7476 149036.5962 12681.4820 1131950.3890 45940.1409 91165.1296 78323.7269 46719.4294 353158.2619 85867.0860 133191.3597 269428.2029 24008.3411 100438.4279 569761.2440 1068434.4070 77384.1412 88466.1213 228810.9066 611854.2697 372760.5888 37806.4493 36368.2631 2116073.1160 2146729.0420 911318.3978 141309.9594 43221.2172 1330471.5550 320480.8791 2265447.4740 2212658.9470 1948278.6950 100762.2903 114701.6817 379372.9083 353877.1764 450642.6444 463047.0594 1601583.4770 504388.0719 85158.6714 206633.4073 339873.9452 299432.5354 993941.0824 574979.4992 3644322.6360 81285.9488 199792.1886 63837.9196 4664292.9370 28945.5838 98616.9032 159651.0950 50131.1259 566430.6561 98944.0419 2834165.0170 3400747.8150 196167.6067 2198460.2640 1360299.6000 174801.7192 310458.4332 139970.1709 16448.5216 284971.5284 67597.4413 975691.8728 601681.7219 343951.3902 1133657.1660 94400.7708 54147.3023 1883458.1040 194386.1235 27105.8521 363774.7018 33520.1300 230657.1013 71793.2709 472843.5215 241883.3133 667123.4865 224292.9860 114293.0974 469159.2608 1263547.2740 118078.0313 53591.2919 323306.9273 845303.9323 132528.3521 71196.0961 149712.7988 172646.7706 290714.3503 23078.6353 152760.8061 6718529.6750 235462.3221 13750.8103 16550.5736 234025.3186 232729.9597 158540.2064 246276.2450 369677.9951 375896.1725 163075.3673 273086.7823 390838.0187 371626.3291 107598.0879 377224.5240 3530250.0960 5159011.4620 242264.6448 193182.2552 96903.6796 592363.8500 635743.3780 104150.1249 457100.0326 1348031.8030 149740.3686 707784.8244 294333.6833 150903.3872 1968367.6560 210229.4050 113224.3429 182193.9389 341774.9433 141797.2246 162933.0187 24402.5790 1837932.7550 1638997.8220 2377762.3610 308795.5674 158598.1388 2642779.3510 254169.1573 110854.1073 2841965.8540 779616.2728 556240.6520 49607.4739 50611.6624 261454.4478 409808.8756 36935.2244 591559.9805 297867.8316 841300.4901 167212.8558 12050.4315 190386.5273 207035.2079 92704.0474 6062.1132 1153465.4620 495194.1110 36472.4933 279266.9716 23421.4434 181826.7485 1773743.6760 89282.6135 1850439.2700 2922032.3200 87303.4605 683582.4721 1302198.2730 308687.6614 175927.0302 214291.7224 38729.5846 793160.8127 247886.3691 408543.6287 89260.4390 278146.3178 850866.0934 71906.8082 57068.1238 21055.1837 150000.1132 528070.9260 1643734.9060 352529.2637 584886.0205 45227.6848 66834.3640 330233.0258 69769.7727 870648.3917 183548.4221 1461758.2220 327382.8292 646767.4347 131385.9748 1907198.1650 162231.8877 154577.0539 1504866.2370 833235.6775 1124991.1300 1179176.0940 219051.4383 44929.1081 32947.9378 301949.2814 145696.1102 47818.8654 171003.0400 241158.3878 18081.7424 30548.4254 1578244.9750 82892.7681 428022.5184 470754.3605 899553.0985 32220.8251 542156.4295 224617.7431 634933.8668 217707.3757 440992.5219 84191.1681 35884.3407 443942.8745 66666.1769 181580.1356 155482.3940 745972.2815 251919.3279 1551531.4300 120401.5308 1117890.6500 259800.0176 1402261.9620 92714.7335 1470643.1260 143388.4277 530393.6651 1018138.1150 117309.0235 41782.0744 20933.1804 4479328.6910 838794.5173 1615210.2640 97592.2134 585443.3797 239948.4421 1530134.9570 1476429.8330 377422.3131 60295.1706 167072.9596 630650.9741 105779.5604 227975.6490 427253.4084 1254741.6200 714650.8019 12437.7385 434652.9580 909274.2098 742815.5994 250737.2835 740379.9678 2589858.7510 113373.2850 1964523.4920 679202.8297 806282.2374 100864.2888 50420.3171 29498.9044 243816.9626 959056.6207 450650.4723 193224.6543 1807665.8600 41778.6480 45311.5839 263502.0844 286356.2588 388947.8062 308695.9630 27275.5567 277098.1301 244812.4114 920728.4864 1879227.9290 118007.3690 2058999.6540 8562.3280 94649.7749 925541.6341 419546.6802 1056565.7680 1928595.6730 424849.6151 614554.3377 614830.3074 2097944.9320 1028758.7100 296831.0594 102960.0549 107175.6580 1458807.6310 274242.1471 23504.2173 67261.8901 47303.0778 283444.0457 652833.5570 67598.8097 700717.2786 1631749.7970 58268.8120 64284.8093 140800.6408 41495.6490 53501.0330 125792.9142 709268.8037 1381214.7360 94685.2293 264158.4593 460119.9253 297371.8458 439138.2801 944797.9898 101965.8115 239828.7275 253808.0481 354598.9084 74295.0563 270322.7496 435454.3332 1398837.3490 2361949.9410 795435.1438 415577.0022 286631.2859 723534.3949 75743.4344 30562.1392 273772.6859 808053.4808 321363.8541 165584.0753 1456382.1080 34555.7040 1097138.8310 13993.6858 51072.2286 179347.9891 30036.0347 2814445.6530 1349008.4670 64363.0075 422504.4561 159651.4783 1870561.2930 2792349.9690 238502.1001 589070.8555 822678.2880 566273.9011 19904.1776 223005.5684 88739.9859 733161.7115 915907.2409 62999.6151 440527.7108 175148.3311 247455.5565 110265.9884 131865.9922 159232.1348 20 Dihydrocortisol 246223.3589 162220.9859 136155.0666 66835.0057 106684.1681 253531.3858 257567.7812 193609.5028 171972.3140 466944.9545 53799.7438 105917.4093 686725.8172 46669.0261 119756.3947 153757.8369 110813.3371 108394.1769 127102.9128 162780.5717 113795.4462 116741.5159 106363.6002 101003.5277 219095.1406 209869.2561 222029.4595 117501.5225 121538.4227 73503.5749 302657.2825 130466.2200 252695.9208 289584.1856 140032.7845 363943.0931 380619.4435 44991.5714 254437.2060 733916.0784 227765.2499 315901.8052 521979.9740 20599.1171 1320590.2050 46984.1963 84507.9598 162581.0409 66262.4445 122039.2317 150960.1777 165938.2705 178546.4957 39742.4675 111344.2213 340364.9613 81947.5090 107026.4057 101320.7146 155522.7954 236458.5483 179253.9820 362738.4216 85965.7359 285237.0980 746687.7502 71920.2170 167206.4537 66346.7356 42994.3817 125371.2278 867076.1070 198796.2507 276139.9802 106803.1366 358546.3111 72080.0896 138798.8112 337596.3297 70496.2701 125243.1762 110599.5911 69989.1666 56080.6043 198840.9646 475509.9157 133342.9879 155311.2627 604187.6444 623067.8920 129642.5057 170768.8932 251451.7790 283824.5345 70082.8537 706074.3769 163580.8606 123241.2899 330926.4648 118578.9342 62596.9492 295743.0437 79211.1626 80761.1640 205139.8716 80938.9274 390247.8719 246767.9515 131269.3499 95463.9338 505139.2839 54246.4747 561451.3382 50380.9794 113250.0579 90093.7309 179616.0837 231451.0679 295094.8823 392133.0865 377963.8646 66892.4412 81359.1665 172234.2932 173285.4941 269253.8076 106332.0422 42242.7195 544733.8322 150336.7015 182898.9135 99291.4792 232506.6675 65946.7558 172341.5732 76421.4752 151334.7137 391203.9106 56310.6250 115484.0564 68835.8853 102532.3864 255521.2397 92943.0165 111516.3006 88121.5586 58304.6222 226184.7547 183615.1099 25281.5476 101502.3076 87714.3293 83527.3980 163745.1261 162925.0780 162172.6930 84652.0229 203793.1305 172704.3324 167287.3580 123683.3473 84943.3000 78320.0608 203843.8645 102386.1539 655838.7093 173562.1082 54626.7824 51598.7659 155743.6313 429566.2471 74553.9475 256841.2005 595148.3772 86676.9451 285379.4274 88600.6722 313360.6008 345707.8594 123072.0786 188212.6608 221892.1517 175410.8258 416887.3664 69180.1426 259836.9804 180955.7464 94776.6451 1778025.1310 79185.3108 153541.6658 120214.0104 459547.8216 120966.3418 113206.0256 103880.4045 73806.6830 3958275.6830 133792.7157 136979.6938 88107.8212 623204.4540 139947.3058 252801.4186 72946.4478 346576.4255 719886.0054 168272.6773 372454.7212 88831.0243 144812.8894 261897.1398 98148.7649 104668.0485 78506.9923 109983.4930 160836.6753 408443.3262 239775.8385 128976.1030 248734.7006 506701.7036 78614.8281 91262.8531 42125.4924 132158.4033 244118.4168 76661.4542 91612.2731 165937.9039 94873.0635 57969.3851 98829.2202 55626.7482 50961.2216 125052.8654 75881.4419 86308.1037 158514.6975 239847.7122 325285.8892 135590.6777 238802.6518 86650.8558 375116.3748 270993.7049 178202.9124 462910.5275 81135.2137 449409.6433 165200.3496 127194.5282 287883.0115 241169.4719 120479.3269 142109.2189 181814.7487 124760.1844 261095.5295 349040.3591 478154.3551 141134.8002 207022.2472 62991.6799 385059.6137 148048.6976 277475.1153 946231.9033 207982.3299 99588.2968 391781.6590 79069.3317 36201.6151 547937.5189 138334.5634 2398714.7450 107229.0645 96617.2366 179149.9359 165482.9924 88693.3494 112473.9350 76964.4432 90190.8925 167352.9332 319518.0016 109189.1421 236545.9294 281434.2020 55686.5311 237437.5442 351891.9949 215938.6350 195462.9700 121454.7098 202163.2380 57416.1867 146113.5624 829394.7683 51738.3584 241130.8111 136667.2730 258576.9709 316531.6582 140510.9816 85026.5077 200364.9916 8087.4043 51222.9115 120308.9392 105917.9725 172753.6048 162442.6009 126331.0722 65445.0985 304531.1570 161869.4659 94237.2327 98563.3763 123213.8195 54860.4676 362500.8675 200886.0883 165270.0933 467136.0476 330704.4041 336498.1628 491495.1784 146693.0882 186282.0934 195308.8671 118678.6133 52740.6463 316880.2682 135734.1534 227411.8069 101248.0250 250808.8111 38295.4022 207179.4528 188240.9617 405520.6293 80031.9374 258197.1871 155158.6917 157542.6282 180647.1935 65626.8810 122483.0165 132969.5447 181762.7228 107558.6602 119627.7448 119110.5476 138259.5609 30228.7343 97277.9186 196896.3082 127155.9385 53977.4170 344840.9407 84874.3788 75359.1326 33869.7218 81912.8797 20122.9604 73834.6516 219132.9454 137556.5967 132459.4545 88554.9417 464668.3966 142611.9986 256956.9466 190651.0187 147508.2921 57851.2435 389702.4615 244552.1778 65438.9520 204142.6442 160190.6043 454592.6771 187231.7801 271656.5939 146439.1905 148340.8748 2071614.7380 157047.3006 593058.3783 114834.8585 186806.1697 182505.0080 137872.1122 217788.6912 86562.1011 233783.0963 62334.8534 143788.5072 75753.1455 122518.8433 115136.9290 357120.9544 84758.5828 139848.8514 66291.7290 146437.0813 55723.4587 53203.2361 58424.3581 2353075.8810 96909.7236 267505.8175 194041.4501 379647.0657 72491.3391 278210.0358 359573.6603 435081.7952 217303.4773 138932.6659 192243.0952 534831.7405 236062.1418 196296.1622 277370.1529 88358.8396 161762.8557 160245.1257 195045.8224 83912.7435 245292.8161 82083.6683 222799.1998 305097.3561 135221.5938 135179.1923 192714.4922 149700.2015 60633.2993 186851.0154 247397.7750 74982.6496 200109.1830 600131.4867 121998.4326 82151.3099 60636.3835 78075.4068 322958.7914 111448.5001 430901.6330 154259.3905 224053.6417 218449.5470 137953.3131 129477.4661 69728.5899 96691.5212 197282.7794 433036.1319 191045.1290 241755.4361 460072.0865 183056.1245 208021.4902 99094.7164 139646.8400 175117.3108 51380.6600 87574.6204 1192458.7750 209673.3210 250659.1301 87360.6564 183650.9751 186242.7357 93808.8820 60854.7630 286062.5626 88499.3064 186265.5303 141549.0887 312775.4738 66562.3965 87691.6732 118491.9703 111374.8435 238123.7510 245226.8850 82334.8226 299313.7952 157795.7803 94441.0275 100461.2183 148542.0740 160541.2633 240166.0633 113661.0766 559258.3806 225777.0187 1168958.2440 236511.2188 121920.7203 249663.6047 274639.0761 78650.5777 71786.5299 61909.8362 166965.1097 138234.0081 177489.1801 188770.2778 174613.6145 67136.3797 139887.7645 139830.8630 85836.1224 72700.4655 177233.8898 132391.3842 101447.4936 1624250.9970 80557.3896 90980.0827 261781.8938 212074.5102 115192.7448 53801.5009 1058567.4750 786286.8827 161944.5237 147482.2374 279048.8893 50181.9790 126768.4741 217596.2965 194924.8170 225462.0692 397456.3591 180776.5302 143710.1072 146105.9147 177222.2326 219489.8211 150363.4187 177045.7190 201408.8814 274557.4371 209696.3773 152446.2014 214155.4206 88477.0021 112480.1346 128870.8029 26236.8779 232700.0996 72892.3630 120326.7361 160825.5918 210876.3454 169700.4056 293090.8200 102033.5262 348441.8440 93468.1676 132777.6939 112586.8252 167476.6420 59619.6392 1485289.1980 60361.7869 63273.2843 72182.8988 66839.5626 201140.9589 156934.0812 301470.0651 200205.3548 99481.4803 64352.6200 124982.2050 165192.4275 297471.2662 120986.9523 166012.4423 71037.6754 280596.0371 62849.6486 121635.5669 209021.4251 126517.6746 203966.1527 46234.0414 125012.9408 332907.4950 77127.4390 167785.3795 118437.0698 726693.9701 264976.1534 125940.0258 181439.2776 133641.2387 103944.3962 244089.3185 64043.2495 169068.1159 122515.5946 164254.5754 230258.8322 176230.1261 142653.8215 113165.4959 286434.9625 337292.3772 46654.4283 453957.6060 219106.2207 82615.7471 182244.9465 78244.3797 275106.4542 110197.1266 87054.4301 148866.9158 68222.4389 93991.9564 104331.9676 45907.8259 73137.9771 136905.2580 243029.5163 129934.3319 76779.0094 408477.5656 175072.7378 165630.7795 521608.1941 167401.4296 83157.3316 203194.2134 835268.3067 32677.1086 217659.6441 335890.1108 728715.2076 143415.1409 453270.3172 246532.7077 73936.9933 164366.0425 139870.0344 1054676.1590 286082.4606 995162.3026 61973.3918 56918.6868 195429.4883 435282.1393 85647.4061 143231.2595 87566.3123 88941.1489 63502.3408 232455.4191 245168.8437 81033.3340 57189.6268 38317.6484 110471.7739 85618.1007 508981.8615 180991.5557 55909.7348 263748.3669 183862.6200 239838.6985 428421.9812 47464.7078 324852.5613 224652.2799 126880.4840 117629.6014 32477.7434 221038.7889 127545.9608 515697.1863 93372.2133 150448.6467 408526.0116 832643.2724 67673.2562 111161.8119 181214.2285 59520.9577 108425.2022 90742.8299 159619.4010 174568.9865 2 4 Xylidine 4998141.7190 3487996.9270 5518286.3970 4265774.4180 2904441.5560 5488973.3130 3761949.6990 4920822.5270 2804254.9150 3529916.8060 4963061.8790 3579693.1430 3613771.0780 4325444.1180 5368219.9600 3894190.6200 2848706.1410 4184982.3900 5179628.2450 5983909.2240 3726651.3330 3817060.9540 2722661.1300 2916396.1330 4191993.9560 3150092.0280 3934952.7600 8389545.7030 5091505.9470 4250578.7970 3341382.0850 3583818.7750 6724737.9980 4582193.0190 4538112.4650 3572231.8440 3197479.5930 5838948.9420 5321940.7110 3569898.6430 4242367.3940 3931083.3160 4812845.0570 4411186.1770 3786032.6210 5111919.5370 3046537.6720 2367865.0800 5207992.5830 4304751.5800 4359561.1550 3266606.2740 2641682.9980 2771439.5770 4751413.1750 5065466.7260 4382479.5720 3468581.5860 5055609.6140 3806374.0440 4046490.5320 5363204.9980 1358101.7520 4173417.7610 5928925.7340 4112395.1780 5646804.9570 3981619.7880 5037314.5410 4526919.0480 4207774.5730 5069221.2600 4624093.1540 5938757.2460 5251364.5330 5799783.9660 4501551.1240 4644962.9080 5103697.1060 4165490.1900 3941327.2800 4047431.1980 4360309.3630 3976364.9450 4428509.3270 2318208.8390 4321500.6810 4814772.7170 647792.5252 5970747.3280 5084202.2800 4538689.4210 5351210.5780 4701688.5720 4493516.5500 4802415.1740 4626333.6960 3391281.4430 4509988.2810 4864750.1160 5056569.3760 5011228.1110 5198705.9750 4311368.4030 4339586.6260 3549298.1080 4061471.4310 3876349.2290 2259575.2270 4988530.7340 5044458.3910 4069724.0440 4769474.7040 4527343.4830 4327013.7480 3728032.4490 3102954.2430 729071.2406 5116611.5480 5967477.2330 3974348.8560 4507616.7880 4647926.4460 4715416.0280 4048370.5810 3864513.4640 4559471.1180 4200240.4760 4044954.4940 5674589.5830 3208713.2270 5829349.5770 4709125.6090 4220921.9660 4793641.0770 550953.5491 4314820.8400 4935349.5780 2914187.2150 3592593.6750 8793677.6190 3039323.3780 5390542.0570 9144806.3990 9453649.1900 6381065.8180 3497009.7760 3102310.6830 4101839.0680 5526497.3030 2005278.8200 4447853.5480 7607013.8570 1972267.4820 4458747.4910 2926453.7710 1867501.9280 3849027.4220 5118734.9470 2090124.4360 8810585.8990 3910553.1410 2909752.0350 4663866.8900 4497122.9900 10295962.6100 3803322.0290 2817717.2200 8906336.4310 7010053.8630 2336092.5350 4708408.6950 2103813.0100 2049405.1850 3302426.1250 4399168.7310 9666514.2470 4421348.1540 3294693.9240 5242222.8080 2712233.4710 5523103.3300 3106983.1910 4866285.2710 2332438.7720 4903710.5420 7350127.6820 1783509.3310 2187913.4480 5282666.6250 4971970.5280 2564683.3810 4707676.4050 2908085.8910 2617755.3820 2007847.8620 3836739.3480 11086021.1700 2972022.8000 2340441.4760 4577450.7820 4787377.9310 2317535.4650 4416943.5680 2713312.9820 5172814.9400 5496506.5360 3087961.0290 2306285.2930 3306606.3540 5137456.2680 5680412.7760 5556104.3030 3285329.1360 2488653.8320 4812233.1060 4464748.6070 2767671.9770 4822963.7050 4947440.9230 1936861.3100 9852442.2230 2006996.7570 6453405.8830 9331525.6630 10523765.3900 3563101.9630 12967461.4100 4091305.4270 5698788.3880 12197507.8200 5672223.4220 2745398.0990 4704157.6150 4846399.2590 2922608.2670 1596622.7210 2632454.2560 6455518.8310 5142178.3900 2352937.2510 4892399.8190 5678651.0970 6338842.2110 2180075.6750 3515313.2160 5559482.4360 1839440.3700 4710088.6180 6114580.9160 6130901.0850 5350993.7410 5704803.2660 4020321.5790 4360375.5830 4926303.3090 4054206.0710 5665834.4890 2606742.4500 3276769.0440 11009289.2100 6027532.5140 6246564.6690 2003179.9660 5735314.9360 5157978.7910 5093773.0290 6097223.9830 1847794.3300 5264400.7410 4820557.3080 4889777.4360 2503818.5920 2835406.3000 1785850.6820 2268319.7830 3473930.0490 5904018.1830 2206915.9480 9549687.7280 4859909.1220 2243167.7640 1774623.5320 2273457.0280 5934561.0880 5353795.5020 2679126.6970 5451374.0000 3701999.9430 5310229.7190 6121001.2410 2147092.4350 3411535.8620 3406784.5190 5053475.1330 5284554.5920 5045439.4670 1912453.2090 2706185.8440 5824195.9950 6036831.1560 6085690.4290 4209202.8890 2267911.7240 2925609.9490 5286851.7800 2703024.1420 1648718.8660 5275867.0070 1684507.9320 5980984.7470 6042566.6470 5696758.0110 2795101.3800 4920603.9170 2391916.7730 4808612.3220 3666074.2110 4843920.0750 3272196.4060 3157843.5780 6745590.0370 4397528.9890 3126578.8010 2898351.9540 4909657.5220 3405831.3380 4706054.3390 3257079.4660 4649719.5100 3469279.4250 2424870.5780 5403345.4250 5572898.4890 5056635.4570 4979265.0070 3688312.8460 4715567.5820 3754355.2870 6373283.3880 2843412.7560 5039503.5490 3019237.3310 4362673.2200 3794603.0730 3233051.9420 2895410.5590 4972911.1750 5952061.0380 2611601.6780 5169721.3080 7021313.9260 3160658.9050 3441202.0630 3694695.6460 4096535.5400 3320728.2140 4463564.6040 4207408.5740 4520568.8020 3265802.7620 4122313.6520 3686018.3900 4586275.9340 3276975.1460 3327404.8320 3679085.6460 3502057.2580 5635822.6730 3636910.9500 4201355.7810 5416496.7950 4293848.8690 5747284.1570 5098034.2900 5564063.4790 2895101.5080 3293835.6360 3944914.0740 3430087.5430 4994550.4760 4085507.1110 4451461.3480 4234852.0490 4646580.7960 4983051.1510 3256480.7000 3355759.0540 5079776.3840 1736509.3680 1028636.2980 8296194.3720 3088053.1860 3524539.7810 3600024.0820 4073880.6840 4669447.6630 2863963.3100 2451934.8150 4456856.3460 3016208.9790 4079557.0040 11068370.4400 6325117.6190 5190569.2780 2449779.8120 5991589.9740 4339803.5010 2904017.6410 2447667.6150 3844358.7900 6127400.1900 4310447.6500 1077547.6810 2892429.7070 4198772.8590 4864243.0110 3623351.4500 4479928.4950 5046221.4590 6649258.1550 3627311.5080 3881883.9830 4804994.6010 4615372.2050 3609371.6870 5207011.9450 4971754.2750 3426041.6040 3670262.2020 4158647.4130 4080068.1300 5879822.3370 3723769.2410 4172206.2010 4494528.6820 4695475.9740 5181364.3940 5656885.1240 2711427.9210 3682046.8800 2984159.7430 3895571.1780 3916536.2920 9373168.5670 4250255.5650 2268684.1250 3593500.7200 4150247.6290 4176230.6590 6928108.6850 4666039.2450 4815471.0070 2252559.0880 3230346.3240 4525135.0360 5379719.5070 1734908.3600 4678419.7130 5508448.3120 2903603.6410 3116802.3020 6427090.7550 4637608.7810 5038057.3910 4136139.2950 4915483.5680 3574613.8170 2712294.1280 3897222.3760 6349655.0210 5314955.1180 3054444.0710 3033320.3020 4432072.0180 4814116.8850 2238078.4040 3455243.7500 1328236.2360 6873178.7920 4420808.6410 5284193.9170 5916393.4190 3710440.8860 4306826.3140 5778789.0660 5510239.5380 5752210.4360 6357201.1970 9076154.2580 4447215.8810 5007183.6600 3595392.1650 7865659.0980 2162112.5670 2149439.8460 4868719.8970 4423161.0980 3810715.7080 3965623.4320 4651326.6650 6453265.4780 4625721.5380 3844083.8000 5950390.9810 7095522.8410 2527279.6710 2756202.9080 2862753.0660 4101026.7420 4366266.8950 4192585.1960 3260209.5250 4008600.1420 3955182.8420 2907823.8330 3834820.4220 2214938.8770 2940114.2240 3130806.2400 1825446.4760 6753634.0590 6846195.2920 4042668.0230 3238081.7590 5477971.7620 6221135.1450 3108164.8560 2529696.4860 6372851.8150 7155805.9680 1985878.9960 4619310.2600 6406341.4350 4219241.7380 4212266.4270 3845399.8960 4372870.4050 6197373.4980 2231823.3970 4665725.7700 4749761.6570 4745238.1160 3362844.3100 3694360.5090 5286746.6460 4508711.5350 4471108.6830 3777301.5370 2579155.4450 6884648.8600 2681122.8340 5565581.1470 2651804.0770 3707575.0010 5924519.7390 2904281.8970 3838429.0990 2593332.0620 4332074.3730 3891818.2680 4895612.2380 2965396.1000 2675341.3950 3782495.7180 1917327.2180 2161304.5620 4202670.4990 8742513.3430 5727934.8310 2650050.0120 4909539.2640 7600290.4810 1966017.2440 1560774.7770 4716852.6880 2448625.2250 6054012.7530 3816728.2320 5680277.6650 3558072.8350 2428489.8620 3127653.7110 3925542.2960 4148092.6340 10656744.4700 3443960.2910 5941572.5380 5888639.4510 4770685.1170 6712951.1790 6290161.2520 6681878.9980 2818695.9570 3458572.6590 10059659.6100 3732767.1950 2289853.8830 3183702.3290 4922976.1280 4417697.6590 3589593.5440 4806750.2640 4198977.2590 1912031.0910 5797863.3090 2110655.7770 2533410.6340 3122249.4240 3864212.1710 5008623.7190 4995878.4330 2886561.8620 2277327.6470 3069449.7630 6074620.4660 3563775.8450 7918663.7350 4182300.6820 2947053.6930 2769635.2490 5784244.4940 3448293.9170 7707356.5010 3293863.5640 3590686.1370 3762668.7960 9072844.3340 2713370.4130 2372004.3280 4878114.8270 3255881.9160 6004788.6430 7931611.9670 3534337.8910 6858499.2080 2807146.7630 3265531.2560 2971547.6660 2496050.2060 2178790.2770 3006563.0650 7500280.3760 2900192.0160 3040332.2330 4760561.3570 4232455.0890 9926057.3870 3823774.6610 5188401.7260 3458099.8740 2508602.3220 3636556.9100 3135462.8750 9040509.5450 1360826.9460 3221340.2960 3419119.7770 6849461.8760 9573417.7450 3182581.6240 2678393.1190 5507135.7250 5012758.9500 5119088.5320 2779749.6570 2918973.3580 3854922.5740 9562815.1250 2859784.4090 3048636.1520 2930220.1990 7104254.4620 2828799.5260 2651116.2930 4644553.8920 3237808.1330 7643441.0930 7054326.6040 2487782.7420 2938281.4090 3125918.0030 9691731.5110 4585436.8830 3033920.1010 6336421.4250 2813922.0450 5530564.4550 3791470.6820 6170411.4660 3167317.6040 4577071.7650 4751658.9580 2817184.3610 3688360.9360 2584052.5730 5018019.6940 3567773.1730 8778291.2060 2872804.3040 2 Acetamidophenol 8300183.5970 36964387.9200 7205335.8510 54604412.8800 1290634.5280 7501629.5320 26315970.7400 1965825.0500 51840988.5800 2697245.4590 1023239.1780 4005221.1040 2204258.7740 663408.1217 3403534.8620 709868.5208 928728.6654 876569.6592 1010975.5170 4691017.3090 4124546.0830 23827725.6700 565555.9565 6712041.7250 576496.6224 382486.1983 2990858.2610 2631785.1570 42081591.0500 2460388.8140 3352314.3930 42285747.4200 1923332.7270 10282946.9800 2623909.4820 2236572.8270 6455920.7740 5274602.2310 20397080.9500 807466.6079 2962991.1230 2452540.3570 1000967.4100 3182292.9140 2216372.3240 1816377.4530 5889556.7870 8620407.7390 1822566.9940 12955254.0000 8410127.3360 40596172.9400 11057233.6500 6011739.7490 2726532.7320 2199442.9750 2042202.5430 2189228.7340 12511630.8900 3265415.2300 2892706.4710 38093712.5900 13998792.4800 5668678.6110 2978637.6220 2191328.1240 12872077.2500 27437377.8100 42688672.5100 393287.4917 29340254.0800 1659320.9030 26867252.3300 25353404.7900 1833567.7100 19415483.3500 17507723.1300 11781826.1900 4942291.9920 14628009.9000 5134544.5190 6915382.3620 34403408.9300 28520944.6600 1572698.6770 2493206.0130 11887371.7200 19000455.3700 1663837.2890 1945329.7030 2747703.1960 32177055.2800 1489385.5150 24562779.7000 1016972.4730 3666368.1130 2114794.9410 22583107.5200 2653423.5980 1533398.9920 1579453.5760 1581939.2620 1887924.8920 1932109.5650 2477265.1230 1639749.5850 1432405.6730 1425546.4600 4132788.3770 3928748.9300 21939638.5400 1759475.2920 30143845.4400 20335531.4000 5039391.8420 373028.4710 1591743.4250 3432833.4450 770244.7519 2715661.3400 8709782.3100 1046280.7850 5707775.8770 616420.8536 517182.4253 8224669.8430 2083953.9280 637320.8975 389748.5459 1006928.7010 5197251.4870 9400434.2720 6944043.5250 2160486.8990 3707638.0410 1538434.9300 2622126.2160 6815861.0080 12018515.6500 35362431.1400 1407754.1160 1394661.9230 1284637.6430 12675168.0800 34601514.9800 980633.5061 1428041.6770 1128197.1110 6493428.8780 7412025.9070 1238285.6490 31842966.9700 34306737.1700 1042549.5030 26602011.7000 49727103.0600 33196539.0200 1456075.0450 7142027.1090 4958167.4380 996386.8943 5900280.8860 3404707.2310 2046372.2980 11151977.5800 1098538.9700 1404552.7060 2500988.2550 2466821.4950 2765082.1310 5457246.1540 4502720.3750 3073333.4960 5775998.6860 3989664.2360 21514763.0000 3780850.3830 3239808.6750 1399748.1680 6522637.7010 2406122.8920 3383616.1350 48207670.8100 3315859.0200 3745407.2990 3334838.0880 11267158.0100 1968458.4080 1284743.3440 1415673.8370 33878295.5600 3928303.7410 6155021.5200 31729714.6300 1357832.6680 1164004.1760 73525618.6700 1116563.1720 1718251.2060 1533631.0690 5612758.4590 15546259.4600 1183080.6440 4052640.3480 1697963.0550 1322295.6390 1402538.6080 2808627.5040 7368759.8700 6949801.6730 1709062.8850 3144156.8300 1666596.8670 1677582.4720 6470206.3820 1079791.9440 1555878.2880 3081589.3930 13041547.5800 1544005.7000 14200873.1800 7373896.8270 3426995.3900 62392730.0400 880881.6253 1016991.5330 1551016.5190 2638836.5420 2140533.6370 15250941.6900 6590209.9490 3066475.5560 1904839.2000 3175578.0760 21895825.3100 2861534.9030 21534575.3600 7338209.9650 15666782.0200 39850490.2500 41515986.6000 3932911.3920 40970311.5400 24224033.1900 928718.5642 22804200.6700 44452324.9800 2554408.6790 2667372.5080 1393404.9940 1165192.3390 3684624.5020 3954633.3700 25178156.3100 1974993.9380 2316497.4990 1909479.2260 11806600.0900 2022926.8100 3414889.6030 6524678.4470 37258543.0500 19315799.0100 18032429.6200 4257268.5590 24588238.9400 409164.4189 1078802.8700 2394456.1830 2425164.0550 2129110.1060 1863171.1050 1933600.3620 1294688.2540 23012250.7500 2080703.8200 57730600.3200 2347761.0440 1743838.2110 2197917.5000 2262970.6140 2975376.2410 2189545.5530 16260081.0900 1361475.6590 1533373.5790 74379062.2100 538665.3097 3724024.3270 472190.9901 1025799.0320 1250301.6580 5786633.7430 1559186.6610 2122099.9000 2519561.6290 2375851.9000 3081418.7380 1513414.1890 6527718.8800 1966347.9560 1219156.5340 3682015.5730 43749130.8100 987864.6572 1992767.9760 870196.5823 1529838.1720 2538817.6460 22038649.6400 790507.9147 5694453.8100 1440259.9380 3147161.1200 2019397.8460 28977692.8800 1869615.1860 15851491.5800 41375188.0300 5368542.9380 13779097.6600 55820592.8400 2863885.0410 4649776.8200 4166612.1770 5698442.9830 10184883.2400 2999917.0820 677358.5582 3489504.4150 5474766.2820 159572422.7000 3749035.9720 7019084.7180 5534220.1420 662201.9898 1016120.8030 673052.1323 4666840.3290 4938114.5550 5227139.1520 5544543.1080 6194710.0140 4955934.4410 6008972.1570 2888149.3030 2348221.5790 1940430.9100 1279673.2870 934233.5433 846946.7980 6940745.7180 4046936.2610 3587512.7150 4365647.1810 5269603.7330 708308.2753 4793889.9820 4364621.0360 55576019.3400 19936478.0300 41089736.3400 4291045.6790 13568605.2800 8167163.4110 701736.2445 525102.9019 14619747.6800 32648127.6800 973758.4546 560908.6960 689882.6490 2115277.7740 5138054.3750 4880523.4360 29446443.6000 5363064.5170 4565846.3030 3627125.8910 10772527.2800 3691424.7170 3449827.7300 2901573.3300 11190430.0700 5309706.7570 61145613.0200 5246444.2120 4691956.3660 4114457.6990 2376307.1520 5131902.3630 1483853.4010 21179140.7600 1731684.9100 983622.0863 671350.1639 702019.6369 3173146.4770 1140848.5590 69495903.8700 4541026.3230 1012007.0590 3899401.8860 2981148.4610 4407801.9330 2730450.6660 58996646.7300 20781774.7200 13966264.0500 593580.9902 754433.9385 555883.5137 682952.4009 4105148.9890 7041597.0240 2488613.9700 4089659.6320 673193.1872 1366560.8300 3306929.9160 1428766.0800 1656924.3410 1851681.7880 506942.1292 10421116.9300 4190615.3150 26194978.4000 854266.5348 5180266.6790 3649664.1550 2868117.3400 12219964.5900 11900701.9400 1754264.7170 1384798.4540 47894755.1500 1518834.1190 1293095.4000 4636887.3570 1883416.8120 39949763.6200 2195418.2220 3070134.1010 4633771.0520 2613868.1280 71001124.5700 1600176.0860 776535.0955 2737947.6960 89480158.5800 872419.1575 1787497.9080 122526206.7000 50069214.0400 13299580.0100 6008890.3840 24553730.8200 4708695.2920 6609867.6310 49172797.7100 3253380.5060 11411206.5500 14821059.1900 2463713.0940 1198352.6230 8184186.8910 38259511.1600 3969258.8150 8321928.4570 10126316.4300 2132602.9720 2847827.9980 1927703.5420 2374832.6720 772424.6214 4408172.4890 708156.3779 2162233.8790 2151001.9730 2379852.3160 17029225.8900 13279959.9200 529184.8279 2388020.8690 22623053.9300 846551.3241 3384435.5520 3723773.3330 1938726.8820 1356712.6330 3412839.9900 2981378.3410 2354211.9900 19641023.8300 8064641.5050 1855963.5030 1171855.9310 2012707.2710 4015342.1650 1571788.3740 2128742.1390 2006474.9260 5386098.2100 3493770.4450 2720798.6250 3478651.0020 1902335.3510 3325287.1100 1125736.6070 5619309.4960 3231679.9140 22559595.3900 1624294.0680 3146369.8090 1450981.3230 3640283.0920 14519545.6100 1273612.8690 1047699.9590 1168332.3570 11768081.0900 13236151.7600 6047807.7370 2984159.3590 5226961.8750 12262964.6900 3553437.8370 36219878.9000 5200750.3480 2612265.5840 5619844.8770 2509433.0820 3511528.9280 5868840.1570 14063370.2500 3087202.4530 16075740.9800 25414222.1800 3457418.8430 3044114.5780 14555436.5700 2860944.2230 2812265.5280 9491811.5510 30115769.8400 2098317.5600 11586795.0500 714503.7806 411160.1109 3334623.6720 28703311.8600 337915.9846 291961.3821 584866.3279 4037123.7970 18868896.0200 4072923.7540 7488427.9320 1828233.9220 35126118.7100 1358930.9590 4014112.3810 43115793.8700 4790353.6580 2980824.2510 3114746.4710 2573790.5360 39804796.8500 9117219.9490 7778939.9250 1332307.0520 14995122.2000 2169484.7520 566789.3598 2131515.6860 2054038.3980 690330.3947 474500.8409 605892.2053 1479414.9180 13429465.8700 590448.9866 3330791.0830 2789867.4220 9975426.7240 4097109.9500 17865707.0600 1382358.8370 39844037.9300 712630.8271 11185312.3800 18450800.2100 13418715.3900 1327667.7500 5744415.8010 6482792.2900 438756.3598 3739478.6570 14365156.1700 4554766.6480 4585489.3610 1650818.4350 3488784.3910 2931086.3570 973225.1767 14108972.5100 429732.4894 8089053.2960 2248205.5890 9947162.2290 4353210.4720 2362086.6700 17727717.8200 2308468.9180 3738275.2180 4728006.4670 41730333.5000 6492909.6790 5530645.8920 1713334.1680 8356534.8210 50412211.5700 3135965.8470 2726215.2070 22824887.9200 1880393.6780 35588645.7900 9680143.3490 1155775.5980 2265780.9700 8892049.9850 2311928.4680 42632742.3400 3241966.7780 1608245.5580 9569453.3390 1348173.1880 15362227.2100 2154670.4000 1638247.2570 1228062.5010 1455097.6610 2674163.1040 28397642.2700 16191427.7600 2452540.0240 38896773.5800 25657251.1200 3637577.9960 3470071.5310 63986448.6700 1325798.6000 1365220.0830 4828711.3140 3665298.8400 1263237.9320 4238866.8080 29535738.7400 4675805.5990 4410654.9060 2133727.7210 1370014.8890 2500638.5140 1724860.4220 49309363.1800 1953134.2380 2128636.7450 1904113.8470 2403250.7760 22747841.3900 1383759.8140 2069423.3190 2186303.2530 1350431.0620 1121243.0530 2514194.4540 1749382.1470 9646049.7070 2399452.8300 14835727.9100 1675210.8990 2122661.1010 4310862.4010 2389591.9070 2413486.3520 3358201.8480 1494105.9660 13812206.0900 5995912.4080 2360743.4590 1329193.3030 1777990.9290 1948601.0600 1520854.4360 1957525.8280 2939863.2730 2883331.5310 7316423.3520 5610619.1390 1807049.6470 (2-oxo-2_3-dihydro-1H-indol-3-yl)acetic acid 351970.2310 116152.2879 292869.8528 191585.0290 284870.2856 204667.6680 426092.7380 171076.6371 334511.2956 378275.3932 50974.0532 159699.0519 264472.3718 115128.5844 210411.5711 122546.6673 543592.2035 96321.4974 222827.3286 148082.0418 157877.2641 158012.0449 249654.5877 90964.9359 140716.2418 198387.5143 197676.7826 63681.3924 299506.2774 181429.6576 594636.4827 124322.5120 270348.7118 216467.2808 384070.0663 194418.7822 447649.1660 205905.7784 358432.7155 180967.1930 145797.9119 168026.4187 206907.8092 215429.9424 361911.6732 174027.0167 911540.9750 229341.8434 204655.5209 265990.2580 241917.7816 178503.8431 360538.9598 115482.3036 200123.4953 216356.3192 322150.1743 110986.7349 76986.5124 153862.6387 114670.7244 117927.7628 314858.4467 311595.3058 494725.9718 281508.6215 143623.9132 179623.4275 245466.4936 145690.5498 262015.4687 593653.9145 151419.4732 221251.1982 196126.9392 192744.1376 81260.5739 189436.8387 182562.9025 168022.3342 46921.7623 207321.0174 161252.6896 119349.5928 498464.4322 372501.4184 184845.2803 329860.3970 347476.2612 267458.7540 122516.2097 262076.0720 233361.7258 458663.8435 129312.2498 248865.9183 244785.8695 452776.9429 258386.9206 169890.9840 82240.1720 320129.8455 103476.2646 207875.7109 146442.2074 167527.6330 305947.7870 252768.7763 211157.0572 126699.4547 209136.7351 257880.3328 194586.4704 94788.5021 197259.4716 162188.6003 469024.3945 310856.7078 311872.1023 523222.4065 271039.5805 117954.2264 237216.0295 150543.6012 407920.3729 390817.2313 247882.8451 176491.8672 165132.7688 355437.0669 345418.7162 242408.4910 281870.0591 124589.7564 475375.6307 114725.6923 373614.8769 306930.6749 102373.6854 163757.6077 132951.3130 157749.3100 294090.8318 117552.5002 155083.5688 102249.4719 183871.8293 115349.4602 496309.2258 134990.9302 230070.8515 194454.0545 202617.7407 138269.2290 185591.9713 164504.7784 157814.1995 114776.3491 203871.2230 527245.1330 259606.9386 104252.5898 125263.5800 132802.6641 90127.4082 482076.4510 298823.0551 191070.8663 213852.8999 171173.3462 322284.4407 456163.5466 369832.7998 318522.2054 261890.6997 261645.1493 165317.4117 282396.3965 382423.8902 135140.5560 159178.8585 193484.5694 302879.8619 133678.6522 219805.8937 170760.4391 138254.6831 124456.4277 267812.9857 131091.2842 318924.0284 228495.6539 201282.7179 509052.7335 236660.6288 188713.2948 92600.1931 559660.1264 247062.9623 227642.3760 363872.4314 364175.9886 203823.0644 366071.2867 211581.2863 541709.0418 113268.2335 181511.4728 108100.3482 348440.7484 120617.1687 112258.4804 181619.3938 333058.0585 193920.0025 140571.0689 372938.9403 1055118.1250 213592.0793 280795.6065 310110.0512 1040173.4740 169366.4663 182310.3008 200311.7522 227303.7277 48472.4673 116457.6011 166587.5929 494149.2060 291342.2900 90237.2330 89542.8706 113674.6612 151777.3021 128801.3452 310640.0754 148805.2334 227950.5711 117279.7997 214336.0894 177278.0917 197382.7742 363331.7760 117306.6441 221941.9829 666087.0083 393686.3050 198629.6273 255641.2465 291437.7817 148867.4806 180584.6608 89595.5939 171066.3604 70642.9809 393333.6615 254900.0919 106200.9769 529174.1762 380794.3563 479345.7748 130000.0410 224739.3026 226779.6018 140715.6640 155813.7206 228914.1489 159497.7716 199265.0928 311052.5866 82361.3817 288349.4936 147881.0732 247472.9679 146951.2172 156764.7605 110924.1250 161316.3440 374611.0949 117750.7114 222920.4029 181930.3749 172779.3369 304347.1109 233449.9850 328723.5420 112025.8778 221441.4835 209450.4997 194322.1035 334133.4578 289445.4234 193501.8474 188867.1025 99281.9461 148879.5060 296093.6959 361152.8649 587064.4336 533820.1019 124880.1296 127619.2158 238463.2540 304511.4145 218385.7810 668638.0750 108946.8616 365429.0793 244392.1109 99623.7149 194698.4604 139766.5177 315729.2506 638240.2413 311811.5860 384836.9750 108232.6423 85617.0621 205463.5316 249886.6782 355097.6653 123914.5830 177148.5557 564503.1743 226230.5516 520525.9783 270782.3414 196837.4463 120779.2686 179688.7216 275459.8666 120642.6050 316621.2472 340724.3547 119835.1503 138989.0393 537358.1714 129613.8053 364652.8823 158826.3937 234504.6279 149961.1385 323581.6744 216842.3776 285411.9337 138043.7029 82581.1407 633809.0444 184945.7578 153817.9838 263402.6400 127002.1980 153728.2142 172183.6642 129376.2684 151674.6020 177803.2493 268261.8430 129236.2329 336553.4152 172502.4178 204726.3731 232973.9334 253965.1938 95951.3481 199058.9650 126119.7475 204258.9603 352657.5593 124227.8251 162192.0818 303931.6909 218107.7513 379141.0997 63071.8561 183212.0843 633444.4667 87450.8228 96883.9528 246203.3794 200294.0941 515978.4506 157123.7627 208526.7337 73336.5986 266718.7724 236740.8508 166932.7602 516495.2155 182748.0255 831588.4093 211380.8738 342290.6310 159956.7673 199405.9097 863213.7020 132658.9109 237315.2209 151009.4547 121040.3925 155507.2929 227453.1147 213108.7292 129369.5200 221457.5690 330414.1626 63077.2640 267660.8058 200098.0117 194190.9544 215604.7480 125962.4697 243010.5453 673580.1480 145090.9230 463987.9046 143088.0928 160067.6085 243422.7916 134882.3881 203733.2052 382331.5084 660818.0264 129521.3508 219136.4941 253311.9523 210384.1866 362634.4189 92102.7996 230905.2555 622769.4295 74672.3623 204611.5507 96162.9040 157528.0541 195495.4851 124568.8755 112144.5525 138616.5685 89259.9686 121485.4299 118268.7763 212420.7571 162015.4460 94867.4834 143912.5699 139224.7691 128678.5539 609650.9324 455888.9798 458383.2450 242462.3418 178169.0763 441030.0875 289625.5372 175679.9711 146808.7625 109194.0593 508192.8971 140164.4945 68205.5593 170668.8354 559109.2651 202210.7537 265896.9763 193259.3474 160802.6763 109525.0448 116672.4754 197102.6677 945394.5792 81910.6052 192774.6669 273835.3180 162458.9469 158316.9131 193885.3170 166566.0325 736691.5710 174073.8289 222957.2797 450148.6073 415909.4804 146114.0621 124455.7224 318552.7734 253560.2936 176446.3195 321253.0403 229081.7685 168522.4999 215050.8899 247078.7212 102285.1928 248615.3679 318141.5205 200844.0298 128415.5713 243144.3350 313620.2039 472808.0410 317751.9959 244598.0505 424319.9191 569744.5284 78273.8343 173321.2413 120686.2433 171701.9982 290498.9285 225959.2173 295705.2208 277089.8532 111109.0539 207025.4577 252556.0637 198968.6787 105908.7739 201075.8764 246397.1920 94929.7001 76842.7863 152753.8180 192357.1227 160817.4754 193806.1490 97362.4558 219557.3990 210343.6043 96897.1156 198378.0247 141673.6868 206981.4241 135905.4214 167482.7046 249064.5040 273468.2140 51273.0233 333139.6913 198405.9086 167832.7654 109437.5272 281526.2682 208059.8153 102993.2888 104156.7443 261903.6801 193507.9635 426012.9455 167516.3455 862342.7647 140874.5200 139905.3157 417718.1429 322614.2965 252611.7866 228851.2826 622125.5203 208319.6494 231292.0022 284913.0681 551311.9745 144883.5385 280286.1956 543275.4786 413498.8637 104291.2675 203292.8440 220512.3733 538398.9665 134547.2589 104159.4350 413033.6946 405583.7090 144244.2819 186690.1049 99469.6956 255537.8574 208868.0162 132133.7228 264124.2304 247456.8514 350681.0974 190259.6061 285489.2844 165711.8984 356716.6902 203923.0384 121422.6278 682401.5742 127572.8333 125516.8867 297838.9786 156642.2633 159219.6165 192208.4675 340835.2396 95090.8295 774149.0577 207447.3135 130068.7537 171385.2848 138078.0524 440285.7238 335594.4486 372415.6732 125719.2012 153131.8727 175891.8095 237681.9199 81209.9789 180629.8114 133560.3740 407521.4511 225103.0790 160281.1104 374756.0286 207374.2864 215716.4337 178481.4448 156934.0562 141593.4466 252275.2475 65850.7217 99808.6547 88599.7225 83993.9725 227415.0756 155090.7382 225244.9256 206746.0586 288401.5008 434932.8348 211086.9388 316679.8477 196694.7227 365714.5734 237087.6907 160419.3541 121013.6123 256443.9851 240245.3119 207694.4387 1054888.2740 119446.8132 215619.2636 214879.9738 620717.5236 188986.3121 121664.5098 363620.5537 268620.8779 712858.0372 406153.4559 69154.1319 85153.5574 190098.3754 333067.3024 434117.5442 200686.4257 180058.6166 195590.6197 130091.4613 202860.5277 164279.6728 222669.9309 173102.3726 218590.2189 160513.2841 179302.6826 290708.7452 319440.8107 153791.6620 122723.4945 238555.7619 155453.1320 890938.9216 141228.6211 120742.3312 448171.9169 129413.0875 84660.1770 202785.5865 182730.6997 545325.3979 337547.8834 324148.7438 230190.0190 253753.9857 246288.7378 145571.7949 343701.1266 242706.6428 225428.2788 82757.0570 137943.9250 135452.0679 365473.9636 107036.2780 2 Pyridylacetic acid 731725.0672 821143.9847 438223.2151 885196.0373 1033004.6020 817599.4582 720999.4091 728314.9651 794484.0786 1511764.3750 635648.5565 1212527.3080 793444.6878 548682.7319 926972.4759 810608.9234 398357.2171 642679.2437 783931.3427 846432.2112 855112.3243 678729.8977 595179.5904 791086.8357 749157.7059 342434.2921 782163.9587 502274.1670 683317.0134 809298.2461 937145.5247 836797.9355 730654.3730 773723.6523 1343854.7410 1180210.3010 649477.5774 558222.0598 677763.2206 842451.8351 744088.4067 854264.3842 774028.9430 859563.2940 794634.5276 962559.8260 623980.2263 1005405.2640 785588.6947 674092.2447 965576.0815 638575.1227 826989.0951 1050325.9690 906652.3266 1210103.8030 747262.9611 939358.3323 799124.4910 1059108.1180 906054.7016 963529.3459 788025.5538 840012.0793 881796.9356 931410.4985 763586.1891 1060570.9160 847194.9285 626791.2875 863844.7558 748996.6620 509069.0190 760110.7930 789495.2770 1226118.3990 862117.2780 881414.7220 905446.3931 862772.5533 651018.4608 948163.4383 1033226.1500 770475.6799 834415.4566 784643.6689 884174.1446 1149996.0790 807023.1736 558094.6439 693184.7930 831142.3407 674280.4424 829543.6640 517003.2235 844996.8857 855560.3932 735239.5585 1055757.6410 1031358.1380 948881.0941 787650.2565 1004469.6600 858456.0707 919780.0227 1016496.3370 1079157.9820 884322.8119 1109673.9410 781798.3622 661609.6330 809268.6954 638997.2672 630753.6606 688207.6888 493513.1898 770807.1918 840009.2000 677314.4671 620466.8616 1133824.1150 714661.0616 332031.2756 629489.7137 598916.8441 626527.4282 739541.3826 591555.9177 584107.5799 596326.7979 806967.9898 724042.9314 790485.0987 808992.4614 473549.3776 872729.9237 979895.6401 692482.6688 835201.5163 660841.2872 899997.0375 802818.7331 897082.3642 902806.7344 892689.9214 730158.6370 740369.3631 818703.7357 822169.3880 456068.0958 848730.9177 911378.1606 808986.4139 852085.0982 751695.4668 758048.0956 914272.5731 934764.0970 775665.6350 573359.1003 968777.7380 860222.1881 841185.8906 817520.0697 816431.0555 2139720.8420 964638.5673 545926.7110 623273.9749 821165.3797 884421.4511 659902.2310 851589.3945 785543.6772 684681.1955 831111.1824 882651.3436 778719.1550 815788.3071 906191.1482 784952.4745 748642.5678 808328.0102 854492.7240 175051.1883 789549.2084 834918.2601 818281.7145 526923.3961 993738.3581 867537.2108 916453.8586 788831.7039 428448.3789 878593.7841 834999.9339 1162454.7850 1675441.8770 845058.2343 800967.5801 571233.7704 795288.0434 718550.2792 849123.6431 946849.9661 823210.8503 693034.5836 757460.5440 798979.6498 243872.8654 864567.7910 683915.3885 813995.5509 587862.5283 1242638.2340 800158.8513 748113.3611 783931.3672 792750.5747 780597.8435 824514.4425 788152.2242 939096.9580 832583.1867 715518.2069 949354.2800 834800.9645 994113.5645 874664.6890 717191.9535 880390.1649 733436.3286 880633.5953 815105.1025 1012720.9370 984823.2249 738792.0203 886757.7175 608642.3515 847695.8140 818344.1774 617956.1148 849509.4367 774188.9488 888027.6283 830456.0333 722947.8853 860132.3288 826047.4312 931236.0261 775874.0518 861394.9551 887666.2891 983566.8295 997468.3324 802178.9343 831999.2249 781401.1527 872908.2499 852063.7806 954637.6677 733274.1102 712581.3799 989060.2477 678514.4744 470877.2403 955598.4344 658223.6668 974573.6950 821289.0627 704083.6547 527396.4952 872780.1371 776640.0361 972386.4274 942909.9583 975161.2915 480847.6215 917839.0081 798256.3420 867497.2634 1264327.8950 1012523.9000 400832.9260 774257.9846 969369.2799 863948.2171 733005.6172 904983.7202 662497.9584 785612.5245 879746.7245 877888.0280 1122186.4740 876552.0144 739940.3209 911632.8518 844887.8476 737652.6637 217362.1414 731060.0884 435772.7151 296974.7525 853305.9883 1526006.4970 785843.1962 609171.8416 522689.0637 1084363.3460 877956.1716 790943.5304 852099.3858 865465.7310 826488.1223 259821.6063 922739.5030 1444949.5860 925150.9871 868541.8000 1145111.5810 926287.6810 909279.7553 873102.4031 983621.8378 573351.0698 785386.4041 542960.9547 939737.4931 738890.8875 851392.9668 967852.9712 1198916.4890 795548.2935 755327.4238 756018.2135 708773.9609 839017.2204 636175.5915 930410.0162 880293.3572 324307.0225 1443607.1790 999435.1217 783160.6204 820068.1284 720137.9014 734620.6627 697148.2959 347886.5885 428843.6394 986267.6437 943398.4195 1021748.0130 977337.4216 999643.8285 943820.7364 806216.3721 885438.6107 792901.4797 984443.4781 868305.6702 924787.2510 935636.8677 804646.7051 877465.1379 834648.5661 759093.9685 944117.4180 1010000.6400 735493.0776 846845.4427 803034.9702 685702.9981 985466.8359 964381.5304 874046.6904 547446.4945 1766691.7940 639714.3726 404530.1743 927675.6061 984448.9286 711954.8825 822938.9326 982150.8781 911530.0175 479933.9777 761467.0823 950162.9171 717323.9674 780265.7420 558000.4003 607999.6312 339173.3933 792379.2370 780878.8988 996055.6306 670946.9157 786167.6617 923833.6510 920240.7166 906197.2706 834334.7294 78795.3818 788400.7052 485642.4977 536583.3471 798966.7892 817157.0345 761367.8103 840931.6232 592727.8446 849032.1782 774056.3447 637079.3569 652157.3088 857146.4097 683433.5987 667296.6086 696877.8992 726953.9847 893947.9675 962143.2741 604600.2658 769864.2681 761134.9270 627233.7080 791029.5838 862093.3653 832418.8048 929730.9335 587070.3347 727808.6953 792351.5562 874785.3973 898632.0540 878786.9631 851070.8421 1054961.3620 721712.0322 944009.1849 918517.8381 840237.6399 1067640.3280 1010753.2570 913748.6070 702091.1593 632113.1769 693591.9124 1071341.2760 543465.1990 936870.5582 928529.6378 1182224.6400 974463.6649 1002196.4200 923574.1658 692940.7679 692898.3304 881686.1617 870077.1104 655093.6005 1053705.3320 845118.5570 637789.1251 932506.9606 643430.9410 856650.9530 628209.4167 376720.1061 786902.9671 856617.9604 524121.4283 653563.3959 161026.3052 893852.1856 734647.3359 713333.7953 551019.8574 1719328.8890 676912.4674 890177.6046 795343.5660 982587.3765 779222.1906 829271.6807 771423.8878 807492.0228 861958.0543 988578.3622 307927.3915 914941.6561 897534.7319 593355.0810 558621.9828 595964.0318 578030.3860 881704.3641 929555.6242 612958.9376 942049.1180 905353.4362 1052245.2070 799704.1157 995119.3291 1300404.9900 634569.2901 819192.7437 628581.4922 917703.7910 966069.3468 906146.2730 1002659.5150 1022121.0410 664136.8227 1266654.9460 648562.3015 666207.9966 585386.2084 971876.3675 600030.0809 674041.3374 817873.1141 995357.6586 993933.3183 849788.7624 1397512.6690 1094343.2860 732943.0422 936907.5838 803202.1198 863363.7755 1067118.8680 592902.5709 527150.9607 789224.6226 1115797.4060 711823.3653 393335.0086 1009178.7400 824601.5409 1187408.5450 937525.7987 659238.4929 690502.8626 1074610.7200 1100941.8730 697925.2972 690789.7914 440074.3787 1090596.7110 491119.9740 713739.2685 656724.6791 996352.0927 507248.4710 1109660.5790 547257.5530 722449.3434 1003431.0050 909120.5576 769165.9062 1014626.6830 589959.7603 1009001.1070 795498.1395 1069793.0350 640887.1664 744732.4479 849864.7751 793414.9544 514215.5507 671246.7567 823870.9805 894958.6172 793325.1624 796986.1226 460470.7621 607626.3637 620374.5437 818791.1926 534195.6546 845859.7498 708966.1195 1140511.7240 487759.5530 738642.4889 601721.7255 1001454.5340 572989.9803 968751.0193 679237.4163 1222976.6470 1043208.4500 722968.7896 939027.7369 576070.4663 527209.1445 449594.9504 1363564.5570 701852.9719 1125230.2230 611812.5352 581385.3016 755111.8334 708596.1788 801394.9851 1281329.7220 1147357.9000 730576.3351 1258259.8310 964601.0292 833221.1869 514958.1895 684491.2253 1009492.1920 654899.5489 1401187.2030 894167.3736 695589.2219 587299.7541 1000622.5720 623877.0305 1310478.5190 513818.6862 610240.8307 770747.7365 1357421.5870 507129.5186 639192.2907 1004677.2730 792016.6882 1029834.7070 1353505.3810 840336.7736 1350910.0840 637929.4422 732605.4892 635627.2988 668175.4825 628259.9102 565627.4318 1285084.6330 682387.2741 746395.7422 764294.2563 911982.0352 939851.7929 695894.3225 1021465.5700 831478.1617 637002.2846 577677.8523 543863.2869 1329413.4160 847544.0130 884867.0869 708540.1861 1259664.8110 1240941.5980 665353.0632 678024.2735 824855.8542 755595.8167 1113601.6850 690230.1771 675999.2807 801538.0361 1201592.5440 662585.9512 611611.5385 687031.2368 783549.2033 672281.3091 488440.3328 982940.3723 768701.2113 1327402.8230 831886.8444 273361.9574 462483.0485 783374.3552 1321453.0730 869447.8008 860048.8959 1043600.6600 653272.0269 758292.2959 504990.6085 1009505.9570 705970.8771 707523.4172 855632.5588 664175.9848 720811.7207 570790.5026 933302.6812 364611.4003 1416132.3090 708854.8925 3 5 9 3 6 19 Trihydroxyurs 12 en 28 oic acid 358217.3924 259410.3650 166595.3000 491020.1802 248458.7003 295349.6105 164780.6393 344838.8372 346261.7089 712087.4004 231757.3202 412071.0108 250743.7171 237269.2340 351352.4465 411180.8208 311790.6296 138334.7990 129656.6162 344550.0655 202451.8451 336188.1362 232022.5814 317412.2008 360072.2873 553619.5280 242068.7246 429185.4144 453595.8078 417144.7451 330403.0528 312714.2354 180188.9727 395433.5674 186747.3743 306366.4945 197112.7455 315850.1950 336756.1604 595448.8190 443119.3389 242669.7391 259734.1771 283867.9912 354778.9987 251750.2654 302254.7024 250155.2830 119736.1456 314418.6120 232090.6811 297350.4682 186725.1281 327514.4001 355675.1936 477694.4570 195895.8368 303378.9062 440495.0553 515313.7734 469420.9079 289904.1531 368856.4201 265954.2105 261776.1319 554532.0971 501833.9105 517438.6255 333894.9987 334699.4324 273921.8850 373719.2536 87800.0952 469827.3972 344914.1728 410003.1223 298890.9796 414810.5884 631610.3898 295474.9110 373330.1379 380124.2288 304738.8324 408987.9709 323558.7861 394305.9357 414418.4032 586849.2890 742413.7998 209545.7906 241495.6791 190462.4549 272837.1133 434658.2337 144947.9855 361032.7463 275442.3820 267144.1829 325819.4665 478271.5536 145636.2092 226784.9680 305543.4212 238994.7633 284622.9237 319958.4352 327250.4426 249786.8442 417946.3093 82833.9673 365133.3445 313313.0439 338019.4865 329769.7408 392311.4367 399449.8446 283032.5697 564100.5789 180679.2257 310361.4480 535380.9423 146126.8619 242315.6603 248122.2445 241482.4895 292703.5245 88283.6069 247256.2332 352038.1464 245470.4806 174555.5454 250598.0489 478280.9856 127212.0307 252670.9969 237605.5209 276068.5855 294943.3388 383674.7476 147144.9978 376411.1641 159579.2871 422882.1690 439468.1431 672129.4322 610185.1594 290681.0570 575650.5458 395015.3684 591033.7847 584399.9376 432879.4840 269620.8679 350014.3392 215267.1136 612710.2871 547803.3184 445949.9622 475094.8281 249503.0586 451003.4374 285577.7806 493595.9006 408172.4853 84283.7139 432391.9672 187570.5568 239876.1536 292449.1431 695864.6061 213949.1120 231179.5419 378517.0530 258453.9991 242915.9846 311928.4150 465998.7170 326996.8876 217500.3386 383438.6175 325560.0252 407599.8390 279097.8261 278555.0431 261896.1569 150262.0461 295435.9838 297969.3134 436363.2062 217726.7589 222594.8348 617223.7408 419415.8054 293184.3761 372735.5666 445230.1964 95030.1752 386534.6141 189771.6774 192255.6170 221883.3937 237445.9997 204076.9490 274002.3425 346997.0548 173946.3427 341697.6689 399250.4876 280471.4761 226805.5102 215951.6853 276898.7606 349457.7122 208915.8393 116351.7147 170836.6380 148799.2322 220476.5992 190424.2644 217239.4519 348293.8185 174318.4613 308267.6695 326335.0446 293418.9386 220779.7063 254248.3459 355393.1734 440433.3298 347229.6719 498820.2528 223039.4230 470371.4841 440194.3745 370522.7417 436398.3365 280733.7328 483101.9233 262249.4859 270227.0719 600593.2474 362301.7828 449946.5372 270016.4227 671633.0518 577808.4918 230109.5480 315841.3129 268014.6858 596813.0201 229871.5384 411301.7668 351059.4613 272136.1568 160794.0460 488486.6785 498873.5608 321999.7868 420087.1364 198428.5649 339341.5869 289769.0391 330800.4112 329139.8408 234188.4051 346819.0156 107192.6052 317656.8091 133349.8013 407728.5256 256107.3555 141552.1684 265632.1364 205485.2769 561694.0937 321060.7518 130197.4405 175779.1517 301372.8698 173027.0284 384662.7667 348594.8645 385921.2054 360940.2389 399470.0558 492849.4760 284487.2590 295984.6817 523758.0899 236671.2023 563070.1960 375406.7580 325790.6973 516105.1052 350015.0513 226310.9878 73113.4814 227728.0697 259198.5924 127273.0512 316312.9704 457516.3586 274352.5635 298253.1414 154443.3709 105548.6043 322329.9188 158855.3393 236018.8692 341937.7437 286100.5634 441858.1411 519871.4254 237042.9105 118149.4549 373238.0805 111145.5383 539086.9446 502579.0853 355674.3379 325580.8519 549126.3729 198542.1654 200018.7657 342017.8662 431581.7092 200550.6252 282268.3879 149725.7719 596853.1103 471850.0014 142168.5127 163468.2088 320292.0888 452262.9490 231138.2905 180035.9553 385253.0527 178143.1087 443979.1413 297774.0234 435814.8280 95328.2162 512334.2761 168000.0036 234535.0830 165647.8702 194433.3370 400332.0602 318467.6442 401267.0577 318701.5734 481446.5764 318365.5322 390757.8826 550063.3087 461098.2866 628192.5298 143028.1034 553123.2659 284398.8395 430014.5764 415585.8626 337224.6070 282243.5119 547967.4101 314303.2791 486467.8815 386560.0245 202219.5667 334953.4729 495648.2879 206084.3996 588078.9082 272456.0530 410581.4683 321032.0851 243557.0700 212184.9858 278407.8144 175365.5176 396919.2113 206010.7594 275197.3007 178385.3021 509524.5384 272181.6474 120807.4749 219819.0813 247291.3453 320930.5234 333328.1417 252526.7627 92869.0479 150788.1924 437201.2069 217940.3940 389701.2309 515992.3856 361258.2241 630150.0700 246039.8588 200102.7142 92562.1211 294870.2394 334166.4605 443829.4697 359247.1793 327333.3831 309059.9080 281550.2058 187905.5437 489195.5242 327527.1654 241502.5405 208752.4206 206124.8501 317797.1059 200553.6199 290258.8215 86162.5001 232080.8792 245042.5148 215545.0233 228424.4521 265484.0294 322874.9732 336716.2722 182409.5800 435027.0364 372249.6771 160872.6850 202132.4782 329927.1255 294289.1554 520497.4232 278144.7646 485830.6247 580954.6800 132309.3295 377688.4768 383311.0492 225900.8562 424919.6540 426859.8863 483471.2441 307924.0490 410280.3872 316322.3002 478460.1318 187018.6036 369651.7475 518323.8757 621561.1487 369548.3385 393267.2840 564596.0158 150332.0987 324855.8509 352251.6260 255164.3942 326062.9700 485934.9637 253100.6425 249067.1424 235920.0273 185232.0168 370176.3131 288249.4652 247190.4759 417202.8756 295886.3832 268301.7542 190309.6688 180432.6503 477808.7140 380143.9493 305297.2875 331300.3826 299372.4725 212112.0156 538287.7663 174187.9527 328159.4428 405619.6230 243533.0301 280866.3227 327778.6936 388900.6904 330335.8209 125388.7010 174777.5397 416160.3687 415350.9917 309581.5183 368110.9522 202299.3228 607285.7376 210873.6845 92323.9790 254711.2155 226806.3112 334316.2766 153454.1473 185689.0075 185757.6501 284300.7663 292711.4721 301521.6564 405266.1637 296098.8583 497650.9672 282333.9310 441851.4613 379968.1557 86976.9490 209060.8460 332672.9540 218479.4609 283978.2884 79743.9294 427300.1694 388721.1439 281420.8527 151860.2411 327807.7555 266206.8411 396252.5277 252795.9248 475623.9623 271636.7801 202293.0404 341491.3125 235025.6637 196993.1785 300237.5171 376226.9038 264785.3535 189155.7343 218731.2963 266300.8717 302009.3221 312987.5441 686600.1200 252574.5983 374432.0597 233620.8619 270948.7112 250444.9558 211147.9055 580607.3931 265880.9641 249055.4202 200445.3949 167099.6001 206565.9259 935959.0072 120399.2485 207302.2408 311810.0409 255815.5847 455048.7241 304476.5874 343742.6842 300112.9806 197363.1933 326724.7837 245670.2209 529460.5409 247205.1491 220476.0778 292124.2963 250573.6484 380040.7998 365061.6140 279324.8330 496077.3136 316757.2697 250567.5196 187452.8058 356890.5672 197868.1749 314673.5055 301352.6461 277349.1995 500128.6484 249269.4783 220464.3899 256081.2112 197688.5709 253731.2089 178019.5008 297913.8264 248163.2300 310753.6916 185454.1228 267863.5819 353387.8936 2217591.9520 208159.6452 566747.2825 322137.0406 295551.2366 300972.0175 226189.5024 470593.7193 258284.2862 286183.9201 354767.8919 356876.5868 236259.6810 379889.3108 261364.1532 336746.4373 197689.8439 239991.3286 261755.4793 357605.8959 179286.7783 302378.5647 299545.9577 536576.2390 354157.3294 535174.5387 250321.5458 233203.5642 341313.1979 438723.3122 441631.8229 394698.2605 782401.1714 319401.8931 389572.0605 649411.9347 318607.9902 519273.1202 122812.4198 297024.5735 229020.2942 240845.8860 198720.2803 302098.7417 433216.4704 158737.5400 261896.9050 436448.1222 202204.7773 517690.7178 309542.2444 278938.2827 365665.3457 205976.3084 288357.7053 200693.0007 396033.1315 148387.1253 391870.9675 314996.1734 335189.3634 356585.1885 308227.0024 258060.3724 426296.9909 352752.8995 399993.7478 298378.5672 202135.9994 376362.7789 431801.7145 199247.1779 94807.8152 266114.7134 278593.7952 293941.9155 103029.4203 392934.8131 275008.7508 546365.5691 322281.2175 277217.1877 248660.9487 247527.7423 458738.1787 228282.2573 639368.4929 375197.2606 65149.7637 292557.5953 310137.4505 400422.2391 141993.8199 114344.4585 278602.0300 235885.8565 226340.1915 151113.7175 391430.0885 266110.5946 508065.7514 245645.8523 3 Hydroxy 2 methylpyridine 203193.4782 166796.7620 176647.0628 219787.7467 209475.6018 122393.6591 136409.3590 120931.7466 206436.2123 220189.6942 137699.0226 155284.4919 188311.6912 168218.1137 197797.2064 160440.0679 205685.2629 139115.4574 148058.5827 169002.1487 157769.3283 157416.1572 171731.3689 196164.8220 248585.7736 202737.7362 221073.7514 183071.2497 213673.6333 186551.0515 223425.2249 218660.2829 169087.8240 150990.7227 412555.3130 145805.8726 169575.4959 134850.3689 145566.4498 175668.4467 170664.7179 179618.3108 178109.9674 165583.6469 165201.0454 159288.8310 230276.4576 213562.2717 176479.7717 133682.6684 179645.8715 149150.2545 233647.8369 213301.3389 144473.4847 152499.1917 185416.2555 172760.1613 172072.0878 217646.2007 191325.6627 164077.5580 190659.3802 161530.5381 137637.7547 181355.7263 120374.4103 165516.4703 149938.4639 151488.5641 197983.5271 179148.7702 156776.2147 145565.3601 164791.7150 147022.1984 172000.9033 162005.4259 136557.7469 176820.0597 174047.2355 234217.2824 311515.0550 139479.6861 169506.6663 153247.8948 168074.9337 142582.2649 188303.3910 153576.7056 280942.6781 1374744.6350 173488.0654 152720.0986 241679.5709 174141.4351 194902.6471 162195.8259 215016.7504 161771.4926 182332.6491 172628.1436 192144.4872 193669.5125 163495.6659 220915.1919 175173.8485 177184.2081 266035.2619 162375.1862 127044.5310 174045.6115 153441.1017 175307.3135 308414.3263 140450.5812 181374.6554 147984.5047 166553.5229 156116.7213 170560.6836 173166.9510 150547.5015 145635.8295 141463.1308 174508.6480 141191.5707 211021.3074 182147.1819 119556.9363 158110.5152 183408.7484 194089.2484 172692.1235 188522.5556 187028.3949 167084.4605 160478.5347 140722.7626 179712.0930 207156.5958 173857.8522 159591.4188 189929.5563 206665.7600 137670.7332 135180.6039 158060.1940 171009.4272 176356.6725 183161.4778 180087.1222 161036.7246 178618.2674 178156.8653 135214.2575 169297.2742 160712.8535 152621.4261 156590.9463 181417.6720 161038.0972 157554.6217 165366.6339 274975.9598 310799.0276 190731.2171 168188.2571 1379213.2810 196214.7166 234507.3184 245126.9204 146343.9696 184396.6078 176469.4582 153039.9396 210511.5463 149072.8194 172918.5936 153788.0707 160555.7739 120944.1965 171429.7171 180407.4081 154800.9104 146653.0367 188544.6557 191021.4269 166423.7443 176956.5138 155749.1625 159355.8407 160844.5800 183994.1197 149709.1965 163098.6439 365169.1314 162852.9668 159199.0602 184608.8954 206602.6093 154498.2616 154677.1143 152176.0637 161590.1141 154835.6045 148158.1278 155051.9718 185921.3404 155740.3070 170186.2212 128793.4726 215983.2384 147558.2343 559753.9879 145790.0318 171179.8811 141590.9519 157111.5209 153921.2179 180390.5107 145608.8457 176284.5262 206387.0586 167568.9210 237901.0589 193805.8893 199060.9204 136349.8825 188786.3794 190132.1368 456316.2244 159954.0385 183235.9802 178531.6359 169628.9796 164409.5703 171351.7440 141552.5478 160059.1443 136469.0865 171615.9712 159515.9992 149809.7548 173419.7592 139813.8306 223971.8895 186530.5265 154007.5956 155795.5871 146671.7741 175874.1231 149392.8461 165767.1264 154139.7134 135288.2028 173618.8096 173650.5168 189826.8169 166697.2148 174018.6719 150072.8182 149934.2402 501905.0048 161601.0863 152106.8570 554433.4532 145441.5910 174528.3344 165653.8011 153341.7214 144786.8623 184046.2605 144868.4832 209093.4035 209618.3038 188226.2334 155504.9288 164932.1593 162992.1186 160405.5826 972417.4638 735400.9642 166764.1529 138894.2632 179806.9560 176933.3718 147894.9078 170870.2630 152857.2885 133183.6268 172660.5483 155083.9144 157085.6383 169566.7392 147661.7904 200298.0350 172647.6306 161471.3191 149612.4572 145200.8389 158122.0221 158591.1833 209567.2229 409093.5878 163307.4344 180876.7666 170106.3514 162168.3038 175380.3153 146734.6044 149781.5695 169489.8194 166826.9808 151095.1234 164128.3116 203295.9883 183221.9852 179664.0043 674709.3959 163467.5216 161333.6220 154000.9663 171274.8480 159934.9193 189976.8262 160486.7835 130384.0118 153075.0673 192866.1665 186374.5544 681598.8206 171220.7903 148225.2152 174852.9564 154747.2184 172539.6248 156586.4262 159863.2220 151799.8555 179914.7298 177426.8471 163084.3097 176829.6043 155317.2553 137281.3610 160176.6808 181959.9206 149405.3996 156165.9132 165249.0383 453938.8454 159999.2910 158781.0511 179127.4060 146784.0959 290437.6487 142072.0668 337935.3276 166657.4308 146154.0882 128271.8543 142621.6704 149035.4474 169222.6328 163042.6969 155913.6174 151955.5521 214199.3244 952995.0855 169960.4728 164265.7568 219595.2786 214282.7822 140859.6742 172309.1027 156858.5517 159471.8428 138564.5631 164644.2429 221810.9484 150779.3206 142763.5804 156491.8448 154059.3060 145696.6546 141495.0003 159613.9165 132096.2986 160839.7462 153876.6035 186676.1102 173277.3866 124042.5517 120877.8479 157867.4678 171644.3033 156663.1025 158025.3958 184160.0485 157223.6410 157036.0325 183854.4683 162642.5894 165087.4576 152828.8951 148925.9412 232237.5622 158498.8026 132582.8463 156649.0468 722481.5510 130981.1018 159843.4111 171109.2564 165402.6774 140688.9939 134005.6055 163300.4204 155738.1893 154450.1536 149408.0498 151623.0014 117183.7774 188373.2970 162005.1294 132906.3613 177744.4269 923586.8367 165680.1727 155934.1002 140042.8607 150859.7522 139842.3715 166490.3485 177152.3191 191551.4548 183689.0102 195190.7398 127984.2270 160526.7580 171354.7640 150717.3497 194415.5982 196479.2922 163595.0137 132833.1672 142934.4839 142990.4770 186632.3025 284331.8277 260659.2856 189015.1774 199752.1592 187989.7891 163539.6065 162446.4784 139916.1520 310784.1229 122609.2667 145474.9700 152544.2248 192242.0843 200370.2985 114168.3446 190702.3906 142844.8851 134093.4313 125478.7109 117861.9991 165807.0736 193362.9120 119386.0967 144082.9426 152966.8500 282002.2123 221807.0531 427597.2122 126560.9537 207183.0786 146381.1614 189225.2938 239585.9779 338621.7204 127107.0800 189427.6879 139840.4667 144977.7803 171391.9921 196655.3407 123318.7590 180827.7087 171175.4576 174654.5772 142190.8605 128923.5821 190637.2617 193181.4564 153971.7247 127769.4911 180602.9645 120859.6652 172860.1563 174758.0007 206750.0935 207437.1326 111972.7930 140568.3230 124778.1212 173384.1388 178635.8537 176407.1257 892599.6927 436472.6764 119706.4884 406232.8270 189466.0513 155187.3491 108590.9821 257716.5902 232792.6829 169271.2617 149923.6445 147841.6932 214920.0460 95495.3544 378506.0194 185410.3122 172780.1178 137932.5093 169259.4372 148443.4996 169998.7267 173928.5521 148012.3579 202545.8367 197556.3292 190717.1844 344420.0685 156343.2656 186676.9513 183195.5531 184864.4662 167159.7459 131345.5878 135881.3671 173231.0361 176639.7696 96380.1693 104480.8706 152696.1770 134082.8703 149778.7119 139699.0595 148932.7571 115144.1069 193474.7584 129053.1213 136726.3630 146489.0733 193417.3698 184975.4139 213038.1568 214714.2285 843749.4384 176345.1331 143291.8754 161381.9129 185980.4279 117894.1497 191350.1976 92186.4383 197371.4701 176985.1009 151072.3078 202424.1260 469360.5495 179214.4955 231990.4531 169017.0634 179274.1666 156465.8519 235805.4988 186232.5689 166272.1232 149065.9727 144530.1957 105792.2350 152530.4666 181454.3482 151191.3157 160915.5956 166180.7503 150190.3796 192031.8176 170578.6925 336225.2305 277964.8242 245394.3654 175217.9156 232721.5406 207417.7725 160124.2350 245956.2621 170327.1376 126572.5386 193444.5535 187584.2604 145147.1150 412988.7646 166328.1301 209236.1200 167775.5949 214973.1193 143860.2404 190829.6315 152756.6291 253357.3420 156400.6792 165715.5411 158402.1654 204758.9001 156153.0360 173020.5919 132266.3789 134576.7482 133644.2509 662472.6524 139918.5455 147939.7474 191416.0332 159029.6594 187866.1961 222615.4935 178896.0358 194337.9735 101842.0943 146444.0634 126596.2182 161248.7821 166408.1301 144775.5075 255243.7130 220118.7592 207961.2734 169513.8154 276288.3321 300488.1394 154873.9971 198143.3000 215943.6700 128548.7268 91649.3930 137936.0225 310012.0042 153442.0469 175720.2267 759353.0041 260695.8590 299201.5233 152890.0133 148687.8410 205750.4238 117738.0409 287740.4654 155194.6227 98598.7373 164286.4200 165158.1970 133609.7024 126198.4364 150041.6113 180642.3336 134686.5990 164706.9595 222900.0698 165750.9466 288708.6017 164739.3045 152368.8233 118870.4317 171607.9381 211873.9466 136247.1553 170246.4153 251143.8203 179872.5062 224698.1151 137008.7942 220517.5727 120656.7223 185768.3481 168212.2273 131920.5243 154272.8521 206780.7169 151408.2218 87678.2282 204085.5575 196289.2277 3 Hydroxypyridine 210836.3273 316965.5196 116126.1500 338149.0658 334281.3164 307120.5080 286427.7339 332483.7133 335754.8588 355444.7765 313479.4947 336847.3817 339880.6297 293323.0908 316875.4791 323529.8940 89905.7782 336069.9287 265601.2853 183288.3706 338967.5221 351715.9519 285661.2270 275104.4694 380615.9962 129893.9218 323281.0067 323809.6921 315492.1705 335984.6599 236247.4267 333566.9991 305701.5540 243544.6295 341434.8999 325904.8836 282780.1715 126612.8443 336614.2578 300936.3059 326841.7299 340629.4475 277973.4737 257123.5702 342410.9509 262253.7476 133720.9906 323755.0871 229669.9061 153407.3167 285056.6893 315481.0323 329928.8523 219991.9035 325444.1052 288076.8562 214379.6823 307661.6138 350281.0082 334360.9113 397708.7758 260039.1823 260676.8980 276347.2747 263545.8262 233412.0044 199017.6973 305087.6694 240678.1650 304807.1776 256101.8539 252963.7539 283184.3095 341520.5791 274705.7443 420858.9583 314990.8574 395772.9147 256831.0170 303821.8145 281101.6141 308174.9171 441781.9221 331636.3874 251056.9693 260734.8249 246401.3617 230529.9347 288124.5642 212647.6925 333583.7936 192565.5938 255987.9449 258918.1236 287342.9992 288223.9650 298711.2702 243464.1258 287973.9953 330934.4304 396235.8396 290184.7353 340105.4858 311212.9652 384341.8250 328666.8453 273303.8418 287163.6230 422523.4602 266794.3197 392207.6579 242211.3715 389049.6959 312702.5264 268978.6773 277697.7784 231672.1548 257075.6257 301027.0180 209895.9481 316518.1381 298929.7785 84362.1624 271782.9856 293278.2621 233010.2221 343703.9219 358323.5332 267662.5919 222089.8842 146226.6711 213422.1837 301665.8792 309676.8146 94997.3700 321396.2020 276843.0586 274317.9045 320202.9227 257514.1364 312715.1910 344558.4060 321075.8413 313627.3903 321517.7142 283725.6482 267851.5890 334600.4307 299772.9953 117880.8846 314172.4240 289723.2447 307333.2188 324217.9170 309983.5481 308828.2734 319939.3092 341343.4142 308065.2440 163142.6832 304241.3355 328081.6749 332546.9261 326216.1721 223996.1599 188260.9512 344954.4515 224285.3279 156216.1729 305763.1251 291480.2073 255049.0814 313941.9818 314065.7393 209596.2995 296120.3197 316072.8061 270029.5053 302467.7714 325308.3704 293986.8264 311824.7591 306199.2183 311434.9854 54738.8397 282038.3842 296829.1986 293787.1375 172540.2421 311434.3754 336884.1440 333610.5154 321310.7819 143554.1412 334219.2987 306452.0587 146368.1024 209283.1287 354723.0308 304837.6535 222188.0959 304874.3097 294055.4290 321960.1522 311194.6380 322405.5891 241714.5966 304296.9384 300769.2917 70559.2636 301699.3218 295126.5825 337262.6331 227432.6023 178776.3680 328993.1786 299270.7818 228774.9530 319658.0231 308007.2482 330914.6435 275500.5086 314684.4744 308272.1909 289825.0295 286045.0004 328645.0056 348645.5996 310573.2883 300390.8264 332639.9690 292581.4689 304900.7224 272814.3145 320267.5575 340044.9302 268609.5878 322931.4956 239708.2026 309093.9883 283438.1339 320503.5930 336327.2709 283793.9458 335959.3485 285030.4293 269333.5049 317389.4751 339462.4254 304646.3738 338695.9546 323220.9992 293513.2622 308530.5260 326919.2559 321082.5560 226574.1547 316065.6771 318981.8013 291453.3172 344108.1202 264373.1912 296909.5560 321096.5531 281645.1698 199709.5936 137927.1221 267926.3309 281035.2597 282265.2597 258957.4879 236959.0013 314396.5427 300554.8561 326867.0750 320945.7670 178888.5032 165725.1949 348019.6364 194352.2100 329336.2204 365031.8704 332076.6964 123773.9244 297273.1744 309012.5845 346036.1203 301437.3272 319254.0894 281637.5458 274344.3460 324991.1680 312113.0877 297008.7241 301916.7216 277572.3851 291190.1945 299283.3332 315766.7016 71847.4606 295503.4405 283686.5664 85624.2891 280508.5883 227675.1656 260155.9356 257535.6784 172539.0081 311167.9553 326993.0729 300003.6438 313973.5493 317198.6308 304027.6803 65273.0404 317909.8503 220366.6064 340927.2536 355876.7377 278178.9260 259735.4255 345852.7903 286615.4750 337293.7059 160535.5786 332906.8625 155423.8806 257126.8273 280667.1228 363267.5496 372852.2219 226020.2311 263641.1003 348723.0556 236962.4139 317044.3514 269578.3668 295884.8469 282884.0116 276093.0664 101933.1719 339764.9858 303511.8773 222007.7980 318625.4975 206421.6575 271128.3208 350650.5228 258242.9938 150917.4179 312420.8481 342329.7505 314432.9655 301318.2103 307330.3228 274218.9112 238441.6628 289214.9004 335553.5679 291966.1210 312903.5438 297588.0597 250498.3675 258630.3142 279211.3405 280605.2311 250559.9156 295784.5863 419548.1210 286521.0938 288140.7190 341638.8529 333271.8772 458492.2959 299945.9544 390079.6015 115863.1442 268170.7956 229475.9305 112314.6114 302000.9433 280585.1260 226354.4454 329010.8315 300512.0710 280339.8236 103750.7487 280464.4903 278476.6851 293983.1351 287942.6076 385042.6939 165551.4186 215123.0691 268734.1485 298992.0632 314878.1400 173525.6156 300980.7112 359271.0347 298147.0184 290650.0314 372335.2876 103630.6695 319968.0221 63207.7105 322181.9577 264572.9028 261711.4980 273031.4125 289448.8454 279386.3992 255845.0955 242758.5295 164437.3538 288326.8016 306020.3213 270696.1337 290851.8075 166805.3501 230223.8730 284316.2564 273197.0713 236380.6189 339698.7350 309593.7624 193800.8315 317525.2024 320070.1430 332536.7006 294375.8755 116122.0828 271800.5301 264794.3441 307539.9886 306051.9948 301629.8407 313006.6960 397346.8094 224395.1220 310238.8168 357367.0911 241829.3420 396171.3873 386571.2401 331751.3452 254520.7269 181964.1872 216474.8921 340988.3938 256254.7763 405681.2158 363541.9426 391291.2965 409876.2886 302524.2557 281065.7333 252435.5780 274746.2489 279464.3688 185970.4764 187538.4487 379224.3513 308947.1451 226938.4575 358180.7207 226678.7343 264463.5811 190292.1014 94450.5671 321677.9489 226041.3835 227932.6043 231112.4446 90015.1245 309038.5489 246593.8253 235157.4506 176331.0450 303859.0353 240310.1514 380747.6720 233010.1588 370004.9418 267807.8277 278307.5663 283999.3683 264011.9386 316471.8449 378758.6570 226317.5164 252846.6119 354821.2700 154207.8613 172656.1961 268096.5103 407915.5139 429367.0005 245934.8863 181848.0792 362720.6551 227099.6668 330629.5558 292738.1346 377517.8420 237727.6529 226536.9330 253589.4835 210638.4883 329603.7898 361405.4421 354956.3610 465538.9469 332982.6685 207999.1174 173447.6204 170777.4885 256923.0224 211803.2235 366707.1934 246740.2592 377088.2037 357941.0996 251381.0278 267400.8495 163128.0909 307429.5333 206725.6837 194203.4851 214636.4192 367764.9851 199060.2511 259578.3102 363053.9647 174807.2368 288287.4617 350510.1325 253958.9302 350716.8405 202035.6340 361427.0405 284311.8835 360974.3601 261657.4625 188207.3672 362300.8074 263751.7752 373166.8492 198717.5493 166034.9102 201364.5965 168240.4774 263339.8978 244438.8221 214458.9272 173928.8901 244205.6564 188292.9376 194579.5609 225299.6188 348069.9717 214388.4607 248306.4594 398430.2919 226096.9337 184526.9144 208003.6211 365134.0553 359097.1638 184546.3220 179394.4293 155685.4513 261171.0897 207228.3726 192028.4024 395978.7623 341566.8264 232307.5894 400587.5312 389402.7565 224485.3150 185511.3146 412628.0770 438768.3086 359330.9798 217143.6223 268817.4176 257209.1137 213946.6302 386590.9235 243134.2131 356631.4249 371194.2278 365045.8422 378272.1886 364327.6971 179507.6977 394789.6091 283505.9630 229285.7290 454179.6052 305069.6535 401994.7123 396126.5951 247941.7205 359328.0810 213485.8630 389818.2574 232861.2592 487871.0128 297723.0620 345499.7657 252819.1214 234687.3287 252335.6592 337363.4381 232014.3457 493238.1914 298190.0747 263237.7072 277803.4725 345364.6204 244383.8691 456593.7664 236499.7319 265842.6359 236460.0610 486346.2392 200473.7217 261758.7649 317478.2774 275653.4522 350803.7528 420520.6487 296250.6240 394269.6823 202273.6360 229481.6292 219612.1112 257552.0028 244978.8412 218055.7913 390516.7746 230374.8475 184185.2493 270086.6190 304597.5765 225940.2559 262917.6036 314052.4194 265331.4537 199469.7364 204327.1899 209131.4166 418058.0251 210670.5042 277082.6788 243542.7254 441277.4897 441955.2750 261440.6366 237900.9535 286441.0371 230056.5176 381401.6137 235258.5600 222931.8137 257589.1101 401005.6599 206362.7500 177731.8069 212168.1643 280435.9346 237953.8115 232979.3140 329935.1675 237625.6299 420020.8185 300835.9992 75370.3793 210047.4277 281512.3406 479585.6866 292031.7081 292003.7311 372961.0772 179735.8197 288982.5888 183216.9528 305190.8036 247767.1144 222545.7288 280087.8402 228718.5454 244427.7841 234645.4175 315955.7177 77105.9024 459326.5368 224295.8208 4 Acetamidobutanoic acid 277574.9260 484344.1882 6994996.5350 294288.6786 1167599.4630 792114.0066 4375694.7500 724516.0133 453063.0660 1593555.6990 281417.6252 844567.4815 2283810.9240 668433.9616 1270405.6500 465762.4643 1230456.7250 763667.0440 5580812.1440 892512.6080 13279962.4100 873636.8660 6045391.3910 297224.5939 964292.7708 1110231.1840 2136909.4710 471474.0049 1277219.6030 960221.9650 1071626.1020 373196.5243 3549824.0550 293448.6639 2414517.8290 849704.4549 5074728.6190 526148.6271 506380.6824 1315996.4330 264545.3429 523108.7411 1841180.6150 677747.1936 1332932.3590 581976.4733 2891762.2720 4168957.3630 6515315.7850 1102463.6050 4974338.4730 1166012.8660 6872676.9700 627704.2290 1009261.7480 1949012.5420 23555952.2500 898476.6113 451461.1976 1050661.0290 771832.4921 575933.7998 843818.1342 1872537.1710 3292982.2560 2262232.2840 789724.8255 627212.1507 616787.6047 396317.3723 1263473.8840 2790158.3910 843958.2650 607840.7441 546881.0366 379350.6052 551924.6612 328740.8195 946916.8970 346308.3990 821216.2650 600250.2910 525330.2591 611532.5182 3450620.0430 1050467.1220 682312.2946 680120.9642 9695452.9490 1752985.1470 927517.0633 6228133.3690 4676017.2470 964549.0919 1138497.2650 374760.0367 859339.9242 1258389.8350 959076.2682 1031121.8060 574948.1580 1965827.4120 618030.2529 2920047.8160 1475415.9570 1605298.4150 1558326.1250 2147493.7940 1063199.6690 1513371.8190 884743.9832 884724.1185 215564.6012 445350.8610 701865.1656 532349.5535 5709887.4580 1636740.2340 3181386.6390 815493.8197 1087384.5520 283703.2368 2901222.4780 634670.0772 1017742.3710 592234.8149 2002085.3640 746440.8988 337190.0652 10010148.8700 7972422.3340 1839375.7320 1424130.5170 409808.1767 1892240.8480 912098.4806 1297160.1090 861164.3358 519672.7228 883358.3262 620078.2024 1177888.2290 601359.0500 815948.0073 552644.1648 546599.2868 870450.1964 401507.0711 760237.9558 553644.5032 573411.4211 664497.2540 863379.5968 662712.5578 1673504.1440 385333.9515 484772.6103 366331.8473 402794.3753 7791977.0830 873143.6964 347139.6985 347704.0798 613802.2407 13910205.8300 9042435.5540 3947747.9090 7455480.5060 10715741.2800 624751.8701 1355357.4460 2534414.4690 617483.1076 474570.9505 6817699.7110 1352972.4750 820230.9674 725726.3702 1662608.8760 386320.2148 644717.2921 359664.1087 600445.7566 1816243.4270 564041.6004 1508841.7740 452130.5763 1369398.4620 1751792.6910 504997.9415 849113.8543 449700.7948 567225.9822 8387964.1410 483006.5527 655471.6877 6875154.5630 2422644.7040 1880494.5840 2160256.4750 4601140.7060 1151796.2230 6602322.9020 1143458.0840 355136.0833 1312641.6460 2515802.6220 671016.6214 1675871.7790 650446.2660 1111473.2600 311941.4275 487573.0545 7804920.9040 12276035.4000 2002830.8610 4224358.1290 784851.0280 697582.8500 6517860.7160 944841.8313 4815650.6970 1149201.2590 1465054.2250 3071266.8330 1915583.0780 574233.9985 726753.0460 464162.8084 538905.1570 1326566.9590 856308.3618 488891.8270 906651.4286 684018.4690 463660.8023 867745.1258 850781.6305 973780.5343 442860.9592 657608.9635 629055.4225 478693.0225 1281560.1300 419457.8648 547697.4069 965733.4646 931298.8226 788987.5646 538644.1811 870249.8359 818195.3166 556288.1711 454843.7619 5733114.2070 298608.6844 7646676.0350 925684.1716 3240177.8100 4267810.7750 870685.8923 421668.5629 903592.7421 2021197.7180 3980435.6110 319559.4027 14166261.2500 2393983.9150 2030065.4550 969445.6152 410635.5985 21359117.8200 1460623.2390 2351671.7400 1882350.2340 2291869.4330 12561468.4600 2493719.9490 413985.6824 8057112.3530 639730.4292 854597.9263 766372.5169 615269.3526 1908957.7410 2392630.6770 550362.5375 486372.0584 378418.7978 1027238.7480 630280.6791 665997.5976 679079.2857 566507.3396 1412744.5280 866397.8758 2984554.6010 9056096.4180 2171001.7100 2700582.6220 587690.2286 899682.0647 1561059.1260 1038209.9520 10397149.6700 1490655.4990 1175095.3280 15441867.1000 1011009.3190 552418.1503 621387.3718 425974.9527 697478.6382 767395.9284 4771319.7260 555902.6125 6182327.5610 620125.5372 381329.0248 642250.0360 1051700.7150 499808.0943 714181.5023 1294015.0970 1083737.1940 888187.5280 27094850.2700 557484.6265 889831.6086 478696.1717 946873.1922 6199949.4790 371907.4558 724524.7490 3008639.9020 2354547.2600 865090.8151 574142.9554 794277.8699 1117288.1060 3975700.7930 738308.6948 2864571.8690 3340702.7570 1856629.8350 782182.2082 10671848.1800 506443.5512 1030298.8570 3246642.3470 854592.7373 1649222.1700 481381.9609 504171.0860 578987.4878 673731.9063 473353.3919 922675.1011 4646723.4070 416227.0869 923915.5170 1000140.0880 561400.9341 656179.9637 1019310.8710 501206.9289 949097.3159 731690.5721 951405.0969 33057760.3300 513354.2738 836443.1048 44040704.3100 729202.7115 732532.7567 588663.6177 1713259.5420 3142017.9780 3222143.3780 537605.8446 711135.3507 672758.2579 5955283.0890 691296.4319 1083705.3640 339849.9985 881087.7088 2456610.2870 378679.3138 2239956.1590 828889.9019 1297101.9440 1452712.5170 4648756.2940 1949372.2650 2016414.0800 1724513.4320 767911.7247 610337.8720 1671140.1900 709869.5958 672541.4850 4832171.5800 2473571.7360 392979.9561 542559.4248 776144.2260 373677.4008 838319.5919 841184.4956 760260.4417 12750889.0900 877442.4218 1892535.1060 6986536.5960 916899.3171 3756947.2220 700092.2912 772836.4442 979919.1189 551432.3563 623921.3093 2297044.6470 3328988.1180 1198126.7530 515500.5007 605704.4510 1110593.4730 19991428.8300 1285057.5310 788848.2622 3758526.8020 1275863.1450 730068.4007 498210.2323 417317.1786 1135169.0190 614322.6621 646861.8068 605262.2772 561167.8180 1144137.5900 716345.9294 639009.7150 1042754.4440 966158.8941 571454.6554 444610.5437 954966.5588 2166330.4580 9825911.9250 2818656.3510 880541.2807 487884.0201 1506033.4730 331500.5014 518247.8413 668244.2717 562621.7345 434317.3552 13905007.9500 310622.6637 469861.0666 5865074.9560 650978.5176 2725095.7120 522056.9339 424091.3789 1120044.1150 350785.0455 1101455.3760 2945956.0560 626538.3896 8169154.6810 1560961.9790 786951.1446 666449.1770 714059.9587 751521.2839 7689127.0090 2553065.3830 356395.7933 11095611.6600 3162914.8500 758188.8459 1006527.5960 1177616.0750 357536.3314 2164940.6810 1837467.4370 2408175.4420 9127044.6590 432748